*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 4 1a6d_c00 THERMOSOME user 1 4 # 1 A 63 ASP A 108 ASP^? 1000.00 A 96 THR A 133 THR.? 1000.00 A 97 THR A 58 THR^? 1000.00 A 390 ASP A 136 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 15.32 -5.53 -2.56 15.86 -7.55 -2.13 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 16.91 -5.28 -6.65 18.31 -6.88 -6.40 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 4 1a6d_c00 THERMOSOME user 2 4 # 2 A 63 ASP B 108 ASP^? 1000.00 A 96 THR B 133 THR.? 1000.00 A 97 THR B 58 THR^? 1000.00 A 390 ASP B 136 ASP^? 1000.00 coo 16.18 44.42 -24.56 14.59 45.14 -25.79 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 9.05 49.19 -22.25 9.14 47.35 -23.29 29.71 -13.76 -13.24 27.67 -14.35 -13.63 coo 10.51 49.37 -18.77 12.36 48.66 -18.03 29.09 -12.30 -9.13 27.00 -11.87 -9.30 coo 17.04 49.84 -29.27 15.57 48.57 -28.45 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1a6d_c00 source 1a6d THERMOSOME : 2 hits 1a6d_c00 naa= 4 ULMN 4 1a6d_c01 THERMOSOME user 1 4 # 1 B 62 ASP A 108 ASP^? 1000.00 B 95 THR A 58 THR^? 1000.00 B 96 THR A 133 THR.? 1000.00 B 391 ASP A 136 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 16.91 -5.28 -6.65 18.31 -6.88 -6.40 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 15.32 -5.53 -2.56 15.86 -7.55 -2.13 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 4 1a6d_c01 THERMOSOME user 2 4 # 2 B 62 ASP B 108 ASP^? 1000.00 B 95 THR B 58 THR^? 1000.00 B 96 THR B 133 THR.? 1000.00 B 391 ASP B 136 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 29.09 -12.30 -9.13 27.00 -11.87 -9.30 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 29.71 -13.76 -13.24 27.67 -14.35 -13.63 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 36.67 -20.70 -10.25 38.13 -21.34 -8.89 ULMN 4 1a6d_c01 THERMOSOME user 3 4 # 3 B 62 ASP B 108 ASP^? 1000.00 B 95 THR B 133 THR.? 1000.00 B 96 THR B 58 THR^? 1000.00 B 391 ASP B 136 ASP^? 1000.00 coo 43.28 19.55 -23.92 42.88 20.98 -25.36 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 41.59 28.72 -22.17 40.06 27.69 -23.27 29.71 -13.76 -13.24 27.67 -14.35 -13.63 coo 42.85 27.27 -18.86 43.84 25.46 -18.26 29.09 -12.30 -9.13 27.00 -11.87 -9.30 coo 48.74 21.71 -27.93 47.43 22.77 -26.72 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1a6d_c01 source 1a6d THERMOSOME : 3 hits 1a6d_c01 naa= 4 ULMN 4 1am5_c05 PEPSIN user 1 4 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 75 TYR A 77 TYR~? 1000.00 215 ASP A 112 ASP~? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -12.30 10.35 145.24 -10.75 8.55 145.88 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -13.30 2.78 144.49 -12.77 1.96 147.02 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -8.20 12.64 138.30 -8.86 10.97 139.38 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 1am5_c05 PEPSIN user 2 4 # 2 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 75 TYR B 77 TYR~? 1000.00 215 ASP B 112 ASP~? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -12.30 10.35 145.24 -10.75 8.55 145.88 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -13.30 2.78 144.49 -12.77 1.96 147.02 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -8.20 12.64 138.30 -8.86 10.97 139.38 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1am5_c05 source 1am5 PEPSIN : 2 hits 1am5_c05 naa= 4 ULMN 4 1apt_c06 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 4 # 1 E 33 ASP A 83 ASP.? 1000.00 E 36 SER A 82 SER.? 1000.00 E 75 TYR A 77 TYR~? 1000.00 E 213 ASP A 112 ASP~? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 28.33 15.15 21.27 28.70 13.12 19.97 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 26.74 7.85 22.76 28.93 8.53 21.17 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 20.15 16.04 19.79 21.65 14.49 19.86 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 1apt_c06 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 4 # 2 E 33 ASP B 83 ASP.? 1000.00 E 36 SER B 82 SER.? 1000.00 E 75 TYR B 77 TYR~? 1000.00 E 213 ASP B 112 ASP~? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 28.33 15.15 21.27 28.70 13.12 19.97 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 26.74 7.85 22.76 28.93 8.53 21.17 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 20.15 16.04 19.79 21.65 14.49 19.86 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1apt_c06 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 2 hits 1apt_c06 naa= 4 ULMN 4 1bbs_c02 RENIN user 1 4 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 215 ASP A 112 ASP~? 1000.00 218 ALA A 114 ALA~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 66.00 46.17 80.29 64.31 47.92 79.91 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 63.61 40.10 74.06 64.05 42.07 74.70 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 61.04 42.48 71.22 62.11 41.40 71.19 23.32 -6.64 10.22 23.94 -8.01 10.01 ULMN 4 1bbs_c02 RENIN user 2 4 # 2 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 215 ASP B 112 ASP~? 1000.00 218 ALA B 114 ALA~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 63.61 40.10 74.06 64.05 42.07 74.70 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 61.04 42.48 71.22 62.11 41.40 71.19 24.83 -7.46 -26.03 23.33 -7.58 -25.84 1bbs_c02 source 1bbs RENIN : 2 hits 1bbs_c02 naa= 4 ULMN 4 1bbs_c03 RENIN user 1 4 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 215 ASP A 112 ASP~? 1000.00 218 ALA A 114 ALA~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 66.00 46.17 80.29 64.31 47.92 79.91 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 63.61 40.10 74.06 64.05 42.07 74.70 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 61.04 42.48 71.22 62.11 41.40 71.19 23.32 -6.64 10.22 23.94 -8.01 10.01 ULMN 4 1bbs_c03 RENIN user 2 4 # 2 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 215 ASP B 112 ASP~? 1000.00 218 ALA B 114 ALA~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 63.61 40.10 74.06 64.05 42.07 74.70 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 61.04 42.48 71.22 62.11 41.40 71.19 24.83 -7.46 -26.03 23.33 -7.58 -25.84 1bbs_c03 source 1bbs RENIN : 2 hits 1bbs_c03 naa= 4 ULMN 4 1bbs_c08 RENIN user 1 4 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 75 TYR A 77 TYR~? 1000.00 215 ASP A 112 ASP~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 66.00 46.17 80.29 64.31 47.92 79.91 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 65.68 50.76 74.77 64.63 51.40 77.28 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 63.61 40.10 74.06 64.05 42.07 74.70 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 1bbs_c08 RENIN user 2 4 # 2 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 75 TYR B 77 TYR~? 1000.00 215 ASP B 112 ASP~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 65.68 50.76 74.77 64.63 51.40 77.28 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 63.61 40.10 74.06 64.05 42.07 74.70 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1bbs_c08 source 1bbs RENIN : 2 hits 1bbs_c08 naa= 4 ULMN 4 1bbs_c09 RENIN user 1 4 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 75 TYR A 77 TYR~? 1000.00 215 ASP A 112 ASP~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 66.00 46.17 80.29 64.31 47.92 79.91 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 65.68 50.76 74.77 64.63 51.40 77.28 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 63.61 40.10 74.06 64.05 42.07 74.70 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 1bbs_c09 RENIN user 2 4 # 2 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 75 TYR B 77 TYR~? 1000.00 215 ASP B 112 ASP~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 65.68 50.76 74.77 64.63 51.40 77.28 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 63.61 40.10 74.06 64.05 42.07 74.70 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1bbs_c09 source 1bbs RENIN : 2 hits 1bbs_c09 naa= 4 ULMN 4 1cms_c05 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 4 # 1 34 ASP A 83 ASP.? 1000.00 37 SER A 82 SER.? 1000.00 77 TYR A 85 TYR.? 1000.00 216 ASP A 112 ASP~? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 12.23 24.31 30.40 14.55 23.96 31.03 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 20.01 18.56 29.07 21.82 19.91 27.39 9.01 -5.92 4.10 9.03 -8.46 2.93 coo 13.93 25.52 22.10 14.75 24.44 23.75 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 1cms_c05 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 4 # 2 34 ASP B 83 ASP.? 1000.00 37 SER B 82 SER.? 1000.00 77 TYR B 85 TYR.? 1000.00 216 ASP B 112 ASP~? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 12.23 24.31 30.40 14.55 23.96 31.03 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 20.01 18.56 29.07 21.82 19.91 27.39 32.56 -19.53 -19.90 30.36 -20.72 -18.65 coo 13.93 25.52 22.10 14.75 24.44 23.75 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1cms_c05 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 2 hits 1cms_c05 naa= 4 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 1 4 # 1 A 1 THR A 101 THR.? 1000.00 A 33 LYS A 12 LYS^? 1000.00 A 45 GLY A 11 GLY^? 1000.00 A 124 SER A 97 SER.? 1000.00 coo 20.60 80.81 78.25 19.93 81.48 80.23 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 24.21 79.63 86.31 23.19 81.94 80.55 17.98 11.97 -5.29 22.40 15.81 -5.00 coo 20.39 75.93 87.86 19.67 76.00 88.35 16.36 9.18 -7.27 17.00 8.88 -6.94 coo 15.73 80.26 75.45 17.95 80.97 75.03 12.38 15.07 -17.61 11.81 17.40 -17.17 ULMN 4 1doo_c04 HEAT SHOCK LOCUS U user 2 4 # 2 A 1 THR B 101 THR.? 1000.00 A 33 LYS B 12 LYS^? 1000.00 A 45 GLY B 11 GLY^? 1000.00 A 124 SER B 97 SER.? 1000.00 coo 20.60 80.81 78.25 19.93 81.48 80.23 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo 24.21 79.63 86.31 23.19 81.94 80.55 43.44 -2.72 -10.47 44.74 2.97 -10.70 coo 20.39 75.93 87.86 19.67 76.00 88.35 41.92 -5.53 -8.41 41.31 -5.13 -8.74 coo 15.73 80.26 75.45 17.95 80.97 75.03 48.92 -6.09 1.92 51.23 -5.46 1.48 1doo_c04 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c04 naa= 4 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 1 4 # 1 B 1 THR A 101 THR.? 1000.00 B 33 LYS A 12 LYS^? 1000.00 B 45 GLY A 11 GLY^? 1000.00 B 124 SER A 97 SER.? 1000.00 coo 26.69 108.13 78.57 25.70 107.69 80.43 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 30.17 110.91 86.31 27.32 111.03 80.63 17.98 11.97 -5.29 22.40 15.81 -5.00 coo 31.73 106.00 88.02 31.34 105.46 88.62 16.36 9.18 -7.27 17.00 8.88 -6.94 coo 24.65 103.43 76.04 24.59 105.78 75.60 12.38 15.07 -17.61 11.81 17.40 -17.17 ULMN 4 1doo_c05 HEAT SHOCK LOCUS U user 2 4 # 2 B 1 THR B 101 THR.? 1000.00 B 33 LYS B 12 LYS^? 1000.00 B 45 GLY B 11 GLY^? 1000.00 B 124 SER B 97 SER.? 1000.00 coo 26.69 108.13 78.57 25.70 107.69 80.43 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo 30.17 110.91 86.31 27.32 111.03 80.63 43.44 -2.72 -10.47 44.74 2.97 -10.70 coo 31.73 106.00 88.02 31.34 105.46 88.62 41.92 -5.53 -8.41 41.31 -5.13 -8.74 coo 24.65 103.43 76.04 24.59 105.78 75.60 48.92 -6.09 1.92 51.23 -5.46 1.48 1doo_c05 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c05 naa= 4 ULMN 4 1doo_c06 HEAT SHOCK LOCUS U user 1 4 # 1 C 1 THR A 101 THR.? 1000.00 C 33 LYS A 12 LYS^? 1000.00 C 45 GLY A 11 GLY^? 1000.00 C 124 SER A 97 SER.? 1000.00 coo -5.30 26.59 199.66 -4.98 26.05 197.57 9.95 15.91 -11.11 11.74 16.64 -10.15 coo -4.62 30.60 191.94 -3.32 28.83 197.07 17.98 11.97 -5.29 22.40 15.81 -5.00 coo -9.57 29.11 189.94 -9.84 28.44 189.46 16.36 9.18 -7.27 17.00 8.88 -6.94 coo -8.31 23.03 202.48 -6.18 24.15 202.80 12.38 15.07 -17.61 11.81 17.40 -17.17 1doo_c06 source 1doo HEAT SHOCK LOCUS U : 1 hits 1doo_c06 naa= 4 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 1 4 # 1 D 1 THR A 101 THR.? 1000.00 D 33 LYS A 12 LYS^? 1000.00 D 45 GLY A 11 GLY^? 1000.00 D 124 SER A 97 SER.? 1000.00 coo 21.09 18.28 199.42 20.72 17.74 197.38 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 25.54 20.08 191.91 24.21 17.77 197.54 17.98 11.97 -5.29 22.40 15.81 -5.00 coo 21.95 23.77 189.96 21.30 23.70 189.39 16.36 9.18 -7.27 17.00 8.88 -6.94 coo 16.26 18.98 201.87 18.32 18.00 202.67 12.38 15.07 -17.61 11.81 17.40 -17.17 ULMN 4 1doo_c07 HEAT SHOCK LOCUS U user 2 4 # 2 D 1 THR B 101 THR.? 1000.00 D 33 LYS B 12 LYS^? 1000.00 D 45 GLY B 11 GLY^? 1000.00 D 124 SER B 97 SER.? 1000.00 coo 21.09 18.28 199.42 20.72 17.74 197.38 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo 25.54 20.08 191.91 24.21 17.77 197.54 43.44 -2.72 -10.47 44.74 2.97 -10.70 coo 21.95 23.77 189.96 21.30 23.70 189.39 41.92 -5.53 -8.41 41.31 -5.13 -8.74 coo 16.26 18.98 201.87 18.32 18.00 202.67 48.92 -6.09 1.92 51.23 -5.46 1.48 1doo_c07 source 1doo HEAT SHOCK LOCUS U : 2 hits 1doo_c07 naa= 4 ULMN 4 1eag_c05 PEPTIDE INHIBITOR user 1 4 # 1 A 32 ASP A 83 ASP.? 1000.00 A 35 SER A 82 SER.? 1000.00 A 84 TYR A 77 TYR~? 1000.00 A 218 ASP A 112 ASP~? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 43.58 20.85 5.15 44.62 23.01 5.76 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 40.49 26.39 8.83 42.48 26.82 6.92 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 44.05 16.99 12.67 44.05 18.89 11.74 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 1eag_c05 PEPTIDE INHIBITOR user 2 4 # 2 A 32 ASP B 83 ASP.? 1000.00 A 35 SER B 82 SER.? 1000.00 A 84 TYR B 77 TYR~? 1000.00 A 218 ASP B 112 ASP~? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 43.58 20.85 5.15 44.62 23.01 5.76 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 40.49 26.39 8.83 42.48 26.82 6.92 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 44.05 16.99 12.67 44.05 18.89 11.74 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1eag_c05 source 1eag PEPTIDE INHIBITOR : 2 hits 1eag_c05 naa= 4 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 1 4 # 1 B 48 THR A 53 THR.? 1000.00 B 106 TYR A 107 TYR^? 1000.00 B 113 ASN A 110 ASN.? 1000.00 B 190 THR A 133 THR.? 1000.00 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 1.63 -5.35 -8.41 0.42 -5.39 -6.59 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 5.16 0.23 -2.44 3.66 2.42 -3.25 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 13.67 -5.78 2.51 14.50 -7.33 3.70 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 15.32 -5.53 -2.56 15.86 -7.55 -2.13 ULMN 4 1eyp_c01 CHALCONE-FLAVONONE ISOMERASE 1 user 2 4 # 2 B 48 THR B 53 THR.? 1000.00 B 106 TYR B 107 TYR^? 1000.00 B 113 ASN B 110 ASN.? 1000.00 B 190 THR B 133 THR.? 1000.00 coo 31.55 -18.10 62.71 31.91 -16.02 63.16 36.67 -25.61 -7.31 37.21 -26.66 -9.14 coo 31.39 -11.16 66.20 30.18 -10.84 63.67 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 36.52 -5.01 57.74 37.90 -6.60 58.02 30.35 -15.39 -18.19 28.64 -15.51 -19.45 coo 32.92 -6.00 53.75 33.40 -5.89 55.87 29.71 -13.76 -13.24 27.67 -14.35 -13.63 1eyp_c01 source 1eyp CHALCONE-FLAVONONE ISOMERASE 1 : 2 hits 1eyp_c01 naa= 4 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 1 4 # 1 A 131 ASP A 112 ASP~? 1000.00 A 179 SER A 113 SER~? 1000.00 A 210 LYS A 79 LYS~? 1000.00 A 263 LYS A 80 LYS~? 1000.00 coo 15.28 27.01 21.57 16.48 25.33 21.25 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 16.21 20.65 20.59 17.61 22.54 21.18 19.73 -5.92 9.27 17.80 -7.10 10.12 coo 18.09 17.00 14.23 20.70 20.73 18.57 18.64 -10.30 17.12 18.99 -5.93 21.84 coo 17.39 20.36 11.09 19.81 23.46 16.09 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 4 1h7o_c00 5-AMINOLAEVULINIC ACID DEHYDRATASE user 2 4 # 2 A 131 ASP B 112 ASP~? 1000.00 A 179 SER B 113 SER~? 1000.00 A 210 LYS B 79 LYS~? 1000.00 A 263 LYS B 80 LYS~? 1000.00 coo 15.28 27.01 21.57 16.48 25.33 21.25 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 16.21 20.65 20.59 17.61 22.54 21.18 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo 18.09 17.00 14.23 20.70 20.73 18.57 24.00 -13.31 -32.93 27.58 -10.91 -37.69 coo 17.39 20.36 11.09 19.81 23.46 16.09 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1h7o_c00 source 1h7o 5-AMINOLAEVULINIC ACID DEHYDRATASE : 2 hits 1h7o_c00 naa= 4 ULMN 4 1mpp_c05 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 4 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 75 TYR A 77 TYR~? 1000.00 215 ASP A 112 ASP~? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 16.04 14.72 33.82 17.27 13.71 31.95 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 15.29 15.16 26.38 15.79 12.61 27.66 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 20.65 22.00 33.80 20.06 20.56 32.39 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 1mpp_c05 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 4 # 2 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 75 TYR B 77 TYR~? 1000.00 215 ASP B 112 ASP~? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 16.04 14.72 33.82 17.27 13.71 31.95 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 15.29 15.16 26.38 15.79 12.61 27.66 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 20.65 22.00 33.80 20.06 20.56 32.39 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1mpp_c05 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 2 hits 1mpp_c05 naa= 4 ULMN 4 1qpr_c00 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 1 4 # 1 A 140 LYS A 51 LYS.? 1000.00 A 201 GLU A 135 GLU.? 1000.00 A 222 ASP A 108 ASP^? 1000.00 B 105 ARG A 46 ARG.? 1000.00 coo -11.51 38.14 15.19 -11.52 43.68 12.98 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 coo -19.59 49.73 17.58 -19.18 48.24 16.13 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo -16.29 52.17 17.14 -15.39 51.30 15.46 8.15 -4.41 0.30 6.77 -4.99 1.79 coo -15.10 38.42 13.00 -14.96 41.36 12.16 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 4 1qpr_c00 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 2 4 # 2 A 140 LYS B 51 LYS.? 1000.00 A 201 GLU B 135 GLU.? 1000.00 A 222 ASP B 108 ASP^? 1000.00 B 105 ARG B 46 ARG.? 1000.00 coo -11.51 38.14 15.19 -11.52 43.68 12.98 39.55 -26.05 -1.63 36.69 -20.49 -2.33 coo -19.59 49.73 17.58 -19.18 48.24 16.13 31.07 -20.83 -12.95 29.80 -19.16 -13.24 coo -16.29 52.17 17.14 -15.39 51.30 15.46 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo -15.10 38.42 13.00 -14.96 41.36 12.16 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1qpr_c00 source 1qpr QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE : 2 hits 1qpr_c00 naa= 4 ULMN 4 1qpr_c01 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 1 4 # 1 A 105 ARG A 46 ARG.? 1000.00 B 140 LYS A 51 LYS.? 1000.00 B 201 GLU A 135 GLU.? 1000.00 B 222 ASP A 108 ASP^? 1000.00 coo 5.99 22.34 12.11 8.70 23.39 13.07 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 4.78 25.84 10.00 10.28 27.12 12.37 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 coo 18.26 21.16 7.75 16.70 20.98 9.16 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo 19.62 24.99 8.43 18.50 25.53 10.14 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 4 1qpr_c01 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 2 4 # 2 A 105 ARG B 46 ARG.? 1000.00 B 140 LYS B 51 LYS.? 1000.00 B 201 GLU B 135 GLU.? 1000.00 B 222 ASP B 108 ASP^? 1000.00 coo 5.99 22.34 12.11 8.70 23.39 13.07 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 4.78 25.84 10.00 10.28 27.12 12.37 39.55 -26.05 -1.63 36.69 -20.49 -2.33 coo 18.26 21.16 7.75 16.70 20.98 9.16 31.07 -20.83 -12.95 29.80 -19.16 -13.24 coo 19.62 24.99 8.43 18.50 25.53 10.14 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1qpr_c01 source 1qpr QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE : 2 hits 1qpr_c01 naa= 4 ULMN 4 1qpr_c02 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 1 4 # 1 C 105 ARG A 46 ARG.? 1000.00 D 140 LYS A 51 LYS.? 1000.00 D 201 GLU A 135 GLU.? 1000.00 D 222 ASP A 108 ASP^? 1000.00 coo -9.86 79.84 14.03 -10.46 76.94 14.81 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo -6.18 79.25 11.90 -7.84 73.64 13.86 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 coo -16.93 69.92 8.53 -16.33 71.18 10.11 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo -13.97 66.95 9.08 -12.97 67.49 10.89 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 4 1qpr_c02 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 2 4 # 2 C 105 ARG B 46 ARG.? 1000.00 D 140 LYS B 51 LYS.? 1000.00 D 201 GLU B 135 GLU.? 1000.00 D 222 ASP B 108 ASP^? 1000.00 coo -9.86 79.84 14.03 -10.46 76.94 14.81 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo -6.18 79.25 11.90 -7.84 73.64 13.86 39.55 -26.05 -1.63 36.69 -20.49 -2.33 coo -16.93 69.92 8.53 -16.33 71.18 10.11 31.07 -20.83 -12.95 29.80 -19.16 -13.24 coo -13.97 66.95 9.08 -12.97 67.49 10.89 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1qpr_c02 source 1qpr QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE : 2 hits 1qpr_c02 naa= 4 ULMN 4 1qpr_c03 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 1 4 # 1 C 140 LYS A 51 LYS.? 1000.00 C 201 GLU A 135 GLU.? 1000.00 C 222 ASP A 108 ASP^? 1000.00 D 105 ARG A 46 ARG.? 1000.00 coo 12.30 86.98 18.22 17.49 84.50 15.82 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 coo 26.37 87.92 20.80 24.95 88.49 19.40 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo 26.89 83.89 19.81 25.71 83.67 18.10 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 14.40 90.06 16.34 16.77 88.53 15.24 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 4 1qpr_c03 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 2 4 # 2 C 140 LYS B 51 LYS.? 1000.00 C 201 GLU B 135 GLU.? 1000.00 C 222 ASP B 108 ASP^? 1000.00 D 105 ARG B 46 ARG.? 1000.00 coo 12.30 86.98 18.22 17.49 84.50 15.82 39.55 -26.05 -1.63 36.69 -20.49 -2.33 coo 26.37 87.92 20.80 24.95 88.49 19.40 31.07 -20.83 -12.95 29.80 -19.16 -13.24 coo 26.89 83.89 19.81 25.71 83.67 18.10 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 14.40 90.06 16.34 16.77 88.53 15.24 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1qpr_c03 source 1qpr QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE : 2 hits 1qpr_c03 naa= 4 ULMN 4 1qpr_c04 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 1 4 # 1 E 105 ARG A 46 ARG.? 1000.00 F 140 LYS A 51 LYS.? 1000.00 F 201 GLU A 135 GLU.? 1000.00 F 222 ASP A 108 ASP^? 1000.00 coo 47.70 64.65 13.97 45.55 66.58 14.99 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 45.38 62.12 11.80 41.51 66.11 14.27 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 coo 42.73 76.29 9.57 43.53 74.88 10.92 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo 38.81 75.35 10.17 38.84 74.09 11.87 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 4 1qpr_c04 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 2 4 # 2 E 105 ARG B 46 ARG.? 1000.00 F 140 LYS B 51 LYS.? 1000.00 F 201 GLU B 135 GLU.? 1000.00 F 222 ASP B 108 ASP^? 1000.00 coo 47.70 64.65 13.97 45.55 66.58 14.99 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 45.38 62.12 11.80 41.51 66.11 14.27 39.55 -26.05 -1.63 36.69 -20.49 -2.33 coo 42.73 76.29 9.57 43.53 74.88 10.92 31.07 -20.83 -12.95 29.80 -19.16 -13.24 coo 38.81 75.35 10.17 38.84 74.09 11.87 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1qpr_c04 source 1qpr QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE : 2 hits 1qpr_c04 naa= 4 ULMN 4 1qpr_c05 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 1 4 # 1 E 140 LYS A 51 LYS.? 1000.00 E 201 GLU A 135 GLU.? 1000.00 E 222 ASP A 108 ASP^? 1000.00 F 105 ARG A 46 ARG.? 1000.00 coo 42.77 41.76 16.64 38.01 38.89 14.06 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 coo 36.59 28.90 18.17 37.71 30.08 16.89 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo 32.97 30.62 17.50 33.27 31.77 15.77 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 44.31 38.55 14.39 41.82 37.16 13.34 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 4 1qpr_c05 QUINOLINIC ACID PHOSPHORIBOSYLTRANSFuser 2 4 # 2 E 140 LYS B 51 LYS.? 1000.00 E 201 GLU B 135 GLU.? 1000.00 E 222 ASP B 108 ASP^? 1000.00 F 105 ARG B 46 ARG.? 1000.00 coo 42.77 41.76 16.64 38.01 38.89 14.06 39.55 -26.05 -1.63 36.69 -20.49 -2.33 coo 36.59 28.90 18.17 37.71 30.08 16.89 31.07 -20.83 -12.95 29.80 -19.16 -13.24 coo 32.97 30.62 17.50 33.27 31.77 15.77 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 44.31 38.55 14.39 41.82 37.16 13.34 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1qpr_c05 source 1qpr QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE : 2 hits 1qpr_c05 naa= 4 ULMN 4 1rne_c02 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 4 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 215 ASP A 112 ASP~? 1000.00 218 ALA A 114 ALA~? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 12.20 12.71 75.45 13.69 13.84 74.03 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 5.22 15.03 71.43 7.19 14.88 70.83 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 6.97 16.73 67.05 5.86 15.77 67.41 23.32 -6.64 10.22 23.94 -8.01 10.01 ULMN 4 1rne_c02 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 4 # 2 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 215 ASP B 112 ASP~? 1000.00 218 ALA B 114 ALA~? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 12.20 12.71 75.45 13.69 13.84 74.03 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 5.22 15.03 71.43 7.19 14.88 70.83 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 6.97 16.73 67.05 5.86 15.77 67.41 24.83 -7.46 -26.03 23.33 -7.58 -25.84 1rne_c02 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 2 hits 1rne_c02 naa= 4 ULMN 4 1rne_c05 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 4 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 75 TYR A 77 TYR~? 1000.00 215 ASP A 112 ASP~? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 12.20 12.71 75.45 13.69 13.84 74.03 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 15.08 11.29 68.68 16.45 12.70 70.65 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 5.22 15.03 71.43 7.19 14.88 70.83 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 1rne_c05 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 4 # 2 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 75 TYR B 77 TYR~? 1000.00 215 ASP B 112 ASP~? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 12.20 12.71 75.45 13.69 13.84 74.03 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 15.08 11.29 68.68 16.45 12.70 70.65 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 5.22 15.03 71.43 7.19 14.88 70.83 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1rne_c05 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 2 hits 1rne_c05 naa= 4 ULMN 4 1sme_c06 PLASMEPSIN II user 1 4 # 1 A 34 ASP A 83 ASP.? 1000.00 A 37 SER A 82 SER.? 1000.00 A 77 TYR A 77 TYR~? 1000.00 A 214 ASP A 112 ASP~? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 51.10 65.11 20.73 52.62 63.74 19.42 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 58.03 63.52 22.21 57.19 63.97 19.60 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 48.59 58.89 25.78 50.13 59.74 24.61 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 1sme_c06 PLASMEPSIN II user 2 4 # 2 A 34 ASP B 83 ASP.? 1000.00 A 37 SER B 82 SER.? 1000.00 A 77 TYR B 77 TYR~? 1000.00 A 214 ASP B 112 ASP~? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 51.10 65.11 20.73 52.62 63.74 19.42 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 58.03 63.52 22.21 57.19 63.97 19.60 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 48.59 58.89 25.78 50.13 59.74 24.61 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1sme_c06 source 1sme PLASMEPSIN II : 2 hits 1sme_c06 naa= 4 ULMN 4 1sme_c07 PLASMEPSIN II user 1 4 # 1 B 34 ASP A 83 ASP.? 1000.00 B 37 SER A 82 SER.? 1000.00 B 77 TYR A 77 TYR~? 1000.00 B 214 ASP A 112 ASP~? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 20.67 100.44 55.84 20.21 98.51 54.45 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 21.97 93.33 56.91 23.11 94.24 54.54 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 12.41 98.71 58.47 14.37 98.17 58.05 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 1sme_c07 PLASMEPSIN II user 2 4 # 2 B 34 ASP B 83 ASP.? 1000.00 B 37 SER B 82 SER.? 1000.00 B 77 TYR B 77 TYR~? 1000.00 B 214 ASP B 112 ASP~? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 20.67 100.44 55.84 20.21 98.51 54.45 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 21.97 93.33 56.91 23.11 94.24 54.54 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 12.41 98.71 58.47 14.37 98.17 58.05 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1sme_c07 source 1sme PLASMEPSIN II : 2 hits 1sme_c07 naa= 4 ULMN 4 2apr_c05 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 4 # 1 35 ASP A 83 ASP.? 1000.00 38 SER A 82 SER.? 1000.00 77 TYR A 77 TYR~? 1000.00 218 ASP A 112 ASP~? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 46.04 57.35 103.96 44.97 58.52 105.78 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 47.21 64.36 106.26 46.67 62.33 108.12 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 41.33 60.20 97.63 42.00 60.96 99.49 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 2apr_c05 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 4 # 2 35 ASP B 83 ASP.? 1000.00 38 SER B 82 SER.? 1000.00 77 TYR B 77 TYR~? 1000.00 218 ASP B 112 ASP~? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 46.04 57.35 103.96 44.97 58.52 105.78 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 47.21 64.36 106.26 46.67 62.33 108.12 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 41.33 60.20 97.63 42.00 60.96 99.49 24.70 -9.86 -21.06 23.12 -10.03 -22.49 2apr_c05 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 2 hits 2apr_c05 naa= 4 ULMN 4 2jxr_c05 LIGAND CP-081282 user 1 4 # 1 A 32 ASP A 83 ASP.? 1000.00 A 35 SER A 82 SER.? 1000.00 A 75 TYR A 77 TYR~? 1000.00 A 215 ASP A 112 ASP~? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -13.21 66.21 45.84 -15.49 65.90 45.84 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -20.05 66.65 43.47 -19.36 65.65 45.97 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -10.72 64.19 37.77 -12.20 64.43 39.15 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 4 2jxr_c05 LIGAND CP-081282 user 2 4 # 2 A 32 ASP B 83 ASP.? 1000.00 A 35 SER B 82 SER.? 1000.00 A 75 TYR B 77 TYR~? 1000.00 A 215 ASP B 112 ASP~? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -13.21 66.21 45.84 -15.49 65.90 45.84 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -20.05 66.65 43.47 -19.36 65.65 45.97 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -10.72 64.19 37.77 -12.20 64.43 39.15 24.70 -9.86 -21.06 23.12 -10.03 -22.49 2jxr_c05 source 2jxr LIGAND CP-081282 : 2 hits 2jxr_c05 naa= 4 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 135 GLU.? 1000.00 A 60 ASP A 138 ASP^? 1000.00 A 175 TYR A 85 TYR.? 1000.00 coo 46.10 28.27 19.27 45.48 26.99 20.84 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo 56.42 28.06 12.93 55.01 27.92 14.50 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 45.02 22.04 15.38 46.16 24.00 13.76 9.01 -5.92 4.10 9.03 -8.46 2.93 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 2 3 # 2 A 49 GLU B 135 GLU.? 1000.00 A 60 ASP B 138 ASP^? 1000.00 A 175 TYR B 85 TYR.? 1000.00 coo 46.10 28.27 19.27 45.48 26.99 20.84 31.07 -20.83 -12.95 29.80 -19.16 -13.24 coo 56.42 28.06 12.93 55.01 27.92 14.50 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 45.02 22.04 15.38 46.16 24.00 13.76 32.56 -19.53 -19.90 30.36 -20.72 -18.65 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 2 hits 1a50_c03 naa= 3 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 1 3 # 1 33 ASP A 93 ASP.? 1000.00 187 GLU A 102 GLU.? 1000.00 229 LYS A 142 LYS.? 1000.00 coo -52.57 56.60 47.75 -51.52 54.87 46.95 17.45 11.87 -9.91 18.23 9.90 -9.96 coo -45.08 48.37 46.81 -46.53 49.74 45.96 6.41 12.98 -11.22 7.03 11.90 -12.90 coo -47.40 44.36 48.48 -50.80 49.18 46.20 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 2 3 # 2 33 ASP A 136 ASP^? 1000.00 187 GLU A 34 GLU.? 1000.00 229 LYS A 35 LYS.? 1000.00 coo -52.57 56.60 47.75 -51.52 54.87 46.95 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo -45.08 48.37 46.81 -46.53 49.74 45.96 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo -47.40 44.36 48.48 -50.80 49.18 46.20 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 3 3 # 3 33 ASP A 138 ASP^? 1000.00 187 GLU A 102 GLU.? 1000.00 229 LYS A 142 LYS.? 1000.00 coo -52.57 56.60 47.75 -51.52 54.87 46.95 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -45.08 48.37 46.81 -46.53 49.74 45.96 6.41 12.98 -11.22 7.03 11.90 -12.90 coo -47.40 44.36 48.48 -50.80 49.18 46.20 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 4 3 # 4 33 ASP A 138 ASP^? 1000.00 187 GLU A 141 GLU.? 1000.00 229 LYS A 142 LYS.? 1000.00 coo -52.57 56.60 47.75 -51.52 54.87 46.95 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -45.08 48.37 46.81 -46.53 49.74 45.96 3.43 12.79 -4.88 2.72 12.95 -2.84 coo -47.40 44.36 48.48 -50.80 49.18 46.20 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 5 3 # 5 33 ASP B 93 ASP.? 1000.00 187 GLU B 102 GLU.? 1000.00 229 LYS B 142 LYS.? 1000.00 coo -52.57 56.60 47.75 -51.52 54.87 46.95 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo -45.08 48.37 46.81 -46.53 49.74 45.96 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo -47.40 44.36 48.48 -50.80 49.18 46.20 52.98 -12.77 -6.57 54.80 -12.93 -0.57 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 6 3 # 6 33 ASP B 136 ASP^? 1000.00 187 GLU B 34 GLU.? 1000.00 229 LYS B 35 LYS.? 1000.00 coo -52.57 56.60 47.75 -51.52 54.87 46.95 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo -45.08 48.37 46.81 -46.53 49.74 45.96 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo -47.40 44.36 48.48 -50.80 49.18 46.20 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 7 3 # 7 33 ASP B 138 ASP^? 1000.00 187 GLU B 102 GLU.? 1000.00 229 LYS B 142 LYS.? 1000.00 coo -52.57 56.60 47.75 -51.52 54.87 46.95 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -45.08 48.37 46.81 -46.53 49.74 45.96 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo -47.40 44.36 48.48 -50.80 49.18 46.20 52.98 -12.77 -6.57 54.80 -12.93 -0.57 ULMN 3 1ald_c00 ALDOLASE A (E.C.4.1.2.13) user 8 3 # 8 33 ASP B 138 ASP^? 1000.00 187 GLU B 141 GLU.? 1000.00 229 LYS B 142 LYS.? 1000.00 coo -52.57 56.60 47.75 -51.52 54.87 46.95 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -45.08 48.37 46.81 -46.53 49.74 45.96 51.50 -14.92 -10.75 52.03 -15.46 -12.75 coo -47.40 44.36 48.48 -50.80 49.18 46.20 52.98 -12.77 -6.57 54.80 -12.93 -0.57 1ald_c00 source 1ald ALDOLASE A (E.C.4.1.2.13) : 8 hits 1ald_c00 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 215 ASP A 112 ASP~? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -12.30 10.35 145.24 -10.75 8.55 145.88 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -8.20 12.64 138.30 -8.86 10.97 139.38 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP A 93 ASP.? 1000.00 35 SER A 10 SER^? 1000.00 215 ASP A 94 ASP.? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 17.45 11.87 -9.91 18.23 9.90 -9.96 coo -12.30 10.35 145.24 -10.75 8.55 145.88 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -8.20 12.64 138.30 -8.86 10.97 139.38 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1am5_c04 PEPSIN user 3 3 # 3 32 ASP A 94 ASP.? 1000.00 35 SER A 96 SER.? 1000.00 215 ASP A 93 ASP.? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 13.93 10.69 -14.78 14.17 9.66 -16.61 coo -12.30 10.35 145.24 -10.75 8.55 145.88 15.19 13.19 -19.39 14.02 11.94 -21.09 coo -8.20 12.64 138.30 -8.86 10.97 139.38 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1am5_c04 PEPSIN user 4 3 # 4 32 ASP A 94 ASP.? 1000.00 35 SER A 97 SER.? 1000.00 215 ASP A 93 ASP.? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 13.93 10.69 -14.78 14.17 9.66 -16.61 coo -12.30 10.35 145.24 -10.75 8.55 145.88 12.38 15.07 -17.61 11.81 17.40 -17.17 coo -8.20 12.64 138.30 -8.86 10.97 139.38 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1am5_c04 PEPSIN user 5 3 # 5 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 215 ASP B 112 ASP~? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -12.30 10.35 145.24 -10.75 8.55 145.88 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -8.20 12.64 138.30 -8.86 10.97 139.38 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1am5_c04 PEPSIN user 6 3 # 6 32 ASP B 93 ASP.? 1000.00 35 SER B 10 SER^? 1000.00 215 ASP B 94 ASP.? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo -12.30 10.35 145.24 -10.75 8.55 145.88 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -8.20 12.64 138.30 -8.86 10.97 139.38 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1am5_c04 PEPSIN user 7 3 # 7 32 ASP B 94 ASP.? 1000.00 35 SER B 96 SER.? 1000.00 215 ASP B 93 ASP.? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -12.30 10.35 145.24 -10.75 8.55 145.88 45.87 -4.60 3.67 45.38 -6.30 5.31 coo -8.20 12.64 138.30 -8.86 10.97 139.38 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1am5_c04 PEPSIN user 8 3 # 8 32 ASP B 94 ASP.? 1000.00 35 SER B 97 SER.? 1000.00 215 ASP B 93 ASP.? 1000.00 coo -7.18 8.92 145.10 -8.77 8.81 143.59 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -12.30 10.35 145.24 -10.75 8.55 145.88 48.92 -6.09 1.92 51.23 -5.46 1.48 coo -8.20 12.64 138.30 -8.86 10.97 139.38 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1am5_c04 source 1am5 PEPSIN : 8 hits 1am5_c04 naa= 3 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 1 3 # 1 179 ASP A 83 ASP.? 1000.00 227 GLU A 21 GLU^? 1000.00 289 ASP A 108 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 3.96 55.76 41.24 4.83 57.69 41.17 8.36 5.57 14.13 8.30 3.77 15.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 2 3 # 2 179 ASP A 108 ASP^? 1000.00 227 GLU A 21 GLU^? 1000.00 289 ASP A 83 ASP.? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 3.96 55.76 41.24 4.83 57.69 41.17 8.36 5.57 14.13 8.30 3.77 15.28 coo 9.42 68.07 30.27 7.35 68.27 30.10 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 3 3 # 3 179 ASP A 108 ASP^? 1000.00 227 GLU A 22 GLU^? 1000.00 289 ASP A 83 ASP.? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 3.96 55.76 41.24 4.83 57.69 41.17 11.90 9.90 7.95 12.35 11.96 7.71 coo 9.42 68.07 30.27 7.35 68.27 30.10 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 4 3 # 4 179 ASP A 108 ASP^? 1000.00 227 GLU A 22 GLU^? 1000.00 289 ASP A 138 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 3.96 55.76 41.24 4.83 57.69 41.17 11.90 9.90 7.95 12.35 11.96 7.71 coo 9.42 68.07 30.27 7.35 68.27 30.10 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 5 3 # 5 179 ASP A 108 ASP^? 1000.00 227 GLU A 30 GLU^? 1000.00 289 ASP A 138 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 3.96 55.76 41.24 4.83 57.69 41.17 20.47 3.27 -9.94 22.27 3.25 -11.07 coo 9.42 68.07 30.27 7.35 68.27 30.10 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 6 3 # 6 179 ASP A 108 ASP^? 1000.00 227 GLU A 34 GLU.? 1000.00 289 ASP A 138 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 3.96 55.76 41.24 4.83 57.69 41.17 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 9.42 68.07 30.27 7.35 68.27 30.10 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 7 3 # 7 179 ASP A 138 ASP^? 1000.00 227 GLU A 22 GLU^? 1000.00 289 ASP A 108 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 3.96 55.76 41.24 4.83 57.69 41.17 11.90 9.90 7.95 12.35 11.96 7.71 coo 9.42 68.07 30.27 7.35 68.27 30.10 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 8 3 # 8 179 ASP A 138 ASP^? 1000.00 227 GLU A 30 GLU^? 1000.00 289 ASP A 108 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 3.96 55.76 41.24 4.83 57.69 41.17 20.47 3.27 -9.94 22.27 3.25 -11.07 coo 9.42 68.07 30.27 7.35 68.27 30.10 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 9 3 # 9 179 ASP A 138 ASP^? 1000.00 227 GLU A 39 GLU.? 1000.00 289 ASP A 108 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 3.96 55.76 41.24 4.83 57.69 41.17 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 9.42 68.07 30.27 7.35 68.27 30.10 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 10 3 # 10 179 ASP B 83 ASP.? 1000.00 227 GLU B 21 GLU^? 1000.00 289 ASP B 108 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 3.96 55.76 41.24 4.83 57.69 41.17 42.84 -14.24 -29.87 41.38 -15.19 -31.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 11 3 # 11 179 ASP B 108 ASP^? 1000.00 227 GLU B 21 GLU^? 1000.00 289 ASP B 83 ASP.? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 42.84 -14.24 -29.87 41.38 -15.19 -31.09 coo 9.42 68.07 30.27 7.35 68.27 30.10 27.06 -15.40 -22.59 25.67 -13.84 -22.77 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 12 3 # 12 179 ASP B 108 ASP^? 1000.00 227 GLU B 22 GLU^? 1000.00 289 ASP B 83 ASP.? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 9.42 68.07 30.27 7.35 68.27 30.10 27.06 -15.40 -22.59 25.67 -13.84 -22.77 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 13 3 # 13 179 ASP B 108 ASP^? 1000.00 227 GLU B 22 GLU^? 1000.00 289 ASP B 138 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 9.42 68.07 30.27 7.35 68.27 30.10 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 14 3 # 14 179 ASP B 108 ASP^? 1000.00 227 GLU B 30 GLU^? 1000.00 289 ASP B 138 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 34.72 -4.99 -5.76 33.75 -3.44 -4.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 15 3 # 15 179 ASP B 108 ASP^? 1000.00 227 GLU B 34 GLU.? 1000.00 289 ASP B 138 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 3.96 55.76 41.24 4.83 57.69 41.17 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 9.42 68.07 30.27 7.35 68.27 30.10 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 16 3 # 16 179 ASP B 138 ASP^? 1000.00 227 GLU B 22 GLU^? 1000.00 289 ASP B 108 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 9.42 68.07 30.27 7.35 68.27 30.10 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 17 3 # 17 179 ASP B 138 ASP^? 1000.00 227 GLU B 30 GLU^? 1000.00 289 ASP B 108 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 34.72 -4.99 -5.76 33.75 -3.44 -4.67 coo 9.42 68.07 30.27 7.35 68.27 30.10 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1amy_c06 ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE user 18 3 # 18 179 ASP B 138 ASP^? 1000.00 227 GLU B 39 GLU.? 1000.00 289 ASP B 108 ASP^? 1000.00 coo -0.62 65.95 29.97 0.31 67.47 31.05 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 3.96 55.76 41.24 4.83 57.69 41.17 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 9.42 68.07 30.27 7.35 68.27 30.10 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1amy_c06 source 1amy ALPHA-1,4 GLYCAN-4-GLUCANOHYDROLASE (ALPHA-AMY: 18 hits 1amy_c06 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 83 ASP.? 1000.00 E 36 SER A 82 SER.? 1000.00 E 213 ASP A 112 ASP~? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 28.33 15.15 21.27 28.70 13.12 19.97 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 20.15 16.04 19.79 21.65 14.49 19.86 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP A 93 ASP.? 1000.00 E 36 SER A 10 SER^? 1000.00 E 213 ASP A 94 ASP.? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 28.33 15.15 21.27 28.70 13.12 19.97 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 20.15 16.04 19.79 21.65 14.49 19.86 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 3 3 # 3 E 33 ASP A 94 ASP.? 1000.00 E 36 SER A 96 SER.? 1000.00 E 213 ASP A 93 ASP.? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 28.33 15.15 21.27 28.70 13.12 19.97 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 20.15 16.04 19.79 21.65 14.49 19.86 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 4 3 # 4 E 33 ASP A 94 ASP.? 1000.00 E 36 SER A 97 SER.? 1000.00 E 213 ASP A 93 ASP.? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 28.33 15.15 21.27 28.70 13.12 19.97 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 20.15 16.04 19.79 21.65 14.49 19.86 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 5 3 # 5 E 33 ASP B 83 ASP.? 1000.00 E 36 SER B 82 SER.? 1000.00 E 213 ASP B 112 ASP~? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 28.33 15.15 21.27 28.70 13.12 19.97 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 20.15 16.04 19.79 21.65 14.49 19.86 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 6 3 # 6 E 33 ASP B 93 ASP.? 1000.00 E 36 SER B 10 SER^? 1000.00 E 213 ASP B 94 ASP.? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 28.33 15.15 21.27 28.70 13.12 19.97 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 20.15 16.04 19.79 21.65 14.49 19.86 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 7 3 # 7 E 33 ASP B 94 ASP.? 1000.00 E 36 SER B 96 SER.? 1000.00 E 213 ASP B 93 ASP.? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 28.33 15.15 21.27 28.70 13.12 19.97 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 20.15 16.04 19.79 21.65 14.49 19.86 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 8 3 # 8 E 33 ASP B 94 ASP.? 1000.00 E 36 SER B 97 SER.? 1000.00 E 213 ASP B 93 ASP.? 1000.00 coo 26.30 12.96 16.78 25.46 12.99 18.72 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 28.33 15.15 21.27 28.70 13.12 19.97 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 20.15 16.04 19.79 21.65 14.49 19.86 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 8 hits 1apt_c04 naa= 3 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 1 3 # 1 232 HIS A 25 HIS.? 1000.00 254 LYS A 27 LYS^? 1000.00 333 ARG A 103 ARG^? 1000.00 coo 28.11 -1.15 8.51 29.21 0.63 8.34 17.07 12.41 6.63 15.76 13.52 7.84 coo 26.09 4.87 14.60 27.89 3.33 10.26 20.78 10.08 -0.17 21.23 14.77 2.36 coo 37.35 7.47 11.84 34.90 6.11 10.60 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1aq2_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE user 2 3 # 2 232 HIS B 25 HIS^? 1000.00 254 LYS B 27 LYS^? 1000.00 333 ARG B 103 ARG^? 1000.00 coo 28.11 -1.15 8.51 29.21 0.63 8.34 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 26.09 4.87 14.60 27.89 3.33 10.26 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 37.35 7.47 11.84 34.90 6.11 10.60 48.22 -11.67 -13.43 49.99 -12.22 -15.85 1aq2_c00 source 1aq2 PHOSPHOENOLPYRUVATE CARBOXYKINASE : 2 hits 1aq2_c00 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 10 SER^? 1000.00 A 292 ASP B 112 ASP~? 1000.00 A 322 HIS A 25 HIS.? 1000.00 coo 36.34 32.23 39.60 36.43 34.62 39.93 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 19.73 19.18 41.39 21.50 18.65 40.34 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 41.69 45.14 46.60 41.78 47.19 46.18 17.07 12.41 6.63 15.76 13.52 7.84 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 38 SER.? 1000.00 A 292 ASP B 83 ASP.? 1000.00 A 322 HIS A 50 HIS.? 1000.00 coo 36.34 32.23 39.60 36.43 34.62 39.93 6.50 -13.37 -19.74 5.14 -14.76 -18.29 coo 19.73 19.18 41.39 21.50 18.65 40.34 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 41.69 45.14 46.60 41.78 47.19 46.18 -4.24 -1.10 -13.74 -5.24 -2.70 -12.82 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER B 10 SER^? 1000.00 A 292 ASP A 112 ASP~? 1000.00 A 322 HIS B 25 HIS^? 1000.00 coo 36.34 32.23 39.60 36.43 34.62 39.93 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 19.73 19.18 41.39 21.50 18.65 40.34 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 41.69 45.14 46.60 41.78 47.19 46.18 44.38 -3.39 -22.45 45.97 -4.01 -23.66 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER B 38 SER.? 1000.00 A 292 ASP A 83 ASP.? 1000.00 A 322 HIS B 50 HIS.? 1000.00 coo 36.34 32.23 39.60 36.43 34.62 39.93 27.23 -25.34 3.98 26.79 -27.24 2.57 coo 19.73 19.18 41.39 21.50 18.65 40.34 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 41.69 45.14 46.60 41.78 47.19 46.18 43.22 -28.55 -1.93 42.31 -30.23 -2.82 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 4 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 10 SER^? 1000.00 B 292 ASP B 112 ASP~? 1000.00 B 322 HIS A 25 HIS.? 1000.00 coo 35.42 71.28 22.94 36.24 69.06 22.37 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 24.74 78.07 5.59 24.32 79.03 7.46 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 48.81 64.16 26.34 49.30 62.16 26.73 17.07 12.41 6.63 15.76 13.52 7.84 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 38 SER.? 1000.00 B 292 ASP B 83 ASP.? 1000.00 B 322 HIS A 50 HIS.? 1000.00 coo 35.42 71.28 22.94 36.24 69.06 22.37 6.50 -13.37 -19.74 5.14 -14.76 -18.29 coo 24.74 78.07 5.59 24.32 79.03 7.46 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 48.81 64.16 26.34 49.30 62.16 26.73 -4.24 -1.10 -13.74 -5.24 -2.70 -12.82 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 10 SER^? 1000.00 B 292 ASP A 112 ASP~? 1000.00 B 322 HIS B 25 HIS^? 1000.00 coo 35.42 71.28 22.94 36.24 69.06 22.37 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 24.74 78.07 5.59 24.32 79.03 7.46 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 48.81 64.16 26.34 49.30 62.16 26.73 44.38 -3.39 -22.45 45.97 -4.01 -23.66 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 B 194 SER B 38 SER.? 1000.00 B 292 ASP A 83 ASP.? 1000.00 B 322 HIS B 50 HIS.? 1000.00 coo 35.42 71.28 22.94 36.24 69.06 22.37 27.23 -25.34 3.98 26.79 -27.24 2.57 coo 24.74 78.07 5.59 24.32 79.03 7.46 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 48.81 64.16 26.34 49.30 62.16 26.73 43.22 -28.55 -1.93 42.31 -30.23 -2.82 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 4 hits 1aql_c03 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 83 ASP.? 1000.00 A 35 SER A 82 SER.? 1000.00 A 217 ASP A 112 ASP~? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -11.96 5.74 52.90 -10.55 6.74 51.22 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -5.22 1.43 56.08 -5.36 2.84 54.49 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP A 93 ASP.? 1000.00 A 35 SER A 10 SER^? 1000.00 A 217 ASP A 94 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 17.45 11.87 -9.91 18.23 9.90 -9.96 coo -11.96 5.74 52.90 -10.55 6.74 51.22 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -5.22 1.43 56.08 -5.36 2.84 54.49 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1avf_c04 GASTRICSIN user 3 3 # 3 A 32 ASP A 94 ASP.? 1000.00 A 35 SER A 96 SER.? 1000.00 A 217 ASP A 93 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 13.93 10.69 -14.78 14.17 9.66 -16.61 coo -11.96 5.74 52.90 -10.55 6.74 51.22 15.19 13.19 -19.39 14.02 11.94 -21.09 coo -5.22 1.43 56.08 -5.36 2.84 54.49 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1avf_c04 GASTRICSIN user 4 3 # 4 A 32 ASP A 94 ASP.? 1000.00 A 35 SER A 97 SER.? 1000.00 A 217 ASP A 93 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 13.93 10.69 -14.78 14.17 9.66 -16.61 coo -11.96 5.74 52.90 -10.55 6.74 51.22 12.38 15.07 -17.61 11.81 17.40 -17.17 coo -5.22 1.43 56.08 -5.36 2.84 54.49 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1avf_c04 GASTRICSIN user 5 3 # 5 A 32 ASP B 83 ASP.? 1000.00 A 35 SER B 82 SER.? 1000.00 A 217 ASP B 112 ASP~? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -11.96 5.74 52.90 -10.55 6.74 51.22 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -5.22 1.43 56.08 -5.36 2.84 54.49 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1avf_c04 GASTRICSIN user 6 3 # 6 A 32 ASP B 93 ASP.? 1000.00 A 35 SER B 10 SER^? 1000.00 A 217 ASP B 94 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo -11.96 5.74 52.90 -10.55 6.74 51.22 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -5.22 1.43 56.08 -5.36 2.84 54.49 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1avf_c04 GASTRICSIN user 7 3 # 7 A 32 ASP B 94 ASP.? 1000.00 A 35 SER B 96 SER.? 1000.00 A 217 ASP B 93 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -11.96 5.74 52.90 -10.55 6.74 51.22 45.87 -4.60 3.67 45.38 -6.30 5.31 coo -5.22 1.43 56.08 -5.36 2.84 54.49 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1avf_c04 GASTRICSIN user 8 3 # 8 A 32 ASP B 94 ASP.? 1000.00 A 35 SER B 97 SER.? 1000.00 A 217 ASP B 93 ASP.? 1000.00 coo -10.06 2.54 49.69 -8.83 3.73 50.96 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -11.96 5.74 52.90 -10.55 6.74 51.22 48.92 -6.09 1.92 51.23 -5.46 1.48 coo -5.22 1.43 56.08 -5.36 2.84 54.49 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1avf_c04 source 1avf GASTRICSIN : 8 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 83 ASP.? 1000.00 J 35 SER A 82 SER.? 1000.00 J 217 ASP A 112 ASP~? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP A 93 ASP.? 1000.00 J 35 SER A 10 SER^? 1000.00 J 217 ASP A 94 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 17.45 11.87 -9.91 18.23 9.90 -9.96 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1avf_c05 GASTRICSIN user 3 3 # 3 J 32 ASP A 94 ASP.? 1000.00 J 35 SER A 96 SER.? 1000.00 J 217 ASP A 93 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 13.93 10.69 -14.78 14.17 9.66 -16.61 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 15.19 13.19 -19.39 14.02 11.94 -21.09 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1avf_c05 GASTRICSIN user 4 3 # 4 J 32 ASP A 94 ASP.? 1000.00 J 35 SER A 97 SER.? 1000.00 J 217 ASP A 93 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 13.93 10.69 -14.78 14.17 9.66 -16.61 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 12.38 15.07 -17.61 11.81 17.40 -17.17 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1avf_c05 GASTRICSIN user 5 3 # 5 J 32 ASP B 83 ASP.? 1000.00 J 35 SER B 82 SER.? 1000.00 J 217 ASP B 112 ASP~? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1avf_c05 GASTRICSIN user 6 3 # 6 J 32 ASP B 93 ASP.? 1000.00 J 35 SER B 10 SER^? 1000.00 J 217 ASP B 94 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1avf_c05 GASTRICSIN user 7 3 # 7 J 32 ASP B 94 ASP.? 1000.00 J 35 SER B 96 SER.? 1000.00 J 217 ASP B 93 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 45.87 -4.60 3.67 45.38 -6.30 5.31 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1avf_c05 GASTRICSIN user 8 3 # 8 J 32 ASP B 94 ASP.? 1000.00 J 35 SER B 97 SER.? 1000.00 J 217 ASP B 93 ASP.? 1000.00 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 48.92 -6.09 1.92 51.23 -5.46 1.48 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1avf_c05 source 1avf GASTRICSIN : 8 hits 1avf_c05 naa= 3 ULMN 3 1ax4_c04 TRYPTOPHANASE user 1 3 # 1 A 130 PHE A 63 PHE^? 1000.00 A 223 ASP A 112 ASP~? 1000.00 A 265 LYS A 79 LYS~? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 21.53 4.57 4.68 19.76 2.41 4.33 coo 30.70 47.50 67.53 29.83 49.47 67.39 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 19.99 54.53 64.11 20.55 58.78 68.33 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ax4_c04 TRYPTOPHANASE user 2 3 # 2 A 130 PHE A 63 PHE^? 1000.00 A 223 ASP A 112 ASP~? 1000.00 A 265 LYS A 80 LYS~? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 21.53 4.57 4.68 19.76 2.41 4.33 coo 30.70 47.50 67.53 29.83 49.47 67.39 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 19.99 54.53 64.11 20.55 58.78 68.33 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ax4_c04 TRYPTOPHANASE user 3 3 # 3 A 130 PHE A 132 PHE^? 1000.00 A 223 ASP A 112 ASP~? 1000.00 A 265 LYS A 79 LYS~? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 30.70 47.50 67.53 29.83 49.47 67.39 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 19.99 54.53 64.11 20.55 58.78 68.33 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ax4_c04 TRYPTOPHANASE user 4 3 # 4 A 130 PHE A 132 PHE^? 1000.00 A 223 ASP A 112 ASP~? 1000.00 A 265 LYS A 80 LYS~? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 30.70 47.50 67.53 29.83 49.47 67.39 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 19.99 54.53 64.11 20.55 58.78 68.33 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ax4_c04 TRYPTOPHANASE user 5 3 # 5 A 130 PHE A 132 PHE^? 1000.00 A 223 ASP A 112 ASP~? 1000.00 A 265 LYS B 35 LYS.? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 30.70 47.50 67.53 29.83 49.47 67.39 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 19.99 54.53 64.11 20.55 58.78 68.33 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1ax4_c04 TRYPTOPHANASE user 6 3 # 6 A 130 PHE A 134 PHE.? 1000.00 A 223 ASP A 138 ASP^? 1000.00 A 265 LYS A 142 LYS.? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo 30.70 47.50 67.53 29.83 49.47 67.39 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 19.99 54.53 64.11 20.55 58.78 68.33 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1ax4_c04 TRYPTOPHANASE user 7 3 # 7 A 130 PHE B 63 PHE^? 1000.00 A 223 ASP B 112 ASP~? 1000.00 A 265 LYS B 79 LYS~? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 30.70 47.50 67.53 29.83 49.47 67.39 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 19.99 54.53 64.11 20.55 58.78 68.33 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ax4_c04 TRYPTOPHANASE user 8 3 # 8 A 130 PHE B 63 PHE^? 1000.00 A 223 ASP B 112 ASP~? 1000.00 A 265 LYS B 80 LYS~? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 30.70 47.50 67.53 29.83 49.47 67.39 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 19.99 54.53 64.11 20.55 58.78 68.33 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1ax4_c04 TRYPTOPHANASE user 9 3 # 9 A 130 PHE B 132 PHE^? 1000.00 A 223 ASP B 112 ASP~? 1000.00 A 265 LYS A 35 LYS.? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 30.70 47.50 67.53 29.83 49.47 67.39 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 19.99 54.53 64.11 20.55 58.78 68.33 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1ax4_c04 TRYPTOPHANASE user 10 3 # 10 A 130 PHE B 132 PHE^? 1000.00 A 223 ASP B 112 ASP~? 1000.00 A 265 LYS B 79 LYS~? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 30.70 47.50 67.53 29.83 49.47 67.39 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 19.99 54.53 64.11 20.55 58.78 68.33 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ax4_c04 TRYPTOPHANASE user 11 3 # 11 A 130 PHE B 132 PHE^? 1000.00 A 223 ASP B 112 ASP~? 1000.00 A 265 LYS B 80 LYS~? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 30.70 47.50 67.53 29.83 49.47 67.39 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 19.99 54.53 64.11 20.55 58.78 68.33 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1ax4_c04 TRYPTOPHANASE user 12 3 # 12 A 130 PHE B 134 PHE.? 1000.00 A 223 ASP B 138 ASP^? 1000.00 A 265 LYS B 142 LYS.? 1000.00 coo 39.74 52.86 65.74 41.15 55.14 66.52 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo 30.70 47.50 67.53 29.83 49.47 67.39 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 19.99 54.53 64.11 20.55 58.78 68.33 52.98 -12.77 -6.57 54.80 -12.93 -0.57 1ax4_c04 source 1ax4 TRYPTOPHANASE : 12 hits 1ax4_c04 naa= 3 ULMN 3 1ax4_c05 TRYPTOPHANASE user 1 3 # 1 B 130 PHE A 63 PHE^? 1000.00 B 223 ASP A 112 ASP~? 1000.00 B 265 LYS A 79 LYS~? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 21.53 4.57 4.68 19.76 2.41 4.33 coo 10.43 61.66 91.81 9.80 60.04 90.61 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 5.43 58.06 80.08 8.57 53.00 79.37 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ax4_c05 TRYPTOPHANASE user 2 3 # 2 B 130 PHE A 63 PHE^? 1000.00 B 223 ASP A 112 ASP~? 1000.00 B 265 LYS A 80 LYS~? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 21.53 4.57 4.68 19.76 2.41 4.33 coo 10.43 61.66 91.81 9.80 60.04 90.61 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 5.43 58.06 80.08 8.57 53.00 79.37 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ax4_c05 TRYPTOPHANASE user 3 3 # 3 B 130 PHE A 132 PHE^? 1000.00 B 223 ASP A 112 ASP~? 1000.00 B 265 LYS A 79 LYS~? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 10.43 61.66 91.81 9.80 60.04 90.61 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 5.43 58.06 80.08 8.57 53.00 79.37 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ax4_c05 TRYPTOPHANASE user 4 3 # 4 B 130 PHE A 132 PHE^? 1000.00 B 223 ASP A 112 ASP~? 1000.00 B 265 LYS A 80 LYS~? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 10.43 61.66 91.81 9.80 60.04 90.61 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 5.43 58.06 80.08 8.57 53.00 79.37 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ax4_c05 TRYPTOPHANASE user 5 3 # 5 B 130 PHE A 132 PHE^? 1000.00 B 223 ASP A 112 ASP~? 1000.00 B 265 LYS B 35 LYS.? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 10.43 61.66 91.81 9.80 60.04 90.61 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 5.43 58.06 80.08 8.57 53.00 79.37 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1ax4_c05 TRYPTOPHANASE user 6 3 # 6 B 130 PHE A 134 PHE.? 1000.00 B 223 ASP A 138 ASP^? 1000.00 B 265 LYS A 142 LYS.? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo 10.43 61.66 91.81 9.80 60.04 90.61 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 5.43 58.06 80.08 8.57 53.00 79.37 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1ax4_c05 TRYPTOPHANASE user 7 3 # 7 B 130 PHE B 63 PHE^? 1000.00 B 223 ASP B 112 ASP~? 1000.00 B 265 LYS B 79 LYS~? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 10.43 61.66 91.81 9.80 60.04 90.61 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 5.43 58.06 80.08 8.57 53.00 79.37 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ax4_c05 TRYPTOPHANASE user 8 3 # 8 B 130 PHE B 63 PHE^? 1000.00 B 223 ASP B 112 ASP~? 1000.00 B 265 LYS B 80 LYS~? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 10.43 61.66 91.81 9.80 60.04 90.61 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 5.43 58.06 80.08 8.57 53.00 79.37 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1ax4_c05 TRYPTOPHANASE user 9 3 # 9 B 130 PHE B 132 PHE^? 1000.00 B 223 ASP B 112 ASP~? 1000.00 B 265 LYS A 35 LYS.? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 10.43 61.66 91.81 9.80 60.04 90.61 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 5.43 58.06 80.08 8.57 53.00 79.37 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1ax4_c05 TRYPTOPHANASE user 10 3 # 10 B 130 PHE B 132 PHE^? 1000.00 B 223 ASP B 112 ASP~? 1000.00 B 265 LYS B 79 LYS~? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 10.43 61.66 91.81 9.80 60.04 90.61 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 5.43 58.06 80.08 8.57 53.00 79.37 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ax4_c05 TRYPTOPHANASE user 11 3 # 11 B 130 PHE B 132 PHE^? 1000.00 B 223 ASP B 112 ASP~? 1000.00 B 265 LYS B 80 LYS~? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 10.43 61.66 91.81 9.80 60.04 90.61 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 5.43 58.06 80.08 8.57 53.00 79.37 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1ax4_c05 TRYPTOPHANASE user 12 3 # 12 B 130 PHE B 134 PHE.? 1000.00 B 223 ASP B 138 ASP^? 1000.00 B 265 LYS B 142 LYS.? 1000.00 coo 7.48 54.94 99.62 7.67 52.27 100.42 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo 10.43 61.66 91.81 9.80 60.04 90.61 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 5.43 58.06 80.08 8.57 53.00 79.37 52.98 -12.77 -6.57 54.80 -12.93 -0.57 1ax4_c05 source 1ax4 TRYPTOPHANASE : 12 hits 1ax4_c05 naa= 3 ULMN 3 1ax4_c06 TRYPTOPHANASE user 1 3 # 1 C 130 PHE A 63 PHE^? 1000.00 C 223 ASP A 112 ASP~? 1000.00 C 265 LYS A 79 LYS~? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 21.53 4.57 4.68 19.76 2.41 4.33 coo -9.52 75.74 33.62 -8.85 73.74 33.93 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -4.44 67.20 42.32 -7.50 62.41 40.49 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ax4_c06 TRYPTOPHANASE user 2 3 # 2 C 130 PHE A 63 PHE^? 1000.00 C 223 ASP A 112 ASP~? 1000.00 C 265 LYS A 80 LYS~? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 21.53 4.57 4.68 19.76 2.41 4.33 coo -9.52 75.74 33.62 -8.85 73.74 33.93 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -4.44 67.20 42.32 -7.50 62.41 40.49 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ax4_c06 TRYPTOPHANASE user 3 3 # 3 C 130 PHE A 132 PHE^? 1000.00 C 223 ASP A 112 ASP~? 1000.00 C 265 LYS A 79 LYS~? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -9.52 75.74 33.62 -8.85 73.74 33.93 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -4.44 67.20 42.32 -7.50 62.41 40.49 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ax4_c06 TRYPTOPHANASE user 4 3 # 4 C 130 PHE A 132 PHE^? 1000.00 C 223 ASP A 112 ASP~? 1000.00 C 265 LYS A 80 LYS~? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -9.52 75.74 33.62 -8.85 73.74 33.93 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -4.44 67.20 42.32 -7.50 62.41 40.49 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ax4_c06 TRYPTOPHANASE user 5 3 # 5 C 130 PHE A 132 PHE^? 1000.00 C 223 ASP A 112 ASP~? 1000.00 C 265 LYS B 35 LYS.? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -9.52 75.74 33.62 -8.85 73.74 33.93 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -4.44 67.20 42.32 -7.50 62.41 40.49 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1ax4_c06 TRYPTOPHANASE user 6 3 # 6 C 130 PHE A 134 PHE.? 1000.00 C 223 ASP A 138 ASP^? 1000.00 C 265 LYS A 142 LYS.? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo -9.52 75.74 33.62 -8.85 73.74 33.93 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -4.44 67.20 42.32 -7.50 62.41 40.49 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1ax4_c06 TRYPTOPHANASE user 7 3 # 7 C 130 PHE B 63 PHE^? 1000.00 C 223 ASP B 112 ASP~? 1000.00 C 265 LYS B 79 LYS~? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -9.52 75.74 33.62 -8.85 73.74 33.93 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -4.44 67.20 42.32 -7.50 62.41 40.49 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ax4_c06 TRYPTOPHANASE user 8 3 # 8 C 130 PHE B 63 PHE^? 1000.00 C 223 ASP B 112 ASP~? 1000.00 C 265 LYS B 80 LYS~? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -9.52 75.74 33.62 -8.85 73.74 33.93 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -4.44 67.20 42.32 -7.50 62.41 40.49 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1ax4_c06 TRYPTOPHANASE user 9 3 # 9 C 130 PHE B 132 PHE^? 1000.00 C 223 ASP B 112 ASP~? 1000.00 C 265 LYS A 35 LYS.? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -9.52 75.74 33.62 -8.85 73.74 33.93 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -4.44 67.20 42.32 -7.50 62.41 40.49 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1ax4_c06 TRYPTOPHANASE user 10 3 # 10 C 130 PHE B 132 PHE^? 1000.00 C 223 ASP B 112 ASP~? 1000.00 C 265 LYS B 79 LYS~? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -9.52 75.74 33.62 -8.85 73.74 33.93 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -4.44 67.20 42.32 -7.50 62.41 40.49 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ax4_c06 TRYPTOPHANASE user 11 3 # 11 C 130 PHE B 132 PHE^? 1000.00 C 223 ASP B 112 ASP~? 1000.00 C 265 LYS B 80 LYS~? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -9.52 75.74 33.62 -8.85 73.74 33.93 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -4.44 67.20 42.32 -7.50 62.41 40.49 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1ax4_c06 TRYPTOPHANASE user 12 3 # 12 C 130 PHE B 134 PHE.? 1000.00 C 223 ASP B 138 ASP^? 1000.00 C 265 LYS B 142 LYS.? 1000.00 coo -6.55 73.45 23.60 -6.77 71.48 21.66 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo -9.52 75.74 33.62 -8.85 73.74 33.93 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -4.44 67.20 42.32 -7.50 62.41 40.49 52.98 -12.77 -6.57 54.80 -12.93 -0.57 1ax4_c06 source 1ax4 TRYPTOPHANASE : 12 hits 1ax4_c06 naa= 3 ULMN 3 1ax4_c07 TRYPTOPHANASE user 1 3 # 1 D 130 PHE A 63 PHE^? 1000.00 D 223 ASP A 112 ASP~? 1000.00 D 265 LYS A 79 LYS~? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 21.53 4.57 4.68 19.76 2.41 4.33 coo -29.46 51.67 48.51 -28.63 53.31 49.56 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -18.87 56.53 54.79 -19.47 62.22 53.03 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ax4_c07 TRYPTOPHANASE user 2 3 # 2 D 130 PHE A 63 PHE^? 1000.00 D 223 ASP A 112 ASP~? 1000.00 D 265 LYS A 80 LYS~? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 21.53 4.57 4.68 19.76 2.41 4.33 coo -29.46 51.67 48.51 -28.63 53.31 49.56 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -18.87 56.53 54.79 -19.47 62.22 53.03 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ax4_c07 TRYPTOPHANASE user 3 3 # 3 D 130 PHE A 132 PHE^? 1000.00 D 223 ASP A 112 ASP~? 1000.00 D 265 LYS A 79 LYS~? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -29.46 51.67 48.51 -28.63 53.31 49.56 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -18.87 56.53 54.79 -19.47 62.22 53.03 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ax4_c07 TRYPTOPHANASE user 4 3 # 4 D 130 PHE A 132 PHE^? 1000.00 D 223 ASP A 112 ASP~? 1000.00 D 265 LYS A 80 LYS~? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -29.46 51.67 48.51 -28.63 53.31 49.56 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -18.87 56.53 54.79 -19.47 62.22 53.03 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ax4_c07 TRYPTOPHANASE user 5 3 # 5 D 130 PHE A 132 PHE^? 1000.00 D 223 ASP A 112 ASP~? 1000.00 D 265 LYS B 35 LYS.? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -29.46 51.67 48.51 -28.63 53.31 49.56 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -18.87 56.53 54.79 -19.47 62.22 53.03 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1ax4_c07 TRYPTOPHANASE user 6 3 # 6 D 130 PHE A 134 PHE.? 1000.00 D 223 ASP A 138 ASP^? 1000.00 D 265 LYS A 142 LYS.? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo -29.46 51.67 48.51 -28.63 53.31 49.56 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -18.87 56.53 54.79 -19.47 62.22 53.03 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1ax4_c07 TRYPTOPHANASE user 7 3 # 7 D 130 PHE B 63 PHE^? 1000.00 D 223 ASP B 112 ASP~? 1000.00 D 265 LYS B 79 LYS~? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -29.46 51.67 48.51 -28.63 53.31 49.56 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -18.87 56.53 54.79 -19.47 62.22 53.03 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ax4_c07 TRYPTOPHANASE user 8 3 # 8 D 130 PHE B 63 PHE^? 1000.00 D 223 ASP B 112 ASP~? 1000.00 D 265 LYS B 80 LYS~? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -29.46 51.67 48.51 -28.63 53.31 49.56 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -18.87 56.53 54.79 -19.47 62.22 53.03 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1ax4_c07 TRYPTOPHANASE user 9 3 # 9 D 130 PHE B 132 PHE^? 1000.00 D 223 ASP B 112 ASP~? 1000.00 D 265 LYS A 35 LYS.? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -29.46 51.67 48.51 -28.63 53.31 49.56 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -18.87 56.53 54.79 -19.47 62.22 53.03 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1ax4_c07 TRYPTOPHANASE user 10 3 # 10 D 130 PHE B 132 PHE^? 1000.00 D 223 ASP B 112 ASP~? 1000.00 D 265 LYS B 79 LYS~? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -29.46 51.67 48.51 -28.63 53.31 49.56 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -18.87 56.53 54.79 -19.47 62.22 53.03 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ax4_c07 TRYPTOPHANASE user 11 3 # 11 D 130 PHE B 132 PHE^? 1000.00 D 223 ASP B 112 ASP~? 1000.00 D 265 LYS B 80 LYS~? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -29.46 51.67 48.51 -28.63 53.31 49.56 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -18.87 56.53 54.79 -19.47 62.22 53.03 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1ax4_c07 TRYPTOPHANASE user 12 3 # 12 D 130 PHE B 134 PHE.? 1000.00 D 223 ASP B 138 ASP^? 1000.00 D 265 LYS B 142 LYS.? 1000.00 coo -38.60 55.38 52.70 -40.06 57.72 53.04 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo -29.46 51.67 48.51 -28.63 53.31 49.56 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -18.87 56.53 54.79 -19.47 62.22 53.03 52.98 -12.77 -6.57 54.80 -12.93 -0.57 1ax4_c07 source 1ax4 TRYPTOPHANASE : 12 hits 1ax4_c07 naa= 3 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 A 145 TYR A 77 TYR~? 1000.00 A 230 ASP A 83 ASP.? 1000.00 A 273 LYS A 115 LYS~? 1000.00 coo 9.23 21.44 106.88 10.18 19.34 105.31 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 1.45 22.80 104.16 2.58 21.02 104.01 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 2.97 11.64 107.87 6.59 15.13 107.03 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1b8g_c04 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 A 145 TYR B 77 TYR~? 1000.00 A 230 ASP B 83 ASP.? 1000.00 A 273 LYS B 115 LYS~? 1000.00 coo 9.23 21.44 106.88 10.18 19.34 105.31 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 1.45 22.80 104.16 2.58 21.02 104.01 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 2.97 11.64 107.87 6.59 15.13 107.03 25.77 -5.51 -22.92 25.67 -7.99 -17.65 1b8g_c04 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c04 naa= 3 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 1 3 # 1 B 145 TYR A 77 TYR~? 1000.00 B 230 ASP A 83 ASP.? 1000.00 B 273 LYS A 115 LYS~? 1000.00 coo 11.81 13.41 73.03 10.00 13.03 75.12 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 19.17 11.01 76.14 17.26 10.42 76.77 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 11.10 2.31 76.60 10.24 7.24 75.62 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1b8g_c05 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYuser 2 3 # 2 B 145 TYR B 77 TYR~? 1000.00 B 230 ASP B 83 ASP.? 1000.00 B 273 LYS B 115 LYS~? 1000.00 coo 11.81 13.41 73.03 10.00 13.03 75.12 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 19.17 11.01 76.14 17.26 10.42 76.77 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 11.10 2.31 76.60 10.24 7.24 75.62 25.77 -5.51 -22.92 25.67 -7.99 -17.65 1b8g_c05 source 1b8g 1-AMINOCYCLOPROPANE-1-CARBOXYLATE SYNTHASE : 2 hits 1b8g_c05 naa= 3 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 1 3 # 1 A 88 PHE A 70 PHE~? 1000.00 A 159 ASP A 76 ASP~? 1000.00 A 188 LYS A 115 LYS~? 1000.00 coo 13.91 34.58 14.67 12.95 36.00 12.47 17.83 3.19 11.63 17.23 1.65 9.39 coo 20.97 28.40 16.26 20.19 30.15 15.34 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 22.55 41.65 15.60 18.92 37.20 14.63 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1b9h_c02 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHAuser 2 3 # 2 A 88 PHE B 70 PHE~? 1000.00 A 159 ASP B 76 ASP~? 1000.00 A 188 LYS B 115 LYS~? 1000.00 coo 13.91 34.58 14.67 12.95 36.00 12.47 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo 20.97 28.40 16.26 20.19 30.15 15.34 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 22.55 41.65 15.60 18.92 37.20 14.63 25.77 -5.51 -22.92 25.67 -7.99 -17.65 1b9h_c02 source 1b9h 3-AMINO-5-HYDROXYBENZOIC ACID SYNTHASE : 2 hits 1b9h_c02 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 215 ASP A 112 ASP~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 66.00 46.17 80.29 64.31 47.92 79.91 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 63.61 40.10 74.06 64.05 42.07 74.70 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP A 93 ASP.? 1000.00 35 SER A 10 SER^? 1000.00 215 ASP A 94 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 66.00 46.17 80.29 64.31 47.92 79.91 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 63.61 40.10 74.06 64.05 42.07 74.70 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1bbs_c06 RENIN user 3 3 # 3 32 ASP A 94 ASP.? 1000.00 35 SER A 96 SER.? 1000.00 215 ASP A 93 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 66.00 46.17 80.29 64.31 47.92 79.91 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 63.61 40.10 74.06 64.05 42.07 74.70 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1bbs_c06 RENIN user 4 3 # 4 32 ASP A 94 ASP.? 1000.00 35 SER A 97 SER.? 1000.00 215 ASP A 93 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 66.00 46.17 80.29 64.31 47.92 79.91 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 63.61 40.10 74.06 64.05 42.07 74.70 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1bbs_c06 RENIN user 5 3 # 5 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 215 ASP B 112 ASP~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 63.61 40.10 74.06 64.05 42.07 74.70 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1bbs_c06 RENIN user 6 3 # 6 32 ASP B 93 ASP.? 1000.00 35 SER B 10 SER^? 1000.00 215 ASP B 94 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 63.61 40.10 74.06 64.05 42.07 74.70 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1bbs_c06 RENIN user 7 3 # 7 32 ASP B 94 ASP.? 1000.00 35 SER B 96 SER.? 1000.00 215 ASP B 93 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 66.00 46.17 80.29 64.31 47.92 79.91 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 63.61 40.10 74.06 64.05 42.07 74.70 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1bbs_c06 RENIN user 8 3 # 8 32 ASP B 94 ASP.? 1000.00 35 SER B 97 SER.? 1000.00 215 ASP B 93 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 66.00 46.17 80.29 64.31 47.92 79.91 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 63.61 40.10 74.06 64.05 42.07 74.70 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1bbs_c06 source 1bbs RENIN : 8 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 215 ASP A 112 ASP~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 66.00 46.17 80.29 64.31 47.92 79.91 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 63.61 40.10 74.06 64.05 42.07 74.70 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP A 93 ASP.? 1000.00 35 SER A 10 SER^? 1000.00 215 ASP A 94 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 66.00 46.17 80.29 64.31 47.92 79.91 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 63.61 40.10 74.06 64.05 42.07 74.70 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1bbs_c07 RENIN user 3 3 # 3 32 ASP A 94 ASP.? 1000.00 35 SER A 96 SER.? 1000.00 215 ASP A 93 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 66.00 46.17 80.29 64.31 47.92 79.91 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 63.61 40.10 74.06 64.05 42.07 74.70 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1bbs_c07 RENIN user 4 3 # 4 32 ASP A 94 ASP.? 1000.00 35 SER A 97 SER.? 1000.00 215 ASP A 93 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 66.00 46.17 80.29 64.31 47.92 79.91 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 63.61 40.10 74.06 64.05 42.07 74.70 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1bbs_c07 RENIN user 5 3 # 5 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 215 ASP B 112 ASP~? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 63.61 40.10 74.06 64.05 42.07 74.70 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1bbs_c07 RENIN user 6 3 # 6 32 ASP B 93 ASP.? 1000.00 35 SER B 10 SER^? 1000.00 215 ASP B 94 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 66.00 46.17 80.29 64.31 47.92 79.91 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 63.61 40.10 74.06 64.05 42.07 74.70 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1bbs_c07 RENIN user 7 3 # 7 32 ASP B 94 ASP.? 1000.00 35 SER B 96 SER.? 1000.00 215 ASP B 93 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 66.00 46.17 80.29 64.31 47.92 79.91 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 63.61 40.10 74.06 64.05 42.07 74.70 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1bbs_c07 RENIN user 8 3 # 8 32 ASP B 94 ASP.? 1000.00 35 SER B 97 SER.? 1000.00 215 ASP B 93 ASP.? 1000.00 coo 61.19 45.85 78.73 62.86 45.48 77.48 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 66.00 46.17 80.29 64.31 47.92 79.91 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 63.61 40.10 74.06 64.05 42.07 74.70 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1bbs_c07 source 1bbs RENIN : 8 hits 1bbs_c07 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 46 ARG.? 1000.00 A 141 THR A 48 THR.? 1000.00 A 235 ASP A 108 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 6.80 92.87 28.33 4.91 92.74 27.40 2.45 5.56 -16.59 2.90 5.87 -18.70 coo 12.98 90.36 47.57 11.26 89.62 46.62 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 103 ARG^? 1000.00 A 141 THR A 101 THR.? 1000.00 A 235 ASP A 136 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 7.99 11.60 -2.28 6.58 12.81 0.15 coo 6.80 92.87 28.33 4.91 92.74 27.40 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 12.98 90.36 47.57 11.26 89.62 46.62 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG B 46 ARG.? 1000.00 A 141 THR B 48 THR.? 1000.00 A 235 ASP B 108 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 6.80 92.87 28.33 4.91 92.74 27.40 45.67 -19.41 0.89 45.70 -18.81 2.98 coo 12.98 90.36 47.57 11.26 89.62 46.62 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 99 ARG.? 1000.00 A 141 THR B 48 THR.? 1000.00 A 235 ASP B 145 ASP.? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 49.60 -13.15 1.51 47.85 -14.88 -0.33 coo 6.80 92.87 28.33 4.91 92.74 27.40 45.67 -19.41 0.89 45.70 -18.81 2.98 coo 12.98 90.36 47.57 11.26 89.62 46.62 60.34 -11.56 -8.26 58.87 -12.82 -9.07 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG B 103 ARG^? 1000.00 A 141 THR B 101 THR.? 1000.00 A 235 ASP B 136 ASP^? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo 6.80 92.87 28.33 4.91 92.74 27.40 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo 12.98 90.36 47.57 11.26 89.62 46.62 36.67 -20.70 -10.25 38.13 -21.34 -8.89 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG B 103 ARG^? 1000.00 A 141 THR B 105 THR^? 1000.00 A 235 ASP B 145 ASP.? 1000.00 coo 6.21 93.81 36.58 4.58 96.33 37.17 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo 6.80 92.87 28.33 4.91 92.74 27.40 42.53 -14.52 -12.26 43.67 -16.31 -12.51 coo 12.98 90.36 47.57 11.26 89.62 46.62 60.34 -11.56 -8.26 58.87 -12.82 -9.07 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 46 ARG.? 1000.00 D 141 THR A 48 THR.? 1000.00 D 235 ASP A 108 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo -9.24 93.49 108.77 -7.37 94.21 109.61 2.45 5.56 -16.59 2.90 5.87 -18.70 coo -14.64 87.74 89.51 -12.89 87.43 90.65 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 103 ARG^? 1000.00 D 141 THR A 87 THR^? 1000.00 D 235 ASP A 94 ASP.? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 7.99 11.60 -2.28 6.58 12.81 0.15 coo -9.24 93.49 108.77 -7.37 94.21 109.61 9.15 2.06 2.48 7.06 2.46 2.24 coo -14.64 87.74 89.51 -12.89 87.43 90.65 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 103 ARG^? 1000.00 D 141 THR A 101 THR.? 1000.00 D 235 ASP A 136 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 7.99 11.60 -2.28 6.58 12.81 0.15 coo -9.24 93.49 108.77 -7.37 94.21 109.61 9.95 15.91 -11.11 11.74 16.64 -10.15 coo -14.64 87.74 89.51 -12.89 87.43 90.65 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 46 ARG.? 1000.00 D 141 THR B 48 THR.? 1000.00 D 235 ASP B 108 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo -9.24 93.49 108.77 -7.37 94.21 109.61 45.67 -19.41 0.89 45.70 -18.81 2.98 coo -14.64 87.74 89.51 -12.89 87.43 90.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG B 99 ARG.? 1000.00 D 141 THR B 48 THR.? 1000.00 D 235 ASP B 145 ASP.? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 49.60 -13.15 1.51 47.85 -14.88 -0.33 coo -9.24 93.49 108.77 -7.37 94.21 109.61 45.67 -19.41 0.89 45.70 -18.81 2.98 coo -14.64 87.74 89.51 -12.89 87.43 90.65 60.34 -11.56 -8.26 58.87 -12.82 -9.07 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG B 103 ARG^? 1000.00 D 141 THR B 87 THR^? 1000.00 D 235 ASP B 94 ASP.? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo -9.24 93.49 108.77 -7.37 94.21 109.61 39.33 -15.38 -18.25 40.69 -17.00 -17.92 coo -14.64 87.74 89.51 -12.89 87.43 90.65 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 7 3 # 7 D 137 ARG B 103 ARG^? 1000.00 D 141 THR B 101 THR.? 1000.00 D 235 ASP B 136 ASP^? 1000.00 coo -8.33 92.80 100.06 -7.71 95.33 98.44 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo -9.24 93.49 108.77 -7.37 94.21 109.61 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo -14.64 87.74 89.51 -12.89 87.43 90.65 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 7 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 46 ARG.? 1000.00 C 141 THR A 48 THR.? 1000.00 C 235 ASP A 108 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo -6.81 68.31 28.28 -4.82 68.47 27.57 2.45 5.56 -16.59 2.90 5.87 -18.70 coo -13.01 70.96 47.58 -11.44 71.65 46.34 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 103 ARG^? 1000.00 C 141 THR A 101 THR.? 1000.00 C 235 ASP A 136 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 7.99 11.60 -2.28 6.58 12.81 0.15 coo -6.81 68.31 28.28 -4.82 68.47 27.57 9.95 15.91 -11.11 11.74 16.64 -10.15 coo -13.01 70.96 47.58 -11.44 71.65 46.34 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG B 46 ARG.? 1000.00 C 141 THR B 48 THR.? 1000.00 C 235 ASP B 108 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo -6.81 68.31 28.28 -4.82 68.47 27.57 45.67 -19.41 0.89 45.70 -18.81 2.98 coo -13.01 70.96 47.58 -11.44 71.65 46.34 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG B 46 ARG.? 1000.00 C 141 THR B 52 THR.? 1000.00 C 235 ASP B 94 ASP.? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo -6.81 68.31 28.28 -4.82 68.47 27.57 36.53 -26.90 -3.75 34.44 -26.32 -3.74 coo -13.01 70.96 47.58 -11.44 71.65 46.34 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG B 99 ARG.? 1000.00 C 141 THR B 48 THR.? 1000.00 C 235 ASP B 145 ASP.? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 49.60 -13.15 1.51 47.85 -14.88 -0.33 coo -6.81 68.31 28.28 -4.82 68.47 27.57 45.67 -19.41 0.89 45.70 -18.81 2.98 coo -13.01 70.96 47.58 -11.44 71.65 46.34 60.34 -11.56 -8.26 58.87 -12.82 -9.07 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG B 103 ARG^? 1000.00 C 141 THR B 101 THR.? 1000.00 C 235 ASP B 136 ASP^? 1000.00 coo -5.79 67.26 36.83 -4.57 64.58 37.74 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo -6.81 68.31 28.28 -4.82 68.47 27.57 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo -13.01 70.96 47.58 -11.44 71.65 46.34 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 46 ARG.? 1000.00 B 141 THR A 48 THR.? 1000.00 B 235 ASP A 108 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 8.28 67.78 108.81 6.22 67.65 109.43 2.45 5.56 -16.59 2.90 5.87 -18.70 coo 14.55 73.52 89.47 12.81 73.95 90.56 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 46 ARG.? 1000.00 B 141 THR A 52 THR.? 1000.00 B 235 ASP A 94 ASP.? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 8.28 67.78 108.81 6.22 67.65 109.43 0.54 -6.10 -11.97 2.09 -7.62 -12.03 coo 14.55 73.52 89.47 12.81 73.95 90.56 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG A 103 ARG^? 1000.00 B 141 THR A 101 THR.? 1000.00 B 235 ASP A 136 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 7.99 11.60 -2.28 6.58 12.81 0.15 coo 8.28 67.78 108.81 6.22 67.65 109.43 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 14.55 73.52 89.47 12.81 73.95 90.56 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG B 46 ARG.? 1000.00 B 141 THR B 48 THR.? 1000.00 B 235 ASP B 108 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 8.28 67.78 108.81 6.22 67.65 109.43 45.67 -19.41 0.89 45.70 -18.81 2.98 coo 14.55 73.52 89.47 12.81 73.95 90.56 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 B 137 ARG B 46 ARG.? 1000.00 B 141 THR B 52 THR.? 1000.00 B 235 ASP B 94 ASP.? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 8.28 67.78 108.81 6.22 67.65 109.43 36.53 -26.90 -3.75 34.44 -26.32 -3.74 coo 14.55 73.52 89.47 12.81 73.95 90.56 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 B 137 ARG B 103 ARG^? 1000.00 B 141 THR B 101 THR.? 1000.00 B 235 ASP B 136 ASP^? 1000.00 coo 8.13 67.41 100.27 7.18 68.35 97.45 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo 8.28 67.78 108.81 6.22 67.65 109.43 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo 14.55 73.52 89.47 12.81 73.95 90.56 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c03 naa= 3 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 1 3 # 1 B 382 ARG A 103 ARG^? 1000.00 B 451 GLU A 102 GLU.? 1000.00 B 540 GLU A 141 GLU.? 1000.00 coo 82.21 41.07 119.14 83.95 40.66 116.59 7.99 11.60 -2.28 6.58 12.81 0.15 coo 86.52 35.28 112.74 87.08 36.38 110.99 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 83.38 41.19 112.55 85.47 40.59 112.72 3.43 12.79 -4.88 2.72 12.95 -2.84 ULMN 3 1bhg_c05 BETA-GLUCURONIDASE user 2 3 # 2 B 382 ARG B 103 ARG^? 1000.00 B 451 GLU B 102 GLU.? 1000.00 B 540 GLU B 141 GLU.? 1000.00 coo 82.21 41.07 119.14 83.95 40.66 116.59 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo 86.52 35.28 112.74 87.08 36.38 110.99 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 83.38 41.19 112.55 85.47 40.59 112.72 51.50 -14.92 -10.75 52.03 -15.46 -12.75 1bhg_c05 source 1bhg BETA-GLUCURONIDASE : 2 hits 1bhg_c05 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 103 ARG^? 1000.00 A 128 GLU A 102 GLU.? 1000.00 A 225 GLU A 141 GLU.? 1000.00 coo 38.56 19.11 14.83 37.12 21.00 16.76 7.99 11.60 -2.28 6.58 12.81 0.15 coo 36.48 24.43 22.02 36.86 26.34 21.13 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 40.16 23.71 17.01 38.52 24.96 17.40 3.43 12.79 -4.88 2.72 12.95 -2.84 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG B 103 ARG^? 1000.00 A 128 GLU B 102 GLU.? 1000.00 A 225 GLU B 141 GLU.? 1000.00 coo 38.56 19.11 14.83 37.12 21.00 16.76 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo 36.48 24.43 22.02 36.86 26.34 21.13 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 40.16 23.71 17.01 38.52 24.96 17.40 51.50 -14.92 -10.75 52.03 -15.46 -12.75 1bqc_c01 source 1bqc BETA-MANNANASE : 2 hits 1bqc_c01 naa= 3 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 1 3 # 1 B1082 HIS A 25 HIS.? 1000.00 B1168 ARG A 103 ARG^? 1000.00 B1187 LYS A 27 LYS^? 1000.00 coo 35.03 5.72 103.61 36.82 5.00 102.79 17.07 12.41 6.63 15.76 13.52 7.84 coo 41.91 5.48 91.85 40.59 6.81 94.28 7.99 11.60 -2.28 6.58 12.81 0.15 coo 32.93 -0.12 99.60 37.71 2.39 99.23 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1brw_c01 PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE user 2 3 # 2 B1082 HIS B 25 HIS^? 1000.00 B1168 ARG B 103 ARG^? 1000.00 B1187 LYS B 27 LYS^? 1000.00 coo 35.03 5.72 103.61 36.82 5.00 102.79 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 41.91 5.48 91.85 40.59 6.81 94.28 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo 32.93 -0.12 99.60 37.71 2.39 99.23 40.39 -1.34 -15.57 44.33 1.39 -18.11 1brw_c01 source 1brw PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE : 2 hits 1brw_c01 naa= 3 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 1 3 # 1 A 109 PHE A 70 PHE~? 1000.00 A 205 ASP A 112 ASP~? 1000.00 A 236 LYS A 79 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 17.83 3.19 11.63 17.23 1.65 9.39 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 2 3 # 2 A 109 PHE A 86 PHE^? 1000.00 A 205 ASP A 76 ASP~? 1000.00 A 236 LYS A 69 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 3 3 # 3 A 109 PHE A 86 PHE^? 1000.00 A 205 ASP A 120 ASP.? 1000.00 A 236 LYS A 65 LYS.? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 27.77 3.65 13.30 28.81 5.07 14.48 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 23.08 10.16 8.29 20.19 14.81 10.58 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 4 3 # 4 A 109 PHE A 86 PHE^? 1000.00 A 205 ASP A 120 ASP.? 1000.00 A 236 LYS A 69 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 27.77 3.65 13.30 28.81 5.07 14.48 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 5 3 # 5 A 109 PHE A 86 PHE^? 1000.00 A 205 ASP A 120 ASP.? 1000.00 A 236 LYS A 115 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 27.77 3.65 13.30 28.81 5.07 14.48 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 6 3 # 6 A 109 PHE A 111 PHE.? 1000.00 A 205 ASP A 76 ASP~? 1000.00 A 236 LYS A 69 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 18.47 -2.15 3.63 17.47 0.36 2.95 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 7 3 # 7 A 109 PHE A 111 PHE.? 1000.00 A 205 ASP A 120 ASP.? 1000.00 A 236 LYS A 65 LYS.? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 18.47 -2.15 3.63 17.47 0.36 2.95 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 27.77 3.65 13.30 28.81 5.07 14.48 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 23.08 10.16 8.29 20.19 14.81 10.58 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 8 3 # 8 A 109 PHE A 111 PHE.? 1000.00 A 205 ASP A 120 ASP.? 1000.00 A 236 LYS A 69 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 18.47 -2.15 3.63 17.47 0.36 2.95 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 27.77 3.65 13.30 28.81 5.07 14.48 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 9 3 # 9 A 109 PHE A 132 PHE^? 1000.00 A 205 ASP A 93 ASP.? 1000.00 A 236 LYS A 27 LYS^? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 10 3 # 10 A 109 PHE A 134 PHE.? 1000.00 A 205 ASP A 93 ASP.? 1000.00 A 236 LYS A 27 LYS^? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 11 3 # 11 A 109 PHE A 134 PHE.? 1000.00 A 205 ASP A 94 ASP.? 1000.00 A 236 LYS A 12 LYS^? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 17.98 11.97 -5.29 22.40 15.81 -5.00 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 12 3 # 12 A 109 PHE B 70 PHE~? 1000.00 A 205 ASP B 112 ASP~? 1000.00 A 236 LYS B 79 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 13 3 # 13 A 109 PHE B 86 PHE^? 1000.00 A 205 ASP B 76 ASP~? 1000.00 A 236 LYS B 69 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 14 3 # 14 A 109 PHE B 86 PHE^? 1000.00 A 205 ASP B 120 ASP.? 1000.00 A 236 LYS B 65 LYS.? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 39.44 0.72 -24.06 44.98 0.54 -26.26 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 15 3 # 15 A 109 PHE B 86 PHE^? 1000.00 A 205 ASP B 120 ASP.? 1000.00 A 236 LYS B 69 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 16 3 # 16 A 109 PHE B 86 PHE^? 1000.00 A 205 ASP B 120 ASP.? 1000.00 A 236 LYS B 115 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 17 3 # 17 A 109 PHE B 111 PHE.? 1000.00 A 205 ASP B 76 ASP~? 1000.00 A 236 LYS B 69 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 18 3 # 18 A 109 PHE B 111 PHE.? 1000.00 A 205 ASP B 120 ASP.? 1000.00 A 236 LYS B 65 LYS.? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 39.44 0.72 -24.06 44.98 0.54 -26.26 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 19 3 # 19 A 109 PHE B 111 PHE.? 1000.00 A 205 ASP B 120 ASP.? 1000.00 A 236 LYS B 69 LYS~? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 20 3 # 20 A 109 PHE B 132 PHE^? 1000.00 A 205 ASP B 93 ASP.? 1000.00 A 236 LYS B 27 LYS^? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 40.39 -1.34 -15.57 44.33 1.39 -18.11 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 21 3 # 21 A 109 PHE B 134 PHE.? 1000.00 A 205 ASP B 93 ASP.? 1000.00 A 236 LYS B 27 LYS^? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 40.39 -1.34 -15.57 44.33 1.39 -18.11 ULMN 3 1bs0_c01 8-AMINO-7-OXONANOATE SYNTHASE user 22 3 # 22 A 109 PHE B 134 PHE.? 1000.00 A 205 ASP B 94 ASP.? 1000.00 A 236 LYS B 12 LYS^? 1000.00 coo 4.14 2.10 36.34 6.69 3.08 36.92 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo 0.29 -1.62 50.50 1.21 -2.50 52.18 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 6.34 -8.87 44.53 6.49 -3.84 42.65 43.44 -2.72 -10.47 44.74 2.97 -10.70 1bs0_c01 source 1bs0 8-AMINO-7-OXONANOATE SYNTHASE : 22 hits 1bs0_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 89 GLN^? 1000.00 A 91 LEU A 88 LEU^? 1000.00 A 133 GLU A 22 GLU^? 1000.00 coo 43.58 43.67 66.73 42.32 42.78 68.15 7.97 8.72 -0.68 6.11 9.06 0.27 coo 38.58 45.09 70.44 38.28 45.21 72.59 12.94 3.71 0.03 14.38 5.02 -0.93 coo 44.05 36.87 70.65 43.15 38.64 69.97 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 89 GLN^? 1000.00 A 91 LEU B 88 LEU^? 1000.00 A 133 GLU B 22 GLU^? 1000.00 coo 43.58 43.67 66.73 42.32 42.78 68.15 45.67 -13.21 -15.00 46.89 -14.67 -15.95 coo 38.58 45.09 70.44 38.28 45.21 72.59 38.84 -11.30 -15.82 39.13 -9.43 -14.76 coo 44.05 36.87 70.65 43.15 38.64 69.97 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 2 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN A 89 GLN^? 1000.00 B 591 LEU A 88 LEU^? 1000.00 B 633 GLU A 22 GLU^? 1000.00 coo 88.06 44.34 57.19 89.06 45.53 55.74 7.97 8.72 -0.68 6.11 9.06 0.27 coo 86.70 48.66 52.61 87.15 48.69 50.51 12.94 3.71 0.03 14.38 5.02 -0.93 coo 95.42 44.52 54.43 93.46 45.31 54.70 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 2 3 # 2 B 550 GLN B 89 GLN^? 1000.00 B 591 LEU B 88 LEU^? 1000.00 B 633 GLU B 22 GLU^? 1000.00 coo 88.06 44.34 57.19 89.06 45.53 55.74 45.67 -13.21 -15.00 46.89 -14.67 -15.95 coo 86.70 48.66 52.61 87.15 48.69 50.51 38.84 -11.30 -15.82 39.13 -9.43 -14.76 coo 95.42 44.52 54.43 93.46 45.31 54.70 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 2 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN A 89 GLN^? 1000.00 C1091 LEU A 88 LEU^? 1000.00 C1133 GLU A 22 GLU^? 1000.00 coo 68.29 34.44 43.03 66.67 34.74 44.37 7.97 8.72 -0.68 6.11 9.06 0.27 coo 65.83 38.95 47.05 65.46 38.90 49.20 12.94 3.71 0.03 14.38 5.02 -0.93 coo 63.14 29.39 46.25 63.84 31.31 45.74 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 2 3 # 2 C1050 GLN B 89 GLN^? 1000.00 C1091 LEU B 88 LEU^? 1000.00 C1133 GLU B 22 GLU^? 1000.00 coo 68.29 34.44 43.03 66.67 34.74 44.37 45.67 -13.21 -15.00 46.89 -14.67 -15.95 coo 65.83 38.95 47.05 65.46 38.90 49.20 38.84 -11.30 -15.82 39.13 -9.43 -14.76 coo 63.14 29.39 46.25 63.84 31.31 45.74 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 2 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN A 89 GLN^? 1000.00 A 91 LEU A 88 LEU^? 1000.00 A 133 GLU A 22 GLU^? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 7.97 8.72 -0.68 6.11 9.06 0.27 coo 35.40 53.22 73.30 35.37 54.87 74.74 12.94 3.71 0.03 14.38 5.02 -0.93 coo 45.08 56.04 70.60 43.15 55.19 70.77 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 2 3 # 2 A 50 GLN B 89 GLN^? 1000.00 A 91 LEU B 88 LEU^? 1000.00 A 133 GLU B 22 GLU^? 1000.00 coo 38.23 53.34 67.59 38.84 53.87 69.56 45.67 -13.21 -15.00 46.89 -14.67 -15.95 coo 35.40 53.22 73.30 35.37 54.87 74.74 38.84 -11.30 -15.82 39.13 -9.43 -14.76 coo 45.08 56.04 70.60 43.15 55.19 70.77 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 2 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 94 ASP.? 1000.00 B 354 GLU A 102 GLU.? 1000.00 B 421 ASP A 138 ASP^? 1000.00 coo 25.90 8.19 53.87 25.36 6.97 52.29 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 27.87 10.66 47.95 27.82 8.60 48.27 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 26.02 1.87 43.38 25.90 1.97 45.49 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP B 94 ASP.? 1000.00 B 354 GLU B 102 GLU.? 1000.00 B 421 ASP B 138 ASP^? 1000.00 coo 25.90 8.19 53.87 25.36 6.97 52.29 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 27.87 10.66 47.95 27.82 8.60 48.27 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 26.02 1.87 43.38 25.90 1.97 45.49 42.87 -18.30 -9.07 44.47 -19.54 -8.54 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 2 hits 1bvz_c09 naa= 3 ULMN 3 1c54_c00 RIBONUCLEASE SA user 1 3 # 1 A 54 GLU B 39 GLU.? 1000.00 A 65 ARG B 46 ARG.? 1000.00 A 85 HIS B 50 HIS.? 1000.00 coo -3.75 5.08 -16.45 -4.49 7.03 -16.67 32.13 -23.52 1.49 32.40 -25.50 0.81 coo -11.31 0.89 -21.51 -13.74 2.37 -20.15 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo -11.98 -0.40 -12.41 -12.65 1.37 -13.15 43.22 -28.55 -1.93 42.31 -30.23 -2.82 1c54_c00 source 1c54 RIBONUCLEASE SA : 1 hits 1c54_c00 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 83 ASP.? 1000.00 264 GLU A 21 GLU^? 1000.00 328 ASP A 76 ASP~? 1000.00 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 59.69 92.71 39.85 58.53 92.03 41.47 8.36 5.57 14.13 8.30 3.77 15.28 coo 45.39 90.72 40.63 45.07 89.14 41.90 16.07 -4.78 18.64 16.16 -4.88 20.75 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP A 83 ASP.? 1000.00 264 GLU A 34 GLU.? 1000.00 328 ASP A 108 ASP^? 1000.00 coo 45.62 80.42 43.69 45.65 82.01 45.07 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 59.69 92.71 39.85 58.53 92.03 41.47 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 45.39 90.72 40.63 45.07 89.14 41.90 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 3 3 # 3 229 ASP A 108 ASP^? 1000.00 264 GLU A 30 GLU^? 1000.00 328 ASP A 138 ASP^? 1000.00 coo 45.62 80.42 43.69 45.65 82.01 45.07 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 59.69 92.71 39.85 58.53 92.03 41.47 20.47 3.27 -9.94 22.27 3.25 -11.07 coo 45.39 90.72 40.63 45.07 89.14 41.90 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 4 3 # 4 229 ASP A 108 ASP^? 1000.00 264 GLU A 39 GLU.? 1000.00 328 ASP A 138 ASP^? 1000.00 coo 45.62 80.42 43.69 45.65 82.01 45.07 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 59.69 92.71 39.85 58.53 92.03 41.47 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 45.39 90.72 40.63 45.07 89.14 41.90 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 5 3 # 5 229 ASP B 83 ASP.? 1000.00 264 GLU B 21 GLU^? 1000.00 328 ASP B 76 ASP~? 1000.00 coo 45.62 80.42 43.69 45.65 82.01 45.07 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 59.69 92.71 39.85 58.53 92.03 41.47 42.84 -14.24 -29.87 41.38 -15.19 -31.09 coo 45.39 90.72 40.63 45.07 89.14 41.90 30.14 -12.79 -34.44 30.07 -12.72 -36.56 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 6 3 # 6 229 ASP B 83 ASP.? 1000.00 264 GLU B 34 GLU.? 1000.00 328 ASP B 108 ASP^? 1000.00 coo 45.62 80.42 43.69 45.65 82.01 45.07 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 59.69 92.71 39.85 58.53 92.03 41.47 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 45.39 90.72 40.63 45.07 89.14 41.90 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 7 3 # 7 229 ASP B 108 ASP^? 1000.00 264 GLU B 30 GLU^? 1000.00 328 ASP B 138 ASP^? 1000.00 coo 45.62 80.42 43.69 45.65 82.01 45.07 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 34.72 -4.99 -5.76 33.75 -3.44 -4.67 coo 45.39 90.72 40.63 45.07 89.14 41.90 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 8 3 # 8 229 ASP B 108 ASP^? 1000.00 264 GLU B 39 GLU.? 1000.00 328 ASP B 138 ASP^? 1000.00 coo 45.62 80.42 43.69 45.65 82.01 45.07 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 59.69 92.71 39.85 58.53 92.03 41.47 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 45.39 90.72 40.63 45.07 89.14 41.90 42.87 -18.30 -9.07 44.47 -19.54 -8.54 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 8 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 81 GLY.? 1000.00 A 228 SER A 113 SER~? 1000.00 A 549 ASP A 112 ASP~? 1000.00 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 16.94 -12.68 13.10 16.25 -12.29 13.20 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 19.73 -5.92 9.27 17.80 -7.10 10.12 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 100 GLY.? 1000.00 A 228 SER A 97 SER.? 1000.00 A 549 ASP A 94 ASP.? 1000.00 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 9.03 17.25 -14.58 9.15 16.40 -14.49 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY B 81 GLY.? 1000.00 A 228 SER B 113 SER~? 1000.00 A 549 ASP B 112 ASP~? 1000.00 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 22.77 -15.98 -28.97 23.45 -16.38 -29.05 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY B 100 GLY.? 1000.00 A 228 SER B 96 SER.? 1000.00 A 549 ASP B 94 ASP.? 1000.00 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 52.42 -7.85 -1.06 51.64 -8.21 -1.17 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY B 100 GLY.? 1000.00 A 228 SER B 97 SER.? 1000.00 A 549 ASP B 94 ASP.? 1000.00 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 52.42 -7.85 -1.06 51.64 -8.21 -1.17 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 44.37 -6.89 -0.93 43.32 -7.23 0.90 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 5 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 81 GLY.? 1000.00 B1228 SER A 113 SER~? 1000.00 B1549 ASP A 112 ASP~? 1000.00 coo 126.34 72.75 125.66 125.95 73.27 126.11 16.94 -12.68 13.10 16.25 -12.29 13.20 coo 131.65 74.68 129.41 130.31 72.73 128.82 19.73 -5.92 9.27 17.80 -7.10 10.12 coo 134.72 69.43 130.42 133.03 70.65 130.08 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY B 81 GLY.? 1000.00 B1228 SER B 113 SER~? 1000.00 B1549 ASP B 112 ASP~? 1000.00 coo 126.34 72.75 125.66 125.95 73.27 126.11 22.77 -15.98 -28.97 23.45 -16.38 -29.05 coo 131.65 74.68 129.41 130.31 72.73 128.82 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo 134.72 69.43 130.42 133.03 70.65 130.08 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 2 hits 1cjy_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 83 ASP.? 1000.00 37 SER A 82 SER.? 1000.00 216 ASP A 112 ASP~? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 12.23 24.31 30.40 14.55 23.96 31.03 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 13.93 25.52 22.10 14.75 24.44 23.75 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP A 93 ASP.? 1000.00 37 SER A 10 SER^? 1000.00 216 ASP A 94 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 12.23 24.31 30.40 14.55 23.96 31.03 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 13.93 25.52 22.10 14.75 24.44 23.75 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 3 3 # 3 34 ASP A 94 ASP.? 1000.00 37 SER A 96 SER.? 1000.00 216 ASP A 93 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 12.23 24.31 30.40 14.55 23.96 31.03 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 13.93 25.52 22.10 14.75 24.44 23.75 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 4 3 # 4 34 ASP A 94 ASP.? 1000.00 37 SER A 97 SER.? 1000.00 216 ASP A 93 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 12.23 24.31 30.40 14.55 23.96 31.03 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 13.93 25.52 22.10 14.75 24.44 23.75 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 5 3 # 5 34 ASP B 83 ASP.? 1000.00 37 SER B 82 SER.? 1000.00 216 ASP B 112 ASP~? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 12.23 24.31 30.40 14.55 23.96 31.03 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 13.93 25.52 22.10 14.75 24.44 23.75 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 6 3 # 6 34 ASP B 93 ASP.? 1000.00 37 SER B 10 SER^? 1000.00 216 ASP B 94 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 12.23 24.31 30.40 14.55 23.96 31.03 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 13.93 25.52 22.10 14.75 24.44 23.75 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 7 3 # 7 34 ASP B 94 ASP.? 1000.00 37 SER B 96 SER.? 1000.00 216 ASP B 93 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 12.23 24.31 30.40 14.55 23.96 31.03 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 13.93 25.52 22.10 14.75 24.44 23.75 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 8 3 # 8 34 ASP B 94 ASP.? 1000.00 37 SER B 97 SER.? 1000.00 216 ASP B 93 ASP.? 1000.00 coo 16.90 26.20 29.49 16.22 24.50 28.41 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 12.23 24.31 30.40 14.55 23.96 31.03 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 13.93 25.52 22.10 14.75 24.44 23.75 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 8 hits 1cms_c04 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 107 TYR^? 1000.00 A 173 ASP A 108 ASP^? 1000.00 C 48 ARG A 46 ARG.? 1000.00 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 5.16 0.23 -2.44 3.66 2.42 -3.25 coo 24.35 4.55 25.11 25.94 3.23 25.53 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 107 TYR^? 1000.00 A 173 ASP B 108 ASP^? 1000.00 C 48 ARG B 46 ARG.? 1000.00 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 24.35 4.55 25.11 25.94 3.23 25.53 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 46 ARG.? 1000.00 C 101 TYR A 107 TYR^? 1000.00 C 173 ASP A 108 ASP^? 1000.00 coo 32.27 5.62 48.15 31.93 6.48 51.06 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 29.64 3.64 57.39 31.22 5.14 55.65 5.16 0.23 -2.44 3.66 2.42 -3.25 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 46 ARG.? 1000.00 C 101 TYR B 107 TYR^? 1000.00 C 173 ASP B 108 ASP^? 1000.00 coo 32.27 5.62 48.15 31.93 6.48 51.06 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 29.64 3.64 57.39 31.22 5.14 55.65 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 46 ARG.? 1000.00 D 101 TYR A 107 TYR^? 1000.00 D 173 ASP A 108 ASP^? 1000.00 coo 69.08 8.58 32.60 69.70 10.81 30.58 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 71.77 11.86 24.26 70.23 12.22 26.56 5.16 0.23 -2.44 3.66 2.42 -3.25 coo 71.60 6.14 19.25 70.26 6.87 20.69 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 46 ARG.? 1000.00 D 101 TYR B 107 TYR^? 1000.00 D 173 ASP B 108 ASP^? 1000.00 coo 69.08 8.58 32.60 69.70 10.81 30.58 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 71.77 11.86 24.26 70.23 12.22 26.56 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 71.60 6.14 19.25 70.26 6.87 20.69 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 107 TYR^? 1000.00 B 173 ASP A 108 ASP^? 1000.00 D 48 ARG A 46 ARG.? 1000.00 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 5.16 0.23 -2.44 3.66 2.42 -3.25 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 107 TYR^? 1000.00 B 173 ASP B 108 ASP^? 1000.00 D 48 ARG B 46 ARG.? 1000.00 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c03 naa= 3 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 1 3 # 1 A 1 ALA A 31 ALA^? 1000.00 A 74 ASN A 32 ASN^? 1000.00 A 75 GLY A 57 GLY^? 1000.00 coo -1.80 62.71 122.76 -1.88 63.70 123.92 17.12 0.46 -8.20 15.69 0.46 -7.68 coo 1.20 66.40 122.20 2.03 64.53 121.46 17.67 -2.87 -11.10 19.38 -1.89 -11.87 coo 4.68 65.84 125.52 4.11 65.60 126.05 13.45 -5.68 -8.13 13.35 -5.77 -7.37 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 2 3 # 2 A 1 ALA A 55 ALA.? 1000.00 A 74 ASN A 56 ASN.? 1000.00 A 75 GLY A 57 GLY^? 1000.00 coo -1.80 62.71 122.76 -1.88 63.70 123.92 7.72 -4.11 -10.29 7.07 -2.77 -10.02 coo 1.20 66.40 122.20 2.03 64.53 121.46 9.46 -7.73 -7.73 9.95 -8.79 -9.49 coo 4.68 65.84 125.52 4.11 65.60 126.05 13.45 -5.68 -8.13 13.35 -5.77 -7.37 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 3 3 # 3 A 1 ALA B 31 ALA^? 1000.00 A 74 ASN B 32 ASN^? 1000.00 A 75 GLY B 57 GLY^? 1000.00 coo -1.80 62.71 122.76 -1.88 63.70 123.92 33.94 -9.24 -7.62 34.64 -10.47 -8.18 coo 1.20 66.40 122.20 2.03 64.53 121.46 30.82 -10.44 -4.63 30.86 -8.45 -3.90 coo 4.68 65.84 125.52 4.11 65.60 126.05 30.34 -15.56 -7.68 30.36 -15.69 -8.45 ULMN 3 1ct9_c04 ASPARAGINE SYNTHETASE B user 4 3 # 4 A 1 ALA B 55 ALA.? 1000.00 A 74 ASN B 56 ASN.? 1000.00 A 75 GLY B 57 GLY^? 1000.00 coo -1.80 62.71 122.76 -1.88 63.70 123.92 34.72 -19.64 -5.52 36.20 -19.58 -5.81 coo 1.20 66.40 122.20 2.03 64.53 121.46 30.64 -19.94 -7.98 29.63 -20.11 -6.12 coo 4.68 65.84 125.52 4.11 65.60 126.05 30.34 -15.56 -7.68 30.36 -15.69 -8.45 1ct9_c04 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c04 naa= 3 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 1 3 # 1 B 1 ALA A 31 ALA^? 1000.00 B 74 ASN A 32 ASN^? 1000.00 B 75 GLY A 57 GLY^? 1000.00 coo 39.21 14.97 27.55 40.19 16.01 27.08 17.12 0.46 -8.20 15.69 0.46 -7.68 coo 43.06 12.94 25.74 42.26 11.81 27.44 17.67 -2.87 -11.10 19.38 -1.89 -11.87 coo 46.38 13.54 29.18 46.14 14.29 29.26 13.45 -5.68 -8.13 13.35 -5.77 -7.37 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 2 3 # 2 B 1 ALA A 55 ALA.? 1000.00 B 74 ASN A 56 ASN.? 1000.00 B 75 GLY A 57 GLY^? 1000.00 coo 39.21 14.97 27.55 40.19 16.01 27.08 7.72 -4.11 -10.29 7.07 -2.77 -10.02 coo 43.06 12.94 25.74 42.26 11.81 27.44 9.46 -7.73 -7.73 9.95 -8.79 -9.49 coo 46.38 13.54 29.18 46.14 14.29 29.26 13.45 -5.68 -8.13 13.35 -5.77 -7.37 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 3 3 # 3 B 1 ALA B 31 ALA^? 1000.00 B 74 ASN B 32 ASN^? 1000.00 B 75 GLY B 57 GLY^? 1000.00 coo 39.21 14.97 27.55 40.19 16.01 27.08 33.94 -9.24 -7.62 34.64 -10.47 -8.18 coo 43.06 12.94 25.74 42.26 11.81 27.44 30.82 -10.44 -4.63 30.86 -8.45 -3.90 coo 46.38 13.54 29.18 46.14 14.29 29.26 30.34 -15.56 -7.68 30.36 -15.69 -8.45 ULMN 3 1ct9_c05 ASPARAGINE SYNTHETASE B user 4 3 # 4 B 1 ALA B 55 ALA.? 1000.00 B 74 ASN B 56 ASN.? 1000.00 B 75 GLY B 57 GLY^? 1000.00 coo 39.21 14.97 27.55 40.19 16.01 27.08 34.72 -19.64 -5.52 36.20 -19.58 -5.81 coo 43.06 12.94 25.74 42.26 11.81 27.44 30.64 -19.94 -7.98 29.63 -20.11 -6.12 coo 46.38 13.54 29.18 46.14 14.29 29.26 30.34 -15.56 -7.68 30.36 -15.69 -8.45 1ct9_c05 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c05 naa= 3 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 1 3 # 1 C 1 ALA A 31 ALA^? 1000.00 C 74 ASN A 32 ASN^? 1000.00 C 75 GLY A 57 GLY^? 1000.00 coo 16.14 15.08 36.63 15.28 14.65 37.81 17.12 0.46 -8.20 15.69 0.46 -7.68 coo 11.60 16.13 36.70 12.80 17.74 35.96 17.67 -2.87 -11.10 19.38 -1.89 -11.87 coo 10.99 19.23 40.32 11.50 18.77 40.74 13.45 -5.68 -8.13 13.35 -5.77 -7.37 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 2 3 # 2 C 1 ALA A 55 ALA.? 1000.00 C 74 ASN A 56 ASN.? 1000.00 C 75 GLY A 57 GLY^? 1000.00 coo 16.14 15.08 36.63 15.28 14.65 37.81 7.72 -4.11 -10.29 7.07 -2.77 -10.02 coo 11.60 16.13 36.70 12.80 17.74 35.96 9.46 -7.73 -7.73 9.95 -8.79 -9.49 coo 10.99 19.23 40.32 11.50 18.77 40.74 13.45 -5.68 -8.13 13.35 -5.77 -7.37 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 3 3 # 3 C 1 ALA B 31 ALA^? 1000.00 C 74 ASN B 32 ASN^? 1000.00 C 75 GLY B 57 GLY^? 1000.00 coo 16.14 15.08 36.63 15.28 14.65 37.81 33.94 -9.24 -7.62 34.64 -10.47 -8.18 coo 11.60 16.13 36.70 12.80 17.74 35.96 30.82 -10.44 -4.63 30.86 -8.45 -3.90 coo 10.99 19.23 40.32 11.50 18.77 40.74 30.34 -15.56 -7.68 30.36 -15.69 -8.45 ULMN 3 1ct9_c06 ASPARAGINE SYNTHETASE B user 4 3 # 4 C 1 ALA B 55 ALA.? 1000.00 C 74 ASN B 56 ASN.? 1000.00 C 75 GLY B 57 GLY^? 1000.00 coo 16.14 15.08 36.63 15.28 14.65 37.81 34.72 -19.64 -5.52 36.20 -19.58 -5.81 coo 11.60 16.13 36.70 12.80 17.74 35.96 30.64 -19.94 -7.98 29.63 -20.11 -6.12 coo 10.99 19.23 40.32 11.50 18.77 40.74 30.34 -15.56 -7.68 30.36 -15.69 -8.45 1ct9_c06 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c06 naa= 3 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 1 3 # 1 D 1 ALA A 31 ALA^? 1000.00 D 74 ASN A 32 ASN^? 1000.00 D 75 GLY A 57 GLY^? 1000.00 coo -13.31 41.90 116.45 -13.05 40.39 116.25 17.12 0.46 -8.20 15.69 0.46 -7.68 coo -16.85 39.36 115.26 -17.55 40.58 116.90 17.67 -2.87 -11.10 19.38 -1.89 -11.87 coo -17.65 36.37 119.00 -16.85 36.22 119.00 13.45 -5.68 -8.13 13.35 -5.77 -7.37 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 2 3 # 2 D 1 ALA A 55 ALA.? 1000.00 D 74 ASN A 56 ASN.? 1000.00 D 75 GLY A 57 GLY^? 1000.00 coo -13.31 41.90 116.45 -13.05 40.39 116.25 7.72 -4.11 -10.29 7.07 -2.77 -10.02 coo -16.85 39.36 115.26 -17.55 40.58 116.90 9.46 -7.73 -7.73 9.95 -8.79 -9.49 coo -17.65 36.37 119.00 -16.85 36.22 119.00 13.45 -5.68 -8.13 13.35 -5.77 -7.37 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 3 3 # 3 D 1 ALA B 31 ALA^? 1000.00 D 74 ASN B 32 ASN^? 1000.00 D 75 GLY B 57 GLY^? 1000.00 coo -13.31 41.90 116.45 -13.05 40.39 116.25 33.94 -9.24 -7.62 34.64 -10.47 -8.18 coo -16.85 39.36 115.26 -17.55 40.58 116.90 30.82 -10.44 -4.63 30.86 -8.45 -3.90 coo -17.65 36.37 119.00 -16.85 36.22 119.00 30.34 -15.56 -7.68 30.36 -15.69 -8.45 ULMN 3 1ct9_c07 ASPARAGINE SYNTHETASE B user 4 3 # 4 D 1 ALA B 55 ALA.? 1000.00 D 74 ASN B 56 ASN.? 1000.00 D 75 GLY B 57 GLY^? 1000.00 coo -13.31 41.90 116.45 -13.05 40.39 116.25 34.72 -19.64 -5.52 36.20 -19.58 -5.81 coo -16.85 39.36 115.26 -17.55 40.58 116.90 30.64 -19.94 -7.98 29.63 -20.11 -6.12 coo -17.65 36.37 119.00 -16.85 36.22 119.00 30.34 -15.56 -7.68 30.36 -15.69 -8.45 1ct9_c07 source 1ct9 ASPARAGINE SYNTHETASE B : 4 hits 1ct9_c07 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 19 ASP.? 1000.00 315 GLU A 21 GLU^? 1000.00 390 TYR A 77 TYR~? 1000.00 coo 32.46 99.13 19.34 30.94 100.38 20.07 5.19 0.54 10.51 3.14 -0.02 10.52 coo 32.04 94.22 18.23 30.57 94.75 16.88 8.36 5.57 14.13 8.30 3.77 15.28 coo 21.10 94.74 18.36 23.09 96.71 18.59 14.18 -5.59 13.28 11.48 -4.87 13.03 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 1 hits 1ctn_c00 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 64 TYR.? 1000.00 A 243 ASP A 83 ASP.? 1000.00 A 272 LYS A 79 LYS~? 1000.00 coo 2.03 68.31 21.46 0.66 68.36 23.90 22.50 12.53 4.97 22.72 14.77 6.66 coo 16.93 55.67 9.65 17.16 54.23 11.19 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 14.13 45.79 13.40 14.25 49.41 18.30 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 2 3 # 2 A 173 TYR A 64 TYR.? 1000.00 A 243 ASP A 83 ASP.? 1000.00 A 272 LYS A 80 LYS~? 1000.00 coo 2.03 68.31 21.46 0.66 68.36 23.90 22.50 12.53 4.97 22.72 14.77 6.66 coo 16.93 55.67 9.65 17.16 54.23 11.19 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 14.13 45.79 13.40 14.25 49.41 18.30 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 3 3 # 3 A 173 TYR B 64 TYR.? 1000.00 A 243 ASP B 83 ASP.? 1000.00 A 272 LYS B 79 LYS~? 1000.00 coo 2.03 68.31 21.46 0.66 68.36 23.90 41.81 1.40 -20.74 43.72 2.68 -22.34 coo 16.93 55.67 9.65 17.16 54.23 11.19 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 14.13 45.79 13.40 14.25 49.41 18.30 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 4 3 # 4 A 173 TYR B 64 TYR.? 1000.00 A 243 ASP B 83 ASP.? 1000.00 A 272 LYS B 80 LYS~? 1000.00 coo 2.03 68.31 21.46 0.66 68.36 23.90 41.81 1.40 -20.74 43.72 2.68 -22.34 coo 16.93 55.67 9.65 17.16 54.23 11.19 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 14.13 45.79 13.40 14.25 49.41 18.30 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 4 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 A 145 LYS A 115 LYS~? 1000.00 A 177 GLU A 128 GLU.? 1000.00 A 201 LEU A 119 LEU.? 1000.00 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 24.53 -4.83 7.12 22.37 -6.02 1.89 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 29.43 4.89 3.07 29.04 6.89 3.60 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 25.78 2.07 9.10 24.60 1.30 7.47 ULMN 3 1daa_c00 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 A 145 LYS B 115 LYS~? 1000.00 A 177 GLU B 128 GLU.? 1000.00 A 201 LEU B 119 LEU.? 1000.00 coo 46.63 -7.12 50.78 48.41 -11.39 47.79 25.77 -5.51 -22.92 25.67 -7.99 -17.65 coo 47.18 -4.46 40.10 47.54 -4.70 42.20 31.74 3.63 -18.85 33.68 4.26 -19.34 coo 49.45 -5.57 45.73 49.73 -6.78 47.47 31.13 -0.98 -24.87 31.03 -2.37 -23.23 1daa_c00 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c00 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS A 115 LYS~? 1000.00 B 177 GLU A 128 GLU.? 1000.00 B 201 LEU A 119 LEU.? 1000.00 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 24.53 -4.83 7.12 22.37 -6.02 1.89 coo 27.00 6.35 51.01 26.30 4.53 50.18 29.43 4.89 3.07 29.04 6.89 3.60 coo 23.74 1.68 49.50 22.87 -0.24 49.97 25.78 2.07 9.10 24.60 1.30 7.47 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 2 3 # 2 B 145 LYS B 115 LYS~? 1000.00 B 177 GLU B 128 GLU.? 1000.00 B 201 LEU B 119 LEU.? 1000.00 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 25.77 -5.51 -22.92 25.67 -7.99 -17.65 coo 27.00 6.35 51.01 26.30 4.53 50.18 31.74 3.63 -18.85 33.68 4.26 -19.34 coo 23.74 1.68 49.50 22.87 -0.24 49.97 31.13 -0.98 -24.87 31.03 -2.37 -23.23 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 2 hits 1daa_c01 naa= 3 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 1 3 # 1 A 132 THR A 62 THR^? 1000.00 A 156 TYR A 64 TYR.? 1000.00 A 160 LYS A 27 LYS^? 1000.00 coo 10.50 56.87 17.73 11.24 57.93 19.43 23.75 4.97 0.22 25.24 5.64 -1.20 coo 11.64 63.07 23.95 11.76 62.47 21.20 22.50 12.53 4.97 22.72 14.77 6.66 coo 5.78 61.30 21.65 8.04 62.89 17.54 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1db3_c01 GDP-MANNOSE 4,6-DEHYDRATASE user 2 3 # 2 A 132 THR B 62 THR^? 1000.00 A 156 TYR B 64 TYR.? 1000.00 A 160 LYS B 27 LYS^? 1000.00 coo 10.50 56.87 17.73 11.24 57.93 19.43 34.62 -1.27 -15.97 34.38 0.39 -14.61 coo 11.64 63.07 23.95 11.76 62.47 21.20 41.81 1.40 -20.74 43.72 2.68 -22.34 coo 5.78 61.30 21.65 8.04 62.89 17.54 40.39 -1.34 -15.57 44.33 1.39 -18.11 1db3_c01 source 1db3 GDP-MANNOSE 4,6-DEHYDRATASE : 2 hits 1db3_c01 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 34 GLU.? 1000.00 A 226 THR B 62 THR^? 1000.00 A 229 LYS B 27 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 7.24 97.46 49.60 8.11 95.69 48.80 34.62 -1.27 -15.97 34.38 0.39 -14.61 coo 10.53 97.56 43.71 9.33 93.71 47.17 40.39 -1.34 -15.57 44.33 1.39 -18.11 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU B 34 GLU.? 1000.00 A 226 THR A 62 THR^? 1000.00 A 229 LYS A 27 LYS^? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 7.24 97.46 49.60 8.11 95.69 48.80 23.75 4.97 0.22 25.24 5.64 -1.20 coo 10.53 97.56 43.71 9.33 93.71 47.17 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 A 57 GLU B 127 GLU.? 1000.00 A 226 THR A 101 THR.? 1000.00 A 229 LYS A 142 LYS.? 1000.00 coo 9.66 102.78 70.07 9.79 101.18 71.42 25.72 3.94 -16.30 25.78 4.20 -14.20 coo 7.24 97.46 49.60 8.11 95.69 48.80 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 10.53 97.56 43.71 9.33 93.71 47.17 4.61 15.20 -9.08 3.33 16.81 -15.04 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 34 GLU.? 1000.00 B 226 THR B 62 THR^? 1000.00 B 229 LYS B 27 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 20.74 95.78 68.68 19.29 96.84 69.83 34.62 -1.27 -15.97 34.38 0.39 -14.61 coo 22.32 101.61 71.64 17.89 98.63 71.55 40.39 -1.34 -15.57 44.33 1.39 -18.11 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU B 34 GLU.? 1000.00 B 226 THR A 62 THR^? 1000.00 B 229 LYS A 27 LYS^? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 20.74 95.78 68.68 19.29 96.84 69.83 23.75 4.97 0.22 25.24 5.64 -1.20 coo 22.32 101.61 71.64 17.89 98.63 71.55 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 B 57 GLU B 127 GLU.? 1000.00 B 226 THR A 101 THR.? 1000.00 B 229 LYS A 142 LYS.? 1000.00 coo 15.90 87.61 49.61 13.92 86.96 49.36 25.72 3.94 -16.30 25.78 4.20 -14.20 coo 20.74 95.78 68.68 19.29 96.84 69.83 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 22.32 101.61 71.64 17.89 98.63 71.55 4.61 15.20 -9.08 3.33 16.81 -15.04 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 34 GLU.? 1000.00 C 226 THR B 62 THR^? 1000.00 C 229 LYS B 27 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 22.16 45.88 73.63 23.23 47.70 73.25 34.62 -1.27 -15.97 34.38 0.39 -14.61 coo 28.90 45.91 73.55 25.22 49.72 72.97 40.39 -1.34 -15.57 44.33 1.39 -18.11 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU B 34 GLU.? 1000.00 C 226 THR A 62 THR^? 1000.00 C 229 LYS A 27 LYS^? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 22.16 45.88 73.63 23.23 47.70 73.25 23.75 4.97 0.22 25.24 5.64 -1.20 coo 28.90 45.91 73.55 25.22 49.72 72.97 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 C 57 GLU B 127 GLU.? 1000.00 C 226 THR A 101 THR.? 1000.00 C 229 LYS A 142 LYS.? 1000.00 coo 5.43 40.40 61.63 4.27 41.99 60.90 25.72 3.94 -16.30 25.78 4.20 -14.20 coo 22.16 45.88 73.63 23.23 47.70 73.25 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 28.90 45.91 73.55 25.22 49.72 72.97 4.61 15.20 -9.08 3.33 16.81 -15.04 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 34 GLU.? 1000.00 D 226 THR B 62 THR^? 1000.00 D 229 LYS B 27 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 11.79 47.62 52.67 10.10 46.51 53.39 34.62 -1.27 -15.97 34.38 0.39 -14.61 coo 10.05 41.79 49.80 7.94 44.71 53.76 40.39 -1.34 -15.57 44.33 1.39 -18.11 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU B 34 GLU.? 1000.00 D 226 THR A 62 THR^? 1000.00 D 229 LYS A 27 LYS^? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 11.79 47.62 52.67 10.10 46.51 53.39 23.75 4.97 0.22 25.24 5.64 -1.20 coo 10.05 41.79 49.80 7.94 44.71 53.76 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 3 3 # 3 D 57 GLU B 127 GLU.? 1000.00 D 226 THR A 101 THR.? 1000.00 D 229 LYS A 142 LYS.? 1000.00 coo 26.07 55.89 66.14 25.33 56.50 68.01 25.72 3.94 -16.30 25.78 4.20 -14.20 coo 11.79 47.62 52.67 10.10 46.51 53.39 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 10.05 41.79 49.80 7.94 44.71 53.76 4.61 15.20 -9.08 3.33 16.81 -15.04 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 3 hits 1dfo_c07 naa= 3 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 133 TYR A 64 TYR.? 1000.00 A 138 ARG A 15 ARG^? 1000.00 A 161 LYS A 65 LYS.? 1000.00 coo 29.03 88.95 86.80 28.09 90.57 84.75 22.50 12.53 4.97 22.72 14.77 6.66 coo 23.31 93.18 82.88 23.00 93.71 79.86 13.78 12.30 3.30 15.49 14.64 2.27 coo 33.83 91.15 88.62 31.07 91.06 83.02 23.08 10.16 8.29 20.19 14.81 10.58 ULMN 3 1dhp_c00 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 133 TYR B 64 TYR.? 1000.00 A 138 ARG B 15 ARG^? 1000.00 A 161 LYS B 65 LYS.? 1000.00 coo 29.03 88.95 86.80 28.09 90.57 84.75 41.81 1.40 -20.74 43.72 2.68 -22.34 coo 23.31 93.18 82.88 23.00 93.71 79.86 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 33.83 91.15 88.62 31.07 91.06 83.02 39.44 0.72 -24.06 44.98 0.54 -26.26 1dhp_c00 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c00 naa= 3 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 133 TYR A 64 TYR.? 1000.00 B 138 ARG A 15 ARG^? 1000.00 B 161 LYS A 65 LYS.? 1000.00 coo 4.62 122.69 99.88 5.46 122.82 97.24 22.50 12.53 4.97 22.72 14.77 6.66 coo 10.44 122.27 94.08 11.02 123.87 91.53 13.78 12.30 3.30 15.49 14.64 2.27 coo -0.17 119.75 99.65 2.51 123.83 95.70 23.08 10.16 8.29 20.19 14.81 10.58 ULMN 3 1dhp_c01 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 133 TYR B 64 TYR.? 1000.00 B 138 ARG B 15 ARG^? 1000.00 B 161 LYS B 65 LYS.? 1000.00 coo 4.62 122.69 99.88 5.46 122.82 97.24 41.81 1.40 -20.74 43.72 2.68 -22.34 coo 10.44 122.27 94.08 11.02 123.87 91.53 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo -0.17 119.75 99.65 2.51 123.83 95.70 39.44 0.72 -24.06 44.98 0.54 -26.26 1dhp_c01 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 2 hits 1dhp_c01 naa= 3 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 A 44 THR A 52 THR.? 1000.00 A 45 THR A 53 THR.? 1000.00 A 161 LYS A 35 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 0.54 -6.10 -11.97 2.09 -7.62 -12.03 coo 27.73 89.90 76.08 29.24 91.46 75.95 1.63 -5.35 -8.41 0.42 -5.39 -6.59 coo 33.83 91.15 88.62 31.07 91.06 83.02 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 A 44 THR A 52 THR.? 1000.00 A 45 THR A 53 THR.? 1000.00 A 161 LYS A 37 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 0.54 -6.10 -11.97 2.09 -7.62 -12.03 coo 27.73 89.90 76.08 29.24 91.46 75.95 1.63 -5.35 -8.41 0.42 -5.39 -6.59 coo 33.83 91.15 88.62 31.07 91.06 83.02 9.87 -14.01 -18.14 9.86 -17.48 -12.85 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 A 44 THR A 53 THR.? 1000.00 A 45 THR A 52 THR.? 1000.00 A 161 LYS A 35 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 1.63 -5.35 -8.41 0.42 -5.39 -6.59 coo 27.73 89.90 76.08 29.24 91.46 75.95 0.54 -6.10 -11.97 2.09 -7.62 -12.03 coo 33.83 91.15 88.62 31.07 91.06 83.02 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 A 44 THR A 58 THR^? 1000.00 A 45 THR A 133 THR.? 1000.00 A 161 LYS A 35 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 16.91 -5.28 -6.65 18.31 -6.88 -6.40 coo 27.73 89.90 76.08 29.24 91.46 75.95 15.32 -5.53 -2.56 15.86 -7.55 -2.13 coo 33.83 91.15 88.62 31.07 91.06 83.02 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 A 44 THR A 133 THR.? 1000.00 A 45 THR A 58 THR^? 1000.00 A 161 LYS A 115 LYS~? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 15.32 -5.53 -2.56 15.86 -7.55 -2.13 coo 27.73 89.90 76.08 29.24 91.46 75.95 16.91 -5.28 -6.65 18.31 -6.88 -6.40 coo 33.83 91.15 88.62 31.07 91.06 83.02 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 A 44 THR B 52 THR.? 1000.00 A 45 THR B 53 THR.? 1000.00 A 161 LYS B 35 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 36.53 -26.90 -3.75 34.44 -26.32 -3.74 coo 27.73 89.90 76.08 29.24 91.46 75.95 36.67 -25.61 -7.31 37.21 -26.66 -9.14 coo 33.83 91.15 88.62 31.07 91.06 83.02 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 A 44 THR B 52 THR.? 1000.00 A 45 THR B 53 THR.? 1000.00 A 161 LYS B 37 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 36.53 -26.90 -3.75 34.44 -26.32 -3.74 coo 27.73 89.90 76.08 29.24 91.46 75.95 36.67 -25.61 -7.31 37.21 -26.66 -9.14 coo 33.83 91.15 88.62 31.07 91.06 83.02 24.99 -22.75 2.33 21.94 -24.42 -2.96 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 A 44 THR B 53 THR.? 1000.00 A 45 THR B 52 THR.? 1000.00 A 161 LYS B 35 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 36.67 -25.61 -7.31 37.21 -26.66 -9.14 coo 27.73 89.90 76.08 29.24 91.46 75.95 36.53 -26.90 -3.75 34.44 -26.32 -3.74 coo 33.83 91.15 88.62 31.07 91.06 83.02 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 A 44 THR B 58 THR^? 1000.00 A 45 THR B 133 THR.? 1000.00 A 161 LYS B 35 LYS.? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 29.09 -12.30 -9.13 27.00 -11.87 -9.30 coo 27.73 89.90 76.08 29.24 91.46 75.95 29.71 -13.76 -13.24 27.67 -14.35 -13.63 coo 33.83 91.15 88.62 31.07 91.06 83.02 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1dhp_c02 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 A 44 THR B 133 THR.? 1000.00 A 45 THR B 58 THR^? 1000.00 A 161 LYS B 115 LYS~? 1000.00 coo 26.16 88.25 79.16 25.22 89.47 80.71 29.71 -13.76 -13.24 27.67 -14.35 -13.63 coo 27.73 89.90 76.08 29.24 91.46 75.95 29.09 -12.30 -9.13 27.00 -11.87 -9.30 coo 33.83 91.15 88.62 31.07 91.06 83.02 25.77 -5.51 -22.92 25.67 -7.99 -17.65 1dhp_c02 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 10 hits 1dhp_c02 naa= 3 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 1 3 # 1 B 44 THR A 52 THR.? 1000.00 B 45 THR A 53 THR.? 1000.00 B 161 LYS A 35 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 0.54 -6.10 -11.97 2.09 -7.62 -12.03 coo 5.75 129.25 91.25 4.29 128.16 90.07 1.63 -5.35 -8.41 0.42 -5.39 -6.59 coo -0.17 119.75 99.65 2.51 123.83 95.70 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 2 3 # 2 B 44 THR A 52 THR.? 1000.00 B 45 THR A 53 THR.? 1000.00 B 161 LYS A 37 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 0.54 -6.10 -11.97 2.09 -7.62 -12.03 coo 5.75 129.25 91.25 4.29 128.16 90.07 1.63 -5.35 -8.41 0.42 -5.39 -6.59 coo -0.17 119.75 99.65 2.51 123.83 95.70 9.87 -14.01 -18.14 9.86 -17.48 -12.85 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 3 3 # 3 B 44 THR A 53 THR.? 1000.00 B 45 THR A 52 THR.? 1000.00 B 161 LYS A 35 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 1.63 -5.35 -8.41 0.42 -5.39 -6.59 coo 5.75 129.25 91.25 4.29 128.16 90.07 0.54 -6.10 -11.97 2.09 -7.62 -12.03 coo -0.17 119.75 99.65 2.51 123.83 95.70 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 4 3 # 4 B 44 THR A 58 THR^? 1000.00 B 45 THR A 133 THR.? 1000.00 B 161 LYS A 35 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 16.91 -5.28 -6.65 18.31 -6.88 -6.40 coo 5.75 129.25 91.25 4.29 128.16 90.07 15.32 -5.53 -2.56 15.86 -7.55 -2.13 coo -0.17 119.75 99.65 2.51 123.83 95.70 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 5 3 # 5 B 44 THR A 133 THR.? 1000.00 B 45 THR A 58 THR^? 1000.00 B 161 LYS A 115 LYS~? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 15.32 -5.53 -2.56 15.86 -7.55 -2.13 coo 5.75 129.25 91.25 4.29 128.16 90.07 16.91 -5.28 -6.65 18.31 -6.88 -6.40 coo -0.17 119.75 99.65 2.51 123.83 95.70 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 6 3 # 6 B 44 THR B 52 THR.? 1000.00 B 45 THR B 53 THR.? 1000.00 B 161 LYS B 35 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 36.53 -26.90 -3.75 34.44 -26.32 -3.74 coo 5.75 129.25 91.25 4.29 128.16 90.07 36.67 -25.61 -7.31 37.21 -26.66 -9.14 coo -0.17 119.75 99.65 2.51 123.83 95.70 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 7 3 # 7 B 44 THR B 52 THR.? 1000.00 B 45 THR B 53 THR.? 1000.00 B 161 LYS B 37 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 36.53 -26.90 -3.75 34.44 -26.32 -3.74 coo 5.75 129.25 91.25 4.29 128.16 90.07 36.67 -25.61 -7.31 37.21 -26.66 -9.14 coo -0.17 119.75 99.65 2.51 123.83 95.70 24.99 -22.75 2.33 21.94 -24.42 -2.96 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 8 3 # 8 B 44 THR B 53 THR.? 1000.00 B 45 THR B 52 THR.? 1000.00 B 161 LYS B 35 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 36.67 -25.61 -7.31 37.21 -26.66 -9.14 coo 5.75 129.25 91.25 4.29 128.16 90.07 36.53 -26.90 -3.75 34.44 -26.32 -3.74 coo -0.17 119.75 99.65 2.51 123.83 95.70 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 9 3 # 9 B 44 THR B 58 THR^? 1000.00 B 45 THR B 133 THR.? 1000.00 B 161 LYS B 35 LYS.? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 29.09 -12.30 -9.13 27.00 -11.87 -9.30 coo 5.75 129.25 91.25 4.29 128.16 90.07 29.71 -13.76 -13.24 27.67 -14.35 -13.63 coo -0.17 119.75 99.65 2.51 123.83 95.70 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1dhp_c03 DIHYDRODIPICOLINATE SYNTHASE user 10 3 # 10 B 44 THR B 133 THR.? 1000.00 B 45 THR B 58 THR^? 1000.00 B 161 LYS B 115 LYS~? 1000.00 coo 7.39 128.28 94.56 8.34 126.36 94.79 29.71 -13.76 -13.24 27.67 -14.35 -13.63 coo 5.75 129.25 91.25 4.29 128.16 90.07 29.09 -12.30 -9.13 27.00 -11.87 -9.30 coo -0.17 119.75 99.65 2.51 123.83 95.70 25.77 -5.51 -22.92 25.67 -7.99 -17.65 1dhp_c03 source 1dhp DIHYDRODIPICOLINATE SYNTHASE : 10 hits 1dhp_c03 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 20 GLY.? 1000.00 B 144 GLU A 21 GLU^? 1000.00 B 164 GLU A 22 GLU^? 1000.00 coo 88.87 114.43 152.30 88.45 115.15 152.32 5.36 5.36 10.08 6.11 5.11 10.13 coo 85.20 111.99 152.05 86.60 110.89 150.91 8.36 5.57 14.13 8.30 3.77 15.28 coo 88.14 113.46 145.73 86.79 113.92 147.30 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY B 20 GLY.? 1000.00 B 144 GLU B 21 GLU^? 1000.00 B 164 GLU B 22 GLU^? 1000.00 coo 88.87 114.43 152.30 88.45 115.15 152.32 44.09 -16.98 -25.78 43.52 -16.47 -25.80 coo 85.20 111.99 152.05 86.60 110.89 150.91 42.84 -14.24 -29.87 41.38 -15.19 -31.09 coo 88.14 113.46 145.73 86.79 113.92 147.30 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 20 GLY.? 1000.00 C 144 GLU A 21 GLU^? 1000.00 C 164 GLU A 22 GLU^? 1000.00 coo 56.28 104.55 135.84 56.09 105.34 136.05 5.36 5.36 10.08 6.11 5.11 10.13 coo 58.46 103.90 139.48 57.57 102.00 139.16 8.36 5.57 14.13 8.30 3.77 15.28 coo 51.71 102.03 140.09 53.02 103.62 140.54 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY B 20 GLY.? 1000.00 C 144 GLU B 21 GLU^? 1000.00 C 164 GLU B 22 GLU^? 1000.00 coo 56.28 104.55 135.84 56.09 105.34 136.05 44.09 -16.98 -25.78 43.52 -16.47 -25.80 coo 58.46 103.90 139.48 57.57 102.00 139.16 42.84 -14.24 -29.87 41.38 -15.19 -31.09 coo 51.71 102.03 140.09 53.02 103.62 140.54 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 20 GLY.? 1000.00 D 144 GLU A 21 GLU^? 1000.00 D 164 GLU A 22 GLU^? 1000.00 coo 86.19 80.64 132.77 86.38 79.85 132.93 5.36 5.36 10.08 6.11 5.11 10.13 coo 84.75 81.24 136.88 85.62 83.14 136.43 8.36 5.57 14.13 8.30 3.77 15.28 coo 91.47 83.05 136.24 90.35 81.38 136.84 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY B 20 GLY.? 1000.00 D 144 GLU B 21 GLU^? 1000.00 D 164 GLU B 22 GLU^? 1000.00 coo 86.19 80.64 132.77 86.38 79.85 132.93 44.09 -16.98 -25.78 43.52 -16.47 -25.80 coo 84.75 81.24 136.88 85.62 83.14 136.43 42.84 -14.24 -29.87 41.38 -15.19 -31.09 coo 91.47 83.05 136.24 90.35 81.38 136.84 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 20 GLY.? 1000.00 E 144 GLU A 21 GLU^? 1000.00 E 164 GLU A 22 GLU^? 1000.00 coo 90.07 81.07 170.50 90.23 80.26 170.38 5.36 5.36 10.08 6.11 5.11 10.13 coo 87.05 81.30 167.53 86.38 82.74 168.94 8.36 5.57 14.13 8.30 3.77 15.28 coo 84.40 80.02 173.80 85.08 79.06 172.03 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY B 20 GLY.? 1000.00 E 144 GLU B 21 GLU^? 1000.00 E 164 GLU B 22 GLU^? 1000.00 coo 90.07 81.07 170.50 90.23 80.26 170.38 44.09 -16.98 -25.78 43.52 -16.47 -25.80 coo 87.05 81.30 167.53 86.38 82.74 168.94 42.84 -14.24 -29.87 41.38 -15.19 -31.09 coo 84.40 80.02 173.80 85.08 79.06 172.03 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 20 GLY.? 1000.00 F 144 GLU A 21 GLU^? 1000.00 F 164 GLU A 22 GLU^? 1000.00 coo 57.12 70.68 155.10 57.52 69.95 155.02 5.36 5.36 10.08 6.11 5.11 10.13 coo 60.62 73.13 154.21 59.05 74.26 153.35 8.36 5.57 14.13 8.30 3.77 15.28 coo 56.75 71.71 148.46 58.44 71.01 149.54 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY B 20 GLY.? 1000.00 F 144 GLU B 21 GLU^? 1000.00 F 164 GLU B 22 GLU^? 1000.00 coo 57.12 70.68 155.10 57.52 69.95 155.02 44.09 -16.98 -25.78 43.52 -16.47 -25.80 coo 60.62 73.13 154.21 59.05 74.26 153.35 42.84 -14.24 -29.87 41.38 -15.19 -31.09 coo 56.75 71.71 148.46 58.44 71.01 149.54 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c17 naa= 3 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 A 131 LYS A 115 LYS~? 1000.00 A 215 LYS A 65 LYS.? 1000.00 A 277 LYS A 27 LYS^? 1000.00 coo 0.50 24.09 51.68 1.51 29.34 52.35 24.53 -4.83 7.12 22.37 -6.02 1.89 coo 13.06 30.79 51.73 11.40 35.76 53.48 23.08 10.16 8.29 20.19 14.81 10.58 coo 13.04 31.88 60.72 10.57 35.34 57.49 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1e19_c00 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 A 131 LYS B 115 LYS~? 1000.00 A 215 LYS B 65 LYS.? 1000.00 A 277 LYS B 27 LYS^? 1000.00 coo 0.50 24.09 51.68 1.51 29.34 52.35 25.77 -5.51 -22.92 25.67 -7.99 -17.65 coo 13.06 30.79 51.73 11.40 35.76 53.48 39.44 0.72 -24.06 44.98 0.54 -26.26 coo 13.04 31.88 60.72 10.57 35.34 57.49 40.39 -1.34 -15.57 44.33 1.39 -18.11 1e19_c00 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c00 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS A 115 LYS~? 1000.00 B 215 LYS A 65 LYS.? 1000.00 B 277 LYS A 27 LYS^? 1000.00 coo 6.78 45.91 16.15 7.82 40.81 15.84 24.53 -4.83 7.12 22.37 -6.02 1.89 coo 17.88 38.77 19.81 16.38 34.23 17.24 23.08 10.16 8.29 20.19 14.81 10.58 coo 20.33 37.78 11.20 16.77 34.53 13.47 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 2 3 # 2 B 131 LYS B 115 LYS~? 1000.00 B 215 LYS B 65 LYS.? 1000.00 B 277 LYS B 27 LYS^? 1000.00 coo 6.78 45.91 16.15 7.82 40.81 15.84 25.77 -5.51 -22.92 25.67 -7.99 -17.65 coo 17.88 38.77 19.81 16.38 34.23 17.24 39.44 0.72 -24.06 44.98 0.54 -26.26 coo 20.33 37.78 11.20 16.77 34.53 13.47 40.39 -1.34 -15.57 44.33 1.39 -18.11 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 2 hits 1e19_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 24 ALA.? 1000.00 A 136 TYR A 64 TYR.? 1000.00 A 140 LYS A 27 LYS^? 1000.00 coo 55.90 7.49 23.83 56.71 8.23 22.76 17.26 7.41 7.73 17.90 6.09 7.32 coo 59.38 10.02 17.51 59.95 9.89 20.21 22.50 12.53 4.97 22.72 14.77 6.66 coo 59.52 3.69 18.67 62.31 6.19 22.58 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA B 24 ALA^? 1000.00 A 136 TYR B 64 TYR.? 1000.00 A 140 LYS B 27 LYS^? 1000.00 coo 55.90 7.49 23.83 56.71 8.23 22.76 39.97 -5.68 -23.49 38.51 -5.78 -23.09 coo 59.38 10.02 17.51 59.95 9.89 20.21 41.81 1.40 -20.74 43.72 2.68 -22.34 coo 59.52 3.69 18.67 62.31 6.19 22.58 40.39 -1.34 -15.57 44.33 1.39 -18.11 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 2 hits 1e7q_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 83 ASP.? 1000.00 A 35 SER A 82 SER.? 1000.00 A 218 ASP A 112 ASP~? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 43.58 20.85 5.15 44.62 23.01 5.76 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 44.05 16.99 12.67 44.05 18.89 11.74 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP A 93 ASP.? 1000.00 A 35 SER A 10 SER^? 1000.00 A 218 ASP A 94 ASP.? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 43.58 20.85 5.15 44.62 23.01 5.76 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 44.05 16.99 12.67 44.05 18.89 11.74 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 3 3 # 3 A 32 ASP A 94 ASP.? 1000.00 A 35 SER A 96 SER.? 1000.00 A 218 ASP A 93 ASP.? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 43.58 20.85 5.15 44.62 23.01 5.76 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 44.05 16.99 12.67 44.05 18.89 11.74 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 4 3 # 4 A 32 ASP A 94 ASP.? 1000.00 A 35 SER A 97 SER.? 1000.00 A 218 ASP A 93 ASP.? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 43.58 20.85 5.15 44.62 23.01 5.76 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 44.05 16.99 12.67 44.05 18.89 11.74 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 5 3 # 5 A 32 ASP B 83 ASP.? 1000.00 A 35 SER B 82 SER.? 1000.00 A 218 ASP B 112 ASP~? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 43.58 20.85 5.15 44.62 23.01 5.76 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 44.05 16.99 12.67 44.05 18.89 11.74 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 6 3 # 6 A 32 ASP B 93 ASP.? 1000.00 A 35 SER B 10 SER^? 1000.00 A 218 ASP B 94 ASP.? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 43.58 20.85 5.15 44.62 23.01 5.76 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 44.05 16.99 12.67 44.05 18.89 11.74 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 7 3 # 7 A 32 ASP B 94 ASP.? 1000.00 A 35 SER B 96 SER.? 1000.00 A 218 ASP B 93 ASP.? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 43.58 20.85 5.15 44.62 23.01 5.76 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 44.05 16.99 12.67 44.05 18.89 11.74 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 8 3 # 8 A 32 ASP B 94 ASP.? 1000.00 A 35 SER B 97 SER.? 1000.00 A 218 ASP B 93 ASP.? 1000.00 coo 47.22 22.34 8.57 45.16 22.02 9.13 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 43.58 20.85 5.15 44.62 23.01 5.76 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 44.05 16.99 12.67 44.05 18.89 11.74 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1eag_c04 source 1eag PEPTIDE INHIBITOR : 8 hits 1eag_c04 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 83 ASP.? 1000.00 P 35 SER A 82 SER.? 1000.00 P 215 ASP A 112 ASP~? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 7.57 37.60 10.00 8.86 37.02 12.03 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 4.04 29.97 8.82 4.78 31.15 10.46 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP A 93 ASP.? 1000.00 P 35 SER A 10 SER^? 1000.00 P 215 ASP A 94 ASP.? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 7.57 37.60 10.00 8.86 37.02 12.03 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 4.04 29.97 8.82 4.78 31.15 10.46 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 3 3 # 3 P 32 ASP A 94 ASP.? 1000.00 P 35 SER A 96 SER.? 1000.00 P 215 ASP A 93 ASP.? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 7.57 37.60 10.00 8.86 37.02 12.03 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 4.04 29.97 8.82 4.78 31.15 10.46 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 4 3 # 4 P 32 ASP A 94 ASP.? 1000.00 P 35 SER A 97 SER.? 1000.00 P 215 ASP A 93 ASP.? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 7.57 37.60 10.00 8.86 37.02 12.03 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 4.04 29.97 8.82 4.78 31.15 10.46 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 5 3 # 5 P 32 ASP B 83 ASP.? 1000.00 P 35 SER B 82 SER.? 1000.00 P 215 ASP B 112 ASP~? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 7.57 37.60 10.00 8.86 37.02 12.03 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 4.04 29.97 8.82 4.78 31.15 10.46 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 6 3 # 6 P 32 ASP B 93 ASP.? 1000.00 P 35 SER B 10 SER^? 1000.00 P 215 ASP B 94 ASP.? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 7.57 37.60 10.00 8.86 37.02 12.03 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 4.04 29.97 8.82 4.78 31.15 10.46 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 7 3 # 7 P 32 ASP B 94 ASP.? 1000.00 P 35 SER B 96 SER.? 1000.00 P 215 ASP B 93 ASP.? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 7.57 37.60 10.00 8.86 37.02 12.03 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 4.04 29.97 8.82 4.78 31.15 10.46 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 8 3 # 8 P 32 ASP B 94 ASP.? 1000.00 P 35 SER B 97 SER.? 1000.00 P 215 ASP B 93 ASP.? 1000.00 coo 10.15 33.41 11.98 7.98 33.66 12.07 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 7.57 37.60 10.00 8.86 37.02 12.03 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 4.04 29.97 8.82 4.78 31.15 10.46 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 8 hits 1eed_c04 naa= 3 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 1 3 # 1 A 229 ALA A 114 ALA~? 1000.00 A 257 ALA A 117 ALA~? 1000.00 A 328 ASP A 76 ASP~? 1000.00 coo 39.84 24.12 8.44 38.50 24.23 9.11 23.32 -6.64 10.22 23.94 -8.01 10.01 coo 43.22 26.73 5.37 41.81 27.09 5.79 23.98 -2.16 12.13 23.89 -3.41 12.97 coo 38.17 34.10 6.67 37.72 32.06 6.84 16.07 -4.78 18.64 16.16 -4.88 20.75 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 2 3 # 2 A 229 ALA A 114 ALA~? 1000.00 A 257 ALA A 117 ALA~? 1000.00 A 328 ASP A 120 ASP.? 1000.00 coo 39.84 24.12 8.44 38.50 24.23 9.11 23.32 -6.64 10.22 23.94 -8.01 10.01 coo 43.22 26.73 5.37 41.81 27.09 5.79 23.98 -2.16 12.13 23.89 -3.41 12.97 coo 38.17 34.10 6.67 37.72 32.06 6.84 27.77 3.65 13.30 28.81 5.07 14.48 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 3 3 # 3 A 229 ALA A 117 ALA~? 1000.00 A 257 ALA A 114 ALA~? 1000.00 A 328 ASP A 83 ASP.? 1000.00 coo 39.84 24.12 8.44 38.50 24.23 9.11 23.98 -2.16 12.13 23.89 -3.41 12.97 coo 43.22 26.73 5.37 41.81 27.09 5.79 23.32 -6.64 10.22 23.94 -8.01 10.01 coo 38.17 34.10 6.67 37.72 32.06 6.84 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 4 3 # 4 A 229 ALA B 114 ALA~? 1000.00 A 257 ALA B 117 ALA~? 1000.00 A 328 ASP B 76 ASP~? 1000.00 coo 39.84 24.12 8.44 38.50 24.23 9.11 24.83 -7.46 -26.03 23.33 -7.58 -25.84 coo 43.22 26.73 5.37 41.81 27.09 5.79 28.39 -4.62 -27.93 27.39 -5.37 -28.78 coo 38.17 34.10 6.67 37.72 32.06 6.84 30.14 -12.79 -34.44 30.07 -12.72 -36.56 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 5 3 # 5 A 229 ALA B 114 ALA~? 1000.00 A 257 ALA B 117 ALA~? 1000.00 A 328 ASP B 120 ASP.? 1000.00 coo 39.84 24.12 8.44 38.50 24.23 9.11 24.83 -7.46 -26.03 23.33 -7.58 -25.84 coo 43.22 26.73 5.37 41.81 27.09 5.79 28.39 -4.62 -27.93 27.39 -5.37 -28.78 coo 38.17 34.10 6.67 37.72 32.06 6.84 31.54 1.53 -29.08 32.29 3.12 -30.27 ULMN 3 1eo7_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE user 6 3 # 6 A 229 ALA B 117 ALA~? 1000.00 A 257 ALA B 114 ALA~? 1000.00 A 328 ASP B 83 ASP.? 1000.00 coo 39.84 24.12 8.44 38.50 24.23 9.11 28.39 -4.62 -27.93 27.39 -5.37 -28.78 coo 43.22 26.73 5.37 41.81 27.09 5.79 24.83 -7.46 -26.03 23.33 -7.58 -25.84 coo 38.17 34.10 6.67 37.72 32.06 6.84 27.06 -15.40 -22.59 25.67 -13.84 -22.77 1eo7_c00 source 1eo7 CYCLODEXTRIN GLYCOSYLTRANSFERASE : 6 hits 1eo7_c00 naa= 3 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 A 116 SER A 82 SER.? 1000.00 A 140 TYR A 77 TYR~? 1000.00 A 144 LYS A 79 LYS~? 1000.00 coo 34.67 35.79 48.83 33.57 37.88 49.47 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 29.60 38.99 53.89 30.10 37.88 51.36 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 32.73 32.94 54.42 29.29 32.83 50.35 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 A 116 SER A 82 SER.? 1000.00 A 140 TYR A 77 TYR~? 1000.00 A 144 LYS A 80 LYS~? 1000.00 coo 34.67 35.79 48.83 33.57 37.88 49.47 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 29.60 38.99 53.89 30.10 37.88 51.36 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 32.73 32.94 54.42 29.29 32.83 50.35 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 A 116 SER B 82 SER.? 1000.00 A 140 TYR B 77 TYR~? 1000.00 A 144 LYS B 79 LYS~? 1000.00 coo 34.67 35.79 48.83 33.57 37.88 49.47 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 29.60 38.99 53.89 30.10 37.88 51.36 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 32.73 32.94 54.42 29.29 32.83 50.35 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1eq2_c00 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 A 116 SER B 82 SER.? 1000.00 A 140 TYR B 77 TYR~? 1000.00 A 144 LYS B 80 LYS~? 1000.00 coo 34.67 35.79 48.83 33.57 37.88 49.47 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 29.60 38.99 53.89 30.10 37.88 51.36 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 32.73 32.94 54.42 29.29 32.83 50.35 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1eq2_c00 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c00 naa= 3 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 B 116 SER A 82 SER.? 1000.00 B 140 TYR A 77 TYR~? 1000.00 B 144 LYS A 79 LYS~? 1000.00 coo 30.90 35.65 89.60 29.85 37.72 88.83 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 24.43 38.83 86.53 27.07 38.03 86.12 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 25.13 32.62 89.49 27.74 32.61 84.91 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 B 116 SER A 82 SER.? 1000.00 B 140 TYR A 77 TYR~? 1000.00 B 144 LYS A 80 LYS~? 1000.00 coo 30.90 35.65 89.60 29.85 37.72 88.83 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 24.43 38.83 86.53 27.07 38.03 86.12 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 25.13 32.62 89.49 27.74 32.61 84.91 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 B 116 SER B 82 SER.? 1000.00 B 140 TYR B 77 TYR~? 1000.00 B 144 LYS B 79 LYS~? 1000.00 coo 30.90 35.65 89.60 29.85 37.72 88.83 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 24.43 38.83 86.53 27.07 38.03 86.12 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 25.13 32.62 89.49 27.74 32.61 84.91 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1eq2_c01 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 B 116 SER B 82 SER.? 1000.00 B 140 TYR B 77 TYR~? 1000.00 B 144 LYS B 80 LYS~? 1000.00 coo 30.90 35.65 89.60 29.85 37.72 88.83 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 24.43 38.83 86.53 27.07 38.03 86.12 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 25.13 32.62 89.49 27.74 32.61 84.91 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1eq2_c01 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c01 naa= 3 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 C 116 SER A 82 SER.? 1000.00 C 140 TYR A 77 TYR~? 1000.00 C 144 LYS A 79 LYS~? 1000.00 coo -8.96 33.70 98.81 -8.96 35.77 97.56 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -8.28 37.01 91.79 -6.99 36.16 94.13 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -10.48 30.66 93.19 -5.27 31.07 94.32 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 C 116 SER A 82 SER.? 1000.00 C 140 TYR A 77 TYR~? 1000.00 C 144 LYS A 80 LYS~? 1000.00 coo -8.96 33.70 98.81 -8.96 35.77 97.56 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -8.28 37.01 91.79 -6.99 36.16 94.13 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -10.48 30.66 93.19 -5.27 31.07 94.32 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 C 116 SER B 82 SER.? 1000.00 C 140 TYR B 77 TYR~? 1000.00 C 144 LYS B 79 LYS~? 1000.00 coo -8.96 33.70 98.81 -8.96 35.77 97.56 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -8.28 37.01 91.79 -6.99 36.16 94.13 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -10.48 30.66 93.19 -5.27 31.07 94.32 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1eq2_c02 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 C 116 SER B 82 SER.? 1000.00 C 140 TYR B 77 TYR~? 1000.00 C 144 LYS B 80 LYS~? 1000.00 coo -8.96 33.70 98.81 -8.96 35.77 97.56 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -8.28 37.01 91.79 -6.99 36.16 94.13 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -10.48 30.66 93.19 -5.27 31.07 94.32 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1eq2_c02 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c02 naa= 3 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 D 116 SER A 82 SER.? 1000.00 D 140 TYR A 77 TYR~? 1000.00 D 144 LYS A 79 LYS~? 1000.00 coo -29.80 31.30 63.54 -28.79 33.52 63.37 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -23.30 35.33 62.20 -25.10 34.24 64.06 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -24.76 28.82 60.31 -24.27 29.01 65.58 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 D 116 SER A 82 SER.? 1000.00 D 140 TYR A 77 TYR~? 1000.00 D 144 LYS A 80 LYS~? 1000.00 coo -29.80 31.30 63.54 -28.79 33.52 63.37 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -23.30 35.33 62.20 -25.10 34.24 64.06 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -24.76 28.82 60.31 -24.27 29.01 65.58 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 D 116 SER B 82 SER.? 1000.00 D 140 TYR B 77 TYR~? 1000.00 D 144 LYS B 79 LYS~? 1000.00 coo -29.80 31.30 63.54 -28.79 33.52 63.37 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -23.30 35.33 62.20 -25.10 34.24 64.06 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -24.76 28.82 60.31 -24.27 29.01 65.58 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1eq2_c03 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 D 116 SER B 82 SER.? 1000.00 D 140 TYR B 77 TYR~? 1000.00 D 144 LYS B 80 LYS~? 1000.00 coo -29.80 31.30 63.54 -28.79 33.52 63.37 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -23.30 35.33 62.20 -25.10 34.24 64.06 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -24.76 28.82 60.31 -24.27 29.01 65.58 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1eq2_c03 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c03 naa= 3 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 E 116 SER A 82 SER.? 1000.00 E 140 TYR A 77 TYR~? 1000.00 E 144 LYS A 79 LYS~? 1000.00 coo -3.01 32.72 32.71 -2.80 34.91 33.79 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 0.04 36.70 38.68 -2.21 35.46 37.50 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 1.93 30.52 36.31 -2.84 30.18 38.54 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 E 116 SER A 82 SER.? 1000.00 E 140 TYR A 77 TYR~? 1000.00 E 144 LYS A 80 LYS~? 1000.00 coo -3.01 32.72 32.71 -2.80 34.91 33.79 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 0.04 36.70 38.68 -2.21 35.46 37.50 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 1.93 30.52 36.31 -2.84 30.18 38.54 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 E 116 SER B 82 SER.? 1000.00 E 140 TYR B 77 TYR~? 1000.00 E 144 LYS B 79 LYS~? 1000.00 coo -3.01 32.72 32.71 -2.80 34.91 33.79 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 0.04 36.70 38.68 -2.21 35.46 37.50 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 1.93 30.52 36.31 -2.84 30.18 38.54 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1eq2_c04 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 E 116 SER B 82 SER.? 1000.00 E 140 TYR B 77 TYR~? 1000.00 E 144 LYS B 80 LYS~? 1000.00 coo -3.01 32.72 32.71 -2.80 34.91 33.79 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 0.04 36.70 38.68 -2.21 35.46 37.50 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 1.93 30.52 36.31 -2.84 30.18 38.54 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1eq2_c04 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c04 naa= 3 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 F 116 SER A 82 SER.? 1000.00 F 140 TYR A 77 TYR~? 1000.00 F 144 LYS A 79 LYS~? 1000.00 coo 55.30 92.46 56.72 55.15 90.39 55.38 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 54.49 89.31 49.65 53.35 90.16 52.06 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 56.78 95.62 51.15 51.59 95.31 52.37 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 F 116 SER A 82 SER.? 1000.00 F 140 TYR A 77 TYR~? 1000.00 F 144 LYS A 80 LYS~? 1000.00 coo 55.30 92.46 56.72 55.15 90.39 55.38 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 54.49 89.31 49.65 53.35 90.16 52.06 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 56.78 95.62 51.15 51.59 95.31 52.37 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 F 116 SER B 82 SER.? 1000.00 F 140 TYR B 77 TYR~? 1000.00 F 144 LYS B 79 LYS~? 1000.00 coo 55.30 92.46 56.72 55.15 90.39 55.38 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 54.49 89.31 49.65 53.35 90.16 52.06 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 56.78 95.62 51.15 51.59 95.31 52.37 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1eq2_c05 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 F 116 SER B 82 SER.? 1000.00 F 140 TYR B 77 TYR~? 1000.00 F 144 LYS B 80 LYS~? 1000.00 coo 55.30 92.46 56.72 55.15 90.39 55.38 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 54.49 89.31 49.65 53.35 90.16 52.06 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 56.78 95.62 51.15 51.59 95.31 52.37 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1eq2_c05 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c05 naa= 3 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 G 116 SER A 82 SER.? 1000.00 G 140 TYR A 77 TYR~? 1000.00 G 144 LYS A 79 LYS~? 1000.00 coo 76.25 95.63 21.56 75.29 93.40 21.36 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 69.78 91.62 20.06 71.51 92.68 22.02 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 71.19 98.21 18.32 70.69 97.75 23.67 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 G 116 SER A 82 SER.? 1000.00 G 140 TYR A 77 TYR~? 1000.00 G 144 LYS A 80 LYS~? 1000.00 coo 76.25 95.63 21.56 75.29 93.40 21.36 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 69.78 91.62 20.06 71.51 92.68 22.02 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 71.19 98.21 18.32 70.69 97.75 23.67 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 G 116 SER B 82 SER.? 1000.00 G 140 TYR B 77 TYR~? 1000.00 G 144 LYS B 79 LYS~? 1000.00 coo 76.25 95.63 21.56 75.29 93.40 21.36 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 69.78 91.62 20.06 71.51 92.68 22.02 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 71.19 98.21 18.32 70.69 97.75 23.67 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1eq2_c06 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 G 116 SER B 82 SER.? 1000.00 G 140 TYR B 77 TYR~? 1000.00 G 144 LYS B 80 LYS~? 1000.00 coo 76.25 95.63 21.56 75.29 93.40 21.36 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 69.78 91.62 20.06 71.51 92.68 22.02 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 71.19 98.21 18.32 70.69 97.75 23.67 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1eq2_c06 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c06 naa= 3 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 H 116 SER A 82 SER.? 1000.00 H 140 TYR A 77 TYR~? 1000.00 H 144 LYS A 79 LYS~? 1000.00 coo 15.45 90.62 47.70 16.55 88.57 46.97 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 21.92 87.58 44.67 19.30 88.41 44.23 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 21.26 93.70 47.67 18.47 93.68 43.08 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 H 116 SER A 82 SER.? 1000.00 H 140 TYR A 77 TYR~? 1000.00 H 144 LYS A 80 LYS~? 1000.00 coo 15.45 90.62 47.70 16.55 88.57 46.97 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 21.92 87.58 44.67 19.30 88.41 44.23 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 21.26 93.70 47.67 18.47 93.68 43.08 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 H 116 SER B 82 SER.? 1000.00 H 140 TYR B 77 TYR~? 1000.00 H 144 LYS B 79 LYS~? 1000.00 coo 15.45 90.62 47.70 16.55 88.57 46.97 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 21.92 87.58 44.67 19.30 88.41 44.23 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 21.26 93.70 47.67 18.47 93.68 43.08 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1eq2_c07 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 H 116 SER B 82 SER.? 1000.00 H 140 TYR B 77 TYR~? 1000.00 H 144 LYS B 80 LYS~? 1000.00 coo 15.45 90.62 47.70 16.55 88.57 46.97 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 21.92 87.58 44.67 19.30 88.41 44.23 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 21.26 93.70 47.67 18.47 93.68 43.08 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1eq2_c07 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c07 naa= 3 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 I 116 SER A 82 SER.? 1000.00 I 140 TYR A 77 TYR~? 1000.00 I 144 LYS A 79 LYS~? 1000.00 coo 11.78 90.82 7.18 12.84 88.72 7.93 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 16.78 87.76 12.19 16.39 88.69 9.59 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 13.67 93.83 12.65 17.08 93.94 8.58 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 I 116 SER A 82 SER.? 1000.00 I 140 TYR A 77 TYR~? 1000.00 I 144 LYS A 80 LYS~? 1000.00 coo 11.78 90.82 7.18 12.84 88.72 7.93 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 16.78 87.76 12.19 16.39 88.69 9.59 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 13.67 93.83 12.65 17.08 93.94 8.58 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 I 116 SER B 82 SER.? 1000.00 I 140 TYR B 77 TYR~? 1000.00 I 144 LYS B 79 LYS~? 1000.00 coo 11.78 90.82 7.18 12.84 88.72 7.93 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 16.78 87.76 12.19 16.39 88.69 9.59 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 13.67 93.83 12.65 17.08 93.94 8.58 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1eq2_c08 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 I 116 SER B 82 SER.? 1000.00 I 140 TYR B 77 TYR~? 1000.00 I 144 LYS B 80 LYS~? 1000.00 coo 11.78 90.82 7.18 12.84 88.72 7.93 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 16.78 87.76 12.19 16.39 88.69 9.59 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 13.67 93.83 12.65 17.08 93.94 8.58 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1eq2_c08 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c08 naa= 3 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 1 3 # 1 J 116 SER A 82 SER.? 1000.00 J 140 TYR A 77 TYR~? 1000.00 J 144 LYS A 79 LYS~? 1000.00 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 2 3 # 2 J 116 SER A 82 SER.? 1000.00 J 140 TYR A 77 TYR~? 1000.00 J 144 LYS A 80 LYS~? 1000.00 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 3 3 # 3 J 116 SER B 82 SER.? 1000.00 J 140 TYR B 77 TYR~? 1000.00 J 144 LYS B 79 LYS~? 1000.00 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1eq2_c09 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMEuser 4 3 # 4 J 116 SER B 82 SER.? 1000.00 J 140 TYR B 77 TYR~? 1000.00 J 144 LYS B 80 LYS~? 1000.00 coo 49.46 93.97 -9.19 49.31 91.82 -8.04 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 46.51 90.06 -3.08 48.69 91.36 -4.30 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 44.49 96.17 -5.53 49.37 96.61 -3.37 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1eq2_c09 source 1eq2 ADP-L-GLYCERO-D-MANNOHEPTOSE 6-EPIMERASE : 4 hits 1eq2_c09 naa= 3 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 159 LYS A 115 LYS~? 1000.00 A 193 GLU A 128 GLU.? 1000.00 A 217 VAL A 130 VAL^? 1000.00 coo 2.10 10.68 61.44 -2.14 13.16 60.61 24.53 -4.83 7.12 22.37 -6.02 1.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 29.43 4.89 3.07 29.04 6.89 3.60 coo 0.07 12.29 66.53 -0.24 11.95 64.38 24.03 -0.96 0.78 23.62 -0.90 2.85 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 159 LYS A 115 LYS~? 1000.00 A 193 GLU A 129 GLU^? 1000.00 A 217 VAL A 130 VAL^? 1000.00 coo 2.10 10.68 61.44 -2.14 13.16 60.61 24.53 -4.83 7.12 22.37 -6.02 1.89 coo -5.33 11.71 69.72 -4.62 11.92 67.73 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 0.07 12.29 66.53 -0.24 11.95 64.38 24.03 -0.96 0.78 23.62 -0.90 2.85 ULMN 3 1et0_c00 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 159 LYS B 115 LYS~? 1000.00 A 193 GLU B 129 GLU^? 1000.00 A 217 VAL B 130 VAL^? 1000.00 coo 2.10 10.68 61.44 -2.14 13.16 60.61 25.77 -5.51 -22.92 25.67 -7.99 -17.65 coo -5.33 11.71 69.72 -4.62 11.92 67.73 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 0.07 12.29 66.53 -0.24 11.95 64.38 29.34 -4.02 -16.53 29.58 -4.34 -18.61 1et0_c00 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 3 hits 1et0_c00 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 62 THR^? 1000.00 A 159 LYS A 65 LYS.? 1000.00 A 193 GLU A 22 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 23.75 4.97 0.22 25.24 5.64 -1.20 coo 2.10 10.68 61.44 -2.14 13.16 60.61 23.08 10.16 8.29 20.19 14.81 10.58 coo -5.33 11.71 69.72 -4.62 11.92 67.73 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 101 THR.? 1000.00 A 159 LYS A 12 LYS^? 1000.00 A 193 GLU A 30 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 2.10 10.68 61.44 -2.14 13.16 60.61 17.98 11.97 -5.29 22.40 15.81 -5.00 coo -5.33 11.71 69.72 -4.62 11.92 67.73 20.47 3.27 -9.94 22.27 3.25 -11.07 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 62 THR^? 1000.00 A 159 LYS B 65 LYS.? 1000.00 A 193 GLU B 22 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 34.62 -1.27 -15.97 34.38 0.39 -14.61 coo 2.10 10.68 61.44 -2.14 13.16 60.61 39.44 0.72 -24.06 44.98 0.54 -26.26 coo -5.33 11.71 69.72 -4.62 11.92 67.73 44.79 -9.15 -23.60 46.32 -7.71 -23.39 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 101 THR.? 1000.00 A 159 LYS B 12 LYS^? 1000.00 A 193 GLU B 30 GLU^? 1000.00 coo -2.58 16.31 54.79 -4.02 14.93 55.64 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo 2.10 10.68 61.44 -2.14 13.16 60.61 43.44 -2.72 -10.47 44.74 2.97 -10.70 coo -5.33 11.71 69.72 -4.62 11.92 67.73 34.72 -4.99 -5.76 33.75 -3.44 -4.67 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 4 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU A 30 GLU^? 1000.00 A 260 ARG A 103 ARG^? 1000.00 A 270 LYS A 12 LYS^? 1000.00 coo 50.99 29.43 12.86 52.11 29.45 14.65 20.47 3.27 -9.94 22.27 3.25 -11.07 coo 39.80 27.50 22.98 42.20 26.56 21.34 7.99 11.60 -2.28 6.58 12.81 0.15 coo 48.83 21.70 19.50 47.44 24.99 15.25 17.98 11.97 -5.29 22.40 15.81 -5.00 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 2 3 # 2 A 34 GLU A 30 GLU^? 1000.00 A 260 ARG A 103 ARG^? 1000.00 A 270 LYS A 27 LYS^? 1000.00 coo 50.99 29.43 12.86 52.11 29.45 14.65 20.47 3.27 -9.94 22.27 3.25 -11.07 coo 39.80 27.50 22.98 42.20 26.56 21.34 7.99 11.60 -2.28 6.58 12.81 0.15 coo 48.83 21.70 19.50 47.44 24.99 15.25 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 3 3 # 3 A 34 GLU B 30 GLU^? 1000.00 A 260 ARG B 103 ARG^? 1000.00 A 270 LYS B 12 LYS^? 1000.00 coo 50.99 29.43 12.86 52.11 29.45 14.65 34.72 -4.99 -5.76 33.75 -3.44 -4.67 coo 39.80 27.50 22.98 42.20 26.56 21.34 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo 48.83 21.70 19.50 47.44 24.99 15.25 43.44 -2.72 -10.47 44.74 2.97 -10.70 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 4 3 # 4 A 34 GLU B 30 GLU^? 1000.00 A 260 ARG B 103 ARG^? 1000.00 A 270 LYS B 27 LYS^? 1000.00 coo 50.99 29.43 12.86 52.11 29.45 14.65 34.72 -4.99 -5.76 33.75 -3.44 -4.67 coo 39.80 27.50 22.98 42.20 26.56 21.34 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo 48.83 21.70 19.50 47.44 24.99 15.25 40.39 -1.34 -15.57 44.33 1.39 -18.11 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 4 hits 1euy_c00 naa= 3 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 1 3 # 1 A 68 ASP A 136 ASP^? 1000.00 A 74 ASP A 108 ASP^? 1000.00 A 98 GLU A 135 GLU.? 1000.00 coo 17.19 9.05 25.28 15.77 9.98 26.53 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 15.99 8.54 17.36 14.96 7.80 19.05 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 16.31 12.85 18.11 16.71 11.79 19.90 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1eyi_c00 FRUCTOSE-1,6-BISPHOSPHATASE user 2 3 # 2 A 68 ASP B 136 ASP^? 1000.00 A 74 ASP B 108 ASP^? 1000.00 A 98 GLU B 135 GLU.? 1000.00 coo 17.19 9.05 25.28 15.77 9.98 26.53 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 15.99 8.54 17.36 14.96 7.80 19.05 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 16.31 12.85 18.11 16.71 11.79 19.90 31.07 -20.83 -12.95 29.80 -19.16 -13.24 1eyi_c00 source 1eyi FRUCTOSE-1,6-BISPHOSPHATASE : 2 hits 1eyi_c00 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 86 PHE^? 1000.00 A 210 ASP A 112 ASP~? 1000.00 A 244 LYS A 80 LYS~? 1000.00 coo 9.23 46.77 25.11 11.48 48.39 24.76 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 10.51 37.86 19.71 9.07 39.38 20.04 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -1.20 42.34 17.67 3.19 45.13 19.06 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE A 134 PHE.? 1000.00 A 210 ASP A 138 ASP^? 1000.00 A 244 LYS A 51 LYS.? 1000.00 coo 9.23 46.77 25.11 11.48 48.39 24.76 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo 10.51 37.86 19.71 9.07 39.38 20.04 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -1.20 42.34 17.67 3.19 45.13 19.06 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 A 112 PHE A 137 PHE^? 1000.00 A 210 ASP A 94 ASP.? 1000.00 A 244 LYS A 142 LYS.? 1000.00 coo 9.23 46.77 25.11 11.48 48.39 24.76 8.81 1.33 -9.39 8.17 2.24 -11.93 coo 10.51 37.86 19.71 9.07 39.38 20.04 13.93 10.69 -14.78 14.17 9.66 -16.61 coo -1.20 42.34 17.67 3.19 45.13 19.06 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 A 112 PHE B 86 PHE^? 1000.00 A 210 ASP B 112 ASP~? 1000.00 A 244 LYS B 80 LYS~? 1000.00 coo 9.23 46.77 25.11 11.48 48.39 24.76 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 10.51 37.86 19.71 9.07 39.38 20.04 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -1.20 42.34 17.67 3.19 45.13 19.06 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 A 112 PHE B 134 PHE.? 1000.00 A 210 ASP B 138 ASP^? 1000.00 A 244 LYS B 51 LYS.? 1000.00 coo 9.23 46.77 25.11 11.48 48.39 24.76 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo 10.51 37.86 19.71 9.07 39.38 20.04 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 39.55 -26.05 -1.63 36.69 -20.49 -2.33 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 A 112 PHE B 137 PHE^? 1000.00 A 210 ASP B 94 ASP.? 1000.00 A 244 LYS B 142 LYS.? 1000.00 coo 9.23 46.77 25.11 11.48 48.39 24.76 38.85 -16.01 -6.33 39.98 -16.09 -3.79 coo 10.51 37.86 19.71 9.07 39.38 20.04 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -1.20 42.34 17.67 3.19 45.13 19.06 52.98 -12.77 -6.57 54.80 -12.93 -0.57 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 6 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 86 PHE^? 1000.00 B 210 ASP A 112 ASP~? 1000.00 B 244 LYS A 80 LYS~? 1000.00 coo 8.76 47.85 34.91 11.08 46.36 35.41 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 9.06 56.85 40.30 7.71 55.27 39.90 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -2.38 51.82 41.62 2.07 49.19 40.42 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE A 134 PHE.? 1000.00 B 210 ASP A 138 ASP^? 1000.00 B 244 LYS A 51 LYS.? 1000.00 coo 8.76 47.85 34.91 11.08 46.36 35.41 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo 9.06 56.85 40.30 7.71 55.27 39.90 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -2.38 51.82 41.62 2.07 49.19 40.42 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 3 3 # 3 B 112 PHE A 137 PHE^? 1000.00 B 210 ASP A 94 ASP.? 1000.00 B 244 LYS A 142 LYS.? 1000.00 coo 8.76 47.85 34.91 11.08 46.36 35.41 8.81 1.33 -9.39 8.17 2.24 -11.93 coo 9.06 56.85 40.30 7.71 55.27 39.90 13.93 10.69 -14.78 14.17 9.66 -16.61 coo -2.38 51.82 41.62 2.07 49.19 40.42 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 4 3 # 4 B 112 PHE B 86 PHE^? 1000.00 B 210 ASP B 112 ASP~? 1000.00 B 244 LYS B 80 LYS~? 1000.00 coo 8.76 47.85 34.91 11.08 46.36 35.41 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 9.06 56.85 40.30 7.71 55.27 39.90 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -2.38 51.82 41.62 2.07 49.19 40.42 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 5 3 # 5 B 112 PHE B 134 PHE.? 1000.00 B 210 ASP B 138 ASP^? 1000.00 B 244 LYS B 51 LYS.? 1000.00 coo 8.76 47.85 34.91 11.08 46.36 35.41 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo 9.06 56.85 40.30 7.71 55.27 39.90 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 39.55 -26.05 -1.63 36.69 -20.49 -2.33 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 6 3 # 6 B 112 PHE B 137 PHE^? 1000.00 B 210 ASP B 94 ASP.? 1000.00 B 244 LYS B 142 LYS.? 1000.00 coo 8.76 47.85 34.91 11.08 46.36 35.41 38.85 -16.01 -6.33 39.98 -16.09 -3.79 coo 9.06 56.85 40.30 7.71 55.27 39.90 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -2.38 51.82 41.62 2.07 49.19 40.42 52.98 -12.77 -6.57 54.80 -12.93 -0.57 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 6 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 77 TYR~? 1000.00 A 142 LEU A 72 LEU~? 1000.00 A 165 LYS A 79 LYS~? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 19.96 0.81 19.13 19.51 -0.11 21.06 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR A 77 TYR~? 1000.00 A 142 LEU A 72 LEU~? 1000.00 A 165 LYS A 80 LYS~? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 19.96 0.81 19.13 19.51 -0.11 21.06 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 A 137 TYR B 77 TYR~? 1000.00 A 142 LEU B 72 LEU~? 1000.00 A 165 LYS B 79 LYS~? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 32.93 -6.67 -34.90 32.41 -7.47 -36.86 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 A 137 TYR B 77 TYR~? 1000.00 A 142 LEU B 72 LEU~? 1000.00 A 165 LYS B 80 LYS~? 1000.00 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 32.93 -6.67 -34.90 32.41 -7.47 -36.86 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 77 TYR~? 1000.00 B 142 LEU A 72 LEU~? 1000.00 B 165 LYS A 79 LYS~? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 19.96 0.81 19.13 19.51 -0.11 21.06 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR A 77 TYR~? 1000.00 B 142 LEU A 72 LEU~? 1000.00 B 165 LYS A 80 LYS~? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 19.96 0.81 19.13 19.51 -0.11 21.06 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 B 137 TYR B 77 TYR~? 1000.00 B 142 LEU B 72 LEU~? 1000.00 B 165 LYS B 79 LYS~? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 32.93 -6.67 -34.90 32.41 -7.47 -36.86 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 B 137 TYR B 77 TYR~? 1000.00 B 142 LEU B 72 LEU~? 1000.00 B 165 LYS B 80 LYS~? 1000.00 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 32.93 -6.67 -34.90 32.41 -7.47 -36.86 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 77 TYR~? 1000.00 C 142 LEU A 72 LEU~? 1000.00 C 165 LYS A 79 LYS~? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 19.96 0.81 19.13 19.51 -0.11 21.06 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR A 77 TYR~? 1000.00 C 142 LEU A 72 LEU~? 1000.00 C 165 LYS A 80 LYS~? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 19.96 0.81 19.13 19.51 -0.11 21.06 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 C 137 TYR B 77 TYR~? 1000.00 C 142 LEU B 72 LEU~? 1000.00 C 165 LYS B 79 LYS~? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 32.93 -6.67 -34.90 32.41 -7.47 -36.86 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 C 137 TYR B 77 TYR~? 1000.00 C 142 LEU B 72 LEU~? 1000.00 C 165 LYS B 80 LYS~? 1000.00 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 32.93 -6.67 -34.90 32.41 -7.47 -36.86 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 77 TYR~? 1000.00 D 142 LEU A 72 LEU~? 1000.00 D 165 LYS A 79 LYS~? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 19.96 0.81 19.13 19.51 -0.11 21.06 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR A 77 TYR~? 1000.00 D 142 LEU A 72 LEU~? 1000.00 D 165 LYS A 80 LYS~? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 19.96 0.81 19.13 19.51 -0.11 21.06 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 3 3 # 3 D 137 TYR B 77 TYR~? 1000.00 D 142 LEU B 72 LEU~? 1000.00 D 165 LYS B 79 LYS~? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 32.93 -6.67 -34.90 32.41 -7.47 -36.86 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 4 3 # 4 D 137 TYR B 77 TYR~? 1000.00 D 142 LEU B 72 LEU~? 1000.00 D 165 LYS B 80 LYS~? 1000.00 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 32.93 -6.67 -34.90 32.41 -7.47 -36.86 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 4 hits 1fdy_c03 naa= 3 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 103 ARG^? 1000.00 A 136 GLU A 102 GLU.? 1000.00 A 246 GLU A 141 GLU.? 1000.00 coo 13.48 30.30 107.06 11.75 30.99 109.44 7.99 11.60 -2.28 6.58 12.81 0.15 coo 9.46 32.37 115.82 8.50 34.20 115.47 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 11.99 34.33 109.92 10.08 34.19 110.77 3.43 12.79 -4.88 2.72 12.95 -2.84 ULMN 3 1fhl_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 103 ARG^? 1000.00 A 136 GLU B 102 GLU.? 1000.00 A 246 GLU B 141 GLU.? 1000.00 coo 13.48 30.30 107.06 11.75 30.99 109.44 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo 9.46 32.37 115.82 8.50 34.20 115.47 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 11.99 34.33 109.92 10.08 34.19 110.77 51.50 -14.92 -10.75 52.03 -15.46 -12.75 1fhl_c00 source 1fhl BETA-1,4-GALACTANASE : 2 hits 1fhl_c00 naa= 3 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 1 3 # 1 A 45 ARG A 103 ARG^? 1000.00 A 136 GLU A 102 GLU.? 1000.00 A 246 GLU A 141 GLU.? 1000.00 coo 13.94 29.84 106.80 11.67 30.40 108.79 7.99 11.60 -2.28 6.58 12.81 0.15 coo 9.52 31.97 115.23 8.45 33.74 114.72 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 11.92 33.82 109.35 10.10 33.50 110.39 3.43 12.79 -4.88 2.72 12.95 -2.84 ULMN 3 1fob_c00 BETA-1,4-GALACTANASE user 2 3 # 2 A 45 ARG B 103 ARG^? 1000.00 A 136 GLU B 102 GLU.? 1000.00 A 246 GLU B 141 GLU.? 1000.00 coo 13.94 29.84 106.80 11.67 30.40 108.79 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo 9.52 31.97 115.23 8.45 33.74 114.72 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 11.92 33.82 109.35 10.10 33.50 110.39 51.50 -14.92 -10.75 52.03 -15.46 -12.75 1fob_c00 source 1fob BETA-1,4-GALACTANASE : 2 hits 1fob_c00 naa= 3 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 A 317 GLU A 135 GLU.? 1000.00 A 319 ASP A 136 ASP^? 1000.00 A 359 ARG A 46 ARG.? 1000.00 coo 14.41 12.40 16.42 12.92 13.74 15.71 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo 12.25 13.04 23.85 11.56 15.02 23.93 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 10.89 14.95 28.28 12.39 12.53 29.31 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 A 317 GLU A 141 GLU.? 1000.00 A 319 ASP A 138 ASP^? 1000.00 A 359 ARG A 46 ARG.? 1000.00 coo 14.41 12.40 16.42 12.92 13.74 15.71 3.43 12.79 -4.88 2.72 12.95 -2.84 coo 12.25 13.04 23.85 11.56 15.02 23.93 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 10.89 14.95 28.28 12.39 12.53 29.31 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1fr8_c00 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 A 317 GLU B 141 GLU.? 1000.00 A 319 ASP B 138 ASP^? 1000.00 A 359 ARG B 46 ARG.? 1000.00 coo 14.41 12.40 16.42 12.92 13.74 15.71 51.50 -14.92 -10.75 52.03 -15.46 -12.75 coo 12.25 13.04 23.85 11.56 15.02 23.93 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 10.89 14.95 28.28 12.39 12.53 29.31 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1fr8_c00 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 3 hits 1fr8_c00 naa= 3 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 1 3 # 1 B 317 GLU A 135 GLU.? 1000.00 B 319 ASP A 136 ASP^? 1000.00 B 359 ARG A 46 ARG.? 1000.00 coo 10.77 13.13 40.94 11.03 14.73 39.51 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo 3.77 12.64 38.21 3.35 14.53 37.39 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo -1.16 15.32 35.60 -3.32 13.56 36.98 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 2 3 # 2 B 317 GLU A 141 GLU.? 1000.00 B 319 ASP A 138 ASP^? 1000.00 B 359 ARG A 46 ARG.? 1000.00 coo 10.77 13.13 40.94 11.03 14.73 39.51 3.43 12.79 -4.88 2.72 12.95 -2.84 coo 3.77 12.64 38.21 3.35 14.53 37.39 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -1.16 15.32 35.60 -3.32 13.56 36.98 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 3 3 # 3 B 317 GLU B 135 GLU.? 1000.00 B 319 ASP B 136 ASP^? 1000.00 B 359 ARG B 46 ARG.? 1000.00 coo 10.77 13.13 40.94 11.03 14.73 39.51 31.07 -20.83 -12.95 29.80 -19.16 -13.24 coo 3.77 12.64 38.21 3.35 14.53 37.39 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo -1.16 15.32 35.60 -3.32 13.56 36.98 40.40 -21.43 -4.30 39.16 -22.01 -7.08 ULMN 3 1fr8_c01 BETA 1,4 GALACTOSYLTRANSFERASE user 4 3 # 4 B 317 GLU B 141 GLU.? 1000.00 B 319 ASP B 138 ASP^? 1000.00 B 359 ARG B 46 ARG.? 1000.00 coo 10.77 13.13 40.94 11.03 14.73 39.51 51.50 -14.92 -10.75 52.03 -15.46 -12.75 coo 3.77 12.64 38.21 3.35 14.53 37.39 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -1.16 15.32 35.60 -3.32 13.56 36.98 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1fr8_c01 source 1fr8 BETA 1,4 GALACTOSYLTRANSFERASE : 4 hits 1fr8_c01 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 27 LYS^? 1000.00 A 331 GLU A 22 GLU^? 1000.00 B 188 HIS A 25 HIS.? 1000.00 coo 130.22 155.23 83.49 125.21 153.71 84.04 20.78 10.08 -0.17 21.23 14.77 2.36 coo 120.90 152.23 75.28 120.94 153.09 77.19 11.90 9.90 7.95 12.35 11.96 7.71 coo 122.04 152.80 81.06 120.71 154.37 81.46 17.07 12.41 6.63 15.76 13.52 7.84 ULMN 3 1fuq_c00 FUMARASE C user 2 3 # 2 A 324 LYS B 27 LYS^? 1000.00 A 331 GLU B 22 GLU^? 1000.00 B 188 HIS B 25 HIS^? 1000.00 coo 130.22 155.23 83.49 125.21 153.71 84.04 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 120.90 152.23 75.28 120.94 153.09 77.19 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 122.04 152.80 81.06 120.71 154.37 81.46 44.38 -3.39 -22.45 45.97 -4.01 -23.66 1fuq_c00 source 1fuq FUMARASE C : 2 hits 1fuq_c00 naa= 3 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 A 189 PHE A 63 PHE^? 1000.00 A 298 ASP A 120 ASP.? 1000.00 A 329 LYS A 69 LYS~? 1000.00 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 21.53 4.57 4.68 19.76 2.41 4.33 coo 2.59 0.29 25.55 4.65 0.18 25.07 27.77 3.65 13.30 28.81 5.07 14.48 coo 12.42 6.10 23.27 9.95 1.57 20.16 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 A 189 PHE A 70 PHE~? 1000.00 A 298 ASP A 120 ASP.? 1000.00 A 329 LYS A 115 LYS~? 1000.00 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 17.83 3.19 11.63 17.23 1.65 9.39 coo 2.59 0.29 25.55 4.65 0.18 25.07 27.77 3.65 13.30 28.81 5.07 14.48 coo 12.42 6.10 23.27 9.95 1.57 20.16 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 A 189 PHE A 86 PHE^? 1000.00 A 298 ASP A 83 ASP.? 1000.00 A 329 LYS A 115 LYS~? 1000.00 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 2.59 0.29 25.55 4.65 0.18 25.07 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 12.42 6.10 23.27 9.95 1.57 20.16 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 A 189 PHE A 132 PHE^? 1000.00 A 298 ASP A 83 ASP.? 1000.00 A 329 LYS A 115 LYS~? 1000.00 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 2.59 0.29 25.55 4.65 0.18 25.07 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 12.42 6.10 23.27 9.95 1.57 20.16 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 A 189 PHE B 63 PHE^? 1000.00 A 298 ASP B 120 ASP.? 1000.00 A 329 LYS B 69 LYS~? 1000.00 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 2.59 0.29 25.55 4.65 0.18 25.07 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 12.42 6.10 23.27 9.95 1.57 20.16 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 A 189 PHE B 70 PHE~? 1000.00 A 298 ASP B 120 ASP.? 1000.00 A 329 LYS B 115 LYS~? 1000.00 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo 2.59 0.29 25.55 4.65 0.18 25.07 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 12.42 6.10 23.27 9.95 1.57 20.16 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 A 189 PHE B 86 PHE^? 1000.00 A 298 ASP B 83 ASP.? 1000.00 A 329 LYS B 115 LYS~? 1000.00 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 2.59 0.29 25.55 4.65 0.18 25.07 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 12.42 6.10 23.27 9.95 1.57 20.16 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 1gtx_c00 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 A 189 PHE B 132 PHE^? 1000.00 A 298 ASP B 83 ASP.? 1000.00 A 329 LYS B 115 LYS~? 1000.00 coo 6.56 -4.17 18.88 9.26 -4.62 19.48 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 2.59 0.29 25.55 4.65 0.18 25.07 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 12.42 6.10 23.27 9.95 1.57 20.16 25.77 -5.51 -22.92 25.67 -7.99 -17.65 1gtx_c00 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c00 naa= 3 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 B 189 PHE A 63 PHE^? 1000.00 B 298 ASP A 120 ASP.? 1000.00 B 329 LYS A 69 LYS~? 1000.00 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 21.53 4.57 4.68 19.76 2.41 4.33 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 27.77 3.65 13.30 28.81 5.07 14.48 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 B 189 PHE A 70 PHE~? 1000.00 B 298 ASP A 120 ASP.? 1000.00 B 329 LYS A 115 LYS~? 1000.00 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 17.83 3.19 11.63 17.23 1.65 9.39 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 27.77 3.65 13.30 28.81 5.07 14.48 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 B 189 PHE A 86 PHE^? 1000.00 B 298 ASP A 83 ASP.? 1000.00 B 329 LYS A 115 LYS~? 1000.00 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 B 189 PHE A 132 PHE^? 1000.00 B 298 ASP A 83 ASP.? 1000.00 B 329 LYS A 115 LYS~? 1000.00 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 B 189 PHE B 63 PHE^? 1000.00 B 298 ASP B 120 ASP.? 1000.00 B 329 LYS B 69 LYS~? 1000.00 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 B 189 PHE B 70 PHE~? 1000.00 B 298 ASP B 120 ASP.? 1000.00 B 329 LYS B 115 LYS~? 1000.00 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 B 189 PHE B 86 PHE^? 1000.00 B 298 ASP B 83 ASP.? 1000.00 B 329 LYS B 115 LYS~? 1000.00 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 1gtx_c01 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 B 189 PHE B 132 PHE^? 1000.00 B 298 ASP B 83 ASP.? 1000.00 B 329 LYS B 115 LYS~? 1000.00 coo 20.14 -12.51 41.29 18.81 -10.14 40.57 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 25.22 -15.42 34.53 24.48 -13.46 34.89 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 27.68 -4.10 35.68 24.39 -7.59 39.32 25.77 -5.51 -22.92 25.67 -7.99 -17.65 1gtx_c01 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c01 naa= 3 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 C 189 PHE A 63 PHE^? 1000.00 C 298 ASP A 120 ASP.? 1000.00 C 329 LYS A 69 LYS~? 1000.00 coo 17.41 60.57 64.39 18.40 58.12 65.34 21.53 4.57 4.68 19.76 2.41 4.33 coo 24.10 66.43 63.33 24.18 64.30 63.40 27.77 3.65 13.30 28.81 5.07 14.48 coo 27.64 56.61 58.17 22.18 57.92 60.36 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 C 189 PHE A 70 PHE~? 1000.00 C 298 ASP A 120 ASP.? 1000.00 C 329 LYS A 115 LYS~? 1000.00 coo 17.41 60.57 64.39 18.40 58.12 65.34 17.83 3.19 11.63 17.23 1.65 9.39 coo 24.10 66.43 63.33 24.18 64.30 63.40 27.77 3.65 13.30 28.81 5.07 14.48 coo 27.64 56.61 58.17 22.18 57.92 60.36 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 C 189 PHE A 86 PHE^? 1000.00 C 298 ASP A 83 ASP.? 1000.00 C 329 LYS A 115 LYS~? 1000.00 coo 17.41 60.57 64.39 18.40 58.12 65.34 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 24.10 66.43 63.33 24.18 64.30 63.40 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 27.64 56.61 58.17 22.18 57.92 60.36 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 C 189 PHE A 132 PHE^? 1000.00 C 298 ASP A 83 ASP.? 1000.00 C 329 LYS A 115 LYS~? 1000.00 coo 17.41 60.57 64.39 18.40 58.12 65.34 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 24.10 66.43 63.33 24.18 64.30 63.40 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 27.64 56.61 58.17 22.18 57.92 60.36 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 C 189 PHE B 63 PHE^? 1000.00 C 298 ASP B 120 ASP.? 1000.00 C 329 LYS B 69 LYS~? 1000.00 coo 17.41 60.57 64.39 18.40 58.12 65.34 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 24.10 66.43 63.33 24.18 64.30 63.40 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 27.64 56.61 58.17 22.18 57.92 60.36 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 C 189 PHE B 70 PHE~? 1000.00 C 298 ASP B 120 ASP.? 1000.00 C 329 LYS B 115 LYS~? 1000.00 coo 17.41 60.57 64.39 18.40 58.12 65.34 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo 24.10 66.43 63.33 24.18 64.30 63.40 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 27.64 56.61 58.17 22.18 57.92 60.36 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 C 189 PHE B 86 PHE^? 1000.00 C 298 ASP B 83 ASP.? 1000.00 C 329 LYS B 115 LYS~? 1000.00 coo 17.41 60.57 64.39 18.40 58.12 65.34 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 24.10 66.43 63.33 24.18 64.30 63.40 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 27.64 56.61 58.17 22.18 57.92 60.36 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 1gtx_c02 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 C 189 PHE B 132 PHE^? 1000.00 C 298 ASP B 83 ASP.? 1000.00 C 329 LYS B 115 LYS~? 1000.00 coo 17.41 60.57 64.39 18.40 58.12 65.34 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 24.10 66.43 63.33 24.18 64.30 63.40 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 27.64 56.61 58.17 22.18 57.92 60.36 25.77 -5.51 -22.92 25.67 -7.99 -17.65 1gtx_c02 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c02 naa= 3 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 1 3 # 1 D 189 PHE A 63 PHE^? 1000.00 D 298 ASP A 120 ASP.? 1000.00 D 329 LYS A 69 LYS~? 1000.00 coo 35.44 53.35 83.81 35.65 54.53 81.28 21.53 4.57 4.68 19.76 2.41 4.33 coo 29.72 46.46 83.60 30.79 47.36 81.99 27.77 3.65 13.30 28.81 5.07 14.48 coo 36.89 44.91 74.55 37.33 48.94 79.01 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 2 3 # 2 D 189 PHE A 70 PHE~? 1000.00 D 298 ASP A 120 ASP.? 1000.00 D 329 LYS A 115 LYS~? 1000.00 coo 35.44 53.35 83.81 35.65 54.53 81.28 17.83 3.19 11.63 17.23 1.65 9.39 coo 29.72 46.46 83.60 30.79 47.36 81.99 27.77 3.65 13.30 28.81 5.07 14.48 coo 36.89 44.91 74.55 37.33 48.94 79.01 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 3 3 # 3 D 189 PHE A 86 PHE^? 1000.00 D 298 ASP A 83 ASP.? 1000.00 D 329 LYS A 115 LYS~? 1000.00 coo 35.44 53.35 83.81 35.65 54.53 81.28 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 29.72 46.46 83.60 30.79 47.36 81.99 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 36.89 44.91 74.55 37.33 48.94 79.01 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 4 3 # 4 D 189 PHE A 132 PHE^? 1000.00 D 298 ASP A 83 ASP.? 1000.00 D 329 LYS A 115 LYS~? 1000.00 coo 35.44 53.35 83.81 35.65 54.53 81.28 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 29.72 46.46 83.60 30.79 47.36 81.99 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 36.89 44.91 74.55 37.33 48.94 79.01 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 5 3 # 5 D 189 PHE B 63 PHE^? 1000.00 D 298 ASP B 120 ASP.? 1000.00 D 329 LYS B 69 LYS~? 1000.00 coo 35.44 53.35 83.81 35.65 54.53 81.28 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 29.72 46.46 83.60 30.79 47.36 81.99 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 36.89 44.91 74.55 37.33 48.94 79.01 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 6 3 # 6 D 189 PHE B 70 PHE~? 1000.00 D 298 ASP B 120 ASP.? 1000.00 D 329 LYS B 115 LYS~? 1000.00 coo 35.44 53.35 83.81 35.65 54.53 81.28 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo 29.72 46.46 83.60 30.79 47.36 81.99 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 36.89 44.91 74.55 37.33 48.94 79.01 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 7 3 # 7 D 189 PHE B 86 PHE^? 1000.00 D 298 ASP B 83 ASP.? 1000.00 D 329 LYS B 115 LYS~? 1000.00 coo 35.44 53.35 83.81 35.65 54.53 81.28 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 29.72 46.46 83.60 30.79 47.36 81.99 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 36.89 44.91 74.55 37.33 48.94 79.01 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 1gtx_c03 4-AMINOBUTYRATE AMINOTRANSFERASE user 8 3 # 8 D 189 PHE B 132 PHE^? 1000.00 D 298 ASP B 83 ASP.? 1000.00 D 329 LYS B 115 LYS~? 1000.00 coo 35.44 53.35 83.81 35.65 54.53 81.28 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 29.72 46.46 83.60 30.79 47.36 81.99 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 36.89 44.91 74.55 37.33 48.94 79.01 25.77 -5.51 -22.92 25.67 -7.99 -17.65 1gtx_c03 source 1gtx 4-AMINOBUTYRATE AMINOTRANSFERASE : 8 hits 1gtx_c03 naa= 3 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 A 151 SER A 82 SER.? 1000.00 A 164 TYR A 77 TYR~? 1000.00 A 168 LYS A 79 LYS~? 1000.00 coo 32.37 52.40 49.35 31.32 53.88 47.74 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 29.69 55.04 42.83 31.98 53.56 43.49 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 26.96 50.99 47.03 31.03 48.83 44.33 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 A 151 SER A 82 SER.? 1000.00 A 164 TYR A 77 TYR~? 1000.00 A 168 LYS A 80 LYS~? 1000.00 coo 32.37 52.40 49.35 31.32 53.88 47.74 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 29.69 55.04 42.83 31.98 53.56 43.49 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 26.96 50.99 47.03 31.03 48.83 44.33 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 A 151 SER B 82 SER.? 1000.00 A 164 TYR B 77 TYR~? 1000.00 A 168 LYS B 79 LYS~? 1000.00 coo 32.37 52.40 49.35 31.32 53.88 47.74 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 29.69 55.04 42.83 31.98 53.56 43.49 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 26.96 50.99 47.03 31.03 48.83 44.33 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1gz6_c00 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 A 151 SER B 82 SER.? 1000.00 A 164 TYR B 77 TYR~? 1000.00 A 168 LYS B 80 LYS~? 1000.00 coo 32.37 52.40 49.35 31.32 53.88 47.74 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 29.69 55.04 42.83 31.98 53.56 43.49 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 26.96 50.99 47.03 31.03 48.83 44.33 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1gz6_c00 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c00 naa= 3 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 B 151 SER A 82 SER.? 1000.00 B 164 TYR A 77 TYR~? 1000.00 B 168 LYS A 79 LYS~? 1000.00 coo 13.08 50.93 56.67 13.12 48.99 55.27 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 11.52 46.03 51.32 10.06 47.90 52.76 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 15.72 50.86 51.22 10.77 52.35 51.39 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 B 151 SER A 82 SER.? 1000.00 B 164 TYR A 77 TYR~? 1000.00 B 168 LYS A 80 LYS~? 1000.00 coo 13.08 50.93 56.67 13.12 48.99 55.27 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 11.52 46.03 51.32 10.06 47.90 52.76 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 15.72 50.86 51.22 10.77 52.35 51.39 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 B 151 SER B 82 SER.? 1000.00 B 164 TYR B 77 TYR~? 1000.00 B 168 LYS B 79 LYS~? 1000.00 coo 13.08 50.93 56.67 13.12 48.99 55.27 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 11.52 46.03 51.32 10.06 47.90 52.76 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 15.72 50.86 51.22 10.77 52.35 51.39 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1gz6_c01 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 B 151 SER B 82 SER.? 1000.00 B 164 TYR B 77 TYR~? 1000.00 B 168 LYS B 80 LYS~? 1000.00 coo 13.08 50.93 56.67 13.12 48.99 55.27 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 11.52 46.03 51.32 10.06 47.90 52.76 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 15.72 50.86 51.22 10.77 52.35 51.39 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1gz6_c01 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c01 naa= 3 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 C 151 SER A 82 SER.? 1000.00 C 164 TYR A 77 TYR~? 1000.00 C 168 LYS A 79 LYS~? 1000.00 coo 11.22 34.38 82.32 11.07 36.29 83.78 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 8.83 39.27 87.38 7.60 37.43 85.69 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 12.98 34.46 88.14 8.11 32.96 87.14 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 C 151 SER A 82 SER.? 1000.00 C 164 TYR A 77 TYR~? 1000.00 C 168 LYS A 80 LYS~? 1000.00 coo 11.22 34.38 82.32 11.07 36.29 83.78 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 8.83 39.27 87.38 7.60 37.43 85.69 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 12.98 34.46 88.14 8.11 32.96 87.14 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 C 151 SER B 82 SER.? 1000.00 C 164 TYR B 77 TYR~? 1000.00 C 168 LYS B 79 LYS~? 1000.00 coo 11.22 34.38 82.32 11.07 36.29 83.78 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 8.83 39.27 87.38 7.60 37.43 85.69 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 12.98 34.46 88.14 8.11 32.96 87.14 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1gz6_c02 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 C 151 SER B 82 SER.? 1000.00 C 164 TYR B 77 TYR~? 1000.00 C 168 LYS B 80 LYS~? 1000.00 coo 11.22 34.38 82.32 11.07 36.29 83.78 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 8.83 39.27 87.38 7.60 37.43 85.69 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 12.98 34.46 88.14 8.11 32.96 87.14 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1gz6_c02 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c02 naa= 3 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 1 3 # 1 D 151 SER A 82 SER.? 1000.00 D 164 TYR A 77 TYR~? 1000.00 D 168 LYS A 79 LYS~? 1000.00 coo 29.15 32.90 92.57 27.86 31.44 94.02 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 25.49 30.28 98.59 27.88 31.73 98.26 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 23.46 34.31 94.02 27.08 36.46 97.29 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 2 3 # 2 D 151 SER A 82 SER.? 1000.00 D 164 TYR A 77 TYR~? 1000.00 D 168 LYS A 80 LYS~? 1000.00 coo 29.15 32.90 92.57 27.86 31.44 94.02 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 25.49 30.28 98.59 27.88 31.73 98.26 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 23.46 34.31 94.02 27.08 36.46 97.29 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 3 3 # 3 D 151 SER B 82 SER.? 1000.00 D 164 TYR B 77 TYR~? 1000.00 D 168 LYS B 79 LYS~? 1000.00 coo 29.15 32.90 92.57 27.86 31.44 94.02 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 25.49 30.28 98.59 27.88 31.73 98.26 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 23.46 34.31 94.02 27.08 36.46 97.29 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1gz6_c03 ESTRADIOL 17 BETA-DEHYDROGENASE 4 user 4 3 # 4 D 151 SER B 82 SER.? 1000.00 D 164 TYR B 77 TYR~? 1000.00 D 168 LYS B 80 LYS~? 1000.00 coo 29.15 32.90 92.57 27.86 31.44 94.02 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 25.49 30.28 98.59 27.88 31.73 98.26 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 23.46 34.31 94.02 27.08 36.46 97.29 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1gz6_c03 source 1gz6 ESTRADIOL 17 BETA-DEHYDROGENASE 4 : 4 hits 1gz6_c03 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 19 ASP.? 1000.00 A 327 GLU B 102 GLU.? 1000.00 A 339 ARG B 99 ARG.? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 5.19 0.54 10.51 3.14 -0.02 10.52 coo 75.11 41.01 160.30 76.65 40.06 161.41 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 49.60 -13.15 1.51 47.85 -14.88 -0.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP A 76 ASP~? 1000.00 A 327 GLU B 141 GLU.? 1000.00 A 339 ARG B 103 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 75.11 41.01 160.30 76.65 40.06 161.41 51.50 -14.92 -10.75 52.03 -15.46 -12.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 3 3 # 3 A 50 ASP A 138 ASP^? 1000.00 A 327 GLU B 102 GLU.? 1000.00 A 339 ARG B 99 ARG.? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 75.11 41.01 160.30 76.65 40.06 161.41 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 82.23 40.35 159.87 85.09 40.67 161.01 49.60 -13.15 1.51 47.85 -14.88 -0.33 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 4 3 # 4 A 50 ASP A 138 ASP^? 1000.00 A 327 GLU B 141 GLU.? 1000.00 A 339 ARG B 103 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 75.11 41.01 160.30 76.65 40.06 161.41 51.50 -14.92 -10.75 52.03 -15.46 -12.75 coo 82.23 40.35 159.87 85.09 40.67 161.01 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 5 3 # 5 A 50 ASP B 19 ASP.? 1000.00 A 327 GLU A 102 GLU.? 1000.00 A 339 ARG A 99 ARG.? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 40.03 -19.65 -26.21 40.66 -21.65 -26.18 coo 75.11 41.01 160.30 76.65 40.06 161.41 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 82.23 40.35 159.87 85.09 40.67 161.01 5.95 12.14 -17.18 5.36 9.78 -15.32 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 6 3 # 6 A 50 ASP B 76 ASP~? 1000.00 A 327 GLU A 141 GLU.? 1000.00 A 339 ARG A 103 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 75.11 41.01 160.30 76.65 40.06 161.41 3.43 12.79 -4.88 2.72 12.95 -2.84 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 7 3 # 7 A 50 ASP B 138 ASP^? 1000.00 A 327 GLU A 102 GLU.? 1000.00 A 339 ARG A 99 ARG.? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 82.23 40.35 159.87 85.09 40.67 161.01 5.95 12.14 -17.18 5.36 9.78 -15.32 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 8 3 # 8 A 50 ASP B 138 ASP^? 1000.00 A 327 GLU A 102 GLU.? 1000.00 A 339 ARG A 103 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 9 3 # 9 A 50 ASP B 138 ASP^? 1000.00 A 327 GLU A 141 GLU.? 1000.00 A 339 ARG A 103 ARG^? 1000.00 coo 85.81 57.99 116.01 86.03 55.86 115.89 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 3.43 12.79 -4.88 2.72 12.95 -2.84 coo 82.23 40.35 159.87 85.09 40.67 161.01 7.99 11.60 -2.28 6.58 12.81 0.15 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 9 hits 1hto_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 33 VAL^? 1000.00 A 200 ASP A 94 ASP.? 1000.00 A 226 LYS A 142 LYS.? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.97 -3.22 -11.98 11.65 -1.71 -12.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 34.47 51.09 7.19 28.58 51.18 7.53 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1i29_c03 CSDB user 2 3 # 2 A 128 VAL A 33 VAL^? 1000.00 A 200 ASP A 138 ASP^? 1000.00 A 226 LYS A 142 LYS.? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.97 -3.22 -11.98 11.65 -1.71 -12.78 coo 24.51 43.28 11.18 25.17 44.50 9.58 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 34.47 51.09 7.19 28.58 51.18 7.53 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1i29_c03 CSDB user 3 3 # 3 A 128 VAL A 109 VAL^? 1000.00 A 200 ASP A 112 ASP~? 1000.00 A 226 LYS A 79 LYS~? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.55 -2.21 0.20 13.24 -0.23 0.82 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 34.47 51.09 7.19 28.58 51.18 7.53 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1i29_c03 CSDB user 4 3 # 4 A 128 VAL A 109 VAL^? 1000.00 A 200 ASP A 112 ASP~? 1000.00 A 226 LYS A 80 LYS~? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.55 -2.21 0.20 13.24 -0.23 0.82 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 34.47 51.09 7.19 28.58 51.18 7.53 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1i29_c03 CSDB user 5 3 # 5 A 128 VAL A 109 VAL^? 1000.00 A 200 ASP A 112 ASP~? 1000.00 A 226 LYS B 35 LYS.? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.55 -2.21 0.20 13.24 -0.23 0.82 coo 24.51 43.28 11.18 25.17 44.50 9.58 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 34.47 51.09 7.19 28.58 51.18 7.53 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1i29_c03 CSDB user 6 3 # 6 A 128 VAL A 109 VAL^? 1000.00 A 200 ASP A 138 ASP^? 1000.00 A 226 LYS A 142 LYS.? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 12.55 -2.21 0.20 13.24 -0.23 0.82 coo 24.51 43.28 11.18 25.17 44.50 9.58 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 34.47 51.09 7.19 28.58 51.18 7.53 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1i29_c03 CSDB user 7 3 # 7 A 128 VAL B 33 VAL^? 1000.00 A 200 ASP B 94 ASP.? 1000.00 A 226 LYS B 142 LYS.? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 32.82 -14.72 -3.84 34.78 -15.08 -2.99 coo 24.51 43.28 11.18 25.17 44.50 9.58 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 34.47 51.09 7.19 28.58 51.18 7.53 52.98 -12.77 -6.57 54.80 -12.93 -0.57 ULMN 3 1i29_c03 CSDB user 8 3 # 8 A 128 VAL B 33 VAL^? 1000.00 A 200 ASP B 138 ASP^? 1000.00 A 226 LYS B 142 LYS.? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 32.82 -14.72 -3.84 34.78 -15.08 -2.99 coo 24.51 43.28 11.18 25.17 44.50 9.58 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 52.98 -12.77 -6.57 54.80 -12.93 -0.57 ULMN 3 1i29_c03 CSDB user 9 3 # 9 A 128 VAL B 109 VAL^? 1000.00 A 200 ASP B 112 ASP~? 1000.00 A 226 LYS A 35 LYS.? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 33.98 -14.52 -15.82 35.34 -12.98 -16.55 coo 24.51 43.28 11.18 25.17 44.50 9.58 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 34.47 51.09 7.19 28.58 51.18 7.53 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1i29_c03 CSDB user 10 3 # 10 A 128 VAL B 109 VAL^? 1000.00 A 200 ASP B 112 ASP~? 1000.00 A 226 LYS B 79 LYS~? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 33.98 -14.52 -15.82 35.34 -12.98 -16.55 coo 24.51 43.28 11.18 25.17 44.50 9.58 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 34.47 51.09 7.19 28.58 51.18 7.53 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1i29_c03 CSDB user 11 3 # 11 A 128 VAL B 109 VAL^? 1000.00 A 200 ASP B 112 ASP~? 1000.00 A 226 LYS B 80 LYS~? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 33.98 -14.52 -15.82 35.34 -12.98 -16.55 coo 24.51 43.28 11.18 25.17 44.50 9.58 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 34.47 51.09 7.19 28.58 51.18 7.53 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 1i29_c03 CSDB user 12 3 # 12 A 128 VAL B 109 VAL^? 1000.00 A 200 ASP B 138 ASP^? 1000.00 A 226 LYS B 142 LYS.? 1000.00 coo 19.13 38.05 1.41 19.72 38.80 -0.53 33.98 -14.52 -15.82 35.34 -12.98 -16.55 coo 24.51 43.28 11.18 25.17 44.50 9.58 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 34.47 51.09 7.19 28.58 51.18 7.53 52.98 -12.77 -6.57 54.80 -12.93 -0.57 1i29_c03 source 1i29 CSDB : 12 hits 1i29_c03 naa= 3 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 A 14 LYS A 27 LYS^? 1000.00 A 74 LYS A 65 LYS.? 1000.00 A 165 GLU A 127 GLU.? 1000.00 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 20.78 10.08 -0.17 21.23 14.77 2.36 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 23.08 10.16 8.29 20.19 14.81 10.58 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 32.72 -0.17 0.50 32.99 0.01 -1.60 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 A 14 LYS A 37 LYS.? 1000.00 A 74 LYS A 35 LYS.? 1000.00 A 165 GLU A 135 GLU.? 1000.00 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 A 14 LYS A 65 LYS.? 1000.00 A 74 LYS A 27 LYS^? 1000.00 A 165 GLU A 127 GLU.? 1000.00 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 23.08 10.16 8.29 20.19 14.81 10.58 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 20.78 10.08 -0.17 21.23 14.77 2.36 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 32.72 -0.17 0.50 32.99 0.01 -1.60 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 A 14 LYS B 27 LYS^? 1000.00 A 74 LYS B 65 LYS.? 1000.00 A 165 GLU B 127 GLU.? 1000.00 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 39.44 0.72 -24.06 44.98 0.54 -26.26 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 25.72 3.94 -16.30 25.78 4.20 -14.20 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 A 14 LYS B 35 LYS.? 1000.00 A 74 LYS B 37 LYS.? 1000.00 A 165 GLU B 135 GLU.? 1000.00 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 A 14 LYS B 37 LYS.? 1000.00 A 74 LYS B 35 LYS.? 1000.00 A 165 GLU B 135 GLU.? 1000.00 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1idt_c00 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 A 14 LYS B 65 LYS.? 1000.00 A 74 LYS B 27 LYS^? 1000.00 A 165 GLU B 127 GLU.? 1000.00 coo 25.34 -34.49 45.28 21.58 -36.23 48.72 39.44 0.72 -24.06 44.98 0.54 -26.26 coo 27.69 -28.18 47.27 24.45 -33.01 49.69 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 15.58 -28.67 55.46 14.00 -29.94 56.12 25.72 3.94 -16.30 25.78 4.20 -14.20 1idt_c00 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 7 hits 1idt_c00 naa= 3 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 1 3 # 1 B 14 LYS A 27 LYS^? 1000.00 B 74 LYS A 65 LYS.? 1000.00 B 165 GLU A 127 GLU.? 1000.00 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 20.78 10.08 -0.17 21.23 14.77 2.36 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 23.08 10.16 8.29 20.19 14.81 10.58 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 32.72 -0.17 0.50 32.99 0.01 -1.60 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 2 3 # 2 B 14 LYS A 35 LYS.? 1000.00 B 74 LYS A 37 LYS.? 1000.00 B 165 GLU A 135 GLU.? 1000.00 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 3 3 # 3 B 14 LYS A 37 LYS.? 1000.00 B 74 LYS A 35 LYS.? 1000.00 B 165 GLU A 135 GLU.? 1000.00 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 4 3 # 4 B 14 LYS A 65 LYS.? 1000.00 B 74 LYS A 27 LYS^? 1000.00 B 165 GLU A 127 GLU.? 1000.00 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 23.08 10.16 8.29 20.19 14.81 10.58 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 20.78 10.08 -0.17 21.23 14.77 2.36 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 32.72 -0.17 0.50 32.99 0.01 -1.60 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 5 3 # 5 B 14 LYS B 27 LYS^? 1000.00 B 74 LYS B 65 LYS.? 1000.00 B 165 GLU B 127 GLU.? 1000.00 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 39.44 0.72 -24.06 44.98 0.54 -26.26 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 25.72 3.94 -16.30 25.78 4.20 -14.20 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 6 3 # 6 B 14 LYS B 35 LYS.? 1000.00 B 74 LYS B 37 LYS.? 1000.00 B 165 GLU B 135 GLU.? 1000.00 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 29.05 -17.38 0.57 28.07 -15.85 6.68 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 7 3 # 7 B 14 LYS B 37 LYS.? 1000.00 B 74 LYS B 35 LYS.? 1000.00 B 165 GLU B 135 GLU.? 1000.00 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 29.05 -17.38 0.57 28.07 -15.85 6.68 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1idt_c01 MINOR FMN-DEPENDENT NITROREDUCTASE user 8 3 # 8 B 14 LYS B 65 LYS.? 1000.00 B 74 LYS B 27 LYS^? 1000.00 B 165 GLU B 127 GLU.? 1000.00 coo -11.70 -18.16 41.28 -8.37 -16.95 44.27 39.44 0.72 -24.06 44.98 0.54 -26.26 coo -14.25 -24.10 43.55 -12.53 -18.94 44.42 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo -3.83 -22.11 54.11 -2.14 -20.82 54.20 25.72 3.94 -16.30 25.78 4.20 -14.20 1idt_c01 source 1idt MINOR FMN-DEPENDENT NITROREDUCTASE : 8 hits 1idt_c01 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 19 ASP.? 1000.00 158 THR A 87 THR^? 1000.00 317 ASP A 83 ASP.? 1000.00 coo -2.63 8.40 35.07 -3.66 9.81 36.17 5.19 0.54 10.51 3.14 -0.02 10.52 coo -5.30 12.75 41.86 -4.34 13.05 39.99 9.15 2.06 2.48 7.06 2.46 2.24 coo -12.63 17.64 33.66 -10.65 17.90 34.40 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP A 108 ASP^? 1000.00 158 THR A 133 THR.? 1000.00 317 ASP A 112 ASP~? 1000.00 coo -2.63 8.40 35.07 -3.66 9.81 36.17 8.15 -4.41 0.30 6.77 -4.99 1.79 coo -5.30 12.75 41.86 -4.34 13.05 39.99 15.32 -5.53 -2.56 15.86 -7.55 -2.13 coo -12.63 17.64 33.66 -10.65 17.90 34.40 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 3 3 # 3 54 ASP A 138 ASP^? 1000.00 158 THR A 48 THR.? 1000.00 317 ASP A 94 ASP.? 1000.00 coo -2.63 8.40 35.07 -3.66 9.81 36.17 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -5.30 12.75 41.86 -4.34 13.05 39.99 2.45 5.56 -16.59 2.90 5.87 -18.70 coo -12.63 17.64 33.66 -10.65 17.90 34.40 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 4 3 # 4 54 ASP B 19 ASP.? 1000.00 158 THR B 87 THR^? 1000.00 317 ASP B 83 ASP.? 1000.00 coo -2.63 8.40 35.07 -3.66 9.81 36.17 40.03 -19.65 -26.21 40.66 -21.65 -26.18 coo -5.30 12.75 41.86 -4.34 13.05 39.99 39.33 -15.38 -18.25 40.69 -17.00 -17.92 coo -12.63 17.64 33.66 -10.65 17.90 34.40 27.06 -15.40 -22.59 25.67 -13.84 -22.77 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 5 3 # 5 54 ASP B 93 ASP.? 1000.00 158 THR B 101 THR.? 1000.00 317 ASP B 138 ASP^? 1000.00 coo -2.63 8.40 35.07 -3.66 9.81 36.17 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo -5.30 12.75 41.86 -4.34 13.05 39.99 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo -12.63 17.64 33.66 -10.65 17.90 34.40 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 6 3 # 6 54 ASP B 94 ASP.? 1000.00 158 THR B 101 THR.? 1000.00 317 ASP B 138 ASP^? 1000.00 coo -2.63 8.40 35.07 -3.66 9.81 36.17 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -5.30 12.75 41.86 -4.34 13.05 39.99 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo -12.63 17.64 33.66 -10.65 17.90 34.40 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 7 3 # 7 54 ASP B 108 ASP^? 1000.00 158 THR B 133 THR.? 1000.00 317 ASP B 112 ASP~? 1000.00 coo -2.63 8.40 35.07 -3.66 9.81 36.17 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo -5.30 12.75 41.86 -4.34 13.05 39.99 29.71 -13.76 -13.24 27.67 -14.35 -13.63 coo -12.63 17.64 33.66 -10.65 17.90 34.40 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 8 3 # 8 54 ASP B 138 ASP^? 1000.00 158 THR B 48 THR.? 1000.00 317 ASP B 94 ASP.? 1000.00 coo -2.63 8.40 35.07 -3.66 9.81 36.17 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -5.30 12.75 41.86 -4.34 13.05 39.99 45.67 -19.41 0.89 45.70 -18.81 2.98 coo -12.63 17.64 33.66 -10.65 17.90 34.40 44.37 -6.89 -0.93 43.32 -7.23 0.90 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 8 hits 1inp_c02 naa= 3 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 1 3 # 1 A1132 ASP A 136 ASP^? 1000.00 A1134 ALA A 55 ALA.? 1000.00 A1137 ASN A 56 ASN.? 1000.00 coo -27.05 34.58 17.12 -25.81 32.84 17.16 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo -20.53 36.39 15.81 -20.80 35.01 16.40 7.72 -4.11 -10.29 7.07 -2.77 -10.02 coo -23.72 34.69 12.49 -24.32 32.83 13.34 9.46 -7.73 -7.73 9.95 -8.79 -9.49 ULMN 3 1ir3_c02 INSULIN RECEPTOR user 2 3 # 2 A1132 ASP B 136 ASP^? 1000.00 A1134 ALA B 55 ALA.? 1000.00 A1137 ASN B 56 ASN.? 1000.00 coo -27.05 34.58 17.12 -25.81 32.84 17.16 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo -20.53 36.39 15.81 -20.80 35.01 16.40 34.72 -19.64 -5.52 36.20 -19.58 -5.81 coo -23.72 34.69 12.49 -24.32 32.83 13.34 30.64 -19.94 -7.98 29.63 -20.11 -6.12 1ir3_c02 source 1ir3 INSULIN RECEPTOR : 2 hits 1ir3_c02 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 93 ASP.? 1000.00 A 58 ASP A 94 ASP.? 1000.00 A 424 GLU A 30 GLU^? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 58.59 41.80 18.81 58.94 43.89 18.94 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 52.85 46.34 13.34 54.09 44.97 14.42 20.47 3.27 -9.94 22.27 3.25 -11.07 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 93 ASP.? 1000.00 A 58 ASP A 94 ASP.? 1000.00 A 424 GLU A 102 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 58.59 41.80 18.81 58.94 43.89 18.94 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 52.85 46.34 13.34 54.09 44.97 14.42 6.41 12.98 -11.22 7.03 11.90 -12.90 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP A 94 ASP.? 1000.00 A 58 ASP A 93 ASP.? 1000.00 A 424 GLU A 30 GLU^? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 58.59 41.80 18.81 58.94 43.89 18.94 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 52.85 46.34 13.34 54.09 44.97 14.42 20.47 3.27 -9.94 22.27 3.25 -11.07 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP B 93 ASP.? 1000.00 A 58 ASP B 94 ASP.? 1000.00 A 424 GLU B 30 GLU^? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 58.59 41.80 18.81 58.94 43.89 18.94 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 52.85 46.34 13.34 54.09 44.97 14.42 34.72 -4.99 -5.76 33.75 -3.44 -4.67 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP B 93 ASP.? 1000.00 A 58 ASP B 94 ASP.? 1000.00 A 424 GLU B 102 GLU.? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 58.59 41.80 18.81 58.94 43.89 18.94 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 52.85 46.34 13.34 54.09 44.97 14.42 50.20 -12.24 -4.38 48.92 -12.28 -2.69 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP B 94 ASP.? 1000.00 A 58 ASP B 93 ASP.? 1000.00 A 424 GLU B 30 GLU^? 1000.00 coo 58.42 47.76 20.67 58.01 49.10 19.12 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 58.59 41.80 18.81 58.94 43.89 18.94 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 52.85 46.34 13.34 54.09 44.97 14.42 34.72 -4.99 -5.76 33.75 -3.44 -4.67 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 6 hits 1js4_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 39 GLU.? 1000.00 A 56 LYS A 37 LYS.? 1000.00 A 258 ARG A 46 ARG.? 1000.00 coo 42.33 1.56 26.99 42.38 2.91 28.66 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 38.45 -0.44 19.89 37.36 0.90 25.90 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 39 GLU.? 1000.00 A 56 LYS B 37 LYS.? 1000.00 A 258 ARG B 46 ARG.? 1000.00 coo 42.33 1.56 26.99 42.38 2.91 28.66 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 38.45 -0.44 19.89 37.36 0.90 25.90 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 39 GLU.? 1000.00 B 56 LYS A 37 LYS.? 1000.00 B 258 ARG A 46 ARG.? 1000.00 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 2.64 1.83 34.81 1.56 1.13 32.02 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 39 GLU.? 1000.00 B 56 LYS B 37 LYS.? 1000.00 B 258 ARG B 46 ARG.? 1000.00 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 2.64 1.83 34.81 1.56 1.13 32.02 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 39 GLU.? 1000.00 C 56 LYS A 37 LYS.? 1000.00 C 258 ARG A 46 ARG.? 1000.00 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 39 GLU.? 1000.00 C 56 LYS B 37 LYS.? 1000.00 C 258 ARG B 46 ARG.? 1000.00 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 39 GLU.? 1000.00 D 56 LYS A 37 LYS.? 1000.00 D 258 ARG A 46 ARG.? 1000.00 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 39 GLU.? 1000.00 D 56 LYS B 37 LYS.? 1000.00 D 258 ARG B 46 ARG.? 1000.00 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 1 3 # 1 A 290 ARG A 15 ARG^? 1000.00 A 351 HIS A 25 HIS.? 1000.00 A 386 LEU A 16 LEU^? 1000.00 coo 57.36 53.34 128.83 58.45 50.56 128.34 13.78 12.30 3.30 15.49 14.64 2.27 coo 60.60 50.64 133.59 60.63 48.82 132.56 17.07 12.41 6.63 15.76 13.52 7.84 coo 63.28 54.23 126.45 63.53 52.07 126.70 13.48 4.27 4.18 15.12 3.87 5.52 ULMN 3 1knp_c00 L-ASPARTATE OXIDASE user 2 3 # 2 A 290 ARG B 15 ARG^? 1000.00 A 351 HIS B 25 HIS^? 1000.00 A 386 LEU B 16 LEU^? 1000.00 coo 57.36 53.34 128.83 58.45 50.56 128.34 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 60.60 50.64 133.59 60.63 48.82 132.56 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 63.28 54.23 126.45 63.53 52.07 126.70 39.15 -10.52 -19.90 37.98 -9.27 -21.21 1knp_c00 source 1knp L-ASPARTATE OXIDASE : 2 hits 1knp_c00 naa= 3 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 27 LYS^? 1000.00 A 74 LYS A 65 LYS.? 1000.00 A 165 GLU A 127 GLU.? 1000.00 coo 24.97 5.82 58.78 26.79 1.97 55.46 20.78 10.08 -0.17 21.23 14.77 2.36 coo 19.46 3.44 61.93 23.95 1.12 60.13 23.08 10.16 8.29 20.19 14.81 10.58 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 32.72 -0.17 0.50 32.99 0.01 -1.60 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS A 35 LYS.? 1000.00 A 74 LYS A 37 LYS.? 1000.00 A 165 GLU A 135 GLU.? 1000.00 coo 24.97 5.82 58.78 26.79 1.97 55.46 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 19.46 3.44 61.93 23.95 1.12 60.13 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 A 14 LYS A 37 LYS.? 1000.00 A 74 LYS A 35 LYS.? 1000.00 A 165 GLU A 135 GLU.? 1000.00 coo 24.97 5.82 58.78 26.79 1.97 55.46 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 19.46 3.44 61.93 23.95 1.12 60.13 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 A 14 LYS A 65 LYS.? 1000.00 A 74 LYS A 27 LYS^? 1000.00 A 165 GLU A 127 GLU.? 1000.00 coo 24.97 5.82 58.78 26.79 1.97 55.46 23.08 10.16 8.29 20.19 14.81 10.58 coo 19.46 3.44 61.93 23.95 1.12 60.13 20.78 10.08 -0.17 21.23 14.77 2.36 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 32.72 -0.17 0.50 32.99 0.01 -1.60 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 A 14 LYS B 27 LYS^? 1000.00 A 74 LYS B 65 LYS.? 1000.00 A 165 GLU B 127 GLU.? 1000.00 coo 24.97 5.82 58.78 26.79 1.97 55.46 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 19.46 3.44 61.93 23.95 1.12 60.13 39.44 0.72 -24.06 44.98 0.54 -26.26 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 25.72 3.94 -16.30 25.78 4.20 -14.20 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 A 14 LYS B 35 LYS.? 1000.00 A 74 LYS B 37 LYS.? 1000.00 A 165 GLU B 135 GLU.? 1000.00 coo 24.97 5.82 58.78 26.79 1.97 55.46 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 19.46 3.44 61.93 23.95 1.12 60.13 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 A 14 LYS B 37 LYS.? 1000.00 A 74 LYS B 35 LYS.? 1000.00 A 165 GLU B 135 GLU.? 1000.00 coo 24.97 5.82 58.78 26.79 1.97 55.46 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 19.46 3.44 61.93 23.95 1.12 60.13 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1kqc_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 A 14 LYS B 65 LYS.? 1000.00 A 74 LYS B 27 LYS^? 1000.00 A 165 GLU B 127 GLU.? 1000.00 coo 24.97 5.82 58.78 26.79 1.97 55.46 39.44 0.72 -24.06 44.98 0.54 -26.26 coo 19.46 3.44 61.93 23.95 1.12 60.13 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 19.32 -6.09 50.65 20.51 -6.62 48.98 25.72 3.94 -16.30 25.78 4.20 -14.20 1kqc_c00 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 8 hits 1kqc_c00 naa= 3 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 35 LYS.? 1000.00 B 74 LYS A 37 LYS.? 1000.00 B 165 GLU A 135 GLU.? 1000.00 coo 4.84 5.09 23.75 3.30 1.39 27.48 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 10.43 2.88 20.75 5.72 0.41 23.95 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS A 37 LYS.? 1000.00 B 74 LYS A 35 LYS.? 1000.00 B 165 GLU A 135 GLU.? 1000.00 coo 4.84 5.09 23.75 3.30 1.39 27.48 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 10.43 2.88 20.75 5.72 0.41 23.95 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 35 LYS.? 1000.00 B 74 LYS B 37 LYS.? 1000.00 B 165 GLU B 135 GLU.? 1000.00 coo 4.84 5.09 23.75 3.30 1.39 27.48 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 10.43 2.88 20.75 5.72 0.41 23.95 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1kqc_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 B 14 LYS B 37 LYS.? 1000.00 B 74 LYS B 35 LYS.? 1000.00 B 165 GLU B 135 GLU.? 1000.00 coo 4.84 5.09 23.75 3.30 1.39 27.48 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 10.43 2.88 20.75 5.72 0.41 23.95 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 10.70 -6.39 32.24 9.53 -6.89 33.94 31.07 -20.83 -12.95 29.80 -19.16 -13.24 1kqc_c01 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1kqc_c01 naa= 3 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 C 14 LYS A 37 LYS.? 1000.00 C 74 LYS A 35 LYS.? 1000.00 C 165 GLU A 135 GLU.? 1000.00 coo 17.59 37.25 25.80 19.64 34.15 21.60 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 12.29 34.52 28.11 16.84 32.47 25.43 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 12.06 27.10 15.56 13.23 27.02 13.80 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 C 14 LYS B 35 LYS.? 1000.00 C 74 LYS B 37 LYS.? 1000.00 C 165 GLU B 135 GLU.? 1000.00 coo 17.59 37.25 25.80 19.64 34.15 21.60 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 12.29 34.52 28.11 16.84 32.47 25.43 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 12.06 27.10 15.56 13.23 27.02 13.80 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1kqc_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 C 14 LYS B 37 LYS.? 1000.00 C 74 LYS B 35 LYS.? 1000.00 C 165 GLU B 135 GLU.? 1000.00 coo 17.59 37.25 25.80 19.64 34.15 21.60 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 12.29 34.52 28.11 16.84 32.47 25.43 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 12.06 27.10 15.56 13.23 27.02 13.80 31.07 -20.83 -12.95 29.80 -19.16 -13.24 1kqc_c02 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 3 hits 1kqc_c02 naa= 3 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 D 14 LYS A 27 LYS^? 1000.00 D 74 LYS A 65 LYS.? 1000.00 D 165 GLU A 127 GLU.? 1000.00 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 20.78 10.08 -0.17 21.23 14.77 2.36 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 23.08 10.16 8.29 20.19 14.81 10.58 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 32.72 -0.17 0.50 32.99 0.01 -1.60 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 D 14 LYS A 35 LYS.? 1000.00 D 74 LYS A 37 LYS.? 1000.00 D 165 GLU A 135 GLU.? 1000.00 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 D 14 LYS A 37 LYS.? 1000.00 D 74 LYS A 35 LYS.? 1000.00 D 165 GLU A 135 GLU.? 1000.00 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 3 # 4 D 14 LYS A 65 LYS.? 1000.00 D 74 LYS A 27 LYS^? 1000.00 D 165 GLU A 127 GLU.? 1000.00 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 23.08 10.16 8.29 20.19 14.81 10.58 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 20.78 10.08 -0.17 21.23 14.77 2.36 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 32.72 -0.17 0.50 32.99 0.01 -1.60 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 5 3 # 5 D 14 LYS B 27 LYS^? 1000.00 D 74 LYS B 65 LYS.? 1000.00 D 165 GLU B 127 GLU.? 1000.00 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 39.44 0.72 -24.06 44.98 0.54 -26.26 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 25.72 3.94 -16.30 25.78 4.20 -14.20 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 6 3 # 6 D 14 LYS B 35 LYS.? 1000.00 D 74 LYS B 37 LYS.? 1000.00 D 165 GLU B 135 GLU.? 1000.00 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 7 3 # 7 D 14 LYS B 37 LYS.? 1000.00 D 74 LYS B 35 LYS.? 1000.00 D 165 GLU B 135 GLU.? 1000.00 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1kqc_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 8 3 # 8 D 14 LYS B 65 LYS.? 1000.00 D 74 LYS B 27 LYS^? 1000.00 D 165 GLU B 127 GLU.? 1000.00 coo -2.23 43.20 -8.84 -3.98 39.03 -6.02 39.44 0.72 -24.06 44.98 0.54 -26.26 coo 3.33 41.47 -12.31 -1.15 38.64 -10.07 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 3.51 30.30 -2.73 2.31 29.63 -1.11 25.72 3.94 -16.30 25.78 4.20 -14.20 1kqc_c03 source 1kqc OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 8 hits 1kqc_c03 naa= 3 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 1 3 # 1 A 94 LYS A 115 LYS~? 1000.00 A 197 HIS A 25 HIS.? 1000.00 A 446 ARG A 15 ARG^? 1000.00 coo 3.26 62.02 109.14 4.83 57.73 107.38 24.53 -4.83 7.12 22.37 -6.02 1.89 coo 9.48 43.28 113.60 10.05 44.21 111.80 17.07 12.41 6.63 15.76 13.52 7.84 coo 12.14 46.28 115.16 13.57 43.60 115.68 13.78 12.30 3.30 15.49 14.64 2.27 ULMN 3 1kqf_c03 FORMATE DEHYDROGENASE, NITRATE-INDUCuser 2 3 # 2 A 94 LYS B 115 LYS~? 1000.00 A 197 HIS B 25 HIS^? 1000.00 A 446 ARG B 15 ARG^? 1000.00 coo 3.26 62.02 109.14 4.83 57.73 107.38 25.77 -5.51 -22.92 25.67 -7.99 -17.65 coo 9.48 43.28 113.60 10.05 44.21 111.80 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 12.14 46.28 115.16 13.57 43.60 115.68 45.95 -6.29 -19.02 47.14 -3.63 -18.02 1kqf_c03 source 1kqf FORMATE DEHYDROGENASE, NITRATE-INDUCIBLE, CYTO: 2 hits 1kqf_c03 naa= 3 ULMN 3 1lij_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 55 ALA.? 1000.00 A 317 GLY A 54 GLY.? 1000.00 A 318 ASP A 136 ASP^? 1000.00 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 7.72 -4.11 -10.29 7.07 -2.77 -10.02 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 4.96 -6.64 -9.65 4.76 -5.85 -9.47 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1lij_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 55 ALA.? 1000.00 A 317 GLY B 54 GLY.? 1000.00 A 318 ASP B 136 ASP^? 1000.00 coo 144.15 17.54 -4.21 144.96 16.79 -5.26 34.72 -19.64 -5.52 36.20 -19.58 -5.81 coo 145.79 20.97 -4.38 145.13 20.72 -3.93 33.94 -23.32 -6.01 34.72 -23.13 -6.23 coo 141.70 22.54 -2.23 141.09 23.62 -3.92 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1lij_c01 source 1lij ADENOSINE KINASE : 2 hits 1lij_c01 naa= 3 ULMN 3 1lio_c01 ADENOSINE KINASE user 1 3 # 1 A 316 ALA A 55 ALA.? 1000.00 A 317 GLY A 54 GLY.? 1000.00 A 318 ASP A 136 ASP^? 1000.00 coo 27.04 23.54 41.85 25.72 24.19 42.18 7.72 -4.11 -10.29 7.07 -2.77 -10.02 coo 27.87 23.16 38.17 28.43 22.97 38.87 4.96 -6.64 -9.65 4.76 -5.85 -9.47 coo 32.11 22.71 40.58 33.42 24.22 39.78 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1lio_c01 ADENOSINE KINASE user 2 3 # 2 A 316 ALA B 55 ALA.? 1000.00 A 317 GLY B 54 GLY.? 1000.00 A 318 ASP B 136 ASP^? 1000.00 coo 27.04 23.54 41.85 25.72 24.19 42.18 34.72 -19.64 -5.52 36.20 -19.58 -5.81 coo 27.87 23.16 38.17 28.43 22.97 38.87 33.94 -23.32 -6.01 34.72 -23.13 -6.23 coo 32.11 22.71 40.58 33.42 24.22 39.78 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1lio_c01 source 1lio ADENOSINE KINASE : 2 hits 1lio_c01 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 83 ASP.? 1000.00 A 265 GLU A 21 GLU^? 1000.00 A 369 ASP A 108 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 17.36 23.57 72.04 18.68 21.92 71.98 8.36 5.57 14.13 8.30 3.77 15.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 83 ASP.? 1000.00 A 265 GLU A 22 GLU^? 1000.00 A 369 ASP A 108 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.90 9.90 7.95 12.35 11.96 7.71 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP A 108 ASP^? 1000.00 A 265 GLU A 21 GLU^? 1000.00 A 369 ASP A 83 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 8.36 5.57 14.13 8.30 3.77 15.28 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP A 108 ASP^? 1000.00 A 265 GLU A 22 GLU^? 1000.00 A 369 ASP A 83 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.90 9.90 7.95 12.35 11.96 7.71 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 5 3 # 5 A 241 ASP A 108 ASP^? 1000.00 A 265 GLU A 22 GLU^? 1000.00 A 369 ASP A 138 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.90 9.90 7.95 12.35 11.96 7.71 coo 12.19 31.08 87.29 11.13 32.66 86.38 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 6 3 # 6 A 241 ASP A 108 ASP^? 1000.00 A 265 GLU A 30 GLU^? 1000.00 A 369 ASP A 138 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 20.47 3.27 -9.94 22.27 3.25 -11.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 7 3 # 7 A 241 ASP A 108 ASP^? 1000.00 A 265 GLU A 39 GLU.? 1000.00 A 369 ASP A 138 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 8 3 # 8 A 241 ASP A 108 ASP^? 1000.00 A 265 GLU A 141 GLU.? 1000.00 A 369 ASP A 19 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 17.36 23.57 72.04 18.68 21.92 71.98 3.43 12.79 -4.88 2.72 12.95 -2.84 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.19 0.54 10.51 3.14 -0.02 10.52 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 9 3 # 9 A 241 ASP A 138 ASP^? 1000.00 A 265 GLU A 22 GLU^? 1000.00 A 369 ASP A 108 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 17.36 23.57 72.04 18.68 21.92 71.98 11.90 9.90 7.95 12.35 11.96 7.71 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 10 3 # 10 A 241 ASP A 138 ASP^? 1000.00 A 265 GLU A 30 GLU^? 1000.00 A 369 ASP A 108 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 17.36 23.57 72.04 18.68 21.92 71.98 20.47 3.27 -9.94 22.27 3.25 -11.07 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 11 3 # 11 A 241 ASP A 138 ASP^? 1000.00 A 265 GLU A 39 GLU.? 1000.00 A 369 ASP A 108 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 17.36 23.57 72.04 18.68 21.92 71.98 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 12 3 # 12 A 241 ASP B 83 ASP.? 1000.00 A 265 GLU B 21 GLU^? 1000.00 A 369 ASP B 108 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 42.84 -14.24 -29.87 41.38 -15.19 -31.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 13 3 # 13 A 241 ASP B 83 ASP.? 1000.00 A 265 GLU B 22 GLU^? 1000.00 A 369 ASP B 108 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 14 3 # 14 A 241 ASP B 108 ASP^? 1000.00 A 265 GLU B 21 GLU^? 1000.00 A 369 ASP B 83 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 42.84 -14.24 -29.87 41.38 -15.19 -31.09 coo 12.19 31.08 87.29 11.13 32.66 86.38 27.06 -15.40 -22.59 25.67 -13.84 -22.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 15 3 # 15 A 241 ASP B 108 ASP^? 1000.00 A 265 GLU B 22 GLU^? 1000.00 A 369 ASP B 83 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 27.06 -15.40 -22.59 25.67 -13.84 -22.77 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 16 3 # 16 A 241 ASP B 108 ASP^? 1000.00 A 265 GLU B 22 GLU^? 1000.00 A 369 ASP B 138 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 17 3 # 17 A 241 ASP B 108 ASP^? 1000.00 A 265 GLU B 30 GLU^? 1000.00 A 369 ASP B 138 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 34.72 -4.99 -5.76 33.75 -3.44 -4.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 18 3 # 18 A 241 ASP B 108 ASP^? 1000.00 A 265 GLU B 39 GLU.? 1000.00 A 369 ASP B 138 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 17.36 23.57 72.04 18.68 21.92 71.98 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 19 3 # 19 A 241 ASP B 138 ASP^? 1000.00 A 265 GLU B 22 GLU^? 1000.00 A 369 ASP B 108 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 12.19 31.08 87.29 11.13 32.66 86.38 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 20 3 # 20 A 241 ASP B 138 ASP^? 1000.00 A 265 GLU B 30 GLU^? 1000.00 A 369 ASP B 108 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 34.72 -4.99 -5.76 33.75 -3.44 -4.67 coo 12.19 31.08 87.29 11.13 32.66 86.38 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 21 3 # 21 A 241 ASP B 138 ASP^? 1000.00 A 265 GLU B 39 GLU.? 1000.00 A 369 ASP B 108 ASP^? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 17.36 23.57 72.04 18.68 21.92 71.98 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 21 hits 1m53_c05 naa= 3 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 108 ASP^? 1000.00 A 279 GLU A 39 GLU.? 1000.00 A 369 ASP A 19 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 16.54 46.37 63.94 14.77 45.79 62.95 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 12.19 31.08 87.29 11.13 32.66 86.38 5.19 0.54 10.51 3.14 -0.02 10.52 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP A 108 ASP^? 1000.00 A 279 GLU A 141 GLU.? 1000.00 A 369 ASP A 83 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 16.54 46.37 63.94 14.77 45.79 62.95 3.43 12.79 -4.88 2.72 12.95 -2.84 coo 12.19 31.08 87.29 11.13 32.66 86.38 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 3 3 # 3 A 241 ASP B 108 ASP^? 1000.00 A 279 GLU B 39 GLU.? 1000.00 A 369 ASP B 19 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 16.54 46.37 63.94 14.77 45.79 62.95 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 12.19 31.08 87.29 11.13 32.66 86.38 40.03 -19.65 -26.21 40.66 -21.65 -26.18 ULMN 3 1m53_c06 ISOMALTULOSE SYNTHASE user 4 3 # 4 A 241 ASP B 108 ASP^? 1000.00 A 279 GLU B 141 GLU.? 1000.00 A 369 ASP B 83 ASP.? 1000.00 coo 11.74 38.14 80.19 10.63 36.40 80.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 16.54 46.37 63.94 14.77 45.79 62.95 51.50 -14.92 -10.75 52.03 -15.46 -12.75 coo 12.19 31.08 87.29 11.13 32.66 86.38 27.06 -15.40 -22.59 25.67 -13.84 -22.77 1m53_c06 source 1m53 ISOMALTULOSE SYNTHASE : 4 hits 1m53_c06 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 65 LYS.? 1000.00 166 LYS A 27 LYS^? 1000.00 324 SER A 82 SER.? 1000.00 coo 25.93 8.11 25.51 26.40 7.80 19.66 23.08 10.16 8.29 20.19 14.81 10.58 coo 27.27 1.43 25.09 29.18 5.25 22.89 20.78 10.08 -0.17 21.23 14.77 2.36 coo 46.32 14.55 19.93 45.95 12.72 21.27 14.52 -10.91 10.84 12.40 -12.06 11.06 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS B 65 LYS.? 1000.00 166 LYS B 27 LYS^? 1000.00 324 SER B 82 SER.? 1000.00 coo 25.93 8.11 25.51 26.40 7.80 19.66 39.44 0.72 -24.06 44.98 0.54 -26.26 coo 27.27 1.43 25.09 29.18 5.25 22.89 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 46.32 14.55 19.93 45.95 12.72 21.27 25.44 -17.19 -26.64 25.54 -19.61 -26.84 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 2 hits 1mdr_c01 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 215 ASP A 112 ASP~? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 16.04 14.72 33.82 17.27 13.71 31.95 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 20.65 22.00 33.80 20.06 20.56 32.39 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP A 93 ASP.? 1000.00 35 SER A 10 SER^? 1000.00 215 ASP A 94 ASP.? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 16.04 14.72 33.82 17.27 13.71 31.95 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 20.65 22.00 33.80 20.06 20.56 32.39 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 3 3 # 3 32 ASP A 94 ASP.? 1000.00 35 SER A 96 SER.? 1000.00 215 ASP A 93 ASP.? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 16.04 14.72 33.82 17.27 13.71 31.95 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 20.65 22.00 33.80 20.06 20.56 32.39 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 4 3 # 4 32 ASP A 94 ASP.? 1000.00 35 SER A 97 SER.? 1000.00 215 ASP A 93 ASP.? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 16.04 14.72 33.82 17.27 13.71 31.95 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 20.65 22.00 33.80 20.06 20.56 32.39 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 5 3 # 5 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 215 ASP B 112 ASP~? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 16.04 14.72 33.82 17.27 13.71 31.95 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 20.65 22.00 33.80 20.06 20.56 32.39 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 6 3 # 6 32 ASP B 93 ASP.? 1000.00 35 SER B 10 SER^? 1000.00 215 ASP B 94 ASP.? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 16.04 14.72 33.82 17.27 13.71 31.95 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 20.65 22.00 33.80 20.06 20.56 32.39 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 7 3 # 7 32 ASP B 94 ASP.? 1000.00 35 SER B 96 SER.? 1000.00 215 ASP B 93 ASP.? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 16.04 14.72 33.82 17.27 13.71 31.95 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 20.65 22.00 33.80 20.06 20.56 32.39 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 8 3 # 8 32 ASP B 94 ASP.? 1000.00 35 SER B 97 SER.? 1000.00 215 ASP B 93 ASP.? 1000.00 coo 20.97 14.47 32.28 19.66 15.96 31.62 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 16.04 14.72 33.82 17.27 13.71 31.95 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 20.65 22.00 33.80 20.06 20.56 32.39 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 8 hits 1mpp_c04 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 59 GLY^? 1000.00 A 501 ASP A 120 ASP.? 1000.00 B 367 TYR B 64 TYR.? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 18.91 -2.15 -6.07 19.19 -2.68 -5.51 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 27.77 3.65 13.30 28.81 5.07 14.48 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 41.81 1.40 -20.74 43.72 2.68 -22.34 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY A 59 GLY^? 1000.00 A 501 ASP A 120 ASP.? 1000.00 B 367 TYR B 107 TYR^? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 18.91 -2.15 -6.07 19.19 -2.68 -5.51 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 27.77 3.65 13.30 28.81 5.07 14.48 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 39.72 -19.76 -13.26 42.39 -19.94 -12.49 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 3 3 # 3 A 465 GLY B 59 GLY^? 1000.00 A 501 ASP B 120 ASP.? 1000.00 B 367 TYR A 64 TYR.? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.70 -8.96 -9.69 30.09 -8.97 -10.21 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 22.50 12.53 4.97 22.72 14.77 6.66 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 4 3 # 4 A 465 GLY B 59 GLY^? 1000.00 A 501 ASP B 120 ASP.? 1000.00 B 367 TYR A 107 TYR^? 1000.00 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 30.70 -8.96 -9.69 30.09 -8.97 -10.21 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 5.16 0.23 -2.44 3.66 2.42 -3.25 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 4 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 59 GLY^? 1000.00 D 501 ASP A 120 ASP.? 1000.00 E 367 TYR B 64 TYR.? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 18.91 -2.15 -6.07 19.19 -2.68 -5.51 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 27.77 3.65 13.30 28.81 5.07 14.48 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 41.81 1.40 -20.74 43.72 2.68 -22.34 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY A 59 GLY^? 1000.00 D 501 ASP A 120 ASP.? 1000.00 E 367 TYR B 107 TYR^? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 18.91 -2.15 -6.07 19.19 -2.68 -5.51 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 27.77 3.65 13.30 28.81 5.07 14.48 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 39.72 -19.76 -13.26 42.39 -19.94 -12.49 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 3 3 # 3 D 465 GLY B 59 GLY^? 1000.00 D 501 ASP B 120 ASP.? 1000.00 E 367 TYR A 64 TYR.? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.70 -8.96 -9.69 30.09 -8.97 -10.21 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 22.50 12.53 4.97 22.72 14.77 6.66 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 4 3 # 4 D 465 GLY B 59 GLY^? 1000.00 D 501 ASP B 120 ASP.? 1000.00 E 367 TYR A 107 TYR^? 1000.00 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 30.70 -8.96 -9.69 30.09 -8.97 -10.21 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 5.16 0.23 -2.44 3.66 2.42 -3.25 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 4 hits 1mro_c01 naa= 3 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 1 3 # 1 A 50 ASP A 83 ASP.? 1000.00 A 55 TYR A 77 TYR~? 1000.00 A 84 LYS A 79 LYS~? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 9.71 44.83 15.47 10.13 41.43 19.93 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 2 3 # 2 A 50 ASP A 83 ASP.? 1000.00 A 55 TYR A 77 TYR~? 1000.00 A 84 LYS A 80 LYS~? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 4.60 40.33 20.42 7.25 39.50 20.05 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 9.71 44.83 15.47 10.13 41.43 19.93 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 3 3 # 3 A 50 ASP B 83 ASP.? 1000.00 A 55 TYR B 77 TYR~? 1000.00 A 84 LYS B 79 LYS~? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 4.60 40.33 20.42 7.25 39.50 20.05 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 9.71 44.83 15.47 10.13 41.43 19.93 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1mrq_c02 ALDO-KETO REDUCTASE FAMILY 1 MEMBER user 4 3 # 4 A 50 ASP B 83 ASP.? 1000.00 A 55 TYR B 77 TYR~? 1000.00 A 84 LYS B 80 LYS~? 1000.00 coo 11.09 42.89 24.44 11.32 42.06 22.49 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 4.60 40.33 20.42 7.25 39.50 20.05 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 9.71 44.83 15.47 10.13 41.43 19.93 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1mrq_c02 source 1mrq ALDO-KETO REDUCTASE FAMILY 1 MEMBER C1 : 4 hits 1mrq_c02 naa= 3 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 1 3 # 1 A 167 LYS A 12 LYS^? 1000.00 A 169 LYS A 27 LYS^? 1000.00 A 327 GLU A 30 GLU^? 1000.00 coo 20.73 15.53 25.54 22.09 15.64 19.40 17.98 11.97 -5.29 22.40 15.81 -5.00 coo 24.31 10.25 23.71 29.02 12.05 20.75 20.78 10.08 -0.17 21.23 14.77 2.36 coo 21.86 20.40 18.59 22.12 18.33 18.33 20.47 3.27 -9.94 22.27 3.25 -11.07 ULMN 3 1muc_c00 MUCONATE LACTONIZING ENZYME user 2 3 # 2 A 167 LYS B 12 LYS^? 1000.00 A 169 LYS B 27 LYS^? 1000.00 A 327 GLU B 30 GLU^? 1000.00 coo 20.73 15.53 25.54 22.09 15.64 19.40 43.44 -2.72 -10.47 44.74 2.97 -10.70 coo 24.31 10.25 23.71 29.02 12.05 20.75 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 21.86 20.40 18.59 22.12 18.33 18.33 34.72 -4.99 -5.76 33.75 -3.44 -4.67 1muc_c00 source 1muc MUCONATE LACTONIZING ENZYME : 2 hits 1muc_c00 naa= 3 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 1 3 # 1 B 167 LYS A 12 LYS^? 1000.00 B 169 LYS A 27 LYS^? 1000.00 B 327 GLU A 30 GLU^? 1000.00 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 17.98 11.97 -5.29 22.40 15.81 -5.00 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 20.78 10.08 -0.17 21.23 14.77 2.36 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 20.47 3.27 -9.94 22.27 3.25 -11.07 ULMN 3 1muc_c01 MUCONATE LACTONIZING ENZYME user 2 3 # 2 B 167 LYS B 12 LYS^? 1000.00 B 169 LYS B 27 LYS^? 1000.00 B 327 GLU B 30 GLU^? 1000.00 coo 25.79 1.90 -25.69 27.00 2.59 -19.56 43.44 -2.72 -10.47 44.74 2.97 -10.70 coo 25.18 8.17 -23.75 30.94 6.65 -21.59 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 29.96 -1.07 -18.59 28.74 0.63 -18.32 34.72 -4.99 -5.76 33.75 -3.44 -4.67 1muc_c01 source 1muc MUCONATE LACTONIZING ENZYME : 2 hits 1muc_c01 naa= 3 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 1 3 # 1 A 264 HIS A 25 HIS.? 1000.00 A 290 LYS A 27 LYS^? 1000.00 A 405 ARG A 103 ARG^? 1000.00 coo 41.33 25.99 28.05 41.95 26.95 29.80 17.07 12.41 6.63 15.76 13.52 7.84 coo 37.11 33.75 31.82 38.72 27.95 29.90 20.78 10.08 -0.17 21.23 14.77 2.36 coo 42.28 27.98 41.30 43.16 28.14 38.35 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1nhx_c00 PHOSPHOENOLPYRUVATE CARBOXYKINASE, Cuser 2 3 # 2 A 264 HIS B 25 HIS^? 1000.00 A 290 LYS B 27 LYS^? 1000.00 A 405 ARG B 103 ARG^? 1000.00 coo 41.33 25.99 28.05 41.95 26.95 29.80 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 37.11 33.75 31.82 38.72 27.95 29.90 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 42.28 27.98 41.30 43.16 28.14 38.35 48.22 -11.67 -13.43 49.99 -12.22 -15.85 1nhx_c00 source 1nhx PHOSPHOENOLPYRUVATE CARBOXYKINASE, CYTOSOLIC : 2 hits 1nhx_c00 naa= 3 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 46 ARG.? 1000.00 A 101 ASP A 136 ASP^? 1000.00 A 132 ASP A 138 ASP^? 1000.00 coo 11.61 22.83 17.30 14.06 21.71 15.78 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 11.37 24.94 11.48 12.48 24.45 13.28 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 16.14 18.17 13.37 15.92 19.81 14.71 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 46 ARG.? 1000.00 A 101 ASP A 138 ASP^? 1000.00 A 132 ASP A 136 ASP^? 1000.00 coo 11.61 22.83 17.30 14.06 21.71 15.78 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 11.37 24.94 11.48 12.48 24.45 13.28 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 16.14 18.17 13.37 15.92 19.81 14.71 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 46 ARG.? 1000.00 A 101 ASP B 136 ASP^? 1000.00 A 132 ASP B 138 ASP^? 1000.00 coo 11.61 22.83 17.30 14.06 21.71 15.78 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 11.37 24.94 11.48 12.48 24.45 13.28 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 16.14 18.17 13.37 15.92 19.81 14.71 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1nu3_c00 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG B 46 ARG.? 1000.00 A 101 ASP B 138 ASP^? 1000.00 A 132 ASP B 136 ASP^? 1000.00 coo 11.61 22.83 17.30 14.06 21.71 15.78 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 11.37 24.94 11.48 12.48 24.45 13.28 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 16.14 18.17 13.37 15.92 19.81 14.71 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1nu3_c00 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nu3_c00 naa= 3 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG A 46 ARG.? 1000.00 B 101 ASP A 136 ASP^? 1000.00 B 132 ASP A 138 ASP^? 1000.00 coo 11.61 3.43 18.38 9.11 4.29 16.86 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 11.74 0.51 12.98 10.75 1.32 14.67 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 6.93 7.52 14.08 7.18 6.08 15.65 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG A 46 ARG.? 1000.00 B 101 ASP A 138 ASP^? 1000.00 B 132 ASP A 136 ASP^? 1000.00 coo 11.61 3.43 18.38 9.11 4.29 16.86 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 11.74 0.51 12.98 10.75 1.32 14.67 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 6.93 7.52 14.08 7.18 6.08 15.65 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 B 99 ARG B 46 ARG.? 1000.00 B 101 ASP B 136 ASP^? 1000.00 B 132 ASP B 138 ASP^? 1000.00 coo 11.61 3.43 18.38 9.11 4.29 16.86 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 11.74 0.51 12.98 10.75 1.32 14.67 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 6.93 7.52 14.08 7.18 6.08 15.65 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1nu3_c01 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 B 99 ARG B 46 ARG.? 1000.00 B 101 ASP B 138 ASP^? 1000.00 B 132 ASP B 136 ASP^? 1000.00 coo 11.61 3.43 18.38 9.11 4.29 16.86 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 11.74 0.51 12.98 10.75 1.32 14.67 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 6.93 7.52 14.08 7.18 6.08 15.65 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1nu3_c01 source 1nu3 LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nu3_c01 naa= 3 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 A 99 ARG A 46 ARG.? 1000.00 A 101 ASP A 136 ASP^? 1000.00 A 132 ASP A 138 ASP^? 1000.00 coo 11.50 22.77 17.24 14.00 21.62 15.86 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 11.19 25.00 11.76 12.16 24.45 13.59 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 16.04 18.11 13.43 15.88 19.70 14.83 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 A 99 ARG A 46 ARG.? 1000.00 A 101 ASP A 138 ASP^? 1000.00 A 132 ASP A 136 ASP^? 1000.00 coo 11.50 22.77 17.24 14.00 21.62 15.86 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 11.19 25.00 11.76 12.16 24.45 13.59 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 16.04 18.11 13.43 15.88 19.70 14.83 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 3 3 # 3 A 99 ARG B 46 ARG.? 1000.00 A 101 ASP B 136 ASP^? 1000.00 A 132 ASP B 138 ASP^? 1000.00 coo 11.50 22.77 17.24 14.00 21.62 15.86 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 11.19 25.00 11.76 12.16 24.45 13.59 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 16.04 18.11 13.43 15.88 19.70 14.83 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1nww_c02 LIMONENE-1,2-EPOXIDE HYDROLASE user 4 3 # 4 A 99 ARG B 46 ARG.? 1000.00 A 101 ASP B 138 ASP^? 1000.00 A 132 ASP B 136 ASP^? 1000.00 coo 11.50 22.77 17.24 14.00 21.62 15.86 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 11.19 25.00 11.76 12.16 24.45 13.59 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 16.04 18.11 13.43 15.88 19.70 14.83 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1nww_c02 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 4 hits 1nww_c02 naa= 3 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 1 3 # 1 B 99 ARG B 46 ARG.? 1000.00 B 101 ASP B 136 ASP^? 1000.00 B 132 ASP B 138 ASP^? 1000.00 coo 11.48 3.09 18.25 9.01 4.07 16.77 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 11.83 0.33 13.01 10.88 1.04 14.81 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 6.85 7.33 14.07 7.10 5.88 15.60 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1nww_c03 LIMONENE-1,2-EPOXIDE HYDROLASE user 2 3 # 2 B 99 ARG B 46 ARG.? 1000.00 B 101 ASP B 138 ASP^? 1000.00 B 132 ASP B 136 ASP^? 1000.00 coo 11.48 3.09 18.25 9.01 4.07 16.77 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 11.83 0.33 13.01 10.88 1.04 14.81 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 6.85 7.33 14.07 7.10 5.88 15.60 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1nww_c03 source 1nww LIMONENE-1,2-EPOXIDE HYDROLASE : 2 hits 1nww_c03 naa= 3 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 A 24 ASP A 112 ASP~? 1000.00 A 146 TYR A 77 TYR~? 1000.00 A 177 LYS A 79 LYS~? 1000.00 coo -3.50 124.89 25.05 -2.25 124.77 23.26 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 1.87 119.38 16.45 1.41 122.11 16.84 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -2.59 124.07 12.67 -0.91 126.17 18.42 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 A 24 ASP A 112 ASP~? 1000.00 A 146 TYR A 77 TYR~? 1000.00 A 177 LYS A 80 LYS~? 1000.00 coo -3.50 124.89 25.05 -2.25 124.77 23.26 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 1.87 119.38 16.45 1.41 122.11 16.84 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -2.59 124.07 12.67 -0.91 126.17 18.42 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 A 24 ASP B 112 ASP~? 1000.00 A 146 TYR B 77 TYR~? 1000.00 A 177 LYS B 79 LYS~? 1000.00 coo -3.50 124.89 25.05 -2.25 124.77 23.26 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 1.87 119.38 16.45 1.41 122.11 16.84 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -2.59 124.07 12.67 -0.91 126.17 18.42 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ok4_c00 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 A 24 ASP B 112 ASP~? 1000.00 A 146 TYR B 77 TYR~? 1000.00 A 177 LYS B 80 LYS~? 1000.00 coo -3.50 124.89 25.05 -2.25 124.77 23.26 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 1.87 119.38 16.45 1.41 122.11 16.84 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -2.59 124.07 12.67 -0.91 126.17 18.42 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ok4_c00 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c00 naa= 3 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 B 24 ASP A 112 ASP~? 1000.00 B 146 TYR A 77 TYR~? 1000.00 B 177 LYS A 79 LYS~? 1000.00 coo -7.43 109.06 51.23 -5.84 110.54 50.86 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 0.22 114.56 44.62 -0.76 115.18 47.18 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -4.18 120.17 46.85 -4.02 115.31 51.00 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 B 24 ASP A 112 ASP~? 1000.00 B 146 TYR A 77 TYR~? 1000.00 B 177 LYS A 80 LYS~? 1000.00 coo -7.43 109.06 51.23 -5.84 110.54 50.86 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 0.22 114.56 44.62 -0.76 115.18 47.18 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -4.18 120.17 46.85 -4.02 115.31 51.00 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 B 24 ASP B 112 ASP~? 1000.00 B 146 TYR B 77 TYR~? 1000.00 B 177 LYS B 79 LYS~? 1000.00 coo -7.43 109.06 51.23 -5.84 110.54 50.86 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 0.22 114.56 44.62 -0.76 115.18 47.18 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -4.18 120.17 46.85 -4.02 115.31 51.00 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ok4_c01 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 B 24 ASP B 112 ASP~? 1000.00 B 146 TYR B 77 TYR~? 1000.00 B 177 LYS B 80 LYS~? 1000.00 coo -7.43 109.06 51.23 -5.84 110.54 50.86 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 0.22 114.56 44.62 -0.76 115.18 47.18 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -4.18 120.17 46.85 -4.02 115.31 51.00 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ok4_c01 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c01 naa= 3 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 C 24 ASP A 112 ASP~? 1000.00 C 146 TYR A 77 TYR~? 1000.00 C 177 LYS A 79 LYS~? 1000.00 coo -13.49 79.65 43.90 -12.13 80.29 45.45 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -5.65 86.78 48.49 -7.16 84.72 49.65 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -11.22 87.18 53.49 -10.94 81.64 50.31 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 C 24 ASP A 112 ASP~? 1000.00 C 146 TYR A 77 TYR~? 1000.00 C 177 LYS A 80 LYS~? 1000.00 coo -13.49 79.65 43.90 -12.13 80.29 45.45 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -5.65 86.78 48.49 -7.16 84.72 49.65 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -11.22 87.18 53.49 -10.94 81.64 50.31 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 C 24 ASP B 112 ASP~? 1000.00 C 146 TYR B 77 TYR~? 1000.00 C 177 LYS B 79 LYS~? 1000.00 coo -13.49 79.65 43.90 -12.13 80.29 45.45 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -5.65 86.78 48.49 -7.16 84.72 49.65 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -11.22 87.18 53.49 -10.94 81.64 50.31 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ok4_c02 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 C 24 ASP B 112 ASP~? 1000.00 C 146 TYR B 77 TYR~? 1000.00 C 177 LYS B 80 LYS~? 1000.00 coo -13.49 79.65 43.90 -12.13 80.29 45.45 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -5.65 86.78 48.49 -7.16 84.72 49.65 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -11.22 87.18 53.49 -10.94 81.64 50.31 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ok4_c02 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c02 naa= 3 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 D 24 ASP A 112 ASP~? 1000.00 D 146 TYR A 77 TYR~? 1000.00 D 177 LYS A 79 LYS~? 1000.00 coo -13.44 77.36 13.12 -12.53 75.97 14.48 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -7.85 74.44 22.75 -9.22 72.86 20.89 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -14.24 70.61 23.48 -12.55 71.73 17.42 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 D 24 ASP A 112 ASP~? 1000.00 D 146 TYR A 77 TYR~? 1000.00 D 177 LYS A 80 LYS~? 1000.00 coo -13.44 77.36 13.12 -12.53 75.97 14.48 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -7.85 74.44 22.75 -9.22 72.86 20.89 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -14.24 70.61 23.48 -12.55 71.73 17.42 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 D 24 ASP B 112 ASP~? 1000.00 D 146 TYR B 77 TYR~? 1000.00 D 177 LYS B 79 LYS~? 1000.00 coo -13.44 77.36 13.12 -12.53 75.97 14.48 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -7.85 74.44 22.75 -9.22 72.86 20.89 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -14.24 70.61 23.48 -12.55 71.73 17.42 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ok4_c03 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 D 24 ASP B 112 ASP~? 1000.00 D 146 TYR B 77 TYR~? 1000.00 D 177 LYS B 80 LYS~? 1000.00 coo -13.44 77.36 13.12 -12.53 75.97 14.48 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -7.85 74.44 22.75 -9.22 72.86 20.89 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -14.24 70.61 23.48 -12.55 71.73 17.42 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ok4_c03 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c03 naa= 3 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 E 24 ASP A 112 ASP~? 1000.00 E 146 TYR A 77 TYR~? 1000.00 E 177 LYS A 79 LYS~? 1000.00 coo -7.12 105.25 1.43 -6.30 103.34 0.77 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -3.11 94.55 3.01 -3.83 95.92 0.66 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 E 24 ASP A 112 ASP~? 1000.00 E 146 TYR A 77 TYR~? 1000.00 E 177 LYS A 80 LYS~? 1000.00 coo -7.12 105.25 1.43 -6.30 103.34 0.77 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -3.11 94.55 3.01 -3.83 95.92 0.66 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 E 24 ASP B 112 ASP~? 1000.00 E 146 TYR B 77 TYR~? 1000.00 E 177 LYS B 79 LYS~? 1000.00 coo -7.12 105.25 1.43 -6.30 103.34 0.77 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -3.11 94.55 3.01 -3.83 95.92 0.66 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ok4_c04 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 E 24 ASP B 112 ASP~? 1000.00 E 146 TYR B 77 TYR~? 1000.00 E 177 LYS B 80 LYS~? 1000.00 coo -7.12 105.25 1.43 -6.30 103.34 0.77 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -3.11 94.55 3.01 -3.83 95.92 0.66 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -8.77 93.34 -1.70 -6.28 99.15 -2.21 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ok4_c04 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c04 naa= 3 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 F 24 ASP A 112 ASP~? 1000.00 F 146 TYR A 77 TYR~? 1000.00 F 177 LYS A 79 LYS~? 1000.00 coo -44.75 128.15 10.28 -45.68 129.67 11.55 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -50.43 131.90 19.60 -49.04 133.31 17.60 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -44.10 135.86 19.99 -45.67 134.21 14.07 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 F 24 ASP A 112 ASP~? 1000.00 F 146 TYR A 77 TYR~? 1000.00 F 177 LYS A 80 LYS~? 1000.00 coo -44.75 128.15 10.28 -45.68 129.67 11.55 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -50.43 131.90 19.60 -49.04 133.31 17.60 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -44.10 135.86 19.99 -45.67 134.21 14.07 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 F 24 ASP B 112 ASP~? 1000.00 F 146 TYR B 77 TYR~? 1000.00 F 177 LYS B 79 LYS~? 1000.00 coo -44.75 128.15 10.28 -45.68 129.67 11.55 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -50.43 131.90 19.60 -49.04 133.31 17.60 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -44.10 135.86 19.99 -45.67 134.21 14.07 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ok4_c05 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 F 24 ASP B 112 ASP~? 1000.00 F 146 TYR B 77 TYR~? 1000.00 F 177 LYS B 80 LYS~? 1000.00 coo -44.75 128.15 10.28 -45.68 129.67 11.55 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -50.43 131.90 19.60 -49.04 133.31 17.60 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -44.10 135.86 19.99 -45.67 134.21 14.07 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ok4_c05 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c05 naa= 3 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 G 24 ASP A 112 ASP~? 1000.00 G 146 TYR A 77 TYR~? 1000.00 G 177 LYS A 79 LYS~? 1000.00 coo -44.97 128.78 41.20 -46.32 128.26 42.83 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -52.83 122.13 46.42 -51.31 124.30 47.39 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -47.30 122.24 51.49 -47.46 127.44 47.81 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 G 24 ASP A 112 ASP~? 1000.00 G 146 TYR A 77 TYR~? 1000.00 G 177 LYS A 80 LYS~? 1000.00 coo -44.97 128.78 41.20 -46.32 128.26 42.83 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -52.83 122.13 46.42 -51.31 124.30 47.39 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -47.30 122.24 51.49 -47.46 127.44 47.81 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 G 24 ASP B 112 ASP~? 1000.00 G 146 TYR B 77 TYR~? 1000.00 G 177 LYS B 79 LYS~? 1000.00 coo -44.97 128.78 41.20 -46.32 128.26 42.83 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -52.83 122.13 46.42 -51.31 124.30 47.39 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -47.30 122.24 51.49 -47.46 127.44 47.81 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ok4_c06 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 G 24 ASP B 112 ASP~? 1000.00 G 146 TYR B 77 TYR~? 1000.00 G 177 LYS B 80 LYS~? 1000.00 coo -44.97 128.78 41.20 -46.32 128.26 42.83 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -52.83 122.13 46.42 -51.31 124.30 47.39 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -47.30 122.24 51.49 -47.46 127.44 47.81 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ok4_c06 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c06 naa= 3 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 H 24 ASP A 112 ASP~? 1000.00 H 146 TYR A 77 TYR~? 1000.00 H 177 LYS A 79 LYS~? 1000.00 coo -51.11 100.30 51.41 -52.67 98.82 51.12 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -58.70 94.17 45.32 -57.76 93.82 47.92 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -54.32 88.79 48.13 -54.61 94.04 51.74 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 H 24 ASP A 112 ASP~? 1000.00 H 146 TYR A 77 TYR~? 1000.00 H 177 LYS A 80 LYS~? 1000.00 coo -51.11 100.30 51.41 -52.67 98.82 51.12 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -58.70 94.17 45.32 -57.76 93.82 47.92 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -54.32 88.79 48.13 -54.61 94.04 51.74 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 H 24 ASP B 112 ASP~? 1000.00 H 146 TYR B 77 TYR~? 1000.00 H 177 LYS B 79 LYS~? 1000.00 coo -51.11 100.30 51.41 -52.67 98.82 51.12 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -58.70 94.17 45.32 -57.76 93.82 47.92 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -54.32 88.79 48.13 -54.61 94.04 51.74 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ok4_c07 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 H 24 ASP B 112 ASP~? 1000.00 H 146 TYR B 77 TYR~? 1000.00 H 177 LYS B 80 LYS~? 1000.00 coo -51.11 100.30 51.41 -52.67 98.82 51.12 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -58.70 94.17 45.32 -57.76 93.82 47.92 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -54.32 88.79 48.13 -54.61 94.04 51.74 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ok4_c07 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c07 naa= 3 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 I 24 ASP A 112 ASP~? 1000.00 I 146 TYR A 77 TYR~? 1000.00 I 177 LYS A 79 LYS~? 1000.00 coo -54.65 81.97 26.87 -55.88 81.89 25.07 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -59.92 86.62 17.74 -59.42 83.94 18.40 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -55.38 81.61 14.50 -57.11 80.05 20.41 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 I 24 ASP A 112 ASP~? 1000.00 I 146 TYR A 77 TYR~? 1000.00 I 177 LYS A 80 LYS~? 1000.00 coo -54.65 81.97 26.87 -55.88 81.89 25.07 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -59.92 86.62 17.74 -59.42 83.94 18.40 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -55.38 81.61 14.50 -57.11 80.05 20.41 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 I 24 ASP B 112 ASP~? 1000.00 I 146 TYR B 77 TYR~? 1000.00 I 177 LYS B 79 LYS~? 1000.00 coo -54.65 81.97 26.87 -55.88 81.89 25.07 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -59.92 86.62 17.74 -59.42 83.94 18.40 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -55.38 81.61 14.50 -57.11 80.05 20.41 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ok4_c08 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 I 24 ASP B 112 ASP~? 1000.00 I 146 TYR B 77 TYR~? 1000.00 I 177 LYS B 80 LYS~? 1000.00 coo -54.65 81.97 26.87 -55.88 81.89 25.07 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -59.92 86.62 17.74 -59.42 83.94 18.40 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -55.38 81.61 14.50 -57.11 80.05 20.41 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ok4_c08 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c08 naa= 3 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 1 3 # 1 J 24 ASP A 112 ASP~? 1000.00 J 146 TYR A 77 TYR~? 1000.00 J 177 LYS A 79 LYS~? 1000.00 coo -50.64 99.08 1.52 -51.52 100.83 0.67 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 2 3 # 2 J 24 ASP A 112 ASP~? 1000.00 J 146 TYR A 77 TYR~? 1000.00 J 177 LYS A 80 LYS~? 1000.00 coo -50.64 99.08 1.52 -51.52 100.83 0.67 21.33 -7.84 5.22 21.87 -9.36 6.59 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 14.18 -5.59 13.28 11.48 -4.87 13.03 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 3 3 # 3 J 24 ASP B 112 ASP~? 1000.00 J 146 TYR B 77 TYR~? 1000.00 J 177 LYS B 79 LYS~? 1000.00 coo -50.64 99.08 1.52 -51.52 100.83 0.67 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ok4_c09 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASSuser 4 3 # 4 J 24 ASP B 112 ASP~? 1000.00 J 146 TYR B 77 TYR~? 1000.00 J 177 LYS B 80 LYS~? 1000.00 coo -50.64 99.08 1.52 -51.52 100.83 0.67 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo -54.74 109.84 1.86 -54.04 108.22 -0.34 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo -49.01 110.53 -2.89 -51.59 104.72 -2.78 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ok4_c09 source 1ok4 FRUCTOSE-BISPHOSPHATE ALDOLASE CLASS I : 4 hits 1ok4_c09 naa= 3 ULMN 3 1onr_c00 TRANSALDOLASE B user 1 3 # 1 A 17 ASP A 93 ASP.? 1000.00 A 96 GLU A 102 GLU.? 1000.00 A 132 LYS A 142 LYS.? 1000.00 coo 31.23 12.29 16.44 30.82 11.56 18.39 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 26.82 3.20 24.36 27.99 4.86 24.98 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 29.99 0.62 22.18 30.38 6.69 20.81 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1onr_c00 TRANSALDOLASE B user 2 3 # 2 A 17 ASP A 94 ASP.? 1000.00 A 96 GLU A 141 GLU.? 1000.00 A 132 LYS A 142 LYS.? 1000.00 coo 31.23 12.29 16.44 30.82 11.56 18.39 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 26.82 3.20 24.36 27.99 4.86 24.98 3.43 12.79 -4.88 2.72 12.95 -2.84 coo 29.99 0.62 22.18 30.38 6.69 20.81 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1onr_c00 TRANSALDOLASE B user 3 3 # 3 A 17 ASP A 112 ASP~? 1000.00 A 96 GLU B 34 GLU.? 1000.00 A 132 LYS B 35 LYS.? 1000.00 coo 31.23 12.29 16.44 30.82 11.56 18.39 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 26.82 3.20 24.36 27.99 4.86 24.98 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 29.99 0.62 22.18 30.38 6.69 20.81 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1onr_c00 TRANSALDOLASE B user 4 3 # 4 A 17 ASP A 136 ASP^? 1000.00 A 96 GLU A 34 GLU.? 1000.00 A 132 LYS A 35 LYS.? 1000.00 coo 31.23 12.29 16.44 30.82 11.56 18.39 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 26.82 3.20 24.36 27.99 4.86 24.98 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 29.99 0.62 22.18 30.38 6.69 20.81 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1onr_c00 TRANSALDOLASE B user 5 3 # 5 A 17 ASP B 93 ASP.? 1000.00 A 96 GLU B 102 GLU.? 1000.00 A 132 LYS B 142 LYS.? 1000.00 coo 31.23 12.29 16.44 30.82 11.56 18.39 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 26.82 3.20 24.36 27.99 4.86 24.98 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 29.99 0.62 22.18 30.38 6.69 20.81 52.98 -12.77 -6.57 54.80 -12.93 -0.57 ULMN 3 1onr_c00 TRANSALDOLASE B user 6 3 # 6 A 17 ASP B 94 ASP.? 1000.00 A 96 GLU B 141 GLU.? 1000.00 A 132 LYS B 142 LYS.? 1000.00 coo 31.23 12.29 16.44 30.82 11.56 18.39 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 26.82 3.20 24.36 27.99 4.86 24.98 51.50 -14.92 -10.75 52.03 -15.46 -12.75 coo 29.99 0.62 22.18 30.38 6.69 20.81 52.98 -12.77 -6.57 54.80 -12.93 -0.57 ULMN 3 1onr_c00 TRANSALDOLASE B user 7 3 # 7 A 17 ASP B 112 ASP~? 1000.00 A 96 GLU A 34 GLU.? 1000.00 A 132 LYS A 35 LYS.? 1000.00 coo 31.23 12.29 16.44 30.82 11.56 18.39 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 26.82 3.20 24.36 27.99 4.86 24.98 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 29.99 0.62 22.18 30.38 6.69 20.81 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1onr_c00 TRANSALDOLASE B user 8 3 # 8 A 17 ASP B 136 ASP^? 1000.00 A 96 GLU B 34 GLU.? 1000.00 A 132 LYS B 35 LYS.? 1000.00 coo 31.23 12.29 16.44 30.82 11.56 18.39 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 26.82 3.20 24.36 27.99 4.86 24.98 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 29.99 0.62 22.18 30.38 6.69 20.81 29.05 -17.38 0.57 28.07 -15.85 6.68 1onr_c00 source 1onr TRANSALDOLASE B : 8 hits 1onr_c00 naa= 3 ULMN 3 1onr_c01 TRANSALDOLASE B user 1 3 # 1 B 17 ASP A 93 ASP.? 1000.00 B 96 GLU A 102 GLU.? 1000.00 B 132 LYS A 142 LYS.? 1000.00 coo 31.16 57.31 -0.94 30.73 56.64 1.01 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 26.69 48.45 7.18 27.85 50.13 7.74 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 29.82 45.80 5.07 30.26 51.81 3.56 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1onr_c01 TRANSALDOLASE B user 2 3 # 2 B 17 ASP A 94 ASP.? 1000.00 B 96 GLU A 141 GLU.? 1000.00 B 132 LYS A 142 LYS.? 1000.00 coo 31.16 57.31 -0.94 30.73 56.64 1.01 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 26.69 48.45 7.18 27.85 50.13 7.74 3.43 12.79 -4.88 2.72 12.95 -2.84 coo 29.82 45.80 5.07 30.26 51.81 3.56 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 1onr_c01 TRANSALDOLASE B user 3 3 # 3 B 17 ASP A 112 ASP~? 1000.00 B 96 GLU B 34 GLU.? 1000.00 B 132 LYS B 35 LYS.? 1000.00 coo 31.16 57.31 -0.94 30.73 56.64 1.01 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 26.69 48.45 7.18 27.85 50.13 7.74 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 29.82 45.80 5.07 30.26 51.81 3.56 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1onr_c01 TRANSALDOLASE B user 4 3 # 4 B 17 ASP A 136 ASP^? 1000.00 B 96 GLU A 34 GLU.? 1000.00 B 132 LYS A 35 LYS.? 1000.00 coo 31.16 57.31 -0.94 30.73 56.64 1.01 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 26.69 48.45 7.18 27.85 50.13 7.74 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 29.82 45.80 5.07 30.26 51.81 3.56 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1onr_c01 TRANSALDOLASE B user 5 3 # 5 B 17 ASP B 93 ASP.? 1000.00 B 96 GLU B 102 GLU.? 1000.00 B 132 LYS B 142 LYS.? 1000.00 coo 31.16 57.31 -0.94 30.73 56.64 1.01 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 26.69 48.45 7.18 27.85 50.13 7.74 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 29.82 45.80 5.07 30.26 51.81 3.56 52.98 -12.77 -6.57 54.80 -12.93 -0.57 ULMN 3 1onr_c01 TRANSALDOLASE B user 6 3 # 6 B 17 ASP B 94 ASP.? 1000.00 B 96 GLU B 141 GLU.? 1000.00 B 132 LYS B 142 LYS.? 1000.00 coo 31.16 57.31 -0.94 30.73 56.64 1.01 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 26.69 48.45 7.18 27.85 50.13 7.74 51.50 -14.92 -10.75 52.03 -15.46 -12.75 coo 29.82 45.80 5.07 30.26 51.81 3.56 52.98 -12.77 -6.57 54.80 -12.93 -0.57 ULMN 3 1onr_c01 TRANSALDOLASE B user 7 3 # 7 B 17 ASP B 112 ASP~? 1000.00 B 96 GLU A 34 GLU.? 1000.00 B 132 LYS A 35 LYS.? 1000.00 coo 31.16 57.31 -0.94 30.73 56.64 1.01 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 26.69 48.45 7.18 27.85 50.13 7.74 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 29.82 45.80 5.07 30.26 51.81 3.56 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1onr_c01 TRANSALDOLASE B user 8 3 # 8 B 17 ASP B 136 ASP^? 1000.00 B 96 GLU B 34 GLU.? 1000.00 B 132 LYS B 35 LYS.? 1000.00 coo 31.16 57.31 -0.94 30.73 56.64 1.01 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 26.69 48.45 7.18 27.85 50.13 7.74 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 29.82 45.80 5.07 30.26 51.81 3.56 29.05 -17.38 0.57 28.07 -15.85 6.68 1onr_c01 source 1onr TRANSALDOLASE B : 8 hits 1onr_c01 naa= 3 ULMN 3 1oyg_c00 LEVANSUCRASE user 1 3 # 1 A 86 ASP A 93 ASP.? 1000.00 A 247 ASP A 94 ASP.? 1000.00 A 342 GLU A 102 GLU.? 1000.00 coo 44.36 35.68 9.71 43.29 36.20 11.51 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 41.40 28.81 12.91 40.82 30.90 12.97 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 40.37 33.11 18.06 39.99 34.93 17.06 6.41 12.98 -11.22 7.03 11.90 -12.90 ULMN 3 1oyg_c00 LEVANSUCRASE user 2 3 # 2 A 86 ASP B 93 ASP.? 1000.00 A 247 ASP B 94 ASP.? 1000.00 A 342 GLU B 102 GLU.? 1000.00 coo 44.36 35.68 9.71 43.29 36.20 11.51 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 41.40 28.81 12.91 40.82 30.90 12.97 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 40.37 33.11 18.06 39.99 34.93 17.06 50.20 -12.24 -4.38 48.92 -12.28 -2.69 1oyg_c00 source 1oyg LEVANSUCRASE : 2 hits 1oyg_c00 naa= 3 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 1 3 # 1 B1102 ASP A 76 ASP~? 1000.00 B1167 LYS A 79 LYS~? 1000.00 B1201 LYS A 80 LYS~? 1000.00 coo 26.10 12.11 49.61 24.19 12.48 50.51 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 27.70 11.69 56.92 24.82 8.55 52.12 18.64 -10.30 17.12 18.99 -5.93 21.84 coo 23.50 11.64 58.67 22.19 10.19 52.59 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1p1x_c01 DEOXYRIBOSE-PHOSPHATE ALDOLASE user 2 3 # 2 B1102 ASP B 76 ASP~? 1000.00 B1167 LYS B 79 LYS~? 1000.00 B1201 LYS B 80 LYS~? 1000.00 coo 26.10 12.11 49.61 24.19 12.48 50.51 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 27.70 11.69 56.92 24.82 8.55 52.12 24.00 -13.31 -32.93 27.58 -10.91 -37.69 coo 23.50 11.64 58.67 22.19 10.19 52.59 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1p1x_c01 source 1p1x DEOXYRIBOSE-PHOSPHATE ALDOLASE : 2 hits 1p1x_c01 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 90 ALA^? 1000.00 A 126 LEU A 92 LEU^? 1000.00 A 158 GLU A 102 GLU.? 1000.00 coo -2.29 37.66 144.73 -1.46 37.12 145.87 12.48 9.70 -2.47 13.82 9.09 -2.93 coo -4.62 32.83 147.14 -5.50 32.85 149.12 11.84 10.69 -9.71 11.94 8.95 -10.99 coo -0.83 29.57 149.77 -0.39 31.47 148.95 6.41 12.98 -11.22 7.03 11.90 -12.90 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 90 ALA^? 1000.00 A 126 LEU B 92 LEU^? 1000.00 A 158 GLU B 102 GLU.? 1000.00 coo -2.29 37.66 144.73 -1.46 37.12 145.87 44.29 -8.66 -13.29 43.10 -7.78 -12.91 coo -4.62 32.83 147.14 -5.50 32.85 149.12 45.49 -8.72 -5.97 43.97 -9.42 -4.62 coo -0.83 29.57 149.77 -0.39 31.47 148.95 50.20 -12.24 -4.38 48.92 -12.28 -2.69 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 90 ALA^? 1000.00 B 126 LEU A 92 LEU^? 1000.00 B 158 GLU A 102 GLU.? 1000.00 coo -39.79 4.61 147.27 -39.61 5.56 148.47 12.48 9.70 -2.47 13.82 9.09 -2.93 coo -34.22 5.06 149.25 -33.65 4.24 151.15 11.84 10.69 -9.71 11.94 8.95 -10.99 coo -33.03 9.93 151.71 -34.98 9.38 151.11 6.41 12.98 -11.22 7.03 11.90 -12.90 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA B 90 ALA^? 1000.00 B 126 LEU B 92 LEU^? 1000.00 B 158 GLU B 102 GLU.? 1000.00 coo -39.79 4.61 147.27 -39.61 5.56 148.47 44.29 -8.66 -13.29 43.10 -7.78 -12.91 coo -34.22 5.06 149.25 -33.65 4.24 151.15 45.49 -8.72 -5.97 43.97 -9.42 -4.62 coo -33.03 9.93 151.71 -34.98 9.38 151.11 50.20 -12.24 -4.38 48.92 -12.28 -2.69 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 90 ALA^? 1000.00 C 126 LEU A 92 LEU^? 1000.00 C 158 GLU A 102 GLU.? 1000.00 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 12.48 9.70 -2.47 13.82 9.09 -2.93 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 11.84 10.69 -9.71 11.94 8.95 -10.99 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 6.41 12.98 -11.22 7.03 11.90 -12.90 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA B 90 ALA^? 1000.00 C 126 LEU B 92 LEU^? 1000.00 C 158 GLU B 102 GLU.? 1000.00 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 44.29 -8.66 -13.29 43.10 -7.78 -12.91 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 45.49 -8.72 -5.97 43.97 -9.42 -4.62 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 50.20 -12.24 -4.38 48.92 -12.28 -2.69 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c02 naa= 3 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 1 3 # 1 A 248 ASP A 76 ASP~? 1000.00 A 270 LYS A 80 LYS~? 1000.00 A 382 MET A 23 MET?? 1000.00 coo -27.63 121.99 45.48 -26.66 123.86 45.68 16.07 -4.78 18.64 16.16 -4.88 20.75 coo -32.20 115.91 49.56 -31.37 121.03 53.12 15.24 -11.81 16.35 11.55 -7.20 16.52 coo -23.75 127.89 58.42 -26.02 128.79 55.12 14.49 6.17 10.06 12.54 3.19 12.31 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 2 3 # 2 A 248 ASP A 83 ASP.? 1000.00 A 270 LYS A 80 LYS~? 1000.00 A 382 MET A 23 MET?? 1000.00 coo -27.63 121.99 45.48 -26.66 123.86 45.68 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -32.20 115.91 49.56 -31.37 121.03 53.12 15.24 -11.81 16.35 11.55 -7.20 16.52 coo -23.75 127.89 58.42 -26.02 128.79 55.12 14.49 6.17 10.06 12.54 3.19 12.31 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 3 3 # 3 A 248 ASP A 83 ASP.? 1000.00 A 270 LYS A 115 LYS~? 1000.00 A 382 MET A 23 MET?? 1000.00 coo -27.63 121.99 45.48 -26.66 123.86 45.68 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -32.20 115.91 49.56 -31.37 121.03 53.12 24.53 -4.83 7.12 22.37 -6.02 1.89 coo -23.75 127.89 58.42 -26.02 128.79 55.12 14.49 6.17 10.06 12.54 3.19 12.31 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 4 3 # 4 A 248 ASP B 76 ASP~? 1000.00 A 270 LYS B 80 LYS~? 1000.00 A 382 MET B 23 MET?? 1000.00 coo -27.63 121.99 45.48 -26.66 123.86 45.68 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo -32.20 115.91 49.56 -31.37 121.03 53.12 24.38 -17.04 -32.21 30.30 -17.91 -32.35 coo -23.75 127.89 58.42 -26.02 128.79 55.12 40.30 -8.68 -25.81 38.43 -11.67 -28.04 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 5 3 # 5 A 248 ASP B 83 ASP.? 1000.00 A 270 LYS B 80 LYS~? 1000.00 A 382 MET B 23 MET?? 1000.00 coo -27.63 121.99 45.48 -26.66 123.86 45.68 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -32.20 115.91 49.56 -31.37 121.03 53.12 24.38 -17.04 -32.21 30.30 -17.91 -32.35 coo -23.75 127.89 58.42 -26.02 128.79 55.12 40.30 -8.68 -25.81 38.43 -11.67 -28.04 ULMN 3 1pjq_c02 SIROHEME SYNTHASE user 6 3 # 6 A 248 ASP B 83 ASP.? 1000.00 A 270 LYS B 115 LYS~? 1000.00 A 382 MET B 23 MET?? 1000.00 coo -27.63 121.99 45.48 -26.66 123.86 45.68 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -32.20 115.91 49.56 -31.37 121.03 53.12 25.77 -5.51 -22.92 25.67 -7.99 -17.65 coo -23.75 127.89 58.42 -26.02 128.79 55.12 40.30 -8.68 -25.81 38.43 -11.67 -28.04 1pjq_c02 source 1pjq SIROHEME SYNTHASE : 6 hits 1pjq_c02 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 89 GLN^? 1000.00 294 GLU A 102 GLU.? 1000.00 304 ARG A 15 ARG^? 1000.00 coo 15.89 18.45 46.53 15.82 16.91 48.02 7.97 8.72 -0.68 6.11 9.06 0.27 coo 22.84 13.44 52.91 20.84 13.18 52.38 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 8.71 17.11 46.51 7.23 17.64 49.20 13.78 12.30 3.30 15.49 14.64 2.27 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN B 89 GLN^? 1000.00 294 GLU B 102 GLU.? 1000.00 304 ARG B 15 ARG^? 1000.00 coo 15.89 18.45 46.53 15.82 16.91 48.02 45.67 -13.21 -15.00 46.89 -14.67 -15.95 coo 22.84 13.44 52.91 20.84 13.18 52.38 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 8.71 17.11 46.51 7.23 17.64 49.20 45.95 -6.29 -19.02 47.14 -3.63 -18.02 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 2 hits 1pmi_c00 naa= 3 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 A 264 ARG A 15 ARG^? 1000.00 A 479 PHE A 17 PHE^? 1000.00 A 483 GLU A 22 GLU^? 1000.00 coo 17.33 52.29 2.24 18.71 54.03 0.18 13.78 12.30 3.30 15.49 14.64 2.27 coo 20.06 57.44 1.28 18.39 56.19 3.12 8.63 7.13 6.10 9.04 9.77 5.19 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1pow_c02 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 A 264 ARG B 15 ARG^? 1000.00 A 479 PHE B 17 PHE^? 1000.00 A 483 GLU B 22 GLU^? 1000.00 coo 17.33 52.29 2.24 18.71 54.03 0.18 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 20.06 57.44 1.28 18.39 56.19 3.12 44.06 -13.30 -21.85 46.12 -11.60 -21.01 coo 17.33 54.96 -3.04 16.34 56.76 -2.51 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1pow_c02 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c02 naa= 3 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 3 # 1 B 264 ARG A 15 ARG^? 1000.00 B 479 PHE A 17 PHE^? 1000.00 B 483 GLU A 22 GLU^? 1000.00 coo -26.72 93.28 20.13 -28.02 93.55 17.39 13.78 12.30 3.30 15.49 14.64 2.27 coo -29.34 90.48 15.69 -27.62 89.95 17.80 8.63 7.13 6.10 9.04 9.77 5.19 coo -26.63 95.49 14.65 -25.77 93.77 13.77 11.90 9.90 7.95 12.35 11.96 7.71 ULMN 3 1pow_c03 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 3 # 2 B 264 ARG B 15 ARG^? 1000.00 B 479 PHE B 17 PHE^? 1000.00 B 483 GLU B 22 GLU^? 1000.00 coo -26.72 93.28 20.13 -28.02 93.55 17.39 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo -29.34 90.48 15.69 -27.62 89.95 17.80 44.06 -13.30 -21.85 46.12 -11.60 -21.01 coo -26.63 95.49 14.65 -25.77 93.77 13.77 44.79 -9.15 -23.60 46.32 -7.71 -23.39 1pow_c03 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 2 hits 1pow_c03 naa= 3 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 A 48 LEU A 73 LEU~? 1000.00 A 58 ASP A 76 ASP~? 1000.00 A 120 LYS A 79 LYS~? 1000.00 coo 34.02 69.29 75.26 34.82 67.82 76.74 15.85 0.40 15.67 14.13 -0.92 15.36 coo 34.46 72.45 78.57 32.82 72.75 77.28 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 28.96 77.64 81.19 29.05 74.53 77.51 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 A 48 LEU A 73 LEU~? 1000.00 A 58 ASP A 76 ASP~? 1000.00 A 120 LYS A 80 LYS~? 1000.00 coo 34.02 69.29 75.26 34.82 67.82 76.74 15.85 0.40 15.67 14.13 -0.92 15.36 coo 34.46 72.45 78.57 32.82 72.75 77.28 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 28.96 77.64 81.19 29.05 74.53 77.51 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 A 48 LEU B 73 LEU~? 1000.00 A 58 ASP B 76 ASP~? 1000.00 A 120 LYS B 79 LYS~? 1000.00 coo 34.02 69.29 75.26 34.82 67.82 76.74 34.63 -10.41 -31.41 34.32 -12.54 -31.11 coo 34.46 72.45 78.57 32.82 72.75 77.28 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 28.96 77.64 81.19 29.05 74.53 77.51 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1pym_c00 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 A 48 LEU B 73 LEU~? 1000.00 A 58 ASP B 76 ASP~? 1000.00 A 120 LYS B 80 LYS~? 1000.00 coo 34.02 69.29 75.26 34.82 67.82 76.74 34.63 -10.41 -31.41 34.32 -12.54 -31.11 coo 34.46 72.45 78.57 32.82 72.75 77.28 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 28.96 77.64 81.19 29.05 74.53 77.51 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1pym_c00 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 4 hits 1pym_c00 naa= 3 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 1 3 # 1 B 48 LEU A 73 LEU~? 1000.00 B 58 ASP A 76 ASP~? 1000.00 B 120 LYS A 79 LYS~? 1000.00 coo 54.50 104.32 58.69 55.83 105.69 59.81 15.85 0.40 15.67 14.13 -0.92 15.36 coo 57.63 101.19 59.83 56.60 100.89 57.99 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 61.58 95.88 55.22 58.18 99.30 54.71 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 2 3 # 2 B 48 LEU A 73 LEU~? 1000.00 B 58 ASP A 76 ASP~? 1000.00 B 120 LYS A 80 LYS~? 1000.00 coo 54.50 104.32 58.69 55.83 105.69 59.81 15.85 0.40 15.67 14.13 -0.92 15.36 coo 57.63 101.19 59.83 56.60 100.89 57.99 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 61.58 95.88 55.22 58.18 99.30 54.71 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 3 3 # 3 B 48 LEU B 73 LEU~? 1000.00 B 58 ASP B 76 ASP~? 1000.00 B 120 LYS B 79 LYS~? 1000.00 coo 54.50 104.32 58.69 55.83 105.69 59.81 34.63 -10.41 -31.41 34.32 -12.54 -31.11 coo 57.63 101.19 59.83 56.60 100.89 57.99 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 61.58 95.88 55.22 58.18 99.30 54.71 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1pym_c01 PHOSPHOENOLPYRUVATE MUTASE user 4 3 # 4 B 48 LEU B 73 LEU~? 1000.00 B 58 ASP B 76 ASP~? 1000.00 B 120 LYS B 80 LYS~? 1000.00 coo 54.50 104.32 58.69 55.83 105.69 59.81 34.63 -10.41 -31.41 34.32 -12.54 -31.11 coo 57.63 101.19 59.83 56.60 100.89 57.99 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 61.58 95.88 55.22 58.18 99.30 54.71 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1pym_c01 source 1pym PHOSPHOENOLPYRUVATE MUTASE : 4 hits 1pym_c01 naa= 3 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 A 86 GLU A 22 GLU^? 1000.00 A 143 HIS A 25 HIS.? 1000.00 A 170 LYS A 27 LYS^? 1000.00 coo -2.40 27.37 52.92 -1.22 29.09 52.71 11.90 9.90 7.95 12.35 11.96 7.71 coo 1.36 26.79 49.43 3.17 26.89 50.50 17.07 12.41 6.63 15.76 13.52 7.84 coo 7.24 31.80 48.14 6.27 25.92 49.70 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 A 86 GLU A 22 GLU^? 1000.00 A 143 HIS A 25 HIS.? 1000.00 A 170 LYS A 65 LYS.? 1000.00 coo -2.40 27.37 52.92 -1.22 29.09 52.71 11.90 9.90 7.95 12.35 11.96 7.71 coo 1.36 26.79 49.43 3.17 26.89 50.50 17.07 12.41 6.63 15.76 13.52 7.84 coo 7.24 31.80 48.14 6.27 25.92 49.70 23.08 10.16 8.29 20.19 14.81 10.58 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 A 86 GLU B 22 GLU^? 1000.00 A 143 HIS B 25 HIS^? 1000.00 A 170 LYS B 27 LYS^? 1000.00 coo -2.40 27.37 52.92 -1.22 29.09 52.71 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 1.36 26.79 49.43 3.17 26.89 50.50 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 7.24 31.80 48.14 6.27 25.92 49.70 40.39 -1.34 -15.57 44.33 1.39 -18.11 ULMN 3 1qfe_c00 3-DEHYDROQUINATE DEHYDRATASE user 4 3 # 4 A 86 GLU B 22 GLU^? 1000.00 A 143 HIS B 25 HIS^? 1000.00 A 170 LYS B 65 LYS.? 1000.00 coo -2.40 27.37 52.92 -1.22 29.09 52.71 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 1.36 26.79 49.43 3.17 26.89 50.50 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 7.24 31.80 48.14 6.27 25.92 49.70 39.44 0.72 -24.06 44.98 0.54 -26.26 1qfe_c00 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 4 hits 1qfe_c00 naa= 3 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 1 3 # 1 B 86 GLU A 22 GLU^? 1000.00 B 143 HIS A 25 HIS.? 1000.00 B 170 LYS A 27 LYS^? 1000.00 coo 13.90 37.16 5.96 12.00 36.26 6.12 11.90 9.90 7.95 12.35 11.96 7.71 coo 13.52 33.69 9.79 13.20 31.83 8.88 17.07 12.41 6.63 15.76 13.52 7.84 coo 7.52 28.83 11.02 13.59 28.74 9.95 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 2 3 # 2 B 86 GLU A 22 GLU^? 1000.00 B 143 HIS A 25 HIS.? 1000.00 B 170 LYS A 65 LYS.? 1000.00 coo 13.90 37.16 5.96 12.00 36.26 6.12 11.90 9.90 7.95 12.35 11.96 7.71 coo 13.52 33.69 9.79 13.20 31.83 8.88 17.07 12.41 6.63 15.76 13.52 7.84 coo 7.52 28.83 11.02 13.59 28.74 9.95 23.08 10.16 8.29 20.19 14.81 10.58 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 3 3 # 3 B 86 GLU B 22 GLU^? 1000.00 B 143 HIS B 25 HIS^? 1000.00 B 170 LYS B 27 LYS^? 1000.00 coo 13.90 37.16 5.96 12.00 36.26 6.12 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 13.52 33.69 9.79 13.20 31.83 8.88 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 7.52 28.83 11.02 13.59 28.74 9.95 40.39 -1.34 -15.57 44.33 1.39 -18.11 ULMN 3 1qfe_c01 3-DEHYDROQUINATE DEHYDRATASE user 4 3 # 4 B 86 GLU B 22 GLU^? 1000.00 B 143 HIS B 25 HIS^? 1000.00 B 170 LYS B 65 LYS.? 1000.00 coo 13.90 37.16 5.96 12.00 36.26 6.12 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 13.52 33.69 9.79 13.20 31.83 8.88 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 7.52 28.83 11.02 13.59 28.74 9.95 39.44 0.72 -24.06 44.98 0.54 -26.26 1qfe_c01 source 1qfe 3-DEHYDROQUINATE DEHYDRATASE : 4 hits 1qfe_c01 naa= 3 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 155 HIS A 25 HIS.? 1000.00 A 236 ASP A 138 ASP^? 1000.00 A 261 LYS A 51 LYS.? 1000.00 coo 55.45 46.76 42.08 57.34 46.16 42.75 17.07 12.41 6.63 15.76 13.52 7.84 coo 48.87 29.19 44.63 49.10 27.34 43.63 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 47.58 17.35 41.83 51.40 20.85 40.83 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 1qgn_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 155 HIS B 25 HIS^? 1000.00 A 236 ASP B 138 ASP^? 1000.00 A 261 LYS B 51 LYS.? 1000.00 coo 55.45 46.76 42.08 57.34 46.16 42.75 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 48.87 29.19 44.63 49.10 27.34 43.63 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 39.55 -26.05 -1.63 36.69 -20.49 -2.33 1qgn_c00 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c00 naa= 3 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 155 HIS A 25 HIS.? 1000.00 B 236 ASP A 138 ASP^? 1000.00 B 261 LYS A 51 LYS.? 1000.00 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 17.07 12.41 6.63 15.76 13.52 7.84 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 1qgn_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 155 HIS B 25 HIS^? 1000.00 B 236 ASP B 138 ASP^? 1000.00 B 261 LYS B 51 LYS.? 1000.00 coo 17.23 -29.05 11.63 18.63 -29.78 10.25 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 39.55 -26.05 -1.63 36.69 -20.49 -2.33 1qgn_c01 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c01 naa= 3 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 155 HIS A 25 HIS.? 1000.00 C 236 ASP A 138 ASP^? 1000.00 C 261 LYS A 51 LYS.? 1000.00 coo 55.11 47.10 12.61 53.44 47.85 11.58 17.07 12.41 6.63 15.76 13.52 7.84 coo 45.78 31.11 9.51 44.25 30.06 10.53 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 37.54 22.37 12.10 37.83 27.55 13.24 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 1qgn_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 155 HIS B 25 HIS^? 1000.00 C 236 ASP B 138 ASP^? 1000.00 C 261 LYS B 51 LYS.? 1000.00 coo 55.11 47.10 12.61 53.44 47.85 11.58 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 45.78 31.11 9.51 44.25 30.06 10.53 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 39.55 -26.05 -1.63 36.69 -20.49 -2.33 1qgn_c02 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c02 naa= 3 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 155 HIS A 25 HIS.? 1000.00 D 236 ASP A 138 ASP^? 1000.00 D 261 LYS A 51 LYS.? 1000.00 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 17.07 12.41 6.63 15.76 13.52 7.84 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 1qgn_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 155 HIS B 25 HIS^? 1000.00 D 236 ASP B 138 ASP^? 1000.00 D 261 LYS B 51 LYS.? 1000.00 coo 21.65 -31.73 40.91 19.91 -31.10 41.91 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 39.55 -26.05 -1.63 36.69 -20.49 -2.33 1qgn_c03 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c03 naa= 3 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 155 HIS A 25 HIS.? 1000.00 E 236 ASP A 138 ASP^? 1000.00 E 261 LYS A 51 LYS.? 1000.00 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 17.07 12.41 6.63 15.76 13.52 7.84 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 1qgn_c04 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 155 HIS B 25 HIS^? 1000.00 E 236 ASP B 138 ASP^? 1000.00 E 261 LYS B 51 LYS.? 1000.00 coo 76.61 -27.00 -35.69 75.87 -28.77 -34.87 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 39.55 -26.05 -1.63 36.69 -20.49 -2.33 1qgn_c04 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c04 naa= 3 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 155 HIS A 25 HIS.? 1000.00 F 236 ASP A 138 ASP^? 1000.00 F 261 LYS A 51 LYS.? 1000.00 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 17.07 12.41 6.63 15.76 13.52 7.84 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 1qgn_c05 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 155 HIS B 25 HIS^? 1000.00 F 236 ASP B 138 ASP^? 1000.00 F 261 LYS B 51 LYS.? 1000.00 coo 3.13 15.54 -65.72 2.08 14.15 -66.89 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 39.55 -26.05 -1.63 36.69 -20.49 -2.33 1qgn_c05 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c05 naa= 3 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 155 HIS A 25 HIS.? 1000.00 G 236 ASP A 138 ASP^? 1000.00 G 261 LYS A 51 LYS.? 1000.00 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 17.07 12.41 6.63 15.76 13.52 7.84 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 1qgn_c06 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 155 HIS B 25 HIS^? 1000.00 G 236 ASP B 138 ASP^? 1000.00 G 261 LYS B 51 LYS.? 1000.00 coo 76.68 -27.27 -65.07 77.71 -25.72 -66.04 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 39.55 -26.05 -1.63 36.69 -20.49 -2.33 1qgn_c06 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c06 naa= 3 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 155 HIS A 25 HIS.? 1000.00 H 236 ASP A 138 ASP^? 1000.00 H 261 LYS A 51 LYS.? 1000.00 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 17.07 12.41 6.63 15.76 13.52 7.84 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 1qgn_c07 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 155 HIS B 25 HIS^? 1000.00 H 236 ASP B 138 ASP^? 1000.00 H 261 LYS B 51 LYS.? 1000.00 coo 0.50 11.68 -36.58 0.99 13.43 -35.52 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 39.55 -26.05 -1.63 36.69 -20.49 -2.33 1qgn_c07 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c07 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG B 46 ARG.? 1000.00 C 163 TYR B 107 TYR^? 1000.00 C 236 ASP B 108 ASP^? 1000.00 coo 39.01 29.77 22.02 37.48 31.30 19.84 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 39.51 34.34 13.63 37.63 32.61 14.79 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 45.78 31.11 9.51 44.25 30.06 10.53 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG B 46 ARG.? 1000.00 D 163 TYR B 107 TYR^? 1000.00 D 236 ASP B 108 ASP^? 1000.00 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR B 107 TYR^? 1000.00 A 236 ASP B 108 ASP^? 1000.00 C 110 ARG B 46 ARG.? 1000.00 coo 55.48 26.51 40.65 55.39 23.99 39.43 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 48.87 29.19 44.63 49.10 27.34 43.63 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 52.39 23.42 32.10 54.51 23.27 34.29 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 107 TYR^? 1000.00 B 236 ASP A 108 ASP^? 1000.00 D 110 ARG A 46 ARG.? 1000.00 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 5.16 0.23 -2.44 3.66 2.42 -3.25 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 107 TYR^? 1000.00 B 236 ASP B 108 ASP^? 1000.00 D 110 ARG B 46 ARG.? 1000.00 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG B 46 ARG.? 1000.00 G 163 TYR B 107 TYR^? 1000.00 G 236 ASP B 108 ASP^? 1000.00 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 46 ARG.? 1000.00 H 163 TYR A 107 TYR^? 1000.00 H 236 ASP A 108 ASP^? 1000.00 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 5.16 0.23 -2.44 3.66 2.42 -3.25 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 46 ARG.? 1000.00 H 163 TYR B 107 TYR^? 1000.00 H 236 ASP B 108 ASP^? 1000.00 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 107 TYR^? 1000.00 E 236 ASP A 108 ASP^? 1000.00 G 110 ARG A 46 ARG.? 1000.00 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 5.16 0.23 -2.44 3.66 2.42 -3.25 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 107 TYR^? 1000.00 E 236 ASP B 108 ASP^? 1000.00 G 110 ARG B 46 ARG.? 1000.00 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR B 107 TYR^? 1000.00 F 236 ASP B 108 ASP^? 1000.00 H 110 ARG B 46 ARG.? 1000.00 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c23 naa= 3 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 1 3 # 1 A 49 ASP A 108 ASP^? 1000.00 A 147 THR A 133 THR.? 1000.00 A 294 ASP A 112 ASP~? 1000.00 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 15.32 -5.53 -2.56 15.86 -7.55 -2.13 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 2 3 # 2 A 49 ASP A 138 ASP^? 1000.00 A 147 THR A 105 THR^? 1000.00 A 294 ASP A 93 ASP.? 1000.00 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 8.35 5.19 -3.50 6.23 5.38 -3.24 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1qgx_c02 3',5'-ADENOSINE BISPHOSPHATASE user 3 3 # 3 A 49 ASP B 108 ASP^? 1000.00 A 147 THR B 133 THR.? 1000.00 A 294 ASP B 112 ASP~? 1000.00 coo 1.13 15.67 -24.51 2.35 14.34 -25.71 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 29.71 -13.76 -13.24 27.67 -14.35 -13.63 coo 14.48 16.57 -21.30 13.03 16.83 -22.81 24.70 -9.86 -21.06 23.12 -10.03 -22.49 1qgx_c02 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 3 hits 1qgx_c02 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 19 ASP.? 1000.00 A 261 ASP A 112 ASP~? 1000.00 A 329 ASP A 108 ASP^? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 5.19 0.54 10.51 3.14 -0.02 10.52 coo 34.02 79.89 42.60 34.73 78.01 41.86 21.33 -7.84 5.22 21.87 -9.36 6.59 coo 37.87 70.12 31.80 36.61 69.74 30.15 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 83 ASP.? 1000.00 A 261 ASP A 120 ASP.? 1000.00 A 329 ASP A 76 ASP~? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 34.02 79.89 42.60 34.73 78.01 41.86 27.77 3.65 13.30 28.81 5.07 14.48 coo 37.87 70.12 31.80 36.61 69.74 30.15 16.07 -4.78 18.64 16.16 -4.88 20.75 ULMN 3 1qho_c05 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP A 108 ASP^? 1000.00 A 261 ASP A 76 ASP~? 1000.00 A 329 ASP A 19 ASP.? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 34.02 79.89 42.60 34.73 78.01 41.86 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 37.87 70.12 31.80 36.61 69.74 30.15 5.19 0.54 10.51 3.14 -0.02 10.52 ULMN 3 1qho_c05 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP A 108 ASP^? 1000.00 A 261 ASP A 93 ASP.? 1000.00 A 329 ASP A 138 ASP^? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 34.02 79.89 42.60 34.73 78.01 41.86 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 37.87 70.12 31.80 36.61 69.74 30.15 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1qho_c05 ALPHA-AMYLASE user 5 3 # 5 A 228 ASP B 19 ASP.? 1000.00 A 261 ASP B 112 ASP~? 1000.00 A 329 ASP B 108 ASP^? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 40.03 -19.65 -26.21 40.66 -21.65 -26.18 coo 34.02 79.89 42.60 34.73 78.01 41.86 24.70 -9.86 -21.06 23.12 -10.03 -22.49 coo 37.87 70.12 31.80 36.61 69.74 30.15 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1qho_c05 ALPHA-AMYLASE user 6 3 # 6 A 228 ASP B 83 ASP.? 1000.00 A 261 ASP B 120 ASP.? 1000.00 A 329 ASP B 76 ASP~? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 34.02 79.89 42.60 34.73 78.01 41.86 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 37.87 70.12 31.80 36.61 69.74 30.15 30.14 -12.79 -34.44 30.07 -12.72 -36.56 ULMN 3 1qho_c05 ALPHA-AMYLASE user 7 3 # 7 A 228 ASP B 108 ASP^? 1000.00 A 261 ASP B 76 ASP~? 1000.00 A 329 ASP B 19 ASP.? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 34.02 79.89 42.60 34.73 78.01 41.86 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 37.87 70.12 31.80 36.61 69.74 30.15 40.03 -19.65 -26.21 40.66 -21.65 -26.18 ULMN 3 1qho_c05 ALPHA-AMYLASE user 8 3 # 8 A 228 ASP B 108 ASP^? 1000.00 A 261 ASP B 93 ASP.? 1000.00 A 329 ASP B 138 ASP^? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 34.02 79.89 42.60 34.73 78.01 41.86 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 37.87 70.12 31.80 36.61 69.74 30.15 42.87 -18.30 -9.07 44.47 -19.54 -8.54 1qho_c05 source 1qho ALPHA-AMYLASE : 8 hits 1qho_c05 naa= 3 ULMN 3 1qho_c07 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 76 ASP~? 1000.00 A 260 ASP A 19 ASP.? 1000.00 A 329 ASP A 83 ASP.? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 16.07 -4.78 18.64 16.16 -4.88 20.75 coo 30.73 81.29 37.61 31.23 82.07 35.69 5.19 0.54 10.51 3.14 -0.02 10.52 coo 37.87 70.12 31.80 36.61 69.74 30.15 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 1qho_c07 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP A 83 ASP.? 1000.00 A 260 ASP A 19 ASP.? 1000.00 A 329 ASP A 76 ASP~? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 30.73 81.29 37.61 31.23 82.07 35.69 5.19 0.54 10.51 3.14 -0.02 10.52 coo 37.87 70.12 31.80 36.61 69.74 30.15 16.07 -4.78 18.64 16.16 -4.88 20.75 ULMN 3 1qho_c07 ALPHA-AMYLASE user 3 3 # 3 A 228 ASP B 76 ASP~? 1000.00 A 260 ASP B 19 ASP.? 1000.00 A 329 ASP B 83 ASP.? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 30.14 -12.79 -34.44 30.07 -12.72 -36.56 coo 30.73 81.29 37.61 31.23 82.07 35.69 40.03 -19.65 -26.21 40.66 -21.65 -26.18 coo 37.87 70.12 31.80 36.61 69.74 30.15 27.06 -15.40 -22.59 25.67 -13.84 -22.77 ULMN 3 1qho_c07 ALPHA-AMYLASE user 4 3 # 4 A 228 ASP B 83 ASP.? 1000.00 A 260 ASP B 19 ASP.? 1000.00 A 329 ASP B 76 ASP~? 1000.00 coo 28.46 69.88 26.74 30.40 70.70 26.53 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 30.73 81.29 37.61 31.23 82.07 35.69 40.03 -19.65 -26.21 40.66 -21.65 -26.18 coo 37.87 70.12 31.80 36.61 69.74 30.15 30.14 -12.79 -34.44 30.07 -12.72 -36.56 1qho_c07 source 1qho ALPHA-AMYLASE : 4 hits 1qho_c07 naa= 3 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 3 # 1 A 145 THR A 62 THR^? 1000.00 A 182 TYR A 64 TYR.? 1000.00 A 186 LYS A 27 LYS^? 1000.00 coo 69.38 87.38 24.64 71.11 88.47 25.40 23.75 4.97 0.22 25.24 5.64 -1.20 coo 73.61 90.42 31.12 71.36 89.66 29.64 22.50 12.53 4.97 22.72 14.77 6.66 coo 73.54 84.00 28.64 69.01 86.68 29.71 20.78 10.08 -0.17 21.23 14.77 2.36 ULMN 3 1qrr_c01 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 3 # 2 A 145 THR B 62 THR^? 1000.00 A 182 TYR B 64 TYR.? 1000.00 A 186 LYS B 27 LYS^? 1000.00 coo 69.38 87.38 24.64 71.11 88.47 25.40 34.62 -1.27 -15.97 34.38 0.39 -14.61 coo 73.61 90.42 31.12 71.36 89.66 29.64 41.81 1.40 -20.74 43.72 2.68 -22.34 coo 73.54 84.00 28.64 69.01 86.68 29.71 40.39 -1.34 -15.57 44.33 1.39 -18.11 1qrr_c01 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 2 hits 1qrr_c01 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 134 PHE.? 1000.00 A 201 ASP A 136 ASP^? 1000.00 A 227 LYS A 35 LYS.? 1000.00 coo 23.39 49.81 32.16 21.33 51.68 32.26 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo 25.52 45.12 37.98 23.98 46.65 37.85 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 12.68 46.83 36.69 18.26 48.67 34.51 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1qz9_c02 KYNURENINASE user 2 3 # 2 A 129 PHE A 137 PHE^? 1000.00 A 201 ASP A 136 ASP^? 1000.00 A 227 LYS A 35 LYS.? 1000.00 coo 23.39 49.81 32.16 21.33 51.68 32.26 8.81 1.33 -9.39 8.17 2.24 -11.93 coo 25.52 45.12 37.98 23.98 46.65 37.85 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 12.68 46.83 36.69 18.26 48.67 34.51 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 1qz9_c02 KYNURENINASE user 3 3 # 3 A 129 PHE B 134 PHE.? 1000.00 A 201 ASP B 136 ASP^? 1000.00 A 227 LYS B 35 LYS.? 1000.00 coo 23.39 49.81 32.16 21.33 51.68 32.26 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo 25.52 45.12 37.98 23.98 46.65 37.85 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 12.68 46.83 36.69 18.26 48.67 34.51 29.05 -17.38 0.57 28.07 -15.85 6.68 ULMN 3 1qz9_c02 KYNURENINASE user 4 3 # 4 A 129 PHE B 137 PHE^? 1000.00 A 201 ASP B 136 ASP^? 1000.00 A 227 LYS B 35 LYS.? 1000.00 coo 23.39 49.81 32.16 21.33 51.68 32.26 38.85 -16.01 -6.33 39.98 -16.09 -3.79 coo 25.52 45.12 37.98 23.98 46.65 37.85 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 12.68 46.83 36.69 18.26 48.67 34.51 29.05 -17.38 0.57 28.07 -15.85 6.68 1qz9_c02 source 1qz9 KYNURENINASE : 4 hits 1qz9_c02 naa= 3 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 1 3 # 1 A 10 ASP A 108 ASP^? 1000.00 A 186 ASN A 56 ASN.? 1000.00 A 260 ALA A 31 ALA^? 1000.00 coo 11.81 33.10 11.71 13.07 31.45 11.40 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 11.43 26.53 7.41 13.01 27.56 8.43 9.46 -7.73 -7.73 9.95 -8.79 -9.49 coo 21.53 26.33 6.96 20.26 25.69 7.52 17.12 0.46 -8.20 15.69 0.46 -7.68 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 2 3 # 2 A 10 ASP A 136 ASP^? 1000.00 A 186 ASN A 56 ASN.? 1000.00 A 260 ALA A 31 ALA^? 1000.00 coo 11.81 33.10 11.71 13.07 31.45 11.40 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 11.43 26.53 7.41 13.01 27.56 8.43 9.46 -7.73 -7.73 9.95 -8.79 -9.49 coo 21.53 26.33 6.96 20.26 25.69 7.52 17.12 0.46 -8.20 15.69 0.46 -7.68 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 3 3 # 3 A 10 ASP B 108 ASP^? 1000.00 A 186 ASN B 56 ASN.? 1000.00 A 260 ALA B 31 ALA^? 1000.00 coo 11.81 33.10 11.71 13.07 31.45 11.40 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 11.43 26.53 7.41 13.01 27.56 8.43 30.64 -19.94 -7.98 29.63 -20.11 -6.12 coo 21.53 26.33 6.96 20.26 25.69 7.52 33.94 -9.24 -7.62 34.64 -10.47 -8.18 ULMN 3 1r4f_c00 IAG-NUCLEOSIDE HYDROLASE user 4 3 # 4 A 10 ASP B 136 ASP^? 1000.00 A 186 ASN B 56 ASN.? 1000.00 A 260 ALA B 31 ALA^? 1000.00 coo 11.81 33.10 11.71 13.07 31.45 11.40 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 11.43 26.53 7.41 13.01 27.56 8.43 30.64 -19.94 -7.98 29.63 -20.11 -6.12 coo 21.53 26.33 6.96 20.26 25.69 7.52 33.94 -9.24 -7.62 34.64 -10.47 -8.18 1r4f_c00 source 1r4f IAG-NUCLEOSIDE HYDROLASE : 4 hits 1r4f_c00 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 83 ASP.? 1000.00 35 SER A 82 SER.? 1000.00 215 ASP A 112 ASP~? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 12.20 12.71 75.45 13.69 13.84 74.03 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 5.22 15.03 71.43 7.19 14.88 70.83 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP A 93 ASP.? 1000.00 35 SER A 10 SER^? 1000.00 215 ASP A 94 ASP.? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 12.20 12.71 75.45 13.69 13.84 74.03 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 5.22 15.03 71.43 7.19 14.88 70.83 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP A 94 ASP.? 1000.00 35 SER A 96 SER.? 1000.00 215 ASP A 93 ASP.? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 12.20 12.71 75.45 13.69 13.84 74.03 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 5.22 15.03 71.43 7.19 14.88 70.83 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 3 # 4 32 ASP A 94 ASP.? 1000.00 35 SER A 97 SER.? 1000.00 215 ASP A 93 ASP.? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 12.20 12.71 75.45 13.69 13.84 74.03 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 5.22 15.03 71.43 7.19 14.88 70.83 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 5 3 # 5 32 ASP B 83 ASP.? 1000.00 35 SER B 82 SER.? 1000.00 215 ASP B 112 ASP~? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 12.20 12.71 75.45 13.69 13.84 74.03 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 5.22 15.03 71.43 7.19 14.88 70.83 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 6 3 # 6 32 ASP B 93 ASP.? 1000.00 35 SER B 10 SER^? 1000.00 215 ASP B 94 ASP.? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 12.20 12.71 75.45 13.69 13.84 74.03 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 5.22 15.03 71.43 7.19 14.88 70.83 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 7 3 # 7 32 ASP B 94 ASP.? 1000.00 35 SER B 96 SER.? 1000.00 215 ASP B 93 ASP.? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 12.20 12.71 75.45 13.69 13.84 74.03 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 5.22 15.03 71.43 7.19 14.88 70.83 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 8 3 # 8 32 ASP B 94 ASP.? 1000.00 35 SER B 97 SER.? 1000.00 215 ASP B 93 ASP.? 1000.00 coo 11.85 17.24 72.81 11.09 15.37 72.36 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 12.20 12.71 75.45 13.69 13.84 74.03 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 5.22 15.03 71.43 7.19 14.88 70.83 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 8 hits 1rne_c04 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 83 ASP.? 1000.00 A 37 SER A 82 SER.? 1000.00 A 214 ASP A 112 ASP~? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 51.10 65.11 20.73 52.62 63.74 19.42 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 48.59 58.89 25.78 50.13 59.74 24.61 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP A 93 ASP.? 1000.00 A 37 SER A 10 SER^? 1000.00 A 214 ASP A 94 ASP.? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 51.10 65.11 20.73 52.62 63.74 19.42 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 48.59 58.89 25.78 50.13 59.74 24.61 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1sme_c04 PLASMEPSIN II user 3 3 # 3 A 34 ASP A 94 ASP.? 1000.00 A 37 SER A 96 SER.? 1000.00 A 214 ASP A 93 ASP.? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 51.10 65.11 20.73 52.62 63.74 19.42 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 48.59 58.89 25.78 50.13 59.74 24.61 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1sme_c04 PLASMEPSIN II user 4 3 # 4 A 34 ASP A 94 ASP.? 1000.00 A 37 SER A 97 SER.? 1000.00 A 214 ASP A 93 ASP.? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 51.10 65.11 20.73 52.62 63.74 19.42 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 48.59 58.89 25.78 50.13 59.74 24.61 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1sme_c04 PLASMEPSIN II user 5 3 # 5 A 34 ASP B 83 ASP.? 1000.00 A 37 SER B 82 SER.? 1000.00 A 214 ASP B 112 ASP~? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 51.10 65.11 20.73 52.62 63.74 19.42 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 48.59 58.89 25.78 50.13 59.74 24.61 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1sme_c04 PLASMEPSIN II user 6 3 # 6 A 34 ASP B 93 ASP.? 1000.00 A 37 SER B 10 SER^? 1000.00 A 214 ASP B 94 ASP.? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 51.10 65.11 20.73 52.62 63.74 19.42 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 48.59 58.89 25.78 50.13 59.74 24.61 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1sme_c04 PLASMEPSIN II user 7 3 # 7 A 34 ASP B 94 ASP.? 1000.00 A 37 SER B 96 SER.? 1000.00 A 214 ASP B 93 ASP.? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 51.10 65.11 20.73 52.62 63.74 19.42 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 48.59 58.89 25.78 50.13 59.74 24.61 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1sme_c04 PLASMEPSIN II user 8 3 # 8 A 34 ASP B 94 ASP.? 1000.00 A 37 SER B 97 SER.? 1000.00 A 214 ASP B 93 ASP.? 1000.00 coo 51.75 60.57 19.10 52.05 60.90 21.19 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 51.10 65.11 20.73 52.62 63.74 19.42 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 48.59 58.89 25.78 50.13 59.74 24.61 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1sme_c04 source 1sme PLASMEPSIN II : 8 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 83 ASP.? 1000.00 B 37 SER A 82 SER.? 1000.00 B 214 ASP A 112 ASP~? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 20.67 100.44 55.84 20.21 98.51 54.45 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 12.41 98.71 58.47 14.37 98.17 58.05 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP A 93 ASP.? 1000.00 B 37 SER A 10 SER^? 1000.00 B 214 ASP A 94 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 20.67 100.44 55.84 20.21 98.51 54.45 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 12.41 98.71 58.47 14.37 98.17 58.05 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 1sme_c05 PLASMEPSIN II user 3 3 # 3 B 34 ASP A 94 ASP.? 1000.00 B 37 SER A 96 SER.? 1000.00 B 214 ASP A 93 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 20.67 100.44 55.84 20.21 98.51 54.45 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 12.41 98.71 58.47 14.37 98.17 58.05 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1sme_c05 PLASMEPSIN II user 4 3 # 4 B 34 ASP A 94 ASP.? 1000.00 B 37 SER A 97 SER.? 1000.00 B 214 ASP A 93 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 20.67 100.44 55.84 20.21 98.51 54.45 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 12.41 98.71 58.47 14.37 98.17 58.05 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 1sme_c05 PLASMEPSIN II user 5 3 # 5 B 34 ASP B 83 ASP.? 1000.00 B 37 SER B 82 SER.? 1000.00 B 214 ASP B 112 ASP~? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 20.67 100.44 55.84 20.21 98.51 54.45 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 12.41 98.71 58.47 14.37 98.17 58.05 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 1sme_c05 PLASMEPSIN II user 6 3 # 6 B 34 ASP B 93 ASP.? 1000.00 B 37 SER B 10 SER^? 1000.00 B 214 ASP B 94 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 20.67 100.44 55.84 20.21 98.51 54.45 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 12.41 98.71 58.47 14.37 98.17 58.05 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 1sme_c05 PLASMEPSIN II user 7 3 # 7 B 34 ASP B 94 ASP.? 1000.00 B 37 SER B 96 SER.? 1000.00 B 214 ASP B 93 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 20.67 100.44 55.84 20.21 98.51 54.45 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 12.41 98.71 58.47 14.37 98.17 58.05 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 1sme_c05 PLASMEPSIN II user 8 3 # 8 B 34 ASP B 94 ASP.? 1000.00 B 37 SER B 97 SER.? 1000.00 B 214 ASP B 93 ASP.? 1000.00 coo 17.69 97.58 52.73 17.33 97.19 54.77 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 20.67 100.44 55.84 20.21 98.51 54.45 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 12.41 98.71 58.47 14.37 98.17 58.05 43.71 -3.28 -5.83 41.61 -3.57 -5.77 1sme_c05 source 1sme PLASMEPSIN II : 8 hits 1sme_c05 naa= 3 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 1 3 # 1 B 8 HIS A 25 HIS.? 1000.00 B 80 GLU A 22 GLU^? 1000.00 B 223 ARG A 45 ARG.? 1000.00 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 17.07 12.41 6.63 15.76 13.52 7.84 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 11.90 9.90 7.95 12.35 11.96 7.71 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 2.50 -2.41 -19.58 3.25 -4.86 -17.92 ULMN 3 1t0u_c01 URIDINE PHOSPHORYLASE user 2 3 # 2 B 8 HIS B 25 HIS^? 1000.00 B 80 GLU B 22 GLU^? 1000.00 B 223 ARG B 45 ARG.? 1000.00 coo -27.29 12.84 -47.54 -26.57 10.91 -47.95 44.38 -3.39 -22.45 45.97 -4.01 -23.66 coo -24.01 16.61 -49.84 -25.90 15.74 -49.71 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo -14.82 14.90 -18.49 -14.21 12.08 -19.40 38.71 -23.35 3.90 36.31 -24.00 2.16 1t0u_c01 source 1t0u URIDINE PHOSPHORYLASE : 2 hits 1t0u_c01 naa= 3 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 1 3 # 1 A 250 ALA A 55 ALA.? 1000.00 A 251 GLY A 54 GLY.? 1000.00 A 252 ASP A 136 ASP^? 1000.00 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 7.72 -4.11 -10.29 7.07 -2.77 -10.02 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 4.96 -6.64 -9.65 4.76 -5.85 -9.47 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1tz3_c02 PUTATIVE SUGAR KINASE user 2 3 # 2 A 250 ALA B 55 ALA.? 1000.00 A 251 GLY B 54 GLY.? 1000.00 A 252 ASP B 136 ASP^? 1000.00 coo 27.46 -16.39 -4.13 28.50 -15.30 -4.20 34.72 -19.64 -5.52 36.20 -19.58 -5.81 coo 24.64 -14.61 -2.31 24.63 -15.34 -2.63 33.94 -23.32 -6.01 34.72 -23.13 -6.23 coo 21.52 -17.78 -4.15 20.67 -16.16 -5.23 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1tz3_c02 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c02 naa= 3 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 1 3 # 1 B 250 ALA A 55 ALA.? 1000.00 B 251 GLY A 54 GLY.? 1000.00 B 252 ASP A 136 ASP^? 1000.00 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 7.72 -4.11 -10.29 7.07 -2.77 -10.02 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 4.96 -6.64 -9.65 4.76 -5.85 -9.47 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 1tz3_c03 PUTATIVE SUGAR KINASE user 2 3 # 2 B 250 ALA B 55 ALA.? 1000.00 B 251 GLY B 54 GLY.? 1000.00 B 252 ASP B 136 ASP^? 1000.00 coo 16.60 -23.26 -48.35 15.78 -24.48 -48.70 34.72 -19.64 -5.52 36.20 -19.58 -5.81 coo 14.17 -20.48 -49.26 14.89 -20.41 -48.91 33.94 -23.32 -6.01 34.72 -23.13 -6.23 coo 16.67 -17.59 -46.30 15.00 -17.34 -45.02 36.67 -20.70 -10.25 38.13 -21.34 -8.89 1tz3_c03 source 1tz3 PUTATIVE SUGAR KINASE : 2 hits 1tz3_c03 naa= 3 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 108 ASP^? 1000.00 218 GLU B 128 GLU.? 1000.00 329 ASP A 138 ASP^? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 70.09 11.71 8.46 70.56 12.89 6.77 31.74 3.63 -18.85 33.68 4.26 -19.34 coo 59.16 37.82 13.95 57.63 37.03 15.12 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 108 ASP^? 1000.00 218 GLU B 135 GLU.? 1000.00 329 ASP A 83 ASP.? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 70.09 11.71 8.46 70.56 12.89 6.77 31.07 -20.83 -12.95 29.80 -19.16 -13.24 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 138 ASP^? 1000.00 218 GLU B 30 GLU^? 1000.00 329 ASP A 108 ASP^? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 70.09 11.71 8.46 70.56 12.89 6.77 34.72 -4.99 -5.76 33.75 -3.44 -4.67 coo 59.16 37.82 13.95 57.63 37.03 15.12 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP B 108 ASP^? 1000.00 218 GLU A 128 GLU.? 1000.00 329 ASP B 138 ASP^? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 29.43 4.89 3.07 29.04 6.89 3.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 108 ASP^? 1000.00 218 GLU A 135 GLU.? 1000.00 329 ASP B 83 ASP.? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 70.09 11.71 8.46 70.56 12.89 6.77 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.06 -15.40 -22.59 25.67 -13.84 -22.77 ULMN 3 1uok_c04 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 138 ASP^? 1000.00 218 GLU A 30 GLU^? 1000.00 329 ASP B 108 ASP^? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 70.09 11.71 8.46 70.56 12.89 6.77 20.47 3.27 -9.94 22.27 3.25 -11.07 coo 59.16 37.82 13.95 57.63 37.03 15.12 34.19 -19.41 -16.08 34.37 -20.82 -17.63 1uok_c04 source 1uok OLIGO-1,6-GLUCOSIDASE : 6 hits 1uok_c04 naa= 3 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 1 3 # 1 199 ASP A 83 ASP.? 1000.00 242 GLU B 39 GLU.? 1000.00 329 ASP A 108 ASP^? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 30.42 34.74 5.00 29.09 35.09 3.38 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 59.16 37.82 13.95 57.63 37.03 15.12 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 2 3 # 2 199 ASP A 108 ASP^? 1000.00 242 GLU A 102 GLU.? 1000.00 329 ASP A 83 ASP.? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 30.42 34.74 5.00 29.09 35.09 3.38 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 59.16 37.82 13.95 57.63 37.03 15.12 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 3 3 # 3 199 ASP A 108 ASP^? 1000.00 242 GLU B 34 GLU.? 1000.00 329 ASP A 19 ASP.? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 30.42 34.74 5.00 29.09 35.09 3.38 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 5.19 0.54 10.51 3.14 -0.02 10.52 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 4 3 # 4 199 ASP A 108 ASP^? 1000.00 242 GLU B 34 GLU.? 1000.00 329 ASP A 138 ASP^? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 30.42 34.74 5.00 29.09 35.09 3.38 27.06 -17.01 -3.24 26.01 -18.46 -4.35 coo 59.16 37.82 13.95 57.63 37.03 15.12 4.80 3.61 -6.72 2.93 4.41 -7.21 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 5 3 # 5 199 ASP B 83 ASP.? 1000.00 242 GLU A 39 GLU.? 1000.00 329 ASP B 108 ASP^? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 30.42 34.74 5.00 29.09 35.09 3.38 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 59.16 37.82 13.95 57.63 37.03 15.12 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 6 3 # 6 199 ASP B 108 ASP^? 1000.00 242 GLU A 34 GLU.? 1000.00 329 ASP B 19 ASP.? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 30.42 34.74 5.00 29.09 35.09 3.38 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 59.16 37.82 13.95 57.63 37.03 15.12 40.03 -19.65 -26.21 40.66 -21.65 -26.18 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 7 3 # 7 199 ASP B 108 ASP^? 1000.00 242 GLU A 34 GLU.? 1000.00 329 ASP B 138 ASP^? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 30.42 34.74 5.00 29.09 35.09 3.38 13.80 -9.32 -12.57 13.04 -10.94 -11.47 coo 59.16 37.82 13.95 57.63 37.03 15.12 42.87 -18.30 -9.07 44.47 -19.54 -8.54 ULMN 3 1uok_c05 OLIGO-1,6-GLUCOSIDASE user 8 3 # 8 199 ASP B 108 ASP^? 1000.00 242 GLU B 102 GLU.? 1000.00 329 ASP B 83 ASP.? 1000.00 coo 49.16 35.16 15.19 51.08 34.43 15.65 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 30.42 34.74 5.00 29.09 35.09 3.38 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 59.16 37.82 13.95 57.63 37.03 15.12 27.06 -15.40 -22.59 25.67 -13.84 -22.77 1uok_c05 source 1uok OLIGO-1,6-GLUCOSIDASE : 8 hits 1uok_c05 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 13 GLU^? 1000.00 A 596 ARG A 15 ARG^? 1000.00 A 647 ARG A 103 ARG^? 1000.00 coo 69.13 32.20 28.58 68.39 32.96 30.44 18.96 14.69 -1.29 19.68 15.81 0.37 coo 70.89 37.31 29.70 69.54 36.29 32.39 13.78 12.30 3.30 15.49 14.64 2.27 coo 66.09 40.54 34.70 66.92 37.69 35.49 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU A 22 GLU^? 1000.00 A 596 ARG A 15 ARG^? 1000.00 A 647 ARG A 103 ARG^? 1000.00 coo 69.13 32.20 28.58 68.39 32.96 30.44 11.90 9.90 7.95 12.35 11.96 7.71 coo 70.89 37.31 29.70 69.54 36.29 32.39 13.78 12.30 3.30 15.49 14.64 2.27 coo 66.09 40.54 34.70 66.92 37.69 35.49 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 3 3 # 3 A 581 GLU A 39 GLU.? 1000.00 A 596 ARG A 45 ARG.? 1000.00 A 647 ARG A 46 ARG.? 1000.00 coo 69.13 32.20 28.58 68.39 32.96 30.44 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 70.89 37.31 29.70 69.54 36.29 32.39 2.50 -2.41 -19.58 3.25 -4.86 -17.92 coo 66.09 40.54 34.70 66.92 37.69 35.49 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 4 3 # 4 A 581 GLU B 13 GLU^? 1000.00 A 596 ARG B 15 ARG^? 1000.00 A 647 ARG B 103 ARG^? 1000.00 coo 69.13 32.20 28.58 68.39 32.96 30.44 45.36 -0.56 -14.43 46.00 0.62 -16.07 coo 70.89 37.31 29.70 69.54 36.29 32.39 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 66.09 40.54 34.70 66.92 37.69 35.49 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 5 3 # 5 A 581 GLU B 22 GLU^? 1000.00 A 596 ARG B 15 ARG^? 1000.00 A 647 ARG B 103 ARG^? 1000.00 coo 69.13 32.20 28.58 68.39 32.96 30.44 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 70.89 37.31 29.70 69.54 36.29 32.39 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 66.09 40.54 34.70 66.92 37.69 35.49 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 6 3 # 6 A 581 GLU B 39 GLU.? 1000.00 A 596 ARG B 45 ARG.? 1000.00 A 647 ARG B 46 ARG.? 1000.00 coo 69.13 32.20 28.58 68.39 32.96 30.44 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 70.89 37.31 29.70 69.54 36.29 32.39 38.71 -23.35 3.90 36.31 -24.00 2.16 coo 66.09 40.54 34.70 66.92 37.69 35.49 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 6 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 13 GLU^? 1000.00 B 596 ARG A 15 ARG^? 1000.00 B 647 ARG A 103 ARG^? 1000.00 coo 38.22 57.83 70.36 36.82 56.74 69.18 18.96 14.69 -1.29 19.68 15.81 0.37 coo 34.24 60.89 68.08 33.31 57.93 67.63 13.78 12.30 3.30 15.49 14.64 2.27 coo 31.43 57.38 61.97 31.90 55.58 64.41 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU A 22 GLU^? 1000.00 B 596 ARG A 15 ARG^? 1000.00 B 647 ARG A 103 ARG^? 1000.00 coo 38.22 57.83 70.36 36.82 56.74 69.18 11.90 9.90 7.95 12.35 11.96 7.71 coo 34.24 60.89 68.08 33.31 57.93 67.63 13.78 12.30 3.30 15.49 14.64 2.27 coo 31.43 57.38 61.97 31.90 55.58 64.41 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 3 3 # 3 B 581 GLU A 39 GLU.? 1000.00 B 596 ARG A 45 ARG.? 1000.00 B 647 ARG A 46 ARG.? 1000.00 coo 38.22 57.83 70.36 36.82 56.74 69.18 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 34.24 60.89 68.08 33.31 57.93 67.63 2.50 -2.41 -19.58 3.25 -4.86 -17.92 coo 31.43 57.38 61.97 31.90 55.58 64.41 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 4 3 # 4 B 581 GLU B 13 GLU^? 1000.00 B 596 ARG B 15 ARG^? 1000.00 B 647 ARG B 103 ARG^? 1000.00 coo 38.22 57.83 70.36 36.82 56.74 69.18 45.36 -0.56 -14.43 46.00 0.62 -16.07 coo 34.24 60.89 68.08 33.31 57.93 67.63 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 31.43 57.38 61.97 31.90 55.58 64.41 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 5 3 # 5 B 581 GLU B 22 GLU^? 1000.00 B 596 ARG B 15 ARG^? 1000.00 B 647 ARG B 103 ARG^? 1000.00 coo 38.22 57.83 70.36 36.82 56.74 69.18 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 34.24 60.89 68.08 33.31 57.93 67.63 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 31.43 57.38 61.97 31.90 55.58 64.41 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 6 3 # 6 B 581 GLU B 39 GLU.? 1000.00 B 596 ARG B 45 ARG.? 1000.00 B 647 ARG B 46 ARG.? 1000.00 coo 38.22 57.83 70.36 36.82 56.74 69.18 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 34.24 60.89 68.08 33.31 57.93 67.63 38.71 -23.35 3.90 36.31 -24.00 2.16 coo 31.43 57.38 61.97 31.90 55.58 64.41 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 6 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 13 GLU^? 1000.00 C 596 ARG A 15 ARG^? 1000.00 C 647 ARG A 103 ARG^? 1000.00 coo 11.31 31.26 27.00 13.31 30.71 26.58 18.96 14.69 -1.29 19.68 15.81 0.37 coo 13.44 32.78 22.07 15.56 30.91 23.37 13.78 12.30 3.30 15.49 14.64 2.27 coo 21.00 33.35 22.82 19.83 30.82 24.09 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU A 22 GLU^? 1000.00 C 596 ARG A 15 ARG^? 1000.00 C 647 ARG A 103 ARG^? 1000.00 coo 11.31 31.26 27.00 13.31 30.71 26.58 11.90 9.90 7.95 12.35 11.96 7.71 coo 13.44 32.78 22.07 15.56 30.91 23.37 13.78 12.30 3.30 15.49 14.64 2.27 coo 21.00 33.35 22.82 19.83 30.82 24.09 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 3 3 # 3 C 581 GLU A 39 GLU.? 1000.00 C 596 ARG A 45 ARG.? 1000.00 C 647 ARG A 46 ARG.? 1000.00 coo 11.31 31.26 27.00 13.31 30.71 26.58 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 13.44 32.78 22.07 15.56 30.91 23.37 2.50 -2.41 -19.58 3.25 -4.86 -17.92 coo 21.00 33.35 22.82 19.83 30.82 24.09 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 4 3 # 4 C 581 GLU B 13 GLU^? 1000.00 C 596 ARG B 15 ARG^? 1000.00 C 647 ARG B 103 ARG^? 1000.00 coo 11.31 31.26 27.00 13.31 30.71 26.58 45.36 -0.56 -14.43 46.00 0.62 -16.07 coo 13.44 32.78 22.07 15.56 30.91 23.37 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 21.00 33.35 22.82 19.83 30.82 24.09 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 5 3 # 5 C 581 GLU B 22 GLU^? 1000.00 C 596 ARG B 15 ARG^? 1000.00 C 647 ARG B 103 ARG^? 1000.00 coo 11.31 31.26 27.00 13.31 30.71 26.58 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 13.44 32.78 22.07 15.56 30.91 23.37 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 21.00 33.35 22.82 19.83 30.82 24.09 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 6 3 # 6 C 581 GLU B 39 GLU.? 1000.00 C 596 ARG B 45 ARG.? 1000.00 C 647 ARG B 46 ARG.? 1000.00 coo 11.31 31.26 27.00 13.31 30.71 26.58 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 13.44 32.78 22.07 15.56 30.91 23.37 38.71 -23.35 3.90 36.31 -24.00 2.16 coo 21.00 33.35 22.82 19.83 30.82 24.09 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 6 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 13 GLU^? 1000.00 D 596 ARG A 15 ARG^? 1000.00 D 647 ARG A 103 ARG^? 1000.00 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 18.96 14.69 -1.29 19.68 15.81 0.37 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 13.78 12.30 3.30 15.49 14.64 2.27 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU A 22 GLU^? 1000.00 D 596 ARG A 15 ARG^? 1000.00 D 647 ARG A 103 ARG^? 1000.00 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 11.90 9.90 7.95 12.35 11.96 7.71 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 13.78 12.30 3.30 15.49 14.64 2.27 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 3 3 # 3 D 581 GLU A 39 GLU.? 1000.00 D 596 ARG A 45 ARG.? 1000.00 D 647 ARG A 46 ARG.? 1000.00 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 2.50 -2.41 -19.58 3.25 -4.86 -17.92 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 4 3 # 4 D 581 GLU B 13 GLU^? 1000.00 D 596 ARG B 15 ARG^? 1000.00 D 647 ARG B 103 ARG^? 1000.00 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 45.36 -0.56 -14.43 46.00 0.62 -16.07 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 5 3 # 5 D 581 GLU B 22 GLU^? 1000.00 D 596 ARG B 15 ARG^? 1000.00 D 647 ARG B 103 ARG^? 1000.00 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 6 3 # 6 D 581 GLU B 39 GLU.? 1000.00 D 596 ARG B 45 ARG.? 1000.00 D 647 ARG B 46 ARG.? 1000.00 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 32.13 -23.52 1.49 32.40 -25.50 0.81 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 38.71 -23.35 3.90 36.31 -24.00 2.16 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 6 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 13 GLU^? 1000.00 E 596 ARG A 15 ARG^? 1000.00 E 647 ARG A 103 ARG^? 1000.00 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 18.96 14.69 -1.29 19.68 15.81 0.37 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 13.78 12.30 3.30 15.49 14.64 2.27 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU A 22 GLU^? 1000.00 E 596 ARG A 15 ARG^? 1000.00 E 647 ARG A 103 ARG^? 1000.00 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 11.90 9.90 7.95 12.35 11.96 7.71 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 13.78 12.30 3.30 15.49 14.64 2.27 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 3 3 # 3 E 581 GLU A 39 GLU.? 1000.00 E 596 ARG A 45 ARG.? 1000.00 E 647 ARG A 46 ARG.? 1000.00 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 2.50 -2.41 -19.58 3.25 -4.86 -17.92 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 4 3 # 4 E 581 GLU B 13 GLU^? 1000.00 E 596 ARG B 15 ARG^? 1000.00 E 647 ARG B 103 ARG^? 1000.00 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 45.36 -0.56 -14.43 46.00 0.62 -16.07 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 5 3 # 5 E 581 GLU B 22 GLU^? 1000.00 E 596 ARG B 15 ARG^? 1000.00 E 647 ARG B 103 ARG^? 1000.00 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 6 3 # 6 E 581 GLU B 39 GLU.? 1000.00 E 596 ARG B 45 ARG.? 1000.00 E 647 ARG B 46 ARG.? 1000.00 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 38.71 -23.35 3.90 36.31 -24.00 2.16 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 6 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 22 GLU^? 1000.00 F 596 ARG A 15 ARG^? 1000.00 F 647 ARG A 103 ARG^? 1000.00 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 11.90 9.90 7.95 12.35 11.96 7.71 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 13.78 12.30 3.30 15.49 14.64 2.27 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU A 39 GLU.? 1000.00 F 596 ARG A 45 ARG.? 1000.00 F 647 ARG A 46 ARG.? 1000.00 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 2.50 -2.41 -19.58 3.25 -4.86 -17.92 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 3.33 -0.08 -11.42 3.38 -1.44 -8.63 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 3 3 # 3 F 581 GLU B 22 GLU^? 1000.00 F 596 ARG B 15 ARG^? 1000.00 F 647 ARG B 103 ARG^? 1000.00 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 44.79 -9.15 -23.60 46.32 -7.71 -23.39 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 4 3 # 4 F 581 GLU B 39 GLU.? 1000.00 F 596 ARG B 45 ARG.? 1000.00 F 647 ARG B 46 ARG.? 1000.00 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 32.13 -23.52 1.49 32.40 -25.50 0.81 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 38.71 -23.35 3.90 36.31 -24.00 2.16 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 40.40 -21.43 -4.30 39.16 -22.01 -7.08 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 4 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 7 ASN.? 1000.00 457 GLY A 57 GLY^? 1000.00 459 GLU A 34 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 15.46 -2.00 -17.47 13.38 -2.28 -17.08 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 13.45 -5.68 -8.13 13.35 -5.77 -7.37 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 13.80 -9.32 -12.57 13.04 -10.94 -11.47 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN A 36 ASN.? 1000.00 457 GLY A 54 GLY.? 1000.00 459 GLU A 39 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 11.74 -12.02 -14.51 13.26 -13.51 -14.29 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 4.96 -6.64 -9.65 4.76 -5.85 -9.47 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 5.68 -8.26 -17.17 3.79 -8.95 -16.50 ULMN 3 1vom_c00 MYOSIN user 3 3 # 3 233 ASN A 110 ASN.? 1000.00 457 GLY A 57 GLY^? 1000.00 459 GLU A 135 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 13.67 -5.78 2.51 14.50 -7.33 3.70 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 13.45 -5.68 -8.13 13.35 -5.77 -7.37 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1vom_c00 MYOSIN user 4 3 # 4 233 ASN B 7 ASN.? 1000.00 457 GLY B 57 GLY^? 1000.00 459 GLU B 34 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 32.60 -11.94 1.66 33.39 -13.87 1.25 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 30.34 -15.56 -7.68 30.36 -15.69 -8.45 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 27.06 -17.01 -3.24 26.01 -18.46 -4.35 ULMN 3 1vom_c00 MYOSIN user 5 3 # 5 233 ASN B 36 ASN.? 1000.00 457 GLY B 54 GLY.? 1000.00 459 GLU B 39 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 25.75 -20.13 -1.28 23.68 -19.64 -1.46 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 33.94 -23.32 -6.01 34.72 -23.13 -6.23 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 32.13 -23.52 1.49 32.40 -25.50 0.81 ULMN 3 1vom_c00 MYOSIN user 6 3 # 6 233 ASN B 110 ASN.? 1000.00 457 GLY B 57 GLY^? 1000.00 459 GLU B 135 GLU.? 1000.00 coo 59.14 42.15 -25.87 60.93 42.86 -24.97 30.35 -15.39 -18.19 28.64 -15.51 -19.45 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 30.34 -15.56 -7.68 30.36 -15.69 -8.45 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 31.07 -20.83 -12.95 29.80 -19.16 -13.24 1vom_c00 source 1vom MYOSIN : 6 hits 1vom_c00 naa= 3 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 A 100 PHE A 132 PHE^? 1000.00 A 197 ASN A 110 ASN.? 1000.00 A 198 PRO A 84 PRO.? 1000.00 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 13.67 -5.78 2.51 14.50 -7.33 3.70 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 13.61 -4.29 9.19 12.49 -6.02 8.35 ULMN 3 1vq1_c00 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 A 100 PHE B 132 PHE^? 1000.00 A 197 ASN B 110 ASN.? 1000.00 A 198 PRO B 84 PRO.? 1000.00 coo 5.24 -2.19 28.74 3.83 -0.30 30.29 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 30.35 -15.39 -18.19 28.64 -15.51 -19.45 coo 3.80 -4.83 39.13 4.75 -4.51 37.10 31.72 -14.66 -24.92 30.71 -16.46 -24.09 1vq1_c00 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_c00 naa= 3 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 3 # 1 B 100 PHE A 132 PHE^? 1000.00 B 197 ASN A 110 ASN.? 1000.00 B 198 PRO A 84 PRO.? 1000.00 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 13.67 -5.78 2.51 14.50 -7.33 3.70 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 13.61 -4.29 9.19 12.49 -6.02 8.35 ULMN 3 1vq1_c01 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 3 # 2 B 100 PHE B 132 PHE^? 1000.00 B 197 ASN B 110 ASN.? 1000.00 B 198 PRO B 84 PRO.? 1000.00 coo 15.92 -14.38 -0.49 15.85 -16.40 -2.42 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 30.35 -15.39 -18.19 28.64 -15.51 -19.45 coo 21.24 -11.77 -9.43 20.56 -12.14 -7.31 31.72 -14.66 -24.92 30.71 -16.46 -24.09 1vq1_c01 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_c01 naa= 3 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 1 3 # 1 A 105 HIS A 50 HIS.? 1000.00 A 169 ASP A 136 ASP^? 1000.00 A 288 GLU A 135 GLU.? 1000.00 coo 67.72 35.99 30.87 69.77 36.13 31.33 -4.24 -1.10 -13.74 -5.24 -2.70 -12.82 coo 73.17 30.66 22.56 72.87 30.30 20.46 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 74.06 28.51 15.92 73.77 29.56 17.73 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1w1o_c00 CYTOKININ DEHYDROGENASE 1 user 2 3 # 2 A 105 HIS B 50 HIS.? 1000.00 A 169 ASP B 136 ASP^? 1000.00 A 288 GLU B 135 GLU.? 1000.00 coo 67.72 35.99 30.87 69.77 36.13 31.33 43.22 -28.55 -1.93 42.31 -30.23 -2.82 coo 73.17 30.66 22.56 72.87 30.30 20.46 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 74.06 28.51 15.92 73.77 29.56 17.73 31.07 -20.83 -12.95 29.80 -19.16 -13.24 1w1o_c00 source 1w1o CYTOKININ DEHYDROGENASE 1 : 2 hits 1w1o_c00 naa= 3 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 A 164 SER B 82 SER.? 1000.00 A 178 TYR B 77 TYR~? 1000.00 A 182 LYS B 79 LYS~? 1000.00 coo 81.46 10.53 21.66 82.20 10.82 19.39 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 87.67 8.69 17.10 86.62 10.83 18.52 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 85.30 6.17 22.83 87.26 11.02 23.50 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ybv_c00 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 A 164 SER B 82 SER.? 1000.00 A 178 TYR B 77 TYR~? 1000.00 A 182 LYS B 80 LYS~? 1000.00 coo 81.46 10.53 21.66 82.20 10.82 19.39 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 87.67 8.69 17.10 86.62 10.83 18.52 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 85.30 6.17 22.83 87.26 11.02 23.50 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ybv_c00 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_c00 naa= 3 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 3 # 1 B 164 SER B 82 SER.? 1000.00 B 178 TYR B 77 TYR~? 1000.00 B 182 LYS B 79 LYS~? 1000.00 coo 61.22 3.61 34.51 60.46 1.86 35.98 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 54.99 -1.20 35.40 56.04 1.15 36.44 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 57.40 2.23 30.19 55.43 5.44 33.87 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 1ybv_c01 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 3 # 2 B 164 SER B 82 SER.? 1000.00 B 178 TYR B 77 TYR~? 1000.00 B 182 LYS B 80 LYS~? 1000.00 coo 61.22 3.61 34.51 60.46 1.86 35.98 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 54.99 -1.20 35.40 56.04 1.15 36.44 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 57.40 2.23 30.19 55.43 5.44 33.87 24.38 -17.04 -32.21 30.30 -17.91 -32.35 1ybv_c01 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 2 hits 1ybv_c01 naa= 3 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 A 14 LYS A 37 LYS.? 1000.00 A 74 LYS A 35 LYS.? 1000.00 A 165 GLU A 135 GLU.? 1000.00 coo 18.28 7.83 36.39 22.82 8.75 39.52 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 14.16 13.09 37.03 20.00 12.44 37.49 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 22.22 16.06 48.76 23.94 15.33 49.78 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1ylu_c00 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 A 14 LYS B 37 LYS.? 1000.00 A 74 LYS B 35 LYS.? 1000.00 A 165 GLU B 135 GLU.? 1000.00 coo 18.28 7.83 36.39 22.82 8.75 39.52 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 14.16 13.09 37.03 20.00 12.44 37.49 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 22.22 16.06 48.76 23.94 15.33 49.78 31.07 -20.83 -12.95 29.80 -19.16 -13.24 1ylu_c00 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 2 hits 1ylu_c00 naa= 3 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 3 # 1 B 14 LYS A 37 LYS.? 1000.00 B 74 LYS A 35 LYS.? 1000.00 B 165 GLU A 135 GLU.? 1000.00 coo 13.51 0.92 76.10 12.98 6.13 74.68 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 19.89 -0.55 76.51 17.10 4.32 77.43 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 21.39 11.56 68.52 20.24 13.13 67.73 8.47 -7.85 -2.75 10.54 -8.23 -2.60 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 3 # 2 B 14 LYS B 35 LYS.? 1000.00 B 74 LYS B 37 LYS.? 1000.00 B 165 GLU B 135 GLU.? 1000.00 coo 13.51 0.92 76.10 12.98 6.13 74.68 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 19.89 -0.55 76.51 17.10 4.32 77.43 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 21.39 11.56 68.52 20.24 13.13 67.73 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 1ylu_c01 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 3 # 3 B 14 LYS B 37 LYS.? 1000.00 B 74 LYS B 35 LYS.? 1000.00 B 165 GLU B 135 GLU.? 1000.00 coo 13.51 0.92 76.10 12.98 6.13 74.68 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 19.89 -0.55 76.51 17.10 4.32 77.43 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 21.39 11.56 68.52 20.24 13.13 67.73 31.07 -20.83 -12.95 29.80 -19.16 -13.24 1ylu_c01 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 3 hits 1ylu_c01 naa= 3 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 3 # 1 193 ASP A 19 ASP.? 1000.00 231 ASP A 120 ASP.? 1000.00 294 ASP A 108 ASP^? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 5.19 0.54 10.51 3.14 -0.02 10.52 coo 14.74 93.05 -1.00 14.30 94.22 0.73 27.77 3.65 13.30 28.81 5.07 14.48 coo 33.16 106.80 7.72 33.34 104.87 6.92 8.15 -4.41 0.30 6.77 -4.99 1.79 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 3 # 2 193 ASP A 108 ASP^? 1000.00 231 ASP A 93 ASP.? 1000.00 294 ASP A 19 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 14.74 93.05 -1.00 14.30 94.22 0.73 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 33.16 106.80 7.72 33.34 104.87 6.92 5.19 0.54 10.51 3.14 -0.02 10.52 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 3 # 3 193 ASP A 108 ASP^? 1000.00 231 ASP A 93 ASP.? 1000.00 294 ASP A 83 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 8.15 -4.41 0.30 6.77 -4.99 1.79 coo 14.74 93.05 -1.00 14.30 94.22 0.73 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 33.16 106.80 7.72 33.34 104.87 6.92 15.31 -8.59 6.79 17.37 -9.02 6.98 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 3 # 4 193 ASP B 19 ASP.? 1000.00 231 ASP B 120 ASP.? 1000.00 294 ASP B 108 ASP^? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 40.03 -19.65 -26.21 40.66 -21.65 -26.18 coo 14.74 93.05 -1.00 14.30 94.22 0.73 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 33.16 106.80 7.72 33.34 104.87 6.92 34.19 -19.41 -16.08 34.37 -20.82 -17.63 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 3 # 5 193 ASP B 108 ASP^? 1000.00 231 ASP B 93 ASP.? 1000.00 294 ASP B 19 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 14.74 93.05 -1.00 14.30 94.22 0.73 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 40.03 -19.65 -26.21 40.66 -21.65 -26.18 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 3 # 6 193 ASP B 108 ASP^? 1000.00 231 ASP B 93 ASP.? 1000.00 294 ASP B 83 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 14.74 93.05 -1.00 14.30 94.22 0.73 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 33.16 106.80 7.72 33.34 104.87 6.92 27.06 -15.40 -22.59 25.67 -13.84 -22.77 ULMN 3 2amg_c06 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 3 # 7 193 ASP B 108 ASP^? 1000.00 231 ASP B 120 ASP.? 1000.00 294 ASP B 19 ASP.? 1000.00 coo 27.89 102.52 14.98 29.35 101.92 13.57 34.19 -19.41 -16.08 34.37 -20.82 -17.63 coo 14.74 93.05 -1.00 14.30 94.22 0.73 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 33.16 106.80 7.72 33.34 104.87 6.92 40.03 -19.65 -26.21 40.66 -21.65 -26.18 2amg_c06 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 7 hits 2amg_c06 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 83 ASP.? 1000.00 38 SER A 82 SER.? 1000.00 218 ASP A 112 ASP~? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 46.04 57.35 103.96 44.97 58.52 105.78 14.52 -10.91 10.84 12.40 -12.06 11.06 coo 41.33 60.20 97.63 42.00 60.96 99.49 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP A 93 ASP.? 1000.00 38 SER A 10 SER^? 1000.00 218 ASP A 94 ASP.? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 17.45 11.87 -9.91 18.23 9.90 -9.96 coo 46.04 57.35 103.96 44.97 58.52 105.78 17.14 6.15 -9.35 18.92 7.63 -9.94 coo 41.33 60.20 97.63 42.00 60.96 99.49 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 3 3 # 3 35 ASP A 94 ASP.? 1000.00 38 SER A 96 SER.? 1000.00 218 ASP A 93 ASP.? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 46.04 57.35 103.96 44.97 58.52 105.78 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 41.33 60.20 97.63 42.00 60.96 99.49 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 4 3 # 4 35 ASP A 94 ASP.? 1000.00 38 SER A 97 SER.? 1000.00 218 ASP A 93 ASP.? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 13.93 10.69 -14.78 14.17 9.66 -16.61 coo 46.04 57.35 103.96 44.97 58.52 105.78 12.38 15.07 -17.61 11.81 17.40 -17.17 coo 41.33 60.20 97.63 42.00 60.96 99.49 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 5 3 # 5 35 ASP B 83 ASP.? 1000.00 38 SER B 82 SER.? 1000.00 218 ASP B 112 ASP~? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 46.04 57.35 103.96 44.97 58.52 105.78 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo 41.33 60.20 97.63 42.00 60.96 99.49 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 6 3 # 6 35 ASP B 93 ASP.? 1000.00 38 SER B 10 SER^? 1000.00 218 ASP B 94 ASP.? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo 46.04 57.35 103.96 44.97 58.52 105.78 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo 41.33 60.20 97.63 42.00 60.96 99.49 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 7 3 # 7 35 ASP B 94 ASP.? 1000.00 38 SER B 96 SER.? 1000.00 218 ASP B 93 ASP.? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 46.04 57.35 103.96 44.97 58.52 105.78 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 41.33 60.20 97.63 42.00 60.96 99.49 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 8 3 # 8 35 ASP B 94 ASP.? 1000.00 38 SER B 97 SER.? 1000.00 218 ASP B 93 ASP.? 1000.00 coo 41.14 58.72 105.19 42.39 59.85 103.92 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo 46.04 57.35 103.96 44.97 58.52 105.78 48.92 -6.09 1.92 51.23 -5.46 1.48 coo 41.33 60.20 97.63 42.00 60.96 99.49 43.71 -3.28 -5.83 41.61 -3.57 -5.77 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 8 hits 2apr_c04 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 15 ARG^? 1000.00 A 161 ASP A 138 ASP^? 1000.00 A 174 TYR A 107 TYR^? 1000.00 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 13.78 12.30 3.30 15.49 14.64 2.27 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 5.16 0.23 -2.44 3.66 2.42 -3.25 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG B 15 ARG^? 1000.00 A 161 ASP B 138 ASP^? 1000.00 A 174 TYR B 107 TYR^? 1000.00 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 39.72 -19.76 -13.26 42.39 -19.94 -12.49 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 15 ARG^? 1000.00 B 161 ASP A 138 ASP^? 1000.00 B 174 TYR A 107 TYR^? 1000.00 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 13.78 12.30 3.30 15.49 14.64 2.27 coo -14.86 10.19 8.14 -14.82 12.31 8.42 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -21.46 12.70 8.53 -19.04 12.30 7.24 5.16 0.23 -2.44 3.66 2.42 -3.25 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG B 15 ARG^? 1000.00 B 161 ASP B 138 ASP^? 1000.00 B 174 TYR B 107 TYR^? 1000.00 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo -14.86 10.19 8.14 -14.82 12.31 8.42 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -21.46 12.70 8.53 -19.04 12.30 7.24 39.72 -19.76 -13.26 42.39 -19.94 -12.49 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 15 ARG^? 1000.00 C 161 ASP A 138 ASP^? 1000.00 C 174 TYR A 107 TYR^? 1000.00 coo 2.84 19.43 40.34 1.59 20.35 37.65 13.78 12.30 3.30 15.49 14.64 2.27 coo -0.62 11.10 28.05 -0.65 13.15 27.46 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 5.94 13.28 27.17 3.53 13.05 28.58 5.16 0.23 -2.44 3.66 2.42 -3.25 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG B 15 ARG^? 1000.00 C 161 ASP B 138 ASP^? 1000.00 C 174 TYR B 107 TYR^? 1000.00 coo 2.84 19.43 40.34 1.59 20.35 37.65 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo -0.62 11.10 28.05 -0.65 13.15 27.46 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 5.94 13.28 27.17 3.53 13.05 28.58 39.72 -19.76 -13.26 42.39 -19.94 -12.49 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 15 ARG^? 1000.00 D 161 ASP A 138 ASP^? 1000.00 D 174 TYR A 107 TYR^? 1000.00 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 13.78 12.30 3.30 15.49 14.64 2.27 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 5.16 0.23 -2.44 3.66 2.42 -3.25 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG B 15 ARG^? 1000.00 D 161 ASP B 138 ASP^? 1000.00 D 174 TYR B 107 TYR^? 1000.00 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 45.95 -6.29 -19.02 47.14 -3.63 -18.02 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 39.72 -19.76 -13.26 42.39 -19.94 -12.49 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c11 naa= 3 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 1 3 # 1 A 197 ASP A 136 ASP^? 1000.00 A 233 GLU A 135 GLU.? 1000.00 A 300 ASN A 110 ASN.? 1000.00 coo 12.51 17.07 49.46 12.44 16.89 47.35 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 6.52 19.14 48.16 7.77 18.42 46.61 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo 9.30 22.40 41.76 10.10 20.96 40.36 13.67 -5.78 2.51 14.50 -7.33 3.70 ULMN 3 2cpu_c01 ALPHA-AMYLASE user 2 3 # 2 A 197 ASP B 136 ASP^? 1000.00 A 233 GLU B 135 GLU.? 1000.00 A 300 ASN B 110 ASN.? 1000.00 coo 12.51 17.07 49.46 12.44 16.89 47.35 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 6.52 19.14 48.16 7.77 18.42 46.61 31.07 -20.83 -12.95 29.80 -19.16 -13.24 coo 9.30 22.40 41.76 10.10 20.96 40.36 30.35 -15.39 -18.19 28.64 -15.51 -19.45 2cpu_c01 source 2cpu ALPHA-AMYLASE : 2 hits 2cpu_c01 naa= 3 ULMN 3 2dbt_c00 CHITINASE C user 1 3 # 1 A 147 GLU A 129 GLU^? 1000.00 A 156 GLU B 129 GLU^? 1000.00 A 194 ASN A 32 ASN^? 1000.00 coo 74.14 15.91 8.55 72.08 15.36 8.63 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 67.47 20.07 1.34 65.99 20.06 2.88 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 67.44 25.26 13.91 67.54 23.65 15.28 17.67 -2.87 -11.10 19.38 -1.89 -11.87 ULMN 3 2dbt_c00 CHITINASE C user 2 3 # 2 A 147 GLU A 129 GLU^? 1000.00 A 156 GLU B 129 GLU^? 1000.00 A 194 ASN B 32 ASN^? 1000.00 coo 74.14 15.91 8.55 72.08 15.36 8.63 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 67.47 20.07 1.34 65.99 20.06 2.88 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 67.44 25.26 13.91 67.54 23.65 15.28 30.82 -10.44 -4.63 30.86 -8.45 -3.90 ULMN 3 2dbt_c00 CHITINASE C user 3 3 # 3 A 147 GLU B 129 GLU^? 1000.00 A 156 GLU A 129 GLU^? 1000.00 A 194 ASN A 32 ASN^? 1000.00 coo 74.14 15.91 8.55 72.08 15.36 8.63 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 67.47 20.07 1.34 65.99 20.06 2.88 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 67.44 25.26 13.91 67.54 23.65 15.28 17.67 -2.87 -11.10 19.38 -1.89 -11.87 ULMN 3 2dbt_c00 CHITINASE C user 4 3 # 4 A 147 GLU B 129 GLU^? 1000.00 A 156 GLU A 129 GLU^? 1000.00 A 194 ASN B 32 ASN^? 1000.00 coo 74.14 15.91 8.55 72.08 15.36 8.63 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 67.47 20.07 1.34 65.99 20.06 2.88 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 67.44 25.26 13.91 67.54 23.65 15.28 30.82 -10.44 -4.63 30.86 -8.45 -3.90 2dbt_c00 source 2dbt CHITINASE C : 4 hits 2dbt_c00 naa= 3 ULMN 3 2dbt_c01 CHITINASE C user 1 3 # 1 B 147 GLU A 129 GLU^? 1000.00 B 156 GLU B 129 GLU^? 1000.00 B 194 ASN A 32 ASN^? 1000.00 coo 45.64 63.11 17.20 47.48 62.43 16.45 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 54.43 67.89 19.82 55.62 67.90 18.07 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 49.79 70.75 7.78 50.10 68.90 6.86 17.67 -2.87 -11.10 19.38 -1.89 -11.87 ULMN 3 2dbt_c01 CHITINASE C user 2 3 # 2 B 147 GLU A 129 GLU^? 1000.00 B 156 GLU B 129 GLU^? 1000.00 B 194 ASN B 32 ASN^? 1000.00 coo 45.64 63.11 17.20 47.48 62.43 16.45 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 54.43 67.89 19.82 55.62 67.90 18.07 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 49.79 70.75 7.78 50.10 68.90 6.86 30.82 -10.44 -4.63 30.86 -8.45 -3.90 ULMN 3 2dbt_c01 CHITINASE C user 3 3 # 3 B 147 GLU B 129 GLU^? 1000.00 B 156 GLU A 129 GLU^? 1000.00 B 194 ASN A 32 ASN^? 1000.00 coo 45.64 63.11 17.20 47.48 62.43 16.45 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 54.43 67.89 19.82 55.62 67.90 18.07 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 49.79 70.75 7.78 50.10 68.90 6.86 17.67 -2.87 -11.10 19.38 -1.89 -11.87 ULMN 3 2dbt_c01 CHITINASE C user 4 3 # 4 B 147 GLU B 129 GLU^? 1000.00 B 156 GLU A 129 GLU^? 1000.00 B 194 ASN B 32 ASN^? 1000.00 coo 45.64 63.11 17.20 47.48 62.43 16.45 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 54.43 67.89 19.82 55.62 67.90 18.07 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 49.79 70.75 7.78 50.10 68.90 6.86 30.82 -10.44 -4.63 30.86 -8.45 -3.90 2dbt_c01 source 2dbt CHITINASE C : 4 hits 2dbt_c01 naa= 3 ULMN 3 2dbt_c02 CHITINASE C user 1 3 # 1 C 147 GLU A 129 GLU^? 1000.00 C 156 GLU B 129 GLU^? 1000.00 C 194 ASN A 32 ASN^? 1000.00 coo 41.23 29.31 13.28 43.03 29.85 12.29 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 44.75 23.09 5.51 46.77 22.91 6.12 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 49.75 21.00 18.12 50.45 23.02 18.26 17.67 -2.87 -11.10 19.38 -1.89 -11.87 ULMN 3 2dbt_c02 CHITINASE C user 2 3 # 2 C 147 GLU A 129 GLU^? 1000.00 C 156 GLU B 129 GLU^? 1000.00 C 194 ASN B 32 ASN^? 1000.00 coo 41.23 29.31 13.28 43.03 29.85 12.29 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 44.75 23.09 5.51 46.77 22.91 6.12 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 49.75 21.00 18.12 50.45 23.02 18.26 30.82 -10.44 -4.63 30.86 -8.45 -3.90 ULMN 3 2dbt_c02 CHITINASE C user 3 3 # 3 C 147 GLU B 129 GLU^? 1000.00 C 156 GLU A 129 GLU^? 1000.00 C 194 ASN A 32 ASN^? 1000.00 coo 41.23 29.31 13.28 43.03 29.85 12.29 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 44.75 23.09 5.51 46.77 22.91 6.12 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 49.75 21.00 18.12 50.45 23.02 18.26 17.67 -2.87 -11.10 19.38 -1.89 -11.87 ULMN 3 2dbt_c02 CHITINASE C user 4 3 # 4 C 147 GLU B 129 GLU^? 1000.00 C 156 GLU A 129 GLU^? 1000.00 C 194 ASN B 32 ASN^? 1000.00 coo 41.23 29.31 13.28 43.03 29.85 12.29 30.46 0.70 -12.92 29.79 1.09 -10.98 coo 44.75 23.09 5.51 46.77 22.91 6.12 27.38 2.39 -2.95 28.11 1.94 -4.85 coo 49.75 21.00 18.12 50.45 23.02 18.26 30.82 -10.44 -4.63 30.86 -8.45 -3.90 2dbt_c02 source 2dbt CHITINASE C : 4 hits 2dbt_c02 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 35 LYS.? 1000.00 A 184 LYS A 37 LYS.? 1000.00 A 345 ASP B 112 ASP~? 1000.00 coo 5.98 42.76 7.73 10.19 38.62 9.02 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 2.77 37.17 4.99 6.33 34.76 8.06 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 0.07 40.30 18.65 -0.21 42.34 18.18 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 2 3 # 2 A 182 LYS B 35 LYS.? 1000.00 A 184 LYS B 37 LYS.? 1000.00 A 345 ASP A 112 ASP~? 1000.00 coo 5.98 42.76 7.73 10.19 38.62 9.02 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 2.77 37.17 4.99 6.33 34.76 8.06 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 0.07 40.30 18.65 -0.21 42.34 18.18 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 35 LYS.? 1000.00 B 184 LYS A 37 LYS.? 1000.00 B 345 ASP A 136 ASP^? 1000.00 coo 38.76 2.27 4.00 34.00 5.99 4.37 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 40.63 7.13 9.06 35.85 7.36 8.95 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS A 35 LYS.? 1000.00 B 184 LYS A 37 LYS.? 1000.00 B 345 ASP B 112 ASP~? 1000.00 coo 38.76 2.27 4.00 34.00 5.99 4.37 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 40.63 7.13 9.06 35.85 7.36 8.95 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 3 3 # 3 B 182 LYS B 35 LYS.? 1000.00 B 184 LYS B 37 LYS.? 1000.00 B 345 ASP A 112 ASP~? 1000.00 coo 38.76 2.27 4.00 34.00 5.99 4.37 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 40.63 7.13 9.06 35.85 7.36 8.95 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 4 3 # 4 B 182 LYS B 35 LYS.? 1000.00 B 184 LYS B 37 LYS.? 1000.00 B 345 ASP B 136 ASP^? 1000.00 coo 38.76 2.27 4.00 34.00 5.99 4.37 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 40.63 7.13 9.06 35.85 7.36 8.95 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 36.67 -20.70 -10.25 38.13 -21.34 -8.89 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 35 LYS.? 1000.00 C 184 LYS A 37 LYS.? 1000.00 C 345 ASP B 112 ASP~? 1000.00 coo -5.66 12.40 71.13 -2.66 9.98 66.50 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 0.95 12.72 73.51 1.58 12.72 68.31 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo -4.59 24.28 66.67 -6.26 24.34 67.99 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 2 3 # 2 C 182 LYS B 35 LYS.? 1000.00 C 184 LYS B 37 LYS.? 1000.00 C 345 ASP A 112 ASP~? 1000.00 coo -5.66 12.40 71.13 -2.66 9.98 66.50 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 0.95 12.72 73.51 1.58 12.72 68.31 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo -4.59 24.28 66.67 -6.26 24.34 67.99 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 1 3 # 1 D 182 LYS A 35 LYS.? 1000.00 D 184 LYS A 37 LYS.? 1000.00 D 345 ASP B 112 ASP~? 1000.00 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c35 BLL6730 PROTEIN user 2 3 # 2 D 182 LYS B 35 LYS.? 1000.00 D 184 LYS B 37 LYS.? 1000.00 D 345 ASP A 112 ASP~? 1000.00 coo 29.31 -12.29 40.88 26.50 -8.82 44.94 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 23.25 -10.73 37.68 24.08 -6.91 41.08 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 35.01 -2.71 35.14 36.51 -4.14 34.87 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c35 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c35 naa= 3 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 1 3 # 1 E 182 LYS A 35 LYS.? 1000.00 E 184 LYS A 37 LYS.? 1000.00 E 345 ASP B 112 ASP~? 1000.00 coo -21.16 62.58 121.86 -16.35 60.33 119.23 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo -23.22 55.98 120.74 -18.11 55.31 120.43 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo -17.15 59.71 133.33 -17.96 61.54 134.01 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c36 BLL6730 PROTEIN user 2 3 # 2 E 182 LYS B 35 LYS.? 1000.00 E 184 LYS B 37 LYS.? 1000.00 E 345 ASP A 112 ASP~? 1000.00 coo -21.16 62.58 121.86 -16.35 60.33 119.23 29.05 -17.38 0.57 28.07 -15.85 6.68 coo -23.22 55.98 120.74 -18.11 55.31 120.43 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo -17.15 59.71 133.33 -17.96 61.54 134.01 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c36 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c36 naa= 3 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 1 3 # 1 F 182 LYS A 12 LYS^? 1000.00 F 184 LYS A 27 LYS^? 1000.00 F 345 ASP A 94 ASP.? 1000.00 coo 10.64 34.02 91.30 6.30 35.60 95.11 17.98 11.97 -5.29 22.40 15.81 -5.00 coo 13.75 39.76 94.12 11.42 37.23 97.89 20.78 10.08 -0.17 21.23 14.77 2.36 coo 16.35 26.90 99.56 16.81 25.90 97.75 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 2 3 # 2 F 182 LYS A 35 LYS.? 1000.00 F 184 LYS A 37 LYS.? 1000.00 F 345 ASP B 112 ASP~? 1000.00 coo 10.64 34.02 91.30 6.30 35.60 95.11 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 13.75 39.76 94.12 11.42 37.23 97.89 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 16.35 26.90 99.56 16.81 25.90 97.75 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 3 3 # 3 F 182 LYS B 12 LYS^? 1000.00 F 184 LYS B 27 LYS^? 1000.00 F 345 ASP B 94 ASP.? 1000.00 coo 10.64 34.02 91.30 6.30 35.60 95.11 43.44 -2.72 -10.47 44.74 2.97 -10.70 coo 13.75 39.76 94.12 11.42 37.23 97.89 40.39 -1.34 -15.57 44.33 1.39 -18.11 coo 16.35 26.90 99.56 16.81 25.90 97.75 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 2dw7_c37 BLL6730 PROTEIN user 4 3 # 4 F 182 LYS B 35 LYS.? 1000.00 F 184 LYS B 37 LYS.? 1000.00 F 345 ASP A 112 ASP~? 1000.00 coo 10.64 34.02 91.30 6.30 35.60 95.11 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 13.75 39.76 94.12 11.42 37.23 97.89 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 16.35 26.90 99.56 16.81 25.90 97.75 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c37 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c37 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 35 LYS.? 1000.00 G 184 LYS A 37 LYS.? 1000.00 G 345 ASP B 112 ASP~? 1000.00 coo 39.68 42.04 76.11 43.42 46.43 74.96 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 36.69 47.69 78.93 39.38 50.40 75.35 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 33.43 44.37 65.47 33.10 42.30 65.37 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 2 3 # 2 G 182 LYS B 35 LYS.? 1000.00 G 184 LYS B 37 LYS.? 1000.00 G 345 ASP A 112 ASP~? 1000.00 coo 39.68 42.04 76.11 43.42 46.43 74.96 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 36.69 47.69 78.93 39.38 50.40 75.35 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 33.43 44.37 65.47 33.10 42.30 65.37 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 1 3 # 1 H 182 LYS A 35 LYS.? 1000.00 H 184 LYS A 37 LYS.? 1000.00 H 345 ASP B 112 ASP~? 1000.00 coo 71.58 83.18 80.51 66.88 79.77 79.84 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 73.65 78.64 75.66 68.14 79.07 75.04 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 67.43 90.73 71.39 68.27 92.30 72.52 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c39 BLL6730 PROTEIN user 2 3 # 2 H 182 LYS B 35 LYS.? 1000.00 H 184 LYS B 37 LYS.? 1000.00 H 345 ASP A 112 ASP~? 1000.00 coo 71.58 83.18 80.51 66.88 79.77 79.84 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 73.65 78.64 75.66 68.14 79.07 75.04 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 67.43 90.73 71.39 68.27 92.30 72.52 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c39 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c39 naa= 3 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 1 3 # 1 I 182 LYS A 35 LYS.? 1000.00 I 184 LYS A 37 LYS.? 1000.00 I 345 ASP B 112 ASP~? 1000.00 coo 60.20 96.92 42.53 57.60 93.13 38.67 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 54.31 95.46 46.01 55.34 91.59 42.65 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 66.35 87.81 48.53 68.10 89.01 48.77 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c40 BLL6730 PROTEIN user 2 3 # 2 I 182 LYS B 35 LYS.? 1000.00 I 184 LYS B 37 LYS.? 1000.00 I 345 ASP A 112 ASP~? 1000.00 coo 60.20 96.92 42.53 57.60 93.13 38.67 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 54.31 95.46 46.01 55.34 91.59 42.65 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 66.35 87.81 48.53 68.10 89.01 48.77 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c40 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c40 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 35 LYS.? 1000.00 J 184 LYS A 37 LYS.? 1000.00 J 345 ASP B 112 ASP~? 1000.00 coo 25.22 70.55 14.03 27.64 73.07 18.65 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 31.73 69.87 11.50 32.73 70.19 16.40 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 25.87 58.42 18.79 23.95 58.54 17.90 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS B 35 LYS.? 1000.00 J 184 LYS B 37 LYS.? 1000.00 J 345 ASP A 112 ASP~? 1000.00 coo 25.22 70.55 14.03 27.64 73.07 18.65 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 31.73 69.87 11.50 32.73 70.19 16.40 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 25.87 58.42 18.79 23.95 58.54 17.90 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 35 LYS.? 1000.00 K 184 LYS A 37 LYS.? 1000.00 K 345 ASP B 112 ASP~? 1000.00 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 2 3 # 2 K 182 LYS B 35 LYS.? 1000.00 K 184 LYS B 37 LYS.? 1000.00 K 345 ASP A 112 ASP~? 1000.00 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 35 LYS.? 1000.00 L 184 LYS A 37 LYS.? 1000.00 L 345 ASP A 136 ASP^? 1000.00 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS A 35 LYS.? 1000.00 L 184 LYS A 37 LYS.? 1000.00 L 345 ASP B 112 ASP~? 1000.00 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 3 3 # 3 L 182 LYS B 35 LYS.? 1000.00 L 184 LYS B 37 LYS.? 1000.00 L 345 ASP A 112 ASP~? 1000.00 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 4 3 # 4 L 182 LYS B 35 LYS.? 1000.00 L 184 LYS B 37 LYS.? 1000.00 L 345 ASP B 136 ASP^? 1000.00 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 36.67 -20.70 -10.25 38.13 -21.34 -8.89 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 35 LYS.? 1000.00 M 184 LYS A 37 LYS.? 1000.00 M 345 ASP A 136 ASP^? 1000.00 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS A 35 LYS.? 1000.00 M 184 LYS A 37 LYS.? 1000.00 M 345 ASP B 112 ASP~? 1000.00 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 3 3 # 3 M 182 LYS B 35 LYS.? 1000.00 M 184 LYS B 37 LYS.? 1000.00 M 345 ASP A 112 ASP~? 1000.00 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 29.05 -17.38 0.57 28.07 -15.85 6.68 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 4 3 # 4 M 182 LYS B 35 LYS.? 1000.00 M 184 LYS B 37 LYS.? 1000.00 M 345 ASP B 136 ASP^? 1000.00 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 29.05 -17.38 0.57 28.07 -15.85 6.68 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 36.67 -20.70 -10.25 38.13 -21.34 -8.89 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 1 3 # 1 N 182 LYS A 35 LYS.? 1000.00 N 184 LYS A 37 LYS.? 1000.00 N 345 ASP B 112 ASP~? 1000.00 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c45 BLL6730 PROTEIN user 2 3 # 2 N 182 LYS B 35 LYS.? 1000.00 N 184 LYS B 37 LYS.? 1000.00 N 345 ASP A 112 ASP~? 1000.00 coo 22.75 -28.13 87.31 18.89 -29.87 83.00 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 16.58 -26.28 90.12 15.40 -29.80 86.61 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 22.32 -38.59 93.74 24.34 -38.41 94.32 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c45 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c45 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 35 LYS.? 1000.00 O 184 LYS A 37 LYS.? 1000.00 O 345 ASP B 112 ASP~? 1000.00 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 2 3 # 2 O 182 LYS B 35 LYS.? 1000.00 O 184 LYS B 37 LYS.? 1000.00 O 345 ASP A 112 ASP~? 1000.00 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 21.33 -7.84 5.22 21.87 -9.36 6.59 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 35 LYS.? 1000.00 P 184 LYS A 37 LYS.? 1000.00 P 345 ASP A 136 ASP^? 1000.00 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 5.83 -2.85 -5.60 4.65 -1.90 -7.06 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS A 35 LYS.? 1000.00 P 184 LYS A 37 LYS.? 1000.00 P 345 ASP B 112 ASP~? 1000.00 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 12.52 -7.80 -16.36 14.38 -7.82 -22.38 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 9.87 -14.01 -18.14 9.86 -17.48 -12.85 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 3 3 # 3 P 182 LYS B 35 LYS.? 1000.00 P 184 LYS B 37 LYS.? 1000.00 P 345 ASP A 112 ASP~? 1000.00 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 4 3 # 4 P 182 LYS B 35 LYS.? 1000.00 P 184 LYS B 37 LYS.? 1000.00 P 345 ASP B 136 ASP^? 1000.00 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 29.05 -17.38 0.57 28.07 -15.85 6.68 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 24.99 -22.75 2.33 21.94 -24.42 -2.96 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 36.67 -20.70 -10.25 38.13 -21.34 -8.89 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 4 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 150 TYR A 77 TYR~? 1000.00 A 245 ASP A 83 ASP.? 1000.00 A 273 LYS A 115 LYS~? 1000.00 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 14.18 -5.59 13.28 11.48 -4.87 13.03 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 150 TYR A 85 TYR.? 1000.00 A 245 ASP A 83 ASP.? 1000.00 A 273 LYS A 80 LYS~? 1000.00 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 9.01 -5.92 4.10 9.03 -8.46 2.93 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 150 TYR B 77 TYR~? 1000.00 A 245 ASP B 83 ASP.? 1000.00 A 273 LYS B 115 LYS~? 1000.00 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 30.32 -14.90 -29.11 32.30 -16.85 -28.78 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 2gsa_c02 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 150 TYR B 85 TYR.? 1000.00 A 245 ASP B 83 ASP.? 1000.00 A 273 LYS B 80 LYS~? 1000.00 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 32.56 -19.53 -19.90 30.36 -20.72 -18.65 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 24.38 -17.04 -32.21 30.30 -17.91 -32.35 2gsa_c02 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c02 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 29 PHE^? 1000.00 A 245 ASP A 93 ASP.? 1000.00 A 273 LYS A 142 LYS.? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 17.24 5.30 -4.20 14.88 5.47 -5.67 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 17.45 11.87 -9.91 18.23 9.90 -9.96 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 3 # 2 A 157 PHE A 86 PHE^? 1000.00 A 245 ASP A 83 ASP.? 1000.00 A 273 LYS A 79 LYS~? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 3 # 3 A 157 PHE A 86 PHE^? 1000.00 A 245 ASP A 83 ASP.? 1000.00 A 273 LYS A 80 LYS~? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 3 # 4 A 157 PHE A 111 PHE.? 1000.00 A 245 ASP A 83 ASP.? 1000.00 A 273 LYS A 79 LYS~? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 18.47 -2.15 3.63 17.47 0.36 2.95 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 18.64 -10.30 17.12 18.99 -5.93 21.84 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 5 3 # 5 A 157 PHE A 111 PHE.? 1000.00 A 245 ASP A 83 ASP.? 1000.00 A 273 LYS A 80 LYS~? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 18.47 -2.15 3.63 17.47 0.36 2.95 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 15.24 -11.81 16.35 11.55 -7.20 16.52 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 6 3 # 6 A 157 PHE A 134 PHE.? 1000.00 A 245 ASP A 138 ASP^? 1000.00 A 273 LYS A 51 LYS.? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 7 3 # 7 A 157 PHE B 29 PHE^? 1000.00 A 245 ASP B 93 ASP.? 1000.00 A 273 LYS B 142 LYS.? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 38.10 -6.68 -11.49 39.46 -8.64 -10.02 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 52.98 -12.77 -6.57 54.80 -12.93 -0.57 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 8 3 # 8 A 157 PHE B 86 PHE^? 1000.00 A 245 ASP B 83 ASP.? 1000.00 A 273 LYS B 79 LYS~? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 9 3 # 9 A 157 PHE B 86 PHE^? 1000.00 A 245 ASP B 83 ASP.? 1000.00 A 273 LYS B 80 LYS~? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 10 3 # 10 A 157 PHE B 111 PHE.? 1000.00 A 245 ASP B 83 ASP.? 1000.00 A 273 LYS B 79 LYS~? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 24.00 -13.31 -32.93 27.58 -10.91 -37.69 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 11 3 # 11 A 157 PHE B 111 PHE.? 1000.00 A 245 ASP B 83 ASP.? 1000.00 A 273 LYS B 80 LYS~? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 24.38 -17.04 -32.21 30.30 -17.91 -32.35 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 12 3 # 12 A 157 PHE B 134 PHE.? 1000.00 A 245 ASP B 138 ASP^? 1000.00 A 273 LYS B 51 LYS.? 1000.00 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 39.55 -26.05 -1.63 36.69 -20.49 -2.33 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 12 hits 2gsa_c04 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 83 ASP.? 1000.00 A 35 SER A 82 SER.? 1000.00 A 215 ASP A 112 ASP~? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -13.21 66.21 45.84 -15.49 65.90 45.84 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -10.72 64.19 37.77 -12.20 64.43 39.15 21.33 -7.84 5.22 21.87 -9.36 6.59 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP A 93 ASP.? 1000.00 A 35 SER A 10 SER^? 1000.00 A 215 ASP A 94 ASP.? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 17.45 11.87 -9.91 18.23 9.90 -9.96 coo -13.21 66.21 45.84 -15.49 65.90 45.84 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -10.72 64.19 37.77 -12.20 64.43 39.15 13.93 10.69 -14.78 14.17 9.66 -16.61 ULMN 3 2jxr_c04 LIGAND CP-081282 user 3 3 # 3 A 32 ASP A 94 ASP.? 1000.00 A 35 SER A 96 SER.? 1000.00 A 215 ASP A 93 ASP.? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 13.93 10.69 -14.78 14.17 9.66 -16.61 coo -13.21 66.21 45.84 -15.49 65.90 45.84 15.19 13.19 -19.39 14.02 11.94 -21.09 coo -10.72 64.19 37.77 -12.20 64.43 39.15 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 2jxr_c04 LIGAND CP-081282 user 4 3 # 4 A 32 ASP A 94 ASP.? 1000.00 A 35 SER A 97 SER.? 1000.00 A 215 ASP A 93 ASP.? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 13.93 10.69 -14.78 14.17 9.66 -16.61 coo -13.21 66.21 45.84 -15.49 65.90 45.84 12.38 15.07 -17.61 11.81 17.40 -17.17 coo -10.72 64.19 37.77 -12.20 64.43 39.15 17.45 11.87 -9.91 18.23 9.90 -9.96 ULMN 3 2jxr_c04 LIGAND CP-081282 user 5 3 # 5 A 32 ASP B 83 ASP.? 1000.00 A 35 SER B 82 SER.? 1000.00 A 215 ASP B 112 ASP~? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -13.21 66.21 45.84 -15.49 65.90 45.84 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -10.72 64.19 37.77 -12.20 64.43 39.15 24.70 -9.86 -21.06 23.12 -10.03 -22.49 ULMN 3 2jxr_c04 LIGAND CP-081282 user 6 3 # 6 A 32 ASP B 93 ASP.? 1000.00 A 35 SER B 10 SER^? 1000.00 A 215 ASP B 94 ASP.? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo -13.21 66.21 45.84 -15.49 65.90 45.84 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -10.72 64.19 37.77 -12.20 64.43 39.15 44.37 -6.89 -0.93 43.32 -7.23 0.90 ULMN 3 2jxr_c04 LIGAND CP-081282 user 7 3 # 7 A 32 ASP B 94 ASP.? 1000.00 A 35 SER B 96 SER.? 1000.00 A 215 ASP B 93 ASP.? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -13.21 66.21 45.84 -15.49 65.90 45.84 45.87 -4.60 3.67 45.38 -6.30 5.31 coo -10.72 64.19 37.77 -12.20 64.43 39.15 43.71 -3.28 -5.83 41.61 -3.57 -5.77 ULMN 3 2jxr_c04 LIGAND CP-081282 user 8 3 # 8 A 32 ASP B 94 ASP.? 1000.00 A 35 SER B 97 SER.? 1000.00 A 215 ASP B 93 ASP.? 1000.00 coo -14.00 61.45 43.99 -14.19 63.14 42.84 44.37 -6.89 -0.93 43.32 -7.23 0.90 coo -13.21 66.21 45.84 -15.49 65.90 45.84 48.92 -6.09 1.92 51.23 -5.46 1.48 coo -10.72 64.19 37.77 -12.20 64.43 39.15 43.71 -3.28 -5.83 41.61 -3.57 -5.77 2jxr_c04 source 2jxr LIGAND CP-081282 : 8 hits 2jxr_c04 naa= 3 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 A 177 PHE A 63 PHE^? 1000.00 A 263 ASP A 120 ASP.? 1000.00 A 292 LYS A 69 LYS~? 1000.00 coo 51.51 50.32 16.39 52.13 49.68 13.75 21.53 4.57 4.68 19.76 2.41 4.33 coo 54.43 44.82 23.74 55.21 45.06 21.80 27.77 3.65 13.30 28.81 5.07 14.48 coo 63.95 45.30 16.71 59.11 49.15 16.05 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 A 177 PHE A 86 PHE^? 1000.00 A 263 ASP A 83 ASP.? 1000.00 A 292 LYS A 115 LYS~? 1000.00 coo 51.51 50.32 16.39 52.13 49.68 13.75 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 54.43 44.82 23.74 55.21 45.06 21.80 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 63.95 45.30 16.71 59.11 49.15 16.05 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 A 177 PHE A 132 PHE^? 1000.00 A 263 ASP A 83 ASP.? 1000.00 A 292 LYS A 115 LYS~? 1000.00 coo 51.51 50.32 16.39 52.13 49.68 13.75 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 54.43 44.82 23.74 55.21 45.06 21.80 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 63.95 45.30 16.71 59.11 49.15 16.05 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 A 177 PHE B 63 PHE^? 1000.00 A 263 ASP B 120 ASP.? 1000.00 A 292 LYS B 69 LYS~? 1000.00 coo 51.51 50.32 16.39 52.13 49.68 13.75 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 54.43 44.82 23.74 55.21 45.06 21.80 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 63.95 45.30 16.71 59.11 49.15 16.05 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 A 177 PHE B 70 PHE~? 1000.00 A 263 ASP B 120 ASP.? 1000.00 A 292 LYS B 115 LYS~? 1000.00 coo 51.51 50.32 16.39 52.13 49.68 13.75 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo 54.43 44.82 23.74 55.21 45.06 21.80 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 63.95 45.30 16.71 59.11 49.15 16.05 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 A 177 PHE B 86 PHE^? 1000.00 A 263 ASP B 83 ASP.? 1000.00 A 292 LYS B 115 LYS~? 1000.00 coo 51.51 50.32 16.39 52.13 49.68 13.75 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 54.43 44.82 23.74 55.21 45.06 21.80 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 63.95 45.30 16.71 59.11 49.15 16.05 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 2oat_c03 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 A 177 PHE B 132 PHE^? 1000.00 A 263 ASP B 83 ASP.? 1000.00 A 292 LYS B 115 LYS~? 1000.00 coo 51.51 50.32 16.39 52.13 49.68 13.75 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 54.43 44.82 23.74 55.21 45.06 21.80 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 63.95 45.30 16.71 59.11 49.15 16.05 25.77 -5.51 -22.92 25.67 -7.99 -17.65 2oat_c03 source 2oat ORNITHINE AMINOTRANSFERASE : 7 hits 2oat_c03 naa= 3 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 B 177 PHE A 63 PHE^? 1000.00 B 263 ASP A 120 ASP.? 1000.00 B 292 LYS A 69 LYS~? 1000.00 coo 49.99 26.05 6.28 51.46 26.87 8.49 21.53 4.57 4.68 19.76 2.41 4.33 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 27.77 3.65 13.30 28.81 5.07 14.48 coo 60.53 31.67 0.97 57.79 27.51 3.63 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 B 177 PHE A 70 PHE~? 1000.00 B 263 ASP A 120 ASP.? 1000.00 B 292 LYS A 115 LYS~? 1000.00 coo 49.99 26.05 6.28 51.46 26.87 8.49 17.83 3.19 11.63 17.23 1.65 9.39 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 27.77 3.65 13.30 28.81 5.07 14.48 coo 60.53 31.67 0.97 57.79 27.51 3.63 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 B 177 PHE A 86 PHE^? 1000.00 B 263 ASP A 83 ASP.? 1000.00 B 292 LYS A 115 LYS~? 1000.00 coo 49.99 26.05 6.28 51.46 26.87 8.49 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 60.53 31.67 0.97 57.79 27.51 3.63 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 B 177 PHE A 132 PHE^? 1000.00 B 263 ASP A 83 ASP.? 1000.00 B 292 LYS A 115 LYS~? 1000.00 coo 49.99 26.05 6.28 51.46 26.87 8.49 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 60.53 31.67 0.97 57.79 27.51 3.63 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 B 177 PHE B 63 PHE^? 1000.00 B 263 ASP B 120 ASP.? 1000.00 B 292 LYS B 69 LYS~? 1000.00 coo 49.99 26.05 6.28 51.46 26.87 8.49 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 60.53 31.67 0.97 57.79 27.51 3.63 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 B 177 PHE B 70 PHE~? 1000.00 B 263 ASP B 120 ASP.? 1000.00 B 292 LYS B 115 LYS~? 1000.00 coo 49.99 26.05 6.28 51.46 26.87 8.49 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 60.53 31.67 0.97 57.79 27.51 3.63 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 B 177 PHE B 86 PHE^? 1000.00 B 263 ASP B 83 ASP.? 1000.00 B 292 LYS B 115 LYS~? 1000.00 coo 49.99 26.05 6.28 51.46 26.87 8.49 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 60.53 31.67 0.97 57.79 27.51 3.63 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 2oat_c04 ORNITHINE AMINOTRANSFERASE user 8 3 # 8 B 177 PHE B 132 PHE^? 1000.00 B 263 ASP B 83 ASP.? 1000.00 B 292 LYS B 115 LYS~? 1000.00 coo 49.99 26.05 6.28 51.46 26.87 8.49 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 49.07 31.32 -1.50 50.64 31.29 -0.07 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 60.53 31.67 0.97 57.79 27.51 3.63 25.77 -5.51 -22.92 25.67 -7.99 -17.65 2oat_c04 source 2oat ORNITHINE AMINOTRANSFERASE : 8 hits 2oat_c04 naa= 3 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 1 3 # 1 C 177 PHE A 63 PHE^? 1000.00 C 263 ASP A 120 ASP.? 1000.00 C 292 LYS A 69 LYS~? 1000.00 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 21.53 4.57 4.68 19.76 2.41 4.33 coo 19.84 12.02 9.33 18.68 11.23 7.75 27.77 3.65 13.30 28.81 5.07 14.48 coo 12.82 3.49 4.98 17.80 5.59 1.90 18.32 4.85 17.59 15.93 10.57 18.20 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 2 3 # 2 C 177 PHE A 86 PHE^? 1000.00 C 263 ASP A 83 ASP.? 1000.00 C 292 LYS A 115 LYS~? 1000.00 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 13.17 -0.51 5.96 15.04 -2.13 7.30 coo 19.84 12.02 9.33 18.68 11.23 7.75 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 12.82 3.49 4.98 17.80 5.59 1.90 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 3 3 # 3 C 177 PHE A 132 PHE^? 1000.00 C 263 ASP A 83 ASP.? 1000.00 C 292 LYS A 115 LYS~? 1000.00 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo 19.84 12.02 9.33 18.68 11.23 7.75 15.31 -8.59 6.79 17.37 -9.02 6.98 coo 12.82 3.49 4.98 17.80 5.59 1.90 24.53 -4.83 7.12 22.37 -6.02 1.89 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 4 3 # 4 C 177 PHE B 63 PHE^? 1000.00 C 263 ASP B 120 ASP.? 1000.00 C 292 LYS B 69 LYS~? 1000.00 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo 19.84 12.02 9.33 18.68 11.23 7.75 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 12.82 3.49 4.98 17.80 5.59 1.90 37.28 -6.07 -33.35 43.44 -5.38 -33.89 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 5 3 # 5 C 177 PHE B 70 PHE~? 1000.00 C 263 ASP B 120 ASP.? 1000.00 C 292 LYS B 115 LYS~? 1000.00 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo 19.84 12.02 9.33 18.68 11.23 7.75 31.54 1.53 -29.08 32.29 3.12 -30.27 coo 12.82 3.49 4.98 17.80 5.59 1.90 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 6 3 # 6 C 177 PHE B 86 PHE^? 1000.00 C 263 ASP B 83 ASP.? 1000.00 C 292 LYS B 115 LYS~? 1000.00 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo 19.84 12.02 9.33 18.68 11.23 7.75 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 12.82 3.49 4.98 17.80 5.59 1.90 25.77 -5.51 -22.92 25.67 -7.99 -17.65 ULMN 3 2oat_c05 ORNITHINE AMINOTRANSFERASE user 7 3 # 7 C 177 PHE B 132 PHE^? 1000.00 C 263 ASP B 83 ASP.? 1000.00 C 292 LYS B 115 LYS~? 1000.00 coo 21.96 11.84 -0.03 20.04 11.74 -2.01 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo 19.84 12.02 9.33 18.68 11.23 7.75 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo 12.82 3.49 4.98 17.80 5.59 1.90 25.77 -5.51 -22.92 25.67 -7.99 -17.65 2oat_c05 source 2oat ORNITHINE AMINOTRANSFERASE : 7 hits 2oat_c05 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 83 ASP.? 1000.00 166 GLY A 54 GLY.? 1000.00 169 GLU A 39 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 15.31 -8.59 6.79 17.37 -9.02 6.98 coo -8.58 13.22 3.21 -8.90 13.15 4.05 4.96 -6.64 -9.65 4.76 -5.85 -9.47 coo -16.67 7.89 2.78 -17.65 6.56 1.49 5.68 -8.26 -17.17 3.79 -8.95 -16.50 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 93 ASP.? 1000.00 166 GLY A 44 GLY.? 1000.00 169 GLU A 39 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 17.45 11.87 -9.91 18.23 9.90 -9.96 coo -8.58 13.22 3.21 -8.90 13.15 4.05 7.31 1.50 -18.78 6.96 1.14 -18.13 coo -16.67 7.89 2.78 -17.65 6.56 1.49 5.68 -8.26 -17.17 3.79 -8.95 -16.50 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP B 83 ASP.? 1000.00 166 GLY B 54 GLY.? 1000.00 169 GLU B 39 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 27.06 -15.40 -22.59 25.67 -13.84 -22.77 coo -8.58 13.22 3.21 -8.90 13.15 4.05 33.94 -23.32 -6.01 34.72 -23.13 -6.23 coo -16.67 7.89 2.78 -17.65 6.56 1.49 32.13 -23.52 1.49 32.40 -25.50 0.81 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP B 93 ASP.? 1000.00 166 GLY B 44 GLY.? 1000.00 169 GLU B 39 GLU.? 1000.00 coo 8.28 6.87 1.62 10.08 5.77 1.34 43.71 -3.28 -5.83 41.61 -3.57 -5.77 coo -8.58 13.22 3.21 -8.90 13.15 4.05 39.64 -17.27 3.09 39.51 -17.75 2.42 coo -16.67 7.89 2.78 -17.65 6.56 1.49 32.13 -23.52 1.49 32.40 -25.50 0.81 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 4 hits 2tdt_c00 naa= 3 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 1 3 # 1 A 122 TYR A 85 TYR.? 1000.00 A 214 ASP A 136 ASP^? 1000.00 A 256 LYS A 35 LYS.? 1000.00 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 9.01 -5.92 4.10 9.03 -8.46 2.93 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 2tpl_c04 TYROSINE PHENOL-LYASE user 2 3 # 2 A 122 TYR B 85 TYR.? 1000.00 A 214 ASP B 136 ASP^? 1000.00 A 256 LYS B 35 LYS.? 1000.00 coo -36.51 -15.34 5.35 -36.90 -16.76 7.69 32.56 -19.53 -19.90 30.36 -20.72 -18.65 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo -18.13 -8.46 4.26 -20.75 -6.32 9.36 29.05 -17.38 0.57 28.07 -15.85 6.68 2tpl_c04 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c04 naa= 3 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 1 3 # 1 B 122 TYR A 85 TYR.? 1000.00 B 214 ASP A 136 ASP^? 1000.00 B 256 LYS A 35 LYS.? 1000.00 coo -32.67 22.74 10.17 -32.85 23.98 7.70 9.01 -5.92 4.10 9.03 -8.46 2.93 coo -26.88 17.61 16.89 -26.08 17.11 15.00 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo -16.04 12.06 11.09 -17.97 10.54 5.71 12.52 -7.80 -16.36 14.38 -7.82 -22.38 ULMN 3 2tpl_c05 TYROSINE PHENOL-LYASE user 2 3 # 2 B 122 TYR B 85 TYR.? 1000.00 B 214 ASP B 136 ASP^? 1000.00 B 256 LYS B 35 LYS.? 1000.00 coo -32.67 22.74 10.17 -32.85 23.98 7.70 32.56 -19.53 -19.90 30.36 -20.72 -18.65 coo -26.88 17.61 16.89 -26.08 17.11 15.00 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo -16.04 12.06 11.09 -17.97 10.54 5.71 29.05 -17.38 0.57 28.07 -15.85 6.68 2tpl_c05 source 2tpl TYROSINE PHENOL-LYASE : 2 hits 2tpl_c05 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG A 45 ARG.? 1000.00 A 130 SER A 38 SER.? 1000.00 A 159 LYS A 51 LYS.? 1000.00 coo 18.35 45.84 20.99 16.20 47.83 21.89 2.50 -2.41 -19.58 3.25 -4.86 -17.92 coo 15.14 43.67 10.77 15.61 44.43 13.04 6.50 -13.37 -19.74 5.14 -14.76 -18.29 coo 11.57 48.49 22.18 13.51 49.99 17.21 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 A 59 ARG B 45 ARG.? 1000.00 A 130 SER B 38 SER.? 1000.00 A 159 LYS B 51 LYS.? 1000.00 coo 18.35 45.84 20.99 16.20 47.83 21.89 38.71 -23.35 3.90 36.31 -24.00 2.16 coo 15.14 43.67 10.77 15.61 44.43 13.04 27.23 -25.34 3.98 26.79 -27.24 2.57 coo 11.57 48.49 22.18 13.51 49.99 17.21 39.55 -26.05 -1.63 36.69 -20.49 -2.33 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 45 ARG.? 1000.00 B 130 SER A 38 SER.? 1000.00 B 159 LYS A 51 LYS.? 1000.00 coo 58.72 31.58 20.45 60.80 29.39 20.94 2.50 -2.41 -19.58 3.25 -4.86 -17.92 coo 61.66 35.17 10.39 61.29 34.14 12.56 6.50 -13.37 -19.74 5.14 -14.76 -18.29 coo 65.38 28.77 21.17 63.49 28.03 16.12 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG A 99 ARG.? 1000.00 B 130 SER A 96 SER.? 1000.00 B 159 LYS A 142 LYS.? 1000.00 coo 58.72 31.58 20.45 60.80 29.39 20.94 5.95 12.14 -17.18 5.36 9.78 -15.32 coo 61.66 35.17 10.39 61.29 34.14 12.56 15.19 13.19 -19.39 14.02 11.94 -21.09 coo 65.38 28.77 21.17 63.49 28.03 16.12 4.61 15.20 -9.08 3.33 16.81 -15.04 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 3 3 # 3 B 59 ARG B 45 ARG.? 1000.00 B 130 SER B 38 SER.? 1000.00 B 159 LYS B 51 LYS.? 1000.00 coo 58.72 31.58 20.45 60.80 29.39 20.94 38.71 -23.35 3.90 36.31 -24.00 2.16 coo 61.66 35.17 10.39 61.29 34.14 12.56 27.23 -25.34 3.98 26.79 -27.24 2.57 coo 65.38 28.77 21.17 63.49 28.03 16.12 39.55 -26.05 -1.63 36.69 -20.49 -2.33 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 4 3 # 4 B 59 ARG B 99 ARG.? 1000.00 B 130 SER B 96 SER.? 1000.00 B 159 LYS B 142 LYS.? 1000.00 coo 58.72 31.58 20.45 60.80 29.39 20.94 49.60 -13.15 1.51 47.85 -14.88 -0.33 coo 61.66 35.17 10.39 61.29 34.14 12.56 45.87 -4.60 3.67 45.38 -6.30 5.31 coo 65.38 28.77 21.17 63.49 28.03 16.12 52.98 -12.77 -6.57 54.80 -12.93 -0.57 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 4 hits 2tps_c01 naa= 3 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 1 3 # 1 A 81 ASP A 136 ASP^? 1000.00 A 99 GLY A 54 GLY.? 1000.00 A 125 ASN A 56 ASN.? 1000.00 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 4.96 -6.64 -9.65 4.76 -5.85 -9.47 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 9.46 -7.73 -7.73 9.95 -8.79 -9.49 ULMN 3 1hkd_p00 PEA LECTIN ALPHA CHAIN user 2 3 # 2 A 81 ASP B 136 ASP^? 1000.00 A 99 GLY B 54 GLY.? 1000.00 A 125 ASN B 56 ASN.? 1000.00 coo -12.71 41.15 -12.81 -13.46 42.96 -13.57 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo -9.98 44.30 -14.04 -9.74 44.63 -13.34 33.94 -23.32 -6.01 34.72 -23.13 -6.23 coo -9.28 44.56 -19.45 -10.46 44.31 -17.70 30.64 -19.94 -7.98 29.63 -20.11 -6.12 1hkd_p00 source 1hkd PEA LECTIN ALPHA CHAIN : 2 hits 1hkd_p00 naa= 3 ULMN 3 1k12_p00 LECTIN user 1 3 # 1 A 52 HIS A 50 HIS.? 1000.00 A 79 ARG A 46 ARG.? 1000.00 A 86 ARG A 45 ARG.? 1000.00 coo -5.53 26.98 5.69 -5.98 25.70 4.09 -4.24 -1.10 -13.74 -5.24 -2.70 -12.82 coo -12.15 26.35 6.05 -10.94 27.19 3.35 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo -9.59 20.48 4.28 -9.21 22.28 1.82 2.50 -2.41 -19.58 3.25 -4.86 -17.92 ULMN 3 1k12_p00 LECTIN user 2 3 # 2 A 52 HIS B 50 HIS.? 1000.00 A 79 ARG B 46 ARG.? 1000.00 A 86 ARG B 45 ARG.? 1000.00 coo -5.53 26.98 5.69 -5.98 25.70 4.09 43.22 -28.55 -1.93 42.31 -30.23 -2.82 coo -12.15 26.35 6.05 -10.94 27.19 3.35 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo -9.59 20.48 4.28 -9.21 22.28 1.82 38.71 -23.35 3.90 36.31 -24.00 2.16 1k12_p00 source 1k12 LECTIN : 2 hits 1k12_p00 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 7 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 15.46 -2.00 -17.47 13.38 -2.28 -17.08 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 32 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 17.67 -2.87 -11.10 19.38 -1.89 -11.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN A 36 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 11.74 -12.02 -14.51 13.26 -13.51 -14.29 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN A 41 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 7.58 -2.60 -21.46 8.69 -1.00 -20.65 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 5 1 # 5 A 461 ASN A 56 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 9.46 -7.73 -7.73 9.95 -8.79 -9.49 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 6 1 # 6 A 461 ASN A 110 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 13.67 -5.78 2.51 14.50 -7.33 3.70 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 7 1 # 7 A 461 ASN B 7 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 32.60 -11.94 1.66 33.39 -13.87 1.25 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 8 1 # 8 A 461 ASN B 32 ASN^? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 30.82 -10.44 -4.63 30.86 -8.45 -3.90 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 9 1 # 9 A 461 ASN B 36 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 25.75 -20.13 -1.28 23.68 -19.64 -1.46 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 10 1 # 10 A 461 ASN B 41 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 35.99 -19.04 5.71 36.86 -17.29 4.87 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 11 1 # 11 A 461 ASN B 56 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 30.64 -19.94 -7.98 29.63 -20.11 -6.12 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 12 1 # 12 A 461 ASN B 110 ASN.? 1000.00 coo 5.80 63.03 55.85 5.52 65.03 56.45 30.35 -15.39 -18.19 28.64 -15.51 -19.45 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 12 hits 1kbk_p00 naa= 1 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 1 3 # 1 A 56 TYR A 107 TYR^? 1000.00 A 112 PHE A 134 PHE.? 1000.00 A 140 ASN A 56 ASN.? 1000.00 coo -6.29 44.15 17.65 -9.00 44.92 17.68 5.16 0.23 -2.44 3.66 2.42 -3.25 coo -7.38 52.77 16.75 -5.54 52.71 18.82 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo -4.46 50.64 12.29 -5.69 49.89 13.85 9.46 -7.73 -7.73 9.95 -8.79 -9.49 ULMN 3 1o8s_p00 PUTATIVE ENDO-XYLANASE user 2 3 # 2 A 56 TYR B 107 TYR^? 1000.00 A 112 PHE B 134 PHE.? 1000.00 A 140 ASN B 56 ASN.? 1000.00 coo -6.29 44.15 17.65 -9.00 44.92 17.68 39.72 -19.76 -13.26 42.39 -19.94 -12.49 coo -7.38 52.77 16.75 -5.54 52.71 18.82 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo -4.46 50.64 12.29 -5.69 49.89 13.85 30.64 -19.94 -7.98 29.63 -20.11 -6.12 1o8s_p00 source 1o8s PUTATIVE ENDO-XYLANASE : 2 hits 1o8s_p00 naa= 3 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 1 3 # 1 A 270 ASN A 56 ASN.? 1000.00 A 384 ASN B 56 ASN.? 1000.00 A 385 GLU B 34 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 9.46 -7.73 -7.73 9.95 -8.79 -9.49 coo 7.06 50.07 96.17 8.50 48.54 96.31 30.64 -19.94 -7.98 29.63 -20.11 -6.12 coo 11.59 49.83 99.41 10.92 47.97 100.16 27.06 -17.01 -3.24 26.01 -18.46 -4.35 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 2 3 # 2 A 270 ASN A 110 ASN.? 1000.00 A 384 ASN A 41 ASN.? 1000.00 A 385 GLU A 39 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 13.67 -5.78 2.51 14.50 -7.33 3.70 coo 7.06 50.07 96.17 8.50 48.54 96.31 7.58 -2.60 -21.46 8.69 -1.00 -20.65 coo 11.59 49.83 99.41 10.92 47.97 100.16 5.68 -8.26 -17.17 3.79 -8.95 -16.50 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 3 3 # 3 A 270 ASN B 41 ASN.? 1000.00 A 384 ASN B 110 ASN.? 1000.00 A 385 GLU B 135 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 35.99 -19.04 5.71 36.86 -17.29 4.87 coo 7.06 50.07 96.17 8.50 48.54 96.31 30.35 -15.39 -18.19 28.64 -15.51 -19.45 coo 11.59 49.83 99.41 10.92 47.97 100.16 31.07 -20.83 -12.95 29.80 -19.16 -13.24 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 4 3 # 4 A 270 ASN B 56 ASN.? 1000.00 A 384 ASN A 56 ASN.? 1000.00 A 385 GLU A 34 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 30.64 -19.94 -7.98 29.63 -20.11 -6.12 coo 7.06 50.07 96.17 8.50 48.54 96.31 9.46 -7.73 -7.73 9.95 -8.79 -9.49 coo 11.59 49.83 99.41 10.92 47.97 100.16 13.80 -9.32 -12.57 13.04 -10.94 -11.47 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 5 3 # 5 A 270 ASN B 110 ASN.? 1000.00 A 384 ASN A 56 ASN.? 1000.00 A 385 GLU A 34 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 30.35 -15.39 -18.19 28.64 -15.51 -19.45 coo 7.06 50.07 96.17 8.50 48.54 96.31 9.46 -7.73 -7.73 9.95 -8.79 -9.49 coo 11.59 49.83 99.41 10.92 47.97 100.16 13.80 -9.32 -12.57 13.04 -10.94 -11.47 ULMN 3 2v3r_p00 EXOGLUCANASE 1 user 6 3 # 6 A 270 ASN B 110 ASN.? 1000.00 A 384 ASN B 41 ASN.? 1000.00 A 385 GLU B 39 GLU.? 1000.00 coo 22.28 63.17 110.61 22.47 65.06 111.53 30.35 -15.39 -18.19 28.64 -15.51 -19.45 coo 7.06 50.07 96.17 8.50 48.54 96.31 35.99 -19.04 5.71 36.86 -17.29 4.87 coo 11.59 49.83 99.41 10.92 47.97 100.16 32.13 -23.52 1.49 32.40 -25.50 0.81 2v3r_p00 source 2v3r EXOGLUCANASE 1 : 6 hits 2v3r_p00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 142 LYS.? 1000.00 D 25 THR A 101 THR.? 1000.00 D 27 SER A 97 SER.? 1000.00 coo 86.60 33.38 44.00 87.05 39.52 42.71 4.61 15.20 -9.08 3.33 16.81 -15.04 coo 81.20 31.58 48.03 79.23 32.24 47.54 9.95 15.91 -11.11 11.74 16.64 -10.15 coo 79.09 29.82 54.20 77.17 28.90 53.05 12.38 15.07 -17.61 11.81 17.40 -17.17 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS B 142 LYS.? 1000.00 D 25 THR B 101 THR.? 1000.00 D 27 SER B 97 SER.? 1000.00 coo 86.60 33.38 44.00 87.05 39.52 42.71 52.98 -12.77 -6.57 54.80 -12.93 -0.57 coo 81.20 31.58 48.03 79.23 32.24 47.54 50.90 -7.81 -4.56 50.59 -5.90 -5.50 coo 79.09 29.82 54.20 77.17 28.90 53.05 48.92 -6.09 1.92 51.23 -5.46 1.48 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 2 hits 1mjo_d00 naa= 3 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 563 LYS A 12 LYS^? 1000.00 A 564 VAL A 91 VAL^? 1000.00 A 568 ARG A 103 ARG^? 1000.00 coo -6.60 80.79 55.64 -8.55 79.48 61.01 17.98 11.97 -5.29 22.40 15.81 -5.00 coo -9.25 78.14 55.31 -11.11 77.94 56.39 12.52 12.32 -5.20 12.58 14.51 -5.05 coo -12.31 74.86 52.32 -13.99 74.91 54.92 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 1r4i_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 563 LYS B 12 LYS^? 1000.00 A 564 VAL B 91 VAL^? 1000.00 A 568 ARG B 103 ARG^? 1000.00 coo -6.60 80.79 55.64 -8.55 79.48 61.01 43.44 -2.72 -10.47 44.74 2.97 -10.70 coo -9.25 78.14 55.31 -11.11 77.94 56.39 46.47 -7.31 -10.51 48.30 -6.16 -10.65 coo -12.31 74.86 52.32 -13.99 74.91 54.92 48.22 -11.67 -13.43 49.99 -12.22 -15.85 1r4i_d00 source 1r4i TRANSCRIPTION/DNA : 2 hits 1r4i_d00 naa= 3 ULMN 4 1r4o_d00 TRANSCRIPTION/DNA user 1 4 # 1 A 461 LYS A 12 LYS^? 1000.00 A 462 VAL A 91 VAL^? 1000.00 A 466 ARG A 103 ARG^? 1000.00 A 511 LYS A 65 LYS.? 1000.00 coo -5.66 13.16 26.70 -4.75 8.81 29.44 17.98 11.97 -5.29 22.40 15.81 -5.00 coo -4.44 10.22 24.56 -5.83 8.69 23.87 12.52 12.32 -5.20 12.58 14.51 -5.05 coo -1.96 7.90 20.67 -4.06 5.76 20.87 7.99 11.60 -2.28 6.58 12.81 0.15 coo -3.55 13.28 40.04 -1.35 8.66 38.23 23.08 10.16 8.29 20.19 14.81 10.58 ULMN 4 1r4o_d00 TRANSCRIPTION/DNA user 2 4 # 2 A 461 LYS B 12 LYS^? 1000.00 A 462 VAL B 91 VAL^? 1000.00 A 466 ARG B 103 ARG^? 1000.00 A 511 LYS B 65 LYS.? 1000.00 coo -5.66 13.16 26.70 -4.75 8.81 29.44 43.44 -2.72 -10.47 44.74 2.97 -10.70 coo -4.44 10.22 24.56 -5.83 8.69 23.87 46.47 -7.31 -10.51 48.30 -6.16 -10.65 coo -1.96 7.90 20.67 -4.06 5.76 20.87 48.22 -11.67 -13.43 49.99 -12.22 -15.85 coo -3.55 13.28 40.04 -1.35 8.66 38.23 39.44 0.72 -24.06 44.98 0.54 -26.26 1r4o_d00 source 1r4o TRANSCRIPTION/DNA : 2 hits 1r4o_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 10 SER^? 1000.00 E 5 VAL A 91 VAL^? 1000.00 E 7 ARG A 103 ARG^? 1000.00 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 12.52 12.32 -5.20 12.58 14.51 -5.05 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 10 SER^? 1000.00 E 5 VAL A 104 VAL^? 1000.00 E 7 ARG A 103 ARG^? 1000.00 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 9.22 7.70 -6.17 10.68 7.19 -7.65 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER A 38 SER.? 1000.00 E 5 VAL A 40 VAL.? 1000.00 E 7 ARG A 45 ARG.? 1000.00 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 6.50 -13.37 -19.74 5.14 -14.76 -18.29 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 6.91 -7.18 -22.18 5.67 -5.72 -23.24 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 2.50 -2.41 -19.58 3.25 -4.86 -17.92 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER B 10 SER^? 1000.00 E 5 VAL B 91 VAL^? 1000.00 E 7 ARG B 103 ARG^? 1000.00 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 46.47 -7.31 -10.51 48.30 -6.16 -10.65 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER B 10 SER^? 1000.00 E 5 VAL B 104 VAL^? 1000.00 E 7 ARG B 103 ARG^? 1000.00 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 44.21 -12.50 -9.58 43.02 -11.47 -8.14 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 48.22 -11.67 -13.43 49.99 -12.22 -15.85 ULMN 3 2bsq_d00 TRANSCRIPTION user 6 3 # 6 E 3 SER B 38 SER.? 1000.00 E 5 VAL B 40 VAL.? 1000.00 E 7 ARG B 45 ARG.? 1000.00 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 27.23 -25.34 3.98 26.79 -27.24 2.57 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 32.35 -21.92 6.45 34.21 -22.24 7.50 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 38.71 -23.35 3.90 36.31 -24.00 2.16 2bsq_d00 source 2bsq TRANSCRIPTION : 6 hits 2bsq_d00 naa= 3 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 1 3 # 1 A 24 ARG A 46 ARG.? 1000.00 A 32 LYS A 51 LYS.? 1000.00 A 46 ARG A 99 ARG.? 1000.00 coo -8.00 4.27 27.74 -7.09 2.66 30.09 3.33 -0.08 -11.42 3.38 -1.44 -8.63 coo -5.15 8.65 26.69 -4.26 5.48 32.02 -0.27 -3.03 -14.04 6.01 -2.72 -13.36 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 5.95 12.14 -17.18 5.36 9.78 -15.32 ULMN 3 2ky8_d00 TRANSCRIPTION/DNA user 2 3 # 2 A 24 ARG B 46 ARG.? 1000.00 A 32 LYS B 51 LYS.? 1000.00 A 46 ARG B 99 ARG.? 1000.00 coo -8.00 4.27 27.74 -7.09 2.66 30.09 40.40 -21.43 -4.30 39.16 -22.01 -7.08 coo -5.15 8.65 26.69 -4.26 5.48 32.02 39.55 -26.05 -1.63 36.69 -20.49 -2.33 coo -0.17 -5.20 27.14 -1.15 -5.34 29.97 49.60 -13.15 1.51 47.85 -14.88 -0.33 2ky8_d00 source 2ky8 TRANSCRIPTION/DNA : 2 hits 2ky8_d00 naa= 3 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 1 3 # 1 B 442 LYS A 12 LYS^? 1000.00 B 443 VAL A 91 VAL^? 1000.00 B 447 ARG A 103 ARG^? 1000.00 coo -11.49 8.72 29.13 -11.20 3.78 25.16 17.98 11.97 -5.29 22.40 15.81 -5.00 coo -11.96 6.22 31.96 -10.74 4.61 32.81 12.52 12.32 -5.20 12.58 14.51 -5.05 coo -14.58 4.58 36.41 -12.11 2.82 36.84 7.99 11.60 -2.28 6.58 12.81 0.15 ULMN 3 4hn5_d00 TRANSCRIPTION/DNA user 2 3 # 2 B 442 LYS B 12 LYS^? 1000.00 B 443 VAL B 91 VAL^? 1000.00 B 447 ARG B 103 ARG^? 1000.00 coo -11.49 8.72 29.13 -11.20 3.78 25.16 43.44 -2.72 -10.47 44.74 2.97 -10.70 coo -11.96 6.22 31.96 -10.74 4.61 32.81 46.47 -7.31 -10.51 48.30 -6.16 -10.65 coo -14.58 4.58 36.41 -12.11 2.82 36.84 48.22 -11.67 -13.43 49.99 -12.22 -15.85 4hn5_d00 source 4hn5 TRANSCRIPTION/DNA : 2 hits 4hn5_d00 naa= 3 ULMN 3 2odj_o00 PORIN D user 1 3 # 1 A 156 HIS A 50 HIS.? 1000.00 A 208 ASP A 136 ASP^? 1000.00 A 296 SER A 97 SER.? 1000.00 coo 12.72 17.48 24.71 12.80 19.37 23.81 -4.24 -1.10 -13.74 -5.24 -2.70 -12.82 coo 18.47 29.19 29.68 19.30 29.17 27.75 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 6.89 17.22 46.63 5.08 16.21 47.91 12.38 15.07 -17.61 11.81 17.40 -17.17 ULMN 3 2odj_o00 PORIN D user 2 3 # 2 A 156 HIS B 50 HIS.? 1000.00 A 208 ASP B 136 ASP^? 1000.00 A 296 SER B 97 SER.? 1000.00 coo 12.72 17.48 24.71 12.80 19.37 23.81 43.22 -28.55 -1.93 42.31 -30.23 -2.82 coo 18.47 29.19 29.68 19.30 29.17 27.75 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 6.89 17.22 46.63 5.08 16.21 47.91 48.92 -6.09 1.92 51.23 -5.46 1.48 2odj_o00 source 2ODJ PORIN D : 2 hits 2odj_o00 naa= 3 ULMN 3 2odj_o01 PORIN D user 1 3 # 1 B 156 HIS A 50 HIS.? 1000.00 B 208 ASP A 136 ASP^? 1000.00 B 296 SER A 96 SER.? 1000.00 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -4.24 -1.10 -13.74 -5.24 -2.70 -12.82 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 15.19 13.19 -19.39 14.02 11.94 -21.09 ULMN 3 2odj_o01 PORIN D user 2 3 # 2 B 156 HIS A 50 HIS.? 1000.00 B 208 ASP A 136 ASP^? 1000.00 B 296 SER A 97 SER.? 1000.00 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 -4.24 -1.10 -13.74 -5.24 -2.70 -12.82 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 12.38 15.07 -17.61 11.81 17.40 -17.17 ULMN 3 2odj_o01 PORIN D user 3 3 # 3 B 156 HIS B 50 HIS.? 1000.00 B 208 ASP B 136 ASP^? 1000.00 B 296 SER B 96 SER.? 1000.00 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 43.22 -28.55 -1.93 42.31 -30.23 -2.82 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 45.87 -4.60 3.67 45.38 -6.30 5.31 ULMN 3 2odj_o01 PORIN D user 4 3 # 4 B 156 HIS B 50 HIS.? 1000.00 B 208 ASP B 136 ASP^? 1000.00 B 296 SER B 97 SER.? 1000.00 coo -2.35 -7.60 76.02 -1.45 -9.49 76.24 43.22 -28.55 -1.93 42.31 -30.23 -2.82 coo -7.90 -19.74 71.88 -5.88 -19.94 71.25 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo -24.72 -6.64 81.21 -24.66 -4.26 81.67 48.92 -6.09 1.92 51.23 -5.46 1.48 2odj_o01 source 2ODJ PORIN D : 4 hits 2odj_o01 naa= 3 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 1 3 # 1 A 130 SER A 10 SER^? 1000.00 A 166 PHE A 132 PHE^? 1000.00 A 182 PHE A 63 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -36.62 39.62 84.60 -38.76 41.24 85.25 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -36.55 45.66 79.22 -38.34 43.94 80.53 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 2 3 # 2 A 130 SER A 82 SER.? 1000.00 A 166 PHE A 86 PHE^? 1000.00 A 182 PHE A 70 PHE~? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -36.62 39.62 84.60 -38.76 41.24 85.25 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -36.55 45.66 79.22 -38.34 43.94 80.53 17.83 3.19 11.63 17.23 1.65 9.39 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 3 3 # 3 A 130 SER A 82 SER.? 1000.00 A 166 PHE A 111 PHE.? 1000.00 A 182 PHE A 70 PHE~? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -36.62 39.62 84.60 -38.76 41.24 85.25 18.47 -2.15 3.63 17.47 0.36 2.95 coo -36.55 45.66 79.22 -38.34 43.94 80.53 17.83 3.19 11.63 17.23 1.65 9.39 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 4 3 # 4 A 130 SER A 113 SER~? 1000.00 A 166 PHE A 63 PHE^? 1000.00 A 182 PHE A 132 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -36.62 39.62 84.60 -38.76 41.24 85.25 21.53 4.57 4.68 19.76 2.41 4.33 coo -36.55 45.66 79.22 -38.34 43.94 80.53 17.41 -1.60 -1.33 16.72 0.22 -3.36 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 5 3 # 5 A 130 SER A 113 SER~? 1000.00 A 166 PHE A 70 PHE~? 1000.00 A 182 PHE A 63 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -36.62 39.62 84.60 -38.76 41.24 85.25 17.83 3.19 11.63 17.23 1.65 9.39 coo -36.55 45.66 79.22 -38.34 43.94 80.53 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 6 3 # 6 A 130 SER A 113 SER~? 1000.00 A 166 PHE A 86 PHE^? 1000.00 A 182 PHE A 63 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -36.62 39.62 84.60 -38.76 41.24 85.25 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -36.55 45.66 79.22 -38.34 43.94 80.53 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 7 3 # 7 A 130 SER A 113 SER~? 1000.00 A 166 PHE A 86 PHE^? 1000.00 A 182 PHE A 132 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -36.62 39.62 84.60 -38.76 41.24 85.25 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -36.55 45.66 79.22 -38.34 43.94 80.53 17.41 -1.60 -1.33 16.72 0.22 -3.36 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 8 3 # 8 A 130 SER A 113 SER~? 1000.00 A 166 PHE A 132 PHE^? 1000.00 A 182 PHE A 63 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -36.62 39.62 84.60 -38.76 41.24 85.25 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -36.55 45.66 79.22 -38.34 43.94 80.53 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 9 3 # 9 A 130 SER A 118 SER~? 1000.00 A 166 PHE A 63 PHE^? 1000.00 A 182 PHE A 86 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -36.62 39.62 84.60 -38.76 41.24 85.25 21.53 4.57 4.68 19.76 2.41 4.33 coo -36.55 45.66 79.22 -38.34 43.94 80.53 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 10 3 # 10 A 130 SER A 118 SER~? 1000.00 A 166 PHE A 63 PHE^? 1000.00 A 182 PHE A 111 PHE.? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -36.62 39.62 84.60 -38.76 41.24 85.25 21.53 4.57 4.68 19.76 2.41 4.33 coo -36.55 45.66 79.22 -38.34 43.94 80.53 18.47 -2.15 3.63 17.47 0.36 2.95 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 11 3 # 11 A 130 SER A 118 SER~? 1000.00 A 166 PHE A 70 PHE~? 1000.00 A 182 PHE A 86 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -36.62 39.62 84.60 -38.76 41.24 85.25 17.83 3.19 11.63 17.23 1.65 9.39 coo -36.55 45.66 79.22 -38.34 43.94 80.53 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 12 3 # 12 A 130 SER A 118 SER~? 1000.00 A 166 PHE A 70 PHE~? 1000.00 A 182 PHE A 111 PHE.? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -36.62 39.62 84.60 -38.76 41.24 85.25 17.83 3.19 11.63 17.23 1.65 9.39 coo -36.55 45.66 79.22 -38.34 43.94 80.53 18.47 -2.15 3.63 17.47 0.36 2.95 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 13 3 # 13 A 130 SER B 10 SER^? 1000.00 A 166 PHE B 132 PHE^? 1000.00 A 182 PHE B 63 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -36.62 39.62 84.60 -38.76 41.24 85.25 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -36.55 45.66 79.22 -38.34 43.94 80.53 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 14 3 # 14 A 130 SER B 10 SER^? 1000.00 A 166 PHE B 134 PHE.? 1000.00 A 182 PHE B 132 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -36.62 39.62 84.60 -38.76 41.24 85.25 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo -36.55 45.66 79.22 -38.34 43.94 80.53 31.99 -10.01 -14.45 33.93 -9.71 -12.45 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 15 3 # 15 A 130 SER B 82 SER.? 1000.00 A 166 PHE B 86 PHE^? 1000.00 A 182 PHE B 70 PHE~? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -36.62 39.62 84.60 -38.76 41.24 85.25 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -36.55 45.66 79.22 -38.34 43.94 80.53 36.11 -7.30 -27.39 35.09 -8.56 -25.12 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 16 3 # 16 A 130 SER B 82 SER.? 1000.00 A 166 PHE B 111 PHE.? 1000.00 A 182 PHE B 70 PHE~? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -36.62 39.62 84.60 -38.76 41.24 85.25 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo -36.55 45.66 79.22 -38.34 43.94 80.53 36.11 -7.30 -27.39 35.09 -8.56 -25.12 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 17 3 # 17 A 130 SER B 113 SER~? 1000.00 A 166 PHE B 63 PHE^? 1000.00 A 182 PHE B 132 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -36.55 45.66 79.22 -38.34 43.94 80.53 31.99 -10.01 -14.45 33.93 -9.71 -12.45 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 18 3 # 18 A 130 SER B 113 SER~? 1000.00 A 166 PHE B 70 PHE~? 1000.00 A 182 PHE B 63 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -36.55 45.66 79.22 -38.34 43.94 80.53 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 19 3 # 19 A 130 SER B 113 SER~? 1000.00 A 166 PHE B 86 PHE^? 1000.00 A 182 PHE B 63 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -36.55 45.66 79.22 -38.34 43.94 80.53 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 20 3 # 20 A 130 SER B 113 SER~? 1000.00 A 166 PHE B 86 PHE^? 1000.00 A 182 PHE B 132 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -36.55 45.66 79.22 -38.34 43.94 80.53 31.99 -10.01 -14.45 33.93 -9.71 -12.45 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 21 3 # 21 A 130 SER B 113 SER~? 1000.00 A 166 PHE B 132 PHE^? 1000.00 A 182 PHE B 63 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -36.55 45.66 79.22 -38.34 43.94 80.53 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 22 3 # 22 A 130 SER B 118 SER~? 1000.00 A 166 PHE B 63 PHE^? 1000.00 A 182 PHE B 86 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -36.55 45.66 79.22 -38.34 43.94 80.53 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 23 3 # 23 A 130 SER B 118 SER~? 1000.00 A 166 PHE B 63 PHE^? 1000.00 A 182 PHE B 111 PHE.? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -36.55 45.66 79.22 -38.34 43.94 80.53 31.03 -9.48 -19.35 33.73 -9.14 -18.69 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 24 3 # 24 A 130 SER B 118 SER~? 1000.00 A 166 PHE B 70 PHE~? 1000.00 A 182 PHE B 86 PHE^? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -36.55 45.66 79.22 -38.34 43.94 80.53 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o00 CARBOXYLESTERASE NP user 25 3 # 25 A 130 SER B 118 SER~? 1000.00 A 166 PHE B 70 PHE~? 1000.00 A 182 PHE B 111 PHE.? 1000.00 coo -46.28 37.24 81.97 -44.96 39.32 82.40 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -36.62 39.62 84.60 -38.76 41.24 85.25 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -36.55 45.66 79.22 -38.34 43.94 80.53 31.03 -9.48 -19.35 33.73 -9.14 -18.69 2r11_o00 source 2R11 CARBOXYLESTERASE NP : 25 hits 2r11_o00 naa= 3 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 1 3 # 1 B 130 SER A 10 SER^? 1000.00 B 166 PHE A 132 PHE^? 1000.00 B 182 PHE A 63 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -29.59 43.40 95.66 -28.22 45.54 94.50 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -32.72 50.15 98.46 -30.32 48.85 97.77 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 2 3 # 2 B 130 SER A 68 SER~? 1000.00 B 166 PHE A 63 PHE^? 1000.00 B 182 PHE A 86 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 21.92 5.71 16.86 23.60 6.97 18.06 coo -29.59 43.40 95.66 -28.22 45.54 94.50 21.53 4.57 4.68 19.76 2.41 4.33 coo -32.72 50.15 98.46 -30.32 48.85 97.77 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 3 3 # 3 B 130 SER A 82 SER.? 1000.00 B 166 PHE A 86 PHE^? 1000.00 B 182 PHE A 70 PHE~? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -29.59 43.40 95.66 -28.22 45.54 94.50 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -32.72 50.15 98.46 -30.32 48.85 97.77 17.83 3.19 11.63 17.23 1.65 9.39 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 4 3 # 4 B 130 SER A 82 SER.? 1000.00 B 166 PHE A 86 PHE^? 1000.00 B 182 PHE A 111 PHE.? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -29.59 43.40 95.66 -28.22 45.54 94.50 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -32.72 50.15 98.46 -30.32 48.85 97.77 18.47 -2.15 3.63 17.47 0.36 2.95 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 5 3 # 5 B 130 SER A 82 SER.? 1000.00 B 166 PHE A 111 PHE.? 1000.00 B 182 PHE A 70 PHE~? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -29.59 43.40 95.66 -28.22 45.54 94.50 18.47 -2.15 3.63 17.47 0.36 2.95 coo -32.72 50.15 98.46 -30.32 48.85 97.77 17.83 3.19 11.63 17.23 1.65 9.39 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 6 3 # 6 B 130 SER A 82 SER.? 1000.00 B 166 PHE A 111 PHE.? 1000.00 B 182 PHE A 86 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -29.59 43.40 95.66 -28.22 45.54 94.50 18.47 -2.15 3.63 17.47 0.36 2.95 coo -32.72 50.15 98.46 -30.32 48.85 97.77 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 7 3 # 7 B 130 SER A 113 SER~? 1000.00 B 166 PHE A 63 PHE^? 1000.00 B 182 PHE A 132 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 21.53 4.57 4.68 19.76 2.41 4.33 coo -32.72 50.15 98.46 -30.32 48.85 97.77 17.41 -1.60 -1.33 16.72 0.22 -3.36 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 8 3 # 8 B 130 SER A 113 SER~? 1000.00 B 166 PHE A 70 PHE~? 1000.00 B 182 PHE A 63 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 17.83 3.19 11.63 17.23 1.65 9.39 coo -32.72 50.15 98.46 -30.32 48.85 97.77 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 9 3 # 9 B 130 SER A 113 SER~? 1000.00 B 166 PHE A 86 PHE^? 1000.00 B 182 PHE A 63 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -32.72 50.15 98.46 -30.32 48.85 97.77 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 10 3 # 10 B 130 SER A 113 SER~? 1000.00 B 166 PHE A 86 PHE^? 1000.00 B 182 PHE A 132 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -32.72 50.15 98.46 -30.32 48.85 97.77 17.41 -1.60 -1.33 16.72 0.22 -3.36 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 11 3 # 11 B 130 SER A 113 SER~? 1000.00 B 166 PHE A 132 PHE^? 1000.00 B 182 PHE A 63 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -29.59 43.40 95.66 -28.22 45.54 94.50 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -32.72 50.15 98.46 -30.32 48.85 97.77 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 12 3 # 12 B 130 SER A 118 SER~? 1000.00 B 166 PHE A 63 PHE^? 1000.00 B 182 PHE A 86 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -29.59 43.40 95.66 -28.22 45.54 94.50 21.53 4.57 4.68 19.76 2.41 4.33 coo -32.72 50.15 98.46 -30.32 48.85 97.77 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 13 3 # 13 B 130 SER A 118 SER~? 1000.00 B 166 PHE A 63 PHE^? 1000.00 B 182 PHE A 111 PHE.? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -29.59 43.40 95.66 -28.22 45.54 94.50 21.53 4.57 4.68 19.76 2.41 4.33 coo -32.72 50.15 98.46 -30.32 48.85 97.77 18.47 -2.15 3.63 17.47 0.36 2.95 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 14 3 # 14 B 130 SER A 118 SER~? 1000.00 B 166 PHE A 70 PHE~? 1000.00 B 182 PHE A 86 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -29.59 43.40 95.66 -28.22 45.54 94.50 17.83 3.19 11.63 17.23 1.65 9.39 coo -32.72 50.15 98.46 -30.32 48.85 97.77 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 15 3 # 15 B 130 SER A 118 SER~? 1000.00 B 166 PHE A 70 PHE~? 1000.00 B 182 PHE A 111 PHE.? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -29.59 43.40 95.66 -28.22 45.54 94.50 17.83 3.19 11.63 17.23 1.65 9.39 coo -32.72 50.15 98.46 -30.32 48.85 97.77 18.47 -2.15 3.63 17.47 0.36 2.95 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 16 3 # 16 B 130 SER A 118 SER~? 1000.00 B 166 PHE A 111 PHE.? 1000.00 B 182 PHE A 86 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -29.59 43.40 95.66 -28.22 45.54 94.50 18.47 -2.15 3.63 17.47 0.36 2.95 coo -32.72 50.15 98.46 -30.32 48.85 97.77 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 17 3 # 17 B 130 SER B 10 SER^? 1000.00 B 166 PHE B 132 PHE^? 1000.00 B 182 PHE B 63 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -29.59 43.40 95.66 -28.22 45.54 94.50 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -32.72 50.15 98.46 -30.32 48.85 97.77 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 18 3 # 18 B 130 SER B 82 SER.? 1000.00 B 166 PHE B 86 PHE^? 1000.00 B 182 PHE B 70 PHE~? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -29.59 43.40 95.66 -28.22 45.54 94.50 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -32.72 50.15 98.46 -30.32 48.85 97.77 36.11 -7.30 -27.39 35.09 -8.56 -25.12 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 19 3 # 19 B 130 SER B 82 SER.? 1000.00 B 166 PHE B 86 PHE^? 1000.00 B 182 PHE B 111 PHE.? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -29.59 43.40 95.66 -28.22 45.54 94.50 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -32.72 50.15 98.46 -30.32 48.85 97.77 31.03 -9.48 -19.35 33.73 -9.14 -18.69 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 20 3 # 20 B 130 SER B 82 SER.? 1000.00 B 166 PHE B 111 PHE.? 1000.00 B 182 PHE B 70 PHE~? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -29.59 43.40 95.66 -28.22 45.54 94.50 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo -32.72 50.15 98.46 -30.32 48.85 97.77 36.11 -7.30 -27.39 35.09 -8.56 -25.12 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 21 3 # 21 B 130 SER B 82 SER.? 1000.00 B 166 PHE B 111 PHE.? 1000.00 B 182 PHE B 86 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -29.59 43.40 95.66 -28.22 45.54 94.50 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo -32.72 50.15 98.46 -30.32 48.85 97.77 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 22 3 # 22 B 130 SER B 113 SER~? 1000.00 B 166 PHE B 63 PHE^? 1000.00 B 182 PHE B 132 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -32.72 50.15 98.46 -30.32 48.85 97.77 31.99 -10.01 -14.45 33.93 -9.71 -12.45 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 23 3 # 23 B 130 SER B 113 SER~? 1000.00 B 166 PHE B 70 PHE~? 1000.00 B 182 PHE B 63 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -32.72 50.15 98.46 -30.32 48.85 97.77 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 24 3 # 24 B 130 SER B 113 SER~? 1000.00 B 166 PHE B 86 PHE^? 1000.00 B 182 PHE B 63 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -32.72 50.15 98.46 -30.32 48.85 97.77 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 25 3 # 25 B 130 SER B 113 SER~? 1000.00 B 166 PHE B 86 PHE^? 1000.00 B 182 PHE B 132 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -32.72 50.15 98.46 -30.32 48.85 97.77 31.99 -10.01 -14.45 33.93 -9.71 -12.45 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 26 3 # 26 B 130 SER B 113 SER~? 1000.00 B 166 PHE B 132 PHE^? 1000.00 B 182 PHE B 63 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -32.72 50.15 98.46 -30.32 48.85 97.77 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 27 3 # 27 B 130 SER B 118 SER~? 1000.00 B 166 PHE B 63 PHE^? 1000.00 B 182 PHE B 86 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -32.72 50.15 98.46 -30.32 48.85 97.77 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 28 3 # 28 B 130 SER B 118 SER~? 1000.00 B 166 PHE B 63 PHE^? 1000.00 B 182 PHE B 111 PHE.? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -32.72 50.15 98.46 -30.32 48.85 97.77 31.03 -9.48 -19.35 33.73 -9.14 -18.69 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 29 3 # 29 B 130 SER B 118 SER~? 1000.00 B 166 PHE B 70 PHE~? 1000.00 B 182 PHE B 86 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -32.72 50.15 98.46 -30.32 48.85 97.77 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 30 3 # 30 B 130 SER B 118 SER~? 1000.00 B 166 PHE B 70 PHE~? 1000.00 B 182 PHE B 111 PHE.? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -32.72 50.15 98.46 -30.32 48.85 97.77 31.03 -9.48 -19.35 33.73 -9.14 -18.69 ULMN 3 2r11_o01 CARBOXYLESTERASE NP user 31 3 # 31 B 130 SER B 118 SER~? 1000.00 B 166 PHE B 111 PHE.? 1000.00 B 182 PHE B 86 PHE^? 1000.00 coo -19.94 46.29 97.83 -22.38 46.56 97.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -29.59 43.40 95.66 -28.22 45.54 94.50 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo -32.72 50.15 98.46 -30.32 48.85 97.77 35.17 -13.16 -21.77 32.82 -12.25 -23.01 2r11_o01 source 2R11 CARBOXYLESTERASE NP : 31 hits 2r11_o01 naa= 3 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 1 3 # 1 C 130 SER A 10 SER^? 1000.00 C 166 PHE A 132 PHE^? 1000.00 C 182 PHE A 63 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -11.14 61.91 46.89 -9.88 60.30 48.76 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -7.71 55.92 42.70 -7.18 57.60 44.85 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 2 3 # 2 C 130 SER A 10 SER^? 1000.00 C 166 PHE A 134 PHE.? 1000.00 C 182 PHE A 132 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -11.14 61.91 46.89 -9.88 60.30 48.76 12.27 -2.34 -5.10 12.90 -2.28 -7.81 coo -7.71 55.92 42.70 -7.18 57.60 44.85 17.41 -1.60 -1.33 16.72 0.22 -3.36 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 3 3 # 3 C 130 SER A 82 SER.? 1000.00 C 166 PHE A 86 PHE^? 1000.00 C 182 PHE A 70 PHE~? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -11.14 61.91 46.89 -9.88 60.30 48.76 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -7.71 55.92 42.70 -7.18 57.60 44.85 17.83 3.19 11.63 17.23 1.65 9.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 4 3 # 4 C 130 SER A 82 SER.? 1000.00 C 166 PHE A 111 PHE.? 1000.00 C 182 PHE A 70 PHE~? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -11.14 61.91 46.89 -9.88 60.30 48.76 18.47 -2.15 3.63 17.47 0.36 2.95 coo -7.71 55.92 42.70 -7.18 57.60 44.85 17.83 3.19 11.63 17.23 1.65 9.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 5 3 # 5 C 130 SER A 113 SER~? 1000.00 C 166 PHE A 63 PHE^? 1000.00 C 182 PHE A 132 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 21.53 4.57 4.68 19.76 2.41 4.33 coo -7.71 55.92 42.70 -7.18 57.60 44.85 17.41 -1.60 -1.33 16.72 0.22 -3.36 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 6 3 # 6 C 130 SER A 113 SER~? 1000.00 C 166 PHE A 70 PHE~? 1000.00 C 182 PHE A 63 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 17.83 3.19 11.63 17.23 1.65 9.39 coo -7.71 55.92 42.70 -7.18 57.60 44.85 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 7 3 # 7 C 130 SER A 113 SER~? 1000.00 C 166 PHE A 86 PHE^? 1000.00 C 182 PHE A 63 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -7.71 55.92 42.70 -7.18 57.60 44.85 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 8 3 # 8 C 130 SER A 113 SER~? 1000.00 C 166 PHE A 86 PHE^? 1000.00 C 182 PHE A 132 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -7.71 55.92 42.70 -7.18 57.60 44.85 17.41 -1.60 -1.33 16.72 0.22 -3.36 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 9 3 # 9 C 130 SER A 113 SER~? 1000.00 C 166 PHE A 132 PHE^? 1000.00 C 182 PHE A 63 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -11.14 61.91 46.89 -9.88 60.30 48.76 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -7.71 55.92 42.70 -7.18 57.60 44.85 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 10 3 # 10 C 130 SER A 118 SER~? 1000.00 C 166 PHE A 63 PHE^? 1000.00 C 182 PHE A 70 PHE~? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -11.14 61.91 46.89 -9.88 60.30 48.76 21.53 4.57 4.68 19.76 2.41 4.33 coo -7.71 55.92 42.70 -7.18 57.60 44.85 17.83 3.19 11.63 17.23 1.65 9.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 11 3 # 11 C 130 SER A 118 SER~? 1000.00 C 166 PHE A 63 PHE^? 1000.00 C 182 PHE A 111 PHE.? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -11.14 61.91 46.89 -9.88 60.30 48.76 21.53 4.57 4.68 19.76 2.41 4.33 coo -7.71 55.92 42.70 -7.18 57.60 44.85 18.47 -2.15 3.63 17.47 0.36 2.95 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 12 3 # 12 C 130 SER A 118 SER~? 1000.00 C 166 PHE A 70 PHE~? 1000.00 C 182 PHE A 111 PHE.? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -11.14 61.91 46.89 -9.88 60.30 48.76 17.83 3.19 11.63 17.23 1.65 9.39 coo -7.71 55.92 42.70 -7.18 57.60 44.85 18.47 -2.15 3.63 17.47 0.36 2.95 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 13 3 # 13 C 130 SER A 118 SER~? 1000.00 C 166 PHE A 111 PHE.? 1000.00 C 182 PHE A 70 PHE~? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -11.14 61.91 46.89 -9.88 60.30 48.76 18.47 -2.15 3.63 17.47 0.36 2.95 coo -7.71 55.92 42.70 -7.18 57.60 44.85 17.83 3.19 11.63 17.23 1.65 9.39 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 14 3 # 14 C 130 SER B 10 SER^? 1000.00 C 166 PHE B 132 PHE^? 1000.00 C 182 PHE B 63 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -11.14 61.91 46.89 -9.88 60.30 48.76 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -7.71 55.92 42.70 -7.18 57.60 44.85 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 15 3 # 15 C 130 SER B 10 SER^? 1000.00 C 166 PHE B 134 PHE.? 1000.00 C 182 PHE B 132 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -11.14 61.91 46.89 -9.88 60.30 48.76 33.96 -14.84 -10.61 33.63 -14.28 -7.91 coo -7.71 55.92 42.70 -7.18 57.60 44.85 31.99 -10.01 -14.45 33.93 -9.71 -12.45 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 16 3 # 16 C 130 SER B 82 SER.? 1000.00 C 166 PHE B 86 PHE^? 1000.00 C 182 PHE B 70 PHE~? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -11.14 61.91 46.89 -9.88 60.30 48.76 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -7.71 55.92 42.70 -7.18 57.60 44.85 36.11 -7.30 -27.39 35.09 -8.56 -25.12 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 17 3 # 17 C 130 SER B 82 SER.? 1000.00 C 166 PHE B 111 PHE.? 1000.00 C 182 PHE B 70 PHE~? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -11.14 61.91 46.89 -9.88 60.30 48.76 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo -7.71 55.92 42.70 -7.18 57.60 44.85 36.11 -7.30 -27.39 35.09 -8.56 -25.12 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 18 3 # 18 C 130 SER B 113 SER~? 1000.00 C 166 PHE B 63 PHE^? 1000.00 C 182 PHE B 132 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -7.71 55.92 42.70 -7.18 57.60 44.85 31.99 -10.01 -14.45 33.93 -9.71 -12.45 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 19 3 # 19 C 130 SER B 113 SER~? 1000.00 C 166 PHE B 70 PHE~? 1000.00 C 182 PHE B 63 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -7.71 55.92 42.70 -7.18 57.60 44.85 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 20 3 # 20 C 130 SER B 113 SER~? 1000.00 C 166 PHE B 86 PHE^? 1000.00 C 182 PHE B 63 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -7.71 55.92 42.70 -7.18 57.60 44.85 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 21 3 # 21 C 130 SER B 113 SER~? 1000.00 C 166 PHE B 86 PHE^? 1000.00 C 182 PHE B 132 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -7.71 55.92 42.70 -7.18 57.60 44.85 31.99 -10.01 -14.45 33.93 -9.71 -12.45 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 22 3 # 22 C 130 SER B 113 SER~? 1000.00 C 166 PHE B 132 PHE^? 1000.00 C 182 PHE B 63 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -7.71 55.92 42.70 -7.18 57.60 44.85 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 23 3 # 23 C 130 SER B 118 SER~? 1000.00 C 166 PHE B 63 PHE^? 1000.00 C 182 PHE B 70 PHE~? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -7.71 55.92 42.70 -7.18 57.60 44.85 36.11 -7.30 -27.39 35.09 -8.56 -25.12 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 24 3 # 24 C 130 SER B 118 SER~? 1000.00 C 166 PHE B 63 PHE^? 1000.00 C 182 PHE B 86 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -7.71 55.92 42.70 -7.18 57.60 44.85 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 25 3 # 25 C 130 SER B 118 SER~? 1000.00 C 166 PHE B 63 PHE^? 1000.00 C 182 PHE B 111 PHE.? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -7.71 55.92 42.70 -7.18 57.60 44.85 31.03 -9.48 -19.35 33.73 -9.14 -18.69 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 26 3 # 26 C 130 SER B 118 SER~? 1000.00 C 166 PHE B 70 PHE~? 1000.00 C 182 PHE B 86 PHE^? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -7.71 55.92 42.70 -7.18 57.60 44.85 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 27 3 # 27 C 130 SER B 118 SER~? 1000.00 C 166 PHE B 70 PHE~? 1000.00 C 182 PHE B 111 PHE.? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -7.71 55.92 42.70 -7.18 57.60 44.85 31.03 -9.48 -19.35 33.73 -9.14 -18.69 ULMN 3 2r11_o02 CARBOXYLESTERASE NP user 28 3 # 28 C 130 SER B 118 SER~? 1000.00 C 166 PHE B 111 PHE.? 1000.00 C 182 PHE B 70 PHE~? 1000.00 coo -2.19 64.27 51.12 -3.34 62.10 50.60 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -11.14 61.91 46.89 -9.88 60.30 48.76 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo -7.71 55.92 42.70 -7.18 57.60 44.85 36.11 -7.30 -27.39 35.09 -8.56 -25.12 2r11_o02 source 2R11 CARBOXYLESTERASE NP : 28 hits 2r11_o02 naa= 3 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 1 3 # 1 D 130 SER A 10 SER^? 1000.00 D 166 PHE A 132 PHE^? 1000.00 D 182 PHE A 63 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 17.14 6.15 -9.35 18.92 7.63 -9.94 coo -23.62 58.20 50.84 -23.76 56.14 48.96 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -23.08 51.44 54.96 -24.43 52.71 52.88 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 2 3 # 2 D 130 SER A 68 SER~? 1000.00 D 166 PHE A 63 PHE^? 1000.00 D 182 PHE A 86 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 21.92 5.71 16.86 23.60 6.97 18.06 coo -23.62 58.20 50.84 -23.76 56.14 48.96 21.53 4.57 4.68 19.76 2.41 4.33 coo -23.08 51.44 54.96 -24.43 52.71 52.88 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 3 3 # 3 D 130 SER A 82 SER.? 1000.00 D 166 PHE A 86 PHE^? 1000.00 D 182 PHE A 70 PHE~? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -23.62 58.20 50.84 -23.76 56.14 48.96 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -23.08 51.44 54.96 -24.43 52.71 52.88 17.83 3.19 11.63 17.23 1.65 9.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 4 3 # 4 D 130 SER A 82 SER.? 1000.00 D 166 PHE A 86 PHE^? 1000.00 D 182 PHE A 111 PHE.? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -23.62 58.20 50.84 -23.76 56.14 48.96 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -23.08 51.44 54.96 -24.43 52.71 52.88 18.47 -2.15 3.63 17.47 0.36 2.95 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 5 3 # 5 D 130 SER A 82 SER.? 1000.00 D 166 PHE A 111 PHE.? 1000.00 D 182 PHE A 70 PHE~? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -23.62 58.20 50.84 -23.76 56.14 48.96 18.47 -2.15 3.63 17.47 0.36 2.95 coo -23.08 51.44 54.96 -24.43 52.71 52.88 17.83 3.19 11.63 17.23 1.65 9.39 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 6 3 # 6 D 130 SER A 82 SER.? 1000.00 D 166 PHE A 111 PHE.? 1000.00 D 182 PHE A 86 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 14.52 -10.91 10.84 12.40 -12.06 11.06 coo -23.62 58.20 50.84 -23.76 56.14 48.96 18.47 -2.15 3.63 17.47 0.36 2.95 coo -23.08 51.44 54.96 -24.43 52.71 52.88 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 7 3 # 7 D 130 SER A 113 SER~? 1000.00 D 166 PHE A 63 PHE^? 1000.00 D 182 PHE A 132 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 21.53 4.57 4.68 19.76 2.41 4.33 coo -23.08 51.44 54.96 -24.43 52.71 52.88 17.41 -1.60 -1.33 16.72 0.22 -3.36 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 8 3 # 8 D 130 SER A 113 SER~? 1000.00 D 166 PHE A 70 PHE~? 1000.00 D 182 PHE A 63 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 17.83 3.19 11.63 17.23 1.65 9.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 9 3 # 9 D 130 SER A 113 SER~? 1000.00 D 166 PHE A 86 PHE^? 1000.00 D 182 PHE A 63 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -23.08 51.44 54.96 -24.43 52.71 52.88 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 10 3 # 10 D 130 SER A 113 SER~? 1000.00 D 166 PHE A 86 PHE^? 1000.00 D 182 PHE A 132 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 13.17 -0.51 5.96 15.04 -2.13 7.30 coo -23.08 51.44 54.96 -24.43 52.71 52.88 17.41 -1.60 -1.33 16.72 0.22 -3.36 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 11 3 # 11 D 130 SER A 113 SER~? 1000.00 D 166 PHE A 132 PHE^? 1000.00 D 182 PHE A 63 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 19.73 -5.92 9.27 17.80 -7.10 10.12 coo -23.62 58.20 50.84 -23.76 56.14 48.96 17.41 -1.60 -1.33 16.72 0.22 -3.36 coo -23.08 51.44 54.96 -24.43 52.71 52.88 21.53 4.57 4.68 19.76 2.41 4.33 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 12 3 # 12 D 130 SER A 118 SER~? 1000.00 D 166 PHE A 63 PHE^? 1000.00 D 182 PHE A 86 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -23.62 58.20 50.84 -23.76 56.14 48.96 21.53 4.57 4.68 19.76 2.41 4.33 coo -23.08 51.44 54.96 -24.43 52.71 52.88 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 13 3 # 13 D 130 SER A 118 SER~? 1000.00 D 166 PHE A 63 PHE^? 1000.00 D 182 PHE A 111 PHE.? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -23.62 58.20 50.84 -23.76 56.14 48.96 21.53 4.57 4.68 19.76 2.41 4.33 coo -23.08 51.44 54.96 -24.43 52.71 52.88 18.47 -2.15 3.63 17.47 0.36 2.95 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 14 3 # 14 D 130 SER A 118 SER~? 1000.00 D 166 PHE A 70 PHE~? 1000.00 D 182 PHE A 86 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -23.62 58.20 50.84 -23.76 56.14 48.96 17.83 3.19 11.63 17.23 1.65 9.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 15 3 # 15 D 130 SER A 118 SER~? 1000.00 D 166 PHE A 70 PHE~? 1000.00 D 182 PHE A 111 PHE.? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -23.62 58.20 50.84 -23.76 56.14 48.96 17.83 3.19 11.63 17.23 1.65 9.39 coo -23.08 51.44 54.96 -24.43 52.71 52.88 18.47 -2.15 3.63 17.47 0.36 2.95 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 16 3 # 16 D 130 SER A 118 SER~? 1000.00 D 166 PHE A 111 PHE.? 1000.00 D 182 PHE A 86 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.48 -2.22 10.64 29.08 -2.90 8.91 coo -23.62 58.20 50.84 -23.76 56.14 48.96 18.47 -2.15 3.63 17.47 0.36 2.95 coo -23.08 51.44 54.96 -24.43 52.71 52.88 13.17 -0.51 5.96 15.04 -2.13 7.30 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 17 3 # 17 D 130 SER B 10 SER^? 1000.00 D 166 PHE B 132 PHE^? 1000.00 D 182 PHE B 63 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 38.89 -6.40 -6.36 39.24 -4.20 -5.54 coo -23.62 58.20 50.84 -23.76 56.14 48.96 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -23.08 51.44 54.96 -24.43 52.71 52.88 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 18 3 # 18 D 130 SER B 68 SER~? 1000.00 D 166 PHE B 63 PHE^? 1000.00 D 182 PHE B 86 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 36.21 -2.51 -32.63 36.55 -0.43 -33.82 coo -23.62 58.20 50.84 -23.76 56.14 48.96 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -23.08 51.44 54.96 -24.43 52.71 52.88 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 19 3 # 19 D 130 SER B 82 SER.? 1000.00 D 166 PHE B 86 PHE^? 1000.00 D 182 PHE B 70 PHE~? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -23.62 58.20 50.84 -23.76 56.14 48.96 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -23.08 51.44 54.96 -24.43 52.71 52.88 36.11 -7.30 -27.39 35.09 -8.56 -25.12 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 20 3 # 20 D 130 SER B 82 SER.? 1000.00 D 166 PHE B 86 PHE^? 1000.00 D 182 PHE B 111 PHE.? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -23.62 58.20 50.84 -23.76 56.14 48.96 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -23.08 51.44 54.96 -24.43 52.71 52.88 31.03 -9.48 -19.35 33.73 -9.14 -18.69 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 21 3 # 21 D 130 SER B 82 SER.? 1000.00 D 166 PHE B 111 PHE.? 1000.00 D 182 PHE B 70 PHE~? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -23.62 58.20 50.84 -23.76 56.14 48.96 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo -23.08 51.44 54.96 -24.43 52.71 52.88 36.11 -7.30 -27.39 35.09 -8.56 -25.12 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 22 3 # 22 D 130 SER B 82 SER.? 1000.00 D 166 PHE B 111 PHE.? 1000.00 D 182 PHE B 86 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 25.44 -17.19 -26.64 25.54 -19.61 -26.84 coo -23.62 58.20 50.84 -23.76 56.14 48.96 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo -23.08 51.44 54.96 -24.43 52.71 52.88 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 23 3 # 23 D 130 SER B 113 SER~? 1000.00 D 166 PHE B 63 PHE^? 1000.00 D 182 PHE B 132 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -23.08 51.44 54.96 -24.43 52.71 52.88 31.99 -10.01 -14.45 33.93 -9.71 -12.45 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 24 3 # 24 D 130 SER B 113 SER~? 1000.00 D 166 PHE B 70 PHE~? 1000.00 D 182 PHE B 63 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -23.08 51.44 54.96 -24.43 52.71 52.88 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 25 3 # 25 D 130 SER B 113 SER~? 1000.00 D 166 PHE B 86 PHE^? 1000.00 D 182 PHE B 63 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -23.08 51.44 54.96 -24.43 52.71 52.88 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 26 3 # 26 D 130 SER B 113 SER~? 1000.00 D 166 PHE B 86 PHE^? 1000.00 D 182 PHE B 132 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 35.17 -13.16 -21.77 32.82 -12.25 -23.01 coo -23.08 51.44 54.96 -24.43 52.71 52.88 31.99 -10.01 -14.45 33.93 -9.71 -12.45 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 27 3 # 27 D 130 SER B 113 SER~? 1000.00 D 166 PHE B 132 PHE^? 1000.00 D 182 PHE B 63 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 27.27 -10.19 -25.06 27.18 -12.46 -25.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 31.99 -10.01 -14.45 33.93 -9.71 -12.45 coo -23.08 51.44 54.96 -24.43 52.71 52.88 35.40 -3.42 -20.35 34.41 -6.03 -20.07 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 28 3 # 28 D 130 SER B 118 SER~? 1000.00 D 166 PHE B 63 PHE^? 1000.00 D 182 PHE B 86 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -23.08 51.44 54.96 -24.43 52.71 52.88 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 29 3 # 29 D 130 SER B 118 SER~? 1000.00 D 166 PHE B 63 PHE^? 1000.00 D 182 PHE B 111 PHE.? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 35.40 -3.42 -20.35 34.41 -6.03 -20.07 coo -23.08 51.44 54.96 -24.43 52.71 52.88 31.03 -9.48 -19.35 33.73 -9.14 -18.69 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 30 3 # 30 D 130 SER B 118 SER~? 1000.00 D 166 PHE B 70 PHE~? 1000.00 D 182 PHE B 86 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -23.08 51.44 54.96 -24.43 52.71 52.88 35.17 -13.16 -21.77 32.82 -12.25 -23.01 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 31 3 # 31 D 130 SER B 118 SER~? 1000.00 D 166 PHE B 70 PHE~? 1000.00 D 182 PHE B 111 PHE.? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 36.11 -7.30 -27.39 35.09 -8.56 -25.12 coo -23.08 51.44 54.96 -24.43 52.71 52.88 31.03 -9.48 -19.35 33.73 -9.14 -18.69 ULMN 3 2r11_o03 CARBOXYLESTERASE NP user 32 3 # 32 D 130 SER B 118 SER~? 1000.00 D 166 PHE B 111 PHE.? 1000.00 D 182 PHE B 86 PHE^? 1000.00 coo -32.42 55.27 46.18 -30.51 54.94 47.67 26.57 -1.65 -26.41 25.09 -0.55 -24.80 coo -23.62 58.20 50.84 -23.76 56.14 48.96 31.03 -9.48 -19.35 33.73 -9.14 -18.69 coo -23.08 51.44 54.96 -24.43 52.71 52.88 35.17 -13.16 -21.77 32.82 -12.25 -23.01 2r11_o03 source 2R11 CARBOXYLESTERASE NP : 32 hits 2r11_o03 naa= 3 ULMN 3 3hde_o00 LYSOZYME user 1 3 # 1 A 35 GLU A 102 GLU.? 1000.00 A 44 ASP A 138 ASP^? 1000.00 A 50 THR A 105 THR^? 1000.00 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 6.41 12.98 -11.22 7.03 11.90 -12.90 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 8.35 5.19 -3.50 6.23 5.38 -3.24 ULMN 3 3hde_o00 LYSOZYME user 2 3 # 2 A 35 GLU A 141 GLU.? 1000.00 A 44 ASP A 138 ASP^? 1000.00 A 50 THR A 105 THR^? 1000.00 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 3.43 12.79 -4.88 2.72 12.95 -2.84 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 8.35 5.19 -3.50 6.23 5.38 -3.24 ULMN 3 3hde_o00 LYSOZYME user 3 3 # 3 A 35 GLU B 102 GLU.? 1000.00 A 44 ASP B 138 ASP^? 1000.00 A 50 THR B 105 THR^? 1000.00 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 42.53 -14.52 -12.26 43.67 -16.31 -12.51 ULMN 3 3hde_o00 LYSOZYME user 4 3 # 4 A 35 GLU B 141 GLU.? 1000.00 A 44 ASP B 138 ASP^? 1000.00 A 50 THR B 105 THR^? 1000.00 coo 3.19 -22.62 -21.80 4.26 -21.93 -23.46 51.50 -14.92 -10.75 52.03 -15.46 -12.75 coo -3.28 -18.53 -28.91 -2.33 -19.01 -30.75 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -4.91 -24.14 -27.53 -3.37 -22.71 -27.06 42.53 -14.52 -12.26 43.67 -16.31 -12.51 3hde_o00 source 3HDE LYSOZYME : 4 hits 3hde_o00 naa= 3 ULMN 3 3hde_o01 LYSOZYME user 1 3 # 1 B 35 GLU A 39 GLU.? 1000.00 B 44 ASP A 136 ASP^? 1000.00 B 50 THR A 53 THR.? 1000.00 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 1.63 -5.35 -8.41 0.42 -5.39 -6.59 ULMN 3 3hde_o01 LYSOZYME user 2 3 # 2 B 35 GLU A 102 GLU.? 1000.00 B 44 ASP A 138 ASP^? 1000.00 B 50 THR A 105 THR^? 1000.00 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 6.41 12.98 -11.22 7.03 11.90 -12.90 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 8.35 5.19 -3.50 6.23 5.38 -3.24 ULMN 3 3hde_o01 LYSOZYME user 3 3 # 3 B 35 GLU A 135 GLU.? 1000.00 B 44 ASP A 138 ASP^? 1000.00 B 50 THR A 105 THR^? 1000.00 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 8.47 -7.85 -2.75 10.54 -8.23 -2.60 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 4.80 3.61 -6.72 2.93 4.41 -7.21 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 8.35 5.19 -3.50 6.23 5.38 -3.24 ULMN 3 3hde_o01 LYSOZYME user 4 3 # 4 B 35 GLU B 39 GLU.? 1000.00 B 44 ASP B 136 ASP^? 1000.00 B 50 THR B 53 THR.? 1000.00 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 32.13 -23.52 1.49 32.40 -25.50 0.81 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 36.67 -25.61 -7.31 37.21 -26.66 -9.14 ULMN 3 3hde_o01 LYSOZYME user 5 3 # 5 B 35 GLU B 102 GLU.? 1000.00 B 44 ASP B 138 ASP^? 1000.00 B 50 THR B 105 THR^? 1000.00 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 42.53 -14.52 -12.26 43.67 -16.31 -12.51 ULMN 3 3hde_o01 LYSOZYME user 6 3 # 6 B 35 GLU B 102 GLU.? 1000.00 B 44 ASP B 145 ASP.? 1000.00 B 50 THR B 146 THR.? 1000.00 coo -10.34 -10.51 -29.93 -8.23 -10.47 -29.91 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo -0.99 -14.50 -23.89 0.18 -12.74 -23.86 60.34 -11.56 -8.26 58.87 -12.82 -9.07 coo -5.24 -12.06 -20.18 -4.96 -12.24 -22.31 62.22 -8.02 -5.96 64.20 -8.94 -6.02 3hde_o01 source 3HDE LYSOZYME : 6 hits 3hde_o01 naa= 3 ULMN 3 3hde_o02 LYSOZYME user 1 3 # 1 C 35 GLU A 39 GLU.? 1000.00 C 44 ASP A 136 ASP^? 1000.00 C 50 THR A 53 THR.? 1000.00 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 5.68 -8.26 -17.17 3.79 -8.95 -16.50 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 5.83 -2.85 -5.60 4.65 -1.90 -7.06 coo 25.48 4.87 1.60 23.90 4.95 0.15 1.63 -5.35 -8.41 0.42 -5.39 -6.59 ULMN 3 3hde_o02 LYSOZYME user 2 3 # 2 C 35 GLU A 102 GLU.? 1000.00 C 44 ASP A 138 ASP^? 1000.00 C 50 THR A 105 THR^? 1000.00 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 6.41 12.98 -11.22 7.03 11.90 -12.90 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 4.80 3.61 -6.72 2.93 4.41 -7.21 coo 25.48 4.87 1.60 23.90 4.95 0.15 8.35 5.19 -3.50 6.23 5.38 -3.24 ULMN 3 3hde_o02 LYSOZYME user 3 3 # 3 C 35 GLU B 39 GLU.? 1000.00 C 44 ASP B 136 ASP^? 1000.00 C 50 THR B 53 THR.? 1000.00 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 32.13 -23.52 1.49 32.40 -25.50 0.81 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 36.67 -20.70 -10.25 38.13 -21.34 -8.89 coo 25.48 4.87 1.60 23.90 4.95 0.15 36.67 -25.61 -7.31 37.21 -26.66 -9.14 ULMN 3 3hde_o02 LYSOZYME user 4 3 # 4 C 35 GLU B 102 GLU.? 1000.00 C 44 ASP B 138 ASP^? 1000.00 C 50 THR B 105 THR^? 1000.00 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 42.87 -18.30 -9.07 44.47 -19.54 -8.54 coo 25.48 4.87 1.60 23.90 4.95 0.15 42.53 -14.52 -12.26 43.67 -16.31 -12.51 ULMN 3 3hde_o02 LYSOZYME user 5 3 # 5 C 35 GLU B 102 GLU.? 1000.00 C 44 ASP B 145 ASP.? 1000.00 C 50 THR B 146 THR.? 1000.00 coo 15.89 -0.52 0.58 15.91 1.38 -0.35 50.20 -12.24 -4.38 48.92 -12.28 -2.69 coo 24.21 6.79 -4.52 23.75 8.67 -3.70 60.34 -11.56 -8.26 58.87 -12.82 -9.07 coo 25.48 4.87 1.60 23.90 4.95 0.15 62.22 -8.02 -5.96 64.20 -8.94 -6.02 3hde_o02 source 3HDE LYSOZYME : 5 hits 3hde_o02 naa= 3